| Package | who.ddcc |
| Type | CodeSystem |
| Id | WHODDCCsnomed |
| FHIR Version | R4 |
| Source | http://smart.who.int/ddcc/https://build.fhir.org/ig/WorldHealthOrganization/ddcc/CodeSystem-WHODDCCsnomed.html |
| URL | http://snomed.info/sct |
| Version | 1.0.0 |
| Status | draft |
| Date | 2025-06-24T09:07:32+00:00 |
| Name | WHODDCCsnomed |
| Title | SNOMED codes used in this IG |
| Realm | uv |
| Authority | who |
| Description | All SNOMED codes from `http://snomed.info/sct` used in this IG. Provided so the FHIR server can perform expansions. |
| Content | complete |
| CodeSystem | |
| HealthChecksSCTSupplement | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
| supplement | SNOMED CT Code System Supplement |
| translationEvidence | Übersetzung Symptom und Manifestation |
| mii-cs-diagnose-lebensphase-supplement-snomed | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
| snomed-pce-supplement | SNOMED Supplement CodeSystem |
| StructureDefinition | |
| MedicationRequest | MedicationRequest |
| CareConnect-ACVPU-Observation-1 | CareConnect-ACVPU-Observation-1 |
| CareConnect-ITK-DM-ApplianceUseReview-Composition-1 | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 |
| CareConnect-ITK-DM-DMIRS-Composition-1 | CareConnect-ITK-DM-DMIRS-Composition-1 |
| CareConnect-ITK-DM-EmergencySupply-Composition-1 | CareConnect-ITK-DM-EmergencySupply-Composition-1 |
| CareConnect-ITK-DM-Immunization-Composition-1 | CareConnect-ITK-DM-Immunization-Composition-1 |
| CareConnect-ITK-DM-MedicationReview-Composition-1 | CareConnect-ITK-DM-MedicationReview-Composition-1 |
| CareConnect-ITK-DM-NewMedicineService-Composition-1 | CareConnect-ITK-DM-NewMedicineService-Composition-1 |
| CareConnect-ITK-ECD-Composition-1 | Electronic Discharge Composition |
| CareConnect-ITK-EDIS-Composition-1 | Electronic Discharge Composition |
| CareConnect-ITK-MH-Composition-1 | Mental Health Electronic Discharge Composition |
| CareConnect-ITK-OPL-Composition-1 | Outpatient Letter Composition |
| CareConnect-NEWS2-Observation-1 | CareConnect-NEWS2-Observation-1 |
| NDOP-Consent-1 | NDOP-Consent-1.xml |
| eRS-ServiceSearchCriteria-Parameters-1 | eRS-ServiceSearchCriteria-Parameters-1 |
| CaseComposition | Fall |
| patient-adoptionInfo | Patient Adoption Info |
| ca-on-accdr-profile-AllergyIntolerance | AllergyIntolerance Profile |
| MedicationRequest | MedicationRequest |
| MedicationRequest_Profile | MedicationRequest_Profile |
| OutbreakComposition | OutbreakComposition |
| ValueSet | |
| VRM-PregnancyOutcomes-vs | Pregnancy Outcome Values |
| ProblemDiseaseCourseVS | Condition Disease Course Value Set |
| riap-caracteristicas-margen-quirurgico-VS | Set de Valores de Caracteristicas del Margen Quirurgico |
| riap-categorias-pTNM-VS | Set de Valores para Categorias pTNM |
| riap-estructuras-anatomincas-VS | Set de Valores Para los Sitios del Cuerpo |
| riap-invasion-linfatica-VS | Set de Valores para Invasión Linfática y Vascular |
| riap-metodos-medicion-VS | Set de Valores de los Metodos de Medición del Tumor |
| riap-morfologico-VS | Set de Valores de Snomed CT para Anomalías Morfológica |
| riap-observaciones-biopsia-VS | Set de Valores para Observaciones Biopsia |
| riap-procedimientos-biopsias-VS | Set de Valores Para Procedimientos |
| riap-reporte-biopsia-vs | Set de Valores de los Reportes de Biopsia |
| riap-respuestas-infiltracion-perineural-vs | Set de Valores Para Hallazgos de Infiltración Perineural |
| riap-respuestas-infiltracion-peritumoral-vs | Set de Valores Para Hallazgos de Infiltración Peritumoral |
| riap-snomed-hallazgos-clinicos-VS | ValueSet de Snomed CT para Hallazgos Clínicos con Mapeo a CIE-10 |
| riap-tipo-especimen-vs | Set de Valores de los Tipos de Especimen |
| riap-tipo-procedimientos-biopsias-VS | Set de Valores Para Tipo de Procedimientos |
| riap-tnm-categoria-metastasis-distante-patologico-vs | Set de Valores Categoría TNM Patológico Metastásico Distante |
| riap-tnm-categoria-nodo-regional-patologico-vs | Set de Valores Categoría TNM Patológico Nodos Regional |
| riap-tnm-categoria-tumor-primario-patologico-vs | Set de Valores Categoría TNM Patológico Tumor Primario |
| riap-topografica-VS | Set de Valores de Snomed CT para Topografía |
| radiology-referral | RANZCR Radiology Referral |
| goal-barrier-codes | Goal Barrier Assessment Codes |
| pco-goal-barrier-types-example-vs | Goal Barrier Types Example |
| what-matters-codes-example | What Matters Codes Example |
| laterality-uv-lab | Body Structure Laterality |
| siteQualifier-uv-lab | Body Structure Qualifier |
| specialty-uv-lab | Laboratory Specialty |
| speciesType-uv-lab | Types of species |
| specimenAdditive-uv-lab | Specimen Additive |
| specimenContainer-uv-lab | Specimen Container |
| specimenType-uv-lab | Specimen Types |
| technique-uv-lab | Laboratory Techniques |
| AidToVisionCodes | Aid to Vision Codes |
| DiagnosticAssessmentEyeTestCodes | Diagnostic Assessment Eye Test Value Set |
| EyecareTargetSiteCodes | Eyecare Target Site Codes |
| PosteriorSegmentObservationCodes | Posterior Segment Observation Codes |
| PosteriorSegmentOrganizerCodes | Posterior Segment Organizer Codes |
| RefractionMethodCodes | Refraction Method Codes |
| RefractionObservationCodes | Refraction Observation Codes |
| VisualAcuityMethodCodes | Visual Acuity Method Codes |
| VisualAcuityObservationCodes | Visual Acuity Observation Codes |
| VisualAcuityOrganizerCodes | Visual Acuity Organizer Codes |
| be-vs-bodysite | Body Site |
| be-vs-laterality | Laterality |
| be-vs-reaction-manifestation-code | Reaction Manifestation Code |
| be-vs-score | Score Value Set |
| encountertype | Encounter Type |
| ethnicitycode | EthnicityCode |
| BARSReferralCode | BARS Referral Code |
| PatientReferral | Patient Referral |
| SmokingStatus | Smoking Status |
| VHConditionCode | VH Condition Code |
| VHImmunisationCode | VH Immunisation Code |
| VHMedicationCode | VH Medication Code |
| VHObservationCode | VH Observation Code |
| VHObservationValueCode | VH Observation Value Code |
| document-entry-class | DocumentEntry Class |
| document-entry-type | DocumentEntry Type |
| adverse-event-contributing-factor-vs | AdverseEvent Contributing Factor |
| adverse-event-mitigating-action-vs | AdverseEvent Mitigating Action |
| adverse-event-supporting-info | AdverseEvent Supporting Information |
| adverse-event-type-vs | AdverseEvent Type |
| socioeconomic-observation-codes-vs | Socioeconomic Observation Codes |
| medication-exposure-category-vs | Medication exposure intent |
| lab-result-findings | Lab result findings (SNOMED CT) |
| specimen-collection-supervision-status | Specimen Collection Supervision Status |
| be-vs-basic-laterality | Basic Laterality |
| be-vs-toothnumber-bodysite | Tooth Number Body Site |
| sct-services | IHE ITI Scheduling Snomed CT Services |
| specialty | IHE ITI Scheduling Specialties |
| vrdr-certifier-types-vs | Certifier Types Value Set |
| vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
| vrdr-death-certification-event-max-vs | Event Code for Death Certificate Composition - Max |
| vrdr-death-certification-event-vs | Event Code for Death Certificate Composition |
| vrdr-manner-of-death-vs | Manner of Death ValueSet |
| vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
| vrdr-place-of-death-vs | Place of Death ValueSet |
| vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
| VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
| VSTiposVacunas | Tipos de Vacunas RNI |
| cl-core-tipo-especimen-vs | Set de Valores de los Tipos de Especimen |
| cz-lab-clinically-relevant-time-VS | ValueSet - Clinically Relevant Time |
| cz-lab-container-types-VS | Laboratory Container Types (CZ) |
| cz-lab-speciality-types-VS | Laboratory Speciality Types (CZ) |
| cz-lab-technique-vs | Laboratory Techniques |
| im-imaging-device-type | Imaging Device Type |
| im-procedure-type | Imaging Procedure Type |
| media-view | Media View types - placeholder for cross-version extension |
| periods-of-life-value-set | Periods of Life |
| ch-orf-vs-consentstatus | Consent Status |
| ch-orf-vs-legalrelation | Legal Relation |
| ch-orf-vs-personalrelation | Personal Relation |
| ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient |
| CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition |
| CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation |
| CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance |
| CHAllergyIntoleranceValueSet | CH AllergyIntolerance |
| DocumentEntry.classCode | DocumentEntry.classCode |
| DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| DocumentEntry.typeCode | DocumentEntry.typeCode |
| HCProfessional.hcProfession | HCProfessional.hcProfession |
| SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| UnitCode | UnitCode |
| ch-vacd-ch-vaccination-plan-immunizations-vs | CH VACD Swiss Vaccination Plan Immunizations |
| ch-vacd-recommendation-categories-vs | CH VACD Recommendation Categories for Immunizations |
| ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs | CH VACD Target disease and illnesses undergone for immunization |
| ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for VaccineCode |
| ch-vacd-vaccines-vs | CH VACD Swissmedic code for VaccineCode |
| snomedct-concept-viraldiseases-vs | Snomed CT Concept Viral Diseases |
| treatmentreason | Treatment Reason |
| chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
| siteLaterality-eu | Body Structure Laterality |
| siteQualifier-eu | Body Structure Qualifier |
| speciesType-eu | Types of species |
| MicrobiolProcedures | Microbiological Procedure |
| clinical-focus-vitamin-d | Vitamin D all possible clinical contexts for test |
| normal-contexts-vitamin-d | Contexts for reimbursement of the vitamin D test |
| reasons-for-order | All Valid Reasons for Ordering a Lab Service |
| ch-vacd-immunization-allergyintolerances-vs | Allergies and Intolerance values for Immunization |
| ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations |
| ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations |
| ch-vacd-risks-preillness-vs | Swiss Preillness Risks For Immunizations |
| ch-vacd-risks-social-vs | Swiss Social Risks For Immunizations |
| ch-vacd-verification-status-vs | Verification Status Codes |
| be-causativeagent | BeCausativeAgent |
| be-exposureroute | BeExposureRoute |
| be-noallergy | BeNoAllergy |
| be-riskmanifestation | BeRiskManifestation |
| be-vs-allergyintolerance-type | BeVSAllergyIntoleranceType |
| ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
| resultvalue-mappings-livd | Result value mappings value set for LIVD |
| at-aps-immunization-vaccine-codes | AT APS Immunitzation Vaccine Codes |
| at-aps-problems | AT APS Problems |
| BodyPosition | Body Position |
| MeasurementSetting | Measurement Setting value set |
| mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs | Benign Neoplasm of Brain and CNS Disorder Value Set |
| mcode-body-location-and-laterality-qualifier-vs | Body Location and Laterality Qualifier Value Set |
| mcode-brachytherapy-high-dose-rate-electronic-technique-vs | Brachytherapy High Dose Rate Electronic Technique Value Set |
| mcode-brachytherapy-high-dose-rate-technique-vs | Brachytherapy High Dose Rate Technique Value Set |
| mcode-brachytherapy-low-dose-rate-temporary-technique-vs | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
| mcode-brachytherapy-modality-vs | Brachytherapy Modality Value Set |
| mcode-brachytherapy-permanent-seeds-technique-vs | Brachytherapy Permanent Seeds Technique Value Set |
| mcode-brachytherapy-pulsed-dose-rate-technique-vs | Brachytherapy Pulsed Dose Rate Technique Value Set |
| mcode-brachytherapy-radiopharmaceutical-technique-vs | Brachytherapy Radiopharmaceutical Technique Value Set |
| mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set |
| mcode-cancer-body-location-vs | Cancer Body Location Value Set |
| mcode-cancer-disease-status-evidence-type-vs | Cancer Disease Status Evidence Type Value Set |
| mcode-cancer-related-surgical-procedure-vs | Cancer-Related Surgical Procedure Value Set |
| mcode-cancer-stage-type-vs | Cancer Stage Type Value Set |
| mcode-cancer-stage-value-vs | Cancer Stage Value Set |
| mcode-cancer-staging-method-vs | Cancer Staging Method Value Set |
| mcode-cancer-staging-prognostic-factor-type-vs | Cancer Staging Prognostic Factors Types |
| mcode-cancer-staging-prognostic-factor-value-vs | Cancer Staging Prognostic Factors Value |
| mcode-carcinoma-in-situ-disorder-vs | Carcinoma In-Situ Disorder Value Set |
| mcode-clark-level-value-vs | Clark Level Value Set |
| mcode-clin-or-path-modifier-vs | Clinical or Pathologic Modifier |
| mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set |
| mcode-condition-status-trend-vs | Condition Status Trend Value Set |
| mcode-cytologic-evidence-malignancy-vs | Cytologic Evidence of Malignancy Value Set |
| mcode-fab-classification-value-vs | FAB Classification Value |
| mcode-figo-staging-method-vs | FIGO Staging Method Value Set |
| mcode-gleason-grade-group-value-vs | Gleason Grade Value Set |
| mcode-histologic-grade-vs | Histologic Grade Value Set |
| mcode-histologic-grading-system-vs | Histologic Grading System Value Set |
| mcode-histology-morphology-behavior-vs | Histology Morphology Behavior Value Set |
| mcode-history-of-metastatic-malignant-neoplasm-vs | History of Metastatic Malignant Neoplasm Value Set |
| mcode-hypereosinophilic-syndrome-disorder-vs | Specific Diagnosis of Cancer Value Set |
| mcode-laterality-qualifier-vs | Laterality Qualifier Value Set |
| mcode-lymphoma-stage-bulky-modifier-vs | Lymphoma Stage Bulky Modifier Value Set |
| mcode-lymphoma-stage-value-modifier-vs | Lymphoma Stage Value Modifier Value Set |
| mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set |
| mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set |
| mcode-melanoma-in-situ-disorder-vs | Melanoma In-Situ Disorder Value Set |
| mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
| mcode-normalization-basis-vs | Normalization Basis Value Set |
| mcode-primary-malignant-neoplasm-disorder-vs | Primary Malignant Neoplasm Disorder Value Set |
| mcode-procedure-intent-vs | Procedure Intent Value Set |
| mcode-radiotherapy-treatment-location-qualifier-vs | Radiotherapy Treatment Location Qualifier Value Set |
| mcode-radiotherapy-treatment-location-vs | Radiotherapy Treatment Location Value Set |
| mcode-radiotherapy-volume-type-vs | Radiotherapy Volume Type Value Set |
| mcode-rai-staging-method-vs | Rai Staging System Value Set |
| mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set |
| mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value |
| mcode-risk-assessment-vs | Risk Assessment Value Set |
| mcode-secondary-cancer-disorder-vs | Secondary Cancer Disorder Value Set |
| mcode-teleradiotherapy-carbon-ion-beam-technique-vs | Carbon Ion Beam Technique Value Set |
| mcode-teleradiotherapy-electron-beam-technique-vs | Electron Beam Technique Value Set |
| mcode-teleradiotherapy-modality-vs | Teleradiotherapy Modality Value Set |
| mcode-teleradiotherapy-neutron-beam-technique-vs | Neutron Beam Technique Value Set |
| mcode-teleradiotherapy-photon-beam-technique-vs | Photon Beam Technique Value Set |
| mcode-teleradiotherapy-proton-beam-technique-vs | Proton Beam Technique Value Set |
| mcode-tnm-distant-metastases-category-vs | TNM Distant Metastases Category Value Set |
| mcode-tnm-distant-metastases-staging-type-vs | TNM Distant Metastases Staging Type Value Set |
| mcode-tnm-primary-tumor-category-vs | TNM Primary Tumor Category Value Set |
| mcode-tnm-primary-tumor-staging-type-vs | TNM Primary Tumor Staging Type Value Set |
| mcode-tnm-regional-nodes-category-vs | TNM Regional Nodes Category Value Set |
| mcode-tnm-regional-nodes-staging-type-vs | TNM Regional Nodes Staging Type Value Set |
| mcode-tnm-stage-group-staging-type-vs | TNM Stage Group Staging Type Value Set |
| mcode-tnm-stage-group-vs | TNM Stage Group Value Set |
| mcode-tnm-staging-method-vs | TNM Staging Method Value Set |
| mcode-treatment-termination-reason-vs | Treatment Termination Reason Value Set |
| mcode-tumor-morphology-code-max-vs | Tumor Morphology Code Max Value Set |
| mcode-tumor-morphology-code-vs | Tumor Morphology Code Value Set |
| mcode-tumor-size-method-vs | Tumor Size Method Value Set |
| mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set |
| mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set |
| holter-event-codes | Holter Event Codes |
| BeVSPopulationScreeningFollowUpAdvice | Population Screening Follow-up Advice Value Set |
| be-populationscreening-result-vs | PopulationScreening Result Value Set |
| be-vs-basic-laterality | Basic Laterality |
| be-vs-patient-relationship-type | BeVSPatientRelationshipType |
| be-vs-patientwill-scope | BeVSPatientWillScope |
| be-vs-populationscreening-type | Population Screening Type Value Set |
| be-vs-toothnumber-bodysite | Tooth Number Body Site |
| be-vs-vaccination-bodysite | BeVSVaccinationBodySite |
| be-vs-vaccination-reason-code | BeVSVaccinationReasonCode |
| be-vs-vaccine-code | BeVSVaccineCode |
| be-vspopulationscreening-body-site-location | PopulationScreening Body Site Value Set |
| body-site-eye | Ophthalmic anatomical location |
| conditions | Ophthalmology Condition ICD10 and SNOMED codes ValueSet |
| iop-methods | Intraocular pressure (IOP) method valueset |
| observable-entities | Ophthalmology observations (SNOMED) |
| observation-visual-acuity-methods | Visual acuity chart valueset (SNOMED) |
| observation-visual-acuity | Visual acuity method valueset (SNOMED) |
| observation-visual-field | Visual Field Observable Entities ValueSet |
| procedures | Ophthalmology Procedures Valueset |
| qualifiers | Ophthalmic anatomical location qualifiers |
| example-clinical-focus | All possible clinical contexts for any lab test |
| example-normal-contexts-vitamin-d | Contextes de remboursement du dosage de la vitamine D |
| example-reasons-for-order | All Valid Reasons for Ordering a Lab Service |
| VS-BiopsyType | Type of Biopsy |
| VS-DREOutcomeCode | DRE Observation Interpretation Codes |
| VS-PCa | Malignant tumor of prostate Value Set |
| ExampleDialysisProcedureCodes | Diabetes Example Dialysis Test Codes |
| ExampleRespiratoryConditionCodes | Covid-19 Example Condition Codes |
| cz-laterality-lab | Body Structure Laterality |
| cz-sitequalifier-vs | Body Structure Qualifier |
| cz-specimenAdditive-vs | Specimen Additive |
| cz-specimencontainer-vs | Specimen Container |
| cz-specimentype-vs | Specimen Type |
| eHDSISeverity | Severity |
| medical-devices-eu-hdr | Medical Devices (SNOMED CT) |
| BodyTempAssociatedSituationVS | Body Temperature Associated Situation value set |
| BodyWeightAssociatedSituationVS | Associated Situation value set |
| MeasSettingVS | Measurement Setting value set |
| bodyPositionVS | Body Position value set |
| bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set |
| bodyTempMeasurementDeviceVS | Body Temperature Measurement Device value set |
| bpCuffSizeVS | Blood Pressure Cuff Size value set |
| bpMeasDeviceVS | Blood Pressure Measurement Device value set |
| bpMeasMethodVS | Blood Pressure Measurement Method value set |
| bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
| definedLimitsVS | Defined Limits value set |
| exertionPhaseVS | Exertion Phase value set |
| heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| heightBodyPositionVS | Height Body Position value set |
| heightLengthMeasDeviceVS | Height Length Measurement Device value set |
| heightLengthMeasMethodVS | Height Length Measurement Method value set |
| respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set |
| respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set |
| sPO2BodyLocationVS | Oxygen Saturation Body Location value set |
| sensorDescriptionVS | Sensor Description value set |
| sleepStatusVS | Sleep Status value set |
| weightMeasurementDeviceVS | Weight Measurement Device value set |
| ch-elm-interpretation-codes-avidity | CH ELM Interpretation Codes AVIDITY |
| ch-elm-interpretation-codes-sero | CH ELM Interpretation Codes SERO |
| ch-elm-lab-study-types | CH ELM Lab Study Types |
| ch-elm-results-bru-org | CH ELM Results Bru Org |
| ch-elm-results-camp-diar-org | CH ELM Results Camp Diar Org |
| ch-elm-results-camp-org | CH ELM Results Camp Org |
| ch-elm-results-chol-org | CH ELM Results Chol Org |
| ch-elm-results-cjd-org | CH ELM Results Cjd Org |
| ch-elm-results-coded-values-laboratory | CH ELM Results Coded Values Laboratory |
| ch-elm-results-complete-spec | CH ELM Results Complete Spec |
| ch-elm-results-diph-org | CH ELM Results Diph Org |
| ch-elm-results-geni-spec | CH ELM Results Geni Spec |
| ch-elm-results-haem-org | CH ELM Results Haem Org |
| ch-elm-results-hanta-org | CH ELM Results Hanta Org |
| ch-elm-results-influenza-hxny-org | CH ELM Results Influenza Hxny Org |
| ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete |
| ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation |
| ch-elm-results-leg-org | CH ELM Results Leg Org |
| ch-elm-results-lis-org | CH ELM Results Lis Org |
| ch-elm-results-mal-org | CH ELM Results Mal Org |
| ch-elm-results-maldi-tof-org | CH ELM Results Maldi-tof Org |
| ch-elm-results-mea-org | CH ELM Results Mea Org |
| ch-elm-results-men-org | CH ELM Results Men Org |
| ch-elm-results-mpox-org | CH ELM Results Mpox Org |
| ch-elm-results-pneu-org | CH ELM Results Pneu Org |
| ch-elm-results-sal-org-complete | CH ELM Results Sal Org Complete |
| ch-elm-results-sal-org | CH ELM Results Sal Org |
| ch-elm-results-shi-org | CH ELM Results Shi Org |
| ch-elm-results-sterile-spec | CH ELM Results Sterile Spec |
| ch-elm-results-tub-org | CH ELM Results Tub Org |
| ch-elm-results-tul-org | CH ELM Results Tul Org |
| ch-elm-results-virus-cult-org | CH ELM Results Virus Cult Org |
| CervicalScreeningStatus-1 | Cervical Screening Status |
| SmokingQuitStatus-1 | Smoking Quit Status |
| TobaccoUseStatus-1 | Tobacco Use Status |
| amt-vaccine-1 | Australian Medicines Terminology Vaccine |
| biological-sex-1 | Biological Sex |
| clinical-condition-1 | Clinical Condition |
| gender-identity-response-1 | Gender Identity Response |
| heart-rhythm-1 | Heart Rhythm |
| medication-reason-taken-1 | Medication Reason Taken |
| smart-health-checks-medicine-products | Smart Health Checks Medicine Products |
| valueset-Hx-UGIB-snomed | Upper gastrointestinal bleed Value Set |
| Advance.Directives.VS | Advance Directives |
| Antepartum.Education.VS | Antepartum Education |
| Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
| Antepartum.History.of.Infection.VS | Antepartum History of Infection |
| Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
| Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
| Smoking.Status.VS | Smoking Status |
| pa-diagnosticreport-category | PA ServiceRequest Category - USCore |
| pa-servicerequest-code | PA ServiceRequest Intervention Codes |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| pcd-sleep-observation-value | Patient contributed data: sleep stage value |
| amt-mp-codes | AMT Medicinal Product and Substances |
| rsg-type | AU Recorded Sex or Gender Type |
| ee-body-position-vs | Body Position ValueSet |
| cancer-stage | SCT + NCI-健保事前審查-癌症分期量表項目值集 |
| medication-path-sct-tw | SNOMED CT + 臺灣健保署-健保事前審查-給藥途徑值集 |
| sct-body-site | SNOMEDCT-健保事前審查-身體部位值集 |
| MAPProblemPriorityVS | Medical Action Plan Problem Priority |
| alcoholUsageStatus-snomed-eu-i4rc | Alcohol Usage Status: SNOMED CT |
| comorbidities-sct-eu-i4rc | Comorbidities: SNOMED |
| hypopharynx-subsite-sct-i4rc | Hypopharynx subsite: Snomed CT |
| larynx-subsite-sct-i4rc | Larynx subsite: Snomed CT |
| lip-subsite-sct-i4rc | Lip subsite: Snomed CT |
| nasal-paranasal-subsite-sct-i4rc | Nasal cavity and paranasal sinuses subsite: Snomed CT |
| nasopharynx-subsite-sct-i4rc | Nasopharynx subsite: Snomed CT |
| oralCavity-subsite-sct-i4rc | Oral cavity subsite: Snomed CT |
| oropharynx-subsite-sct-i4rc | Oropharynx subsite: Snomed CT |
| siteRare-i4rc | Site rare (IDEA4RC) |
| vs-calcest-eu-i4rc | Calculated|Estimated |
| VS-Aandedraetsorganer | Åndedrætsorganer Value Set |
| VS-Aborttype | Aborttype Value Set |
| VS-Anden-operation-i-maveregionen-eller-underlivet | AndenOperationIMaveregionenEllerUnderlivet Value Set |
| VS-andet-nikotinprodukt-under-gravditet | AndetNikotinproduktUnderGravditet Value Set |
| VS-arbejdstidspunkt | Arbejdstidspunkt Value Set |
| VS-barn-disponeret | BarnDisponeret Value Set |
| VS-barns-koen | BarnsKøn Value Set |
| VS-blod-bloddannende-organer-immunsystemet | Blod/BloddannendeOrganer/Immunsystemet Value Set |
| VS-boligforhold | Boligforhold Value Set |
| VS-brystoperation | Brystoperation Value Set |
| VS-diagnosegruppe | Diagnosegruppe Value Set |
| VS-endokrin-metabolisk | Endokrin/Metabolisk Value Set |
| VS-endometrioseoperation | Endometrioseoperation Value Set |
| VS-erhvervsmaessig-tilknytning | ErhvervsmæssigTilknytning Value Set |
| VS-fedmeoperation | Fedmeoperation Value Set |
| VS-fertilitetsbehandlingstype | Fertilitetsbehandlingstype Value Set |
| VS-foedselsforloebstraek | Fødselsforløbstræk Value Set |
| VS-foedselsoplevelse | Fødselsoplevelse Value Set |
| VS-foedselsudfald | Fødselsudfald Value Set |
| VS-foraelder-anlaegsbaerer | ForælderAnlægsbærer Value Set |
| VS-fordoejelsesorganer | Fordøjelsesorganer Value Set |
| VS-fravaersmelding | Fraværsmelding Value Set |
| VS-graviditetsforloebstraek | Graviditetsforløbstræk Value Set |
| VS-henvist-til-tobaks-og-nikotinstop | HenvistTilTobaks-OgNikotinstop Value Set |
| VS-infektioes-sygdom | InfektiøsSygdom Value Set |
| VS-keglesnitsoperation | Keglesnitsoperation Value Set |
| VS-knogler-muskler-bindevaev | Knogler/Muskler/Bindevæv Value Set |
| VS-konsultationsform | Konsultationsform Value Set |
| VS-kraeftsygdomme | Kræftsygdomme Value Set |
| VS-kredsloeb | Kredsløb Value Set |
| VS-nervesystemet | Nervesystemet Value Set |
| VS-oensket-ugedag | ØnsketUgedag Value Set |
| VS-omsorgsniveau | Omsorgsniveau Value Set |
| VS-operation-i-livmoderen | OperationILivmoderen Value Set |
| VS-paavirkningstype | Påvirkningstype Value Set |
| VS-partnerrelation | Partnerrelation Value Set |
| VS-partners-erhvervsmaessige-tilknytning | PartnersErhvervsmæssigeTilknytning Value Set |
| VS-resultat-type | ResultatType Value Set |
| VS-rygoperation | Rygoperation Value Set |
| VS-screening-aktualitet | ScreeningAktualitet Value Set |
| VS-screeningsstatus | Screeningsstatus Value Set |
| VS-screeningstype | Screeningstype Value Set |
| VS-tilstands-svaerhedsgrad | TilstandsSværhedsgrad Value Set |
| VS-tobaksrygning-under-graviditet | TobaksrygningUnderGraviditet Value Set |
| VS-type-rusmiddel-laegemiddel | TypeRusmiddel/Lægemiddel Value Set |
| VS-uddannelsesniveau | Uddannelsesniveau Value Set |
| VS-urinveje-koensorganer | Urinveje/Kønsorganer Value Set |
| VS-vandpibe-dagligt-lejlighedsvist | VandpibeDagligt/Lejlighedsvist Value Set |
| VS-ydelse | Ydelse Value Set |
| HealthProfession | Health professions |
| vdor-gun-owner-codes-vs | VDOR Coding Manual Gun Owner Codes Value Set |
| dk-ihe-healthcarefacilitytypecode-vs | DK_IHE_HealthcareFacilityTypeCode_VS |
| dk-ihe-practicesettingcode-vs | DK_IHE_practiceSettingCode_VS |
| activitydefinition-code | Activity Definition Code |
| clinicalimpression-finding-codes | ClinicalImpression Finding Codes |
| clinicalimpression-investigation-item-codes | ClinicalImpression Investigation Item Codes |
| device-types | Device Types |
| document-class | Document Class |
| facility-type-codes | Facility Type Codes |
| media-codes | Media Codes |
| questionnaire-types | Questionnaire Types |
| sor-organization-type | SorOrganizationType |
| sor-organization-specialty | SorOrganizationSpecialty |
| additivo-campione-it | Additivo Campione |
| campione-container-lab-it | Container Campione |
| results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
| results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
| results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
| tipo-campione-lab-it | Tipo campione |
| valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
| valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
| valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
| siteLaterality-eu | Body Structure Laterality |
| siteQualifier-eu | Body Structure Qualifier |
| speciesType-eu | Types of species |
| device-kind | FHIR Device Types |
| edible-substance-type | Types of Edible Substances |
| gender-identity | Gender Identity |
| snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| v3-AllergyStatus | Allergy Status |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
| v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
| v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
| confidence-scale | RA Confidence Scale |
| sdhr-allergyintolerance-severity-valueset | ValueSet for AllergyIntolerance Severity |
| AxillaSurgeryVS | Axilla surgery ValueSet |
| ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
| ComplicationImpactVS | Impact of complication ValueSet |
| ComplicationTypeVS | Type of complication ValueSet |
| EducationLevelVS | Education level of patient ValueSet |
| EstrogenStatusVS | Estrogen receptor status ValueSet |
| GermlineMutationVS | Germline Mutation ValueSet |
| GradingVS | Grading of tumor ValueSet |
| HER2ReceptorStatusVS | HER2 receptor status ValueSet |
| HistologicalTypeVS | Histological type of the tumor ValueSet |
| HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
| InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
| LateralityNewCancerVS | Laterality of new cancer ValueSet |
| LateralityVS | Laterality of breast cancer ValueSet |
| LocationRadiotherapyVS | The location of radiotherapy ValueSet |
| MenopausalStatusVS | Menopausal status of patient ValueSet |
| PatientTreatPrefVS | Patient treatment preference ValueSet |
| ProgesteroneStatusVS | Progesterone receptor status ValueSet |
| RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
| RecurrenceMethodVS | Recurrence method ValueSet |
| ReoperationReasonVS | Reasoncode of the re-operation |
| ReoperationTypeVS | Type of re-operation |
| SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
| TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
| TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
| TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
| TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
| TargetedTherapyVS | Type of targeted therapy ValueSet |
| TherapyIntentVS | Intent of therapy ValueSet |
| TreatmentTypeVS | Type of treatments ValueSet |
| dental-observation-codes | Dental Observation Codes |
| dental-reason-for-referral | DentalReasonForReferral |
| oral-cavity-area | Oral Cavity Area |
| tooth-identification-valueset | Tooth Identification ValueSet |
| cz-consent-category | CZ Consent Category |
| cz-provision-code | CZ Provision Code |
| eHDSIConditionPOA | eHDSI Condition Present On Admission |
| eHDSITreatmentClass | eHDSI Treatment Class |
| medcom-conditionlist-status-valueset | MedComConditionListStatus |
| be-vs-diabetes-observation-category | BeVSDiabetesObservationCategory |
| be-vs-diabetes-observation-code | BeVSDiabetesObservationCode |
| be-vs-diabetes-report-category | BeVSDiabetesReportCategory |
| be-vs-diabetes-report-code | BeVSDiabetesReportCode |
| routeOfAdministration | Route Of Administration |
| Active.Advance.Directive.Finding.VS | Active Advanced Healthcare Directives Findings Value Set |
| Airbag.Type.VS | Airbag Type Value Set |
| Airway.Device.Confirmation.Method.VS | Airway Device Confirmation Method Value Set |
| Airway.Device.Type.VS | Airway Device Type Value Set |
| Barrier.To.Care.VS | Barrier To Care Value Set |
| Blood.Pressure.Measurement.Method.VS | Blood Pressure Measurement Method Value Set |
| Cardiac.Arrest.Etiology.VS | Cardiac Arrest Etiology Value Set |
| Cardiac.Arrest.Outcome.VS | Cardiac Arrest Outcome Value Set |
| Cardiac.Arrest.Witness.Role.VS | Cardiac Arrest Witness Role Value Set |
| Cardiac.Rhythm.Reading.VS | Cardiac Rhythm Readings Value Set |
| Cardiopulmonary.Resuscitation.Type.VS | Cardiopulmonary Resuscitation Type Value Set |
| ChiefComplaint.Anatomic.Location.VS | ChiefComplaint Anatomic Location Value Set |
| ChiefComplaint.Organ.System.VS | ChiefComplaint Organ System Value Set |
| Collision.Object.VS | Collision Object Value Set |
| Complication.Subset.VS | Complication Subset Value Set |
| Destination.Prearrival.Activation.Type.VS | Destination Prearrival Activation Type Value Set |
| Device.Type.VS | ECG Device Type Value Set |
| Disaster.Type.VS | Disaster Type Value Set |
| IHE.PCC.APGAR.VS | IHE PCC mPSC APGAR Assessment Type Value Set |
| IHE.PCC.Facility.Ward.VS | IHE PCC mPSC Facility Ward Value Set |
| Length.Based.Weight.Class.VS | Length Based Weight Class Value Set |
| Level.Of.Responsiveness.AVPU.VS | Level Of Responsiveness AVPU Value Set |
| Location.In.Vehicle.VS | Location In Vehicle Value Set |
| Mechanism.Of.Injury.VS | Mechanism Of Injury Value Set |
| Medication.Administration.Device.VS | Medication Administration Device Value Set |
| Medication.Complication.VS | Medication Complication Value Set |
| PSC.Location.Type.VS | PSC Location Type Value Set |
| Paramedicine.Emergency.Event.Sub.List.VS | Paramedicine Emergency Event Sub List Value Set |
| Paramedicine.Observation.Interpretation.VS | Paramedicine Observation Interpretation Value Set |
| Paramedicine.Physical.Findings.of.Nervous.System.VS | Physical Finding of Nervous System Value Set |
| Paramedicine.Physical.Findings.of.Respiratory.System.VS | Physical Finding of Respiratory System Value Set |
| Paramedicine.Provider.Roles.VS | Paramedicine Provider Roles Value Set |
| Paramedicine.Reason.For.Visit.VS | Paramedicine Reason For Visit Value Set |
| Paramedicine.Vehicle.Type.VS | Paramedicine Vehicle Type Value Set |
| Pathient.Transfer.to.Ambulance.Method.VS | Pathient Transfer to Ambulance_Method Value Set |
| Physical.Finding.of.Abdomen.TargetSite.VS | Physical Finding of Abdomen Target Site Value Set |
| Physical.Finding.of.Abdomen.VS | Physical Finding of Abdomen Value Set |
| Physical.Finding.of.Back.TargetSite.VS | Physical Finding of Back Target Site Value Set |
| Physical.Finding.of.Back.VS | Physical Finding of Back Value Set |
| Physical.Finding.of.Back.and.Spine.VS | Physical Finding of Back and Spine Value Set |
| Physical.Finding.of.Chest.TargetSite.VS | Physical Finding of Chest Target Site Value Set |
| Physical.Finding.of.Chest.VS | Physical Finding of Chest Value Set |
| Physical.Finding.of.Extremities.TargetSite.VS | Physical Finding of Extremities Target Site Value Set |
| Physical.Finding.of.Extremities.VS | Physical Finding of Extremities Value Set |
| Physical.Finding.of.Eye.TargetSite.VS | Physical Finding of Eye Target Site Value Set |
| Physical.Finding.of.Eye.VS | Physical Finding of Eye Value Set |
| Physical.Finding.of.Face.VS | Physical Finding of Face Value Set |
| Physical.Finding.of.GenitourinaryTract.VS | Physical Finding of Genitourinary Tract Value Set |
| Physical.Finding.of.Head.VS | Physical Finding of Head Value Set |
| Physical.Finding.of.Heart.VS | Physical Finding of Heart Value Set |
| Physical.Finding.of.Lung.TargetSite.VS | Physical Finding of Lung Tartget Site Value Set |
| Physical.Finding.of.Lung.VS | Physical Finding of Lung Value Set |
| Physical.Finding.of.Neck.VS | Physical Finding of Neck Value Set |
| Physical.Finding.of.Pelvis.VS | Physical Finding of Pelvis Value Set |
| Physical.Finding.of.Pelvis.and.Genitourinary.VS | Physical Finding of Pelvis and Genitourinary Value Set |
| Physical.Finding.of.Pupil.TargetSite.VS | Physical Finding of Back and Spine Target Site Value Set |
| Physical.Finding.of.Pupil.VS | Physical Finding of Pupil Value Set |
| Physical.Finding.of.Skin.VS | Physical Finding of Skin Value Set |
| Physical.Finding.of.Spine.TargetSite.VS | Physical Finding of Spine Spine Target Site Value Set |
| Protective.Equipment.VS | Protective Equipment Value Set |
| Pulse.Rhythm.VS | Pulse Rhythm Value Set |
| Reason.For.Visit.VS | Reason For Visit Value Set |
| Respiratory.Effort.VS | Respiratory Effort Value Set |
| Response.VS | Paramedicine Treatment Response Value Set |
| Safety.Equipment.VS | Safety Equipment Value Set |
| Stroke.Assessment.Interpretation.VS | Stroke Assessment Interpretation Value Set |
| Stroke.Scale.Type.VS | Stroke Scale Type Value Set |
| Substance.Use.Evidence.VS | Substance Use Evidence Value Set |
| Transport.Method.VS | Transport Method Value Set |
| Vehicle.Type.VS | Vehicle Type Value Set |
| Weight.Estimation.Tape.Values.VS | Physical Finding of Pelvis and Genitourinary Value Set |
| SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
| allergyintolerance-finding-code | Allergy-Intolerance Finding Code |
| alleryg-intolerance-detailed-type-value-set | Allergy Intolerance Detailed Type Value Set |
| bmi | BMI Observable entity Code |
| bodyheight | Body Height Observable entity Codes |
| bodytemp | Core body temperature Observable entity Code |
| bodyweight | Body weight Observable entity Code |
| dia-bp | Diastolic blood pressure Observable entity Code |
| headcircum | Head circumference Observable entity Code |
| heartrate | Heart rate Observable entity Code |
| oxygensat | Peripehral oxygen saturation Observable entity Code |
| resprate | Respiratory rate Observable entity Code |
| specimen-collection-method | Specimen Collection Method ValueSet |
| specimen-processing-procedure-valueset | Specimen Processing Procedure ValueSet |
| specimen-type | Specimen Value Set |
| syst-bp | Systolic blood pressure Observable entity Code |
| species | Questionnaire Context Species |
| allergies-intolerances-uv-ips | Allergies & Intolerances - IPS |
| allergy-reaction-uv-ips | Allergy Reaction - IPS |
| body-site-uv-ips | Body Site - IPS |
| current-smoking-status-uv-ips | Current Smoking Status - IPS |
| medical-devices-uv-ips | Medical Devices - IPS |
| medication-example-uv-ips | Medications - example (IPS) |
| medication-uv-ips | Medications - IPS |
| medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
| pregnancy-status-uv-ips | Pregnancy Status - IPS |
| problems-uv-ips | Problems - IPS |
| procedures-uv-ips | Procedures - IPS |
| results-coded-values-laboratory-pathology-uv-ips | Results Coded Values Laboratory/Pathology - IPS |
| results-radiology-numobs-uv-ips | Results Radiology Measurement Observation - IPS |
| results-radiology-txtobs-uv-ips | Results Radiology Textual Observation - IPS |
| results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS |
| results-specimen-type-uv-ips | Results Specimen Type - IPS |
| target-diseases-uv-ips | Vaccine Target Diseases - IPS |
| vaccines-uv-ips | Vaccines - IPS |
| ADIDocumentationTypeVS | Documentation Types |
| blood-group | CH EPREG VS: Blood Group |
| fetal-position | CH EPREG VS: Fetal Position |
| parent | CH EPREG VS: Parent |
| gender-vs | Gender ValueSet |
| medication-vs | Medication Value Set |
| Onset | Onset ValueSet |
| im-imaging-device-type | Imaging Device Type |
| im-procedure-type | Imaging Procedure Type |
| media-view | Media View types - placeholder for cross-version extension |
| periods-of-life-value-set | Periods of Life |
| vs-follow-up-plan | Follow-up plan |
| vs-medical-conditions | Conditions |
| vs-reason-for-encounter | Reason For Encounter |
| vs-risk-behaviour-physical-activity | Physical Activity |
| LabTestPathogenCovid19SnomedValueSet | Lab Test - Pathogen - COVID-19 - SNOMED CT |
| LabTestQualitativeResultSnomedValueSet | Lab Test - Qualitative Result - SNOMED CT |
| VaccineCovid19SnomedValueSet | Vaccine - COVID-19 - SNOMED CT |
| lab-laterality-eu-lab | Body Structure Laterality |
| lab-siteQualifier-eu-lab | Body Structure Qualifier |
| lab-specialty-eu-lab | Laboratory Specialty |
| lab-speciesType-eu-vs | Types of species |
| lab-specimenAdditive-eu-lab | Specimen Additive |
| lab-specimenContainer-eu-lab | Specimen Container |
| lab-specimenType-eu-lab | Specimen Types |
| lab-technique-eu-lab | Laboratory Techniques |
| cancer-core-reportability-codes | Cancer Core Reportability Codes |
| serviceRequestCodes | CRD Service Request Codes Value Set |
| conditions-documenting-sleep-disordered-breathing | Sleep disordered breathing |
| conditions-documenting-substance-misuse | Conditions documenting substance misuse |
| conditions-likely-terminal-for-opioid-prescribing | Conditions likely terminal for opioid prescribing |
| hospice-disposition | Hospice Disposition |
| hospice-finding | Hospice Finding |
| hospice-procedure | Hospice Procedure |
| limited-life-expectancy-conditions | Limited life expectancy conditions |
| office-visit | Office Visit |
| opioid-counseling-procedure | Opioid counseling procedure |
| opioid-misuse-assessment-procedure | Opioid misuse assessment procedure |
| opioid-misuse-disorders | Opioid misuse disorders |
| opioid-treatment-assessment-procedure | Opioid treatment assessment procedure |
| pain-management-procedure | Pain management procedure |
| pdmp-data-reviewed-finding | PDMP data reviewed finding |
| pdmp-review-procedure | PDMP review procedure |
| sickle-cell-diseases | Sickle-cell diseases |
| substance-misuse-behavioral-counseling | Substance misuse behavioral counseling |
| therapies-indicating-end-of-life-care | Therapies indicating end of life care |
| routeOfAdministration | Route Of Administration |
| document-entry-class | DocumentEntry Class |
| document-entry-type | DocumentEntry Type |
| ethnicity | Ethnicity |
| specimen-type | Specimen Type |
| codexrt-brachytherapy-applicator-type-vs | Brachytherapy Applicator Type Value Set |
| codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set |
| codexrt-disease-progression-qualifier-vs | Disease Progression Qualifier Value Set |
| codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set |
| codexrt-intrafraction-verification-procedure-vs | Intrafraction Verification Procedure Value Set |
| codexrt-intrafraction-verification-qualifier-vs | Intrafraction Verification Procedure Qualifier Value Set |
| codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set |
| codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set |
| codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set |
| codexrt-radiotherapy-reason-for-revision-or-adaptation-vs | Radiotherapy Reason for Revision or Adaptation Value Set |
| codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set |
| BacterialCodes | Bacterial Codes |
| CandidaCodes | Candida Codes |
| ChlamydiaCodes | Chlamydia Codes |
| CompromisedImmuneSystemCodes | CompromisedImmuneSystem Codes |
| GonokokCodes | Gonokok Codes |
| MycoplasmaCodes | Mycoplasma Codes |
| OncologyPatientCodes | OncologyPatient Codes |
| OtherCodes | Other Codes |
| PregnancyCodes | Pregnancy Codes |
| TrichomonasCodes | Trichomonas Codes |
| snomedCT-additional-dosage-instruction | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) |
| snomedCT-anatomical-body-structure | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) |
| snomedCT-clinical-finding | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) |
| snomedCT-dosage-administration-route | ValueSet dành cho Đường dùng thuốc (SNOMED CT) |
| vaccine-code | ValueSet dành cho Vaccine Code |
| vn-core-condition-code | ValueSet dành cho Mã bệnh tật |
| vn-core-observation-smokingstatus | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) |
| vn-core-occupation | ValueSet dành cho Thông tin nghề nghiệp |
| vn-medication-code | ValueSet dành cho Mã dược phẩm |
| vn-procedure-code | ValueSet dành cho Mã dịch vụ kỹ thuật |
| BreastAssessmentCategoryVS | Breast Assessment Category ValueSet |
| CalcificationDistributionVS | CalcificationDistribution ValueSet |
| ConsistentWithVS | ConsistentWith ValueSet |
| NotPreviouslySeenVS | NotPreviouslySeen ValueSet |
| PreviouslyDemonstratedByVS | PreviouslyDemonstratedBy ValueSet |
| admission-voluntary-status-vs | Encounter Voluntary Status Value Set |
| allergy-intolerance-substances-eu-hdr | Allergy Intolerance |
| condition-eu-hdr | Condition Value Set |
| exposureAgent-eu-hdr | Exposure of transmissible agents |
| hdr-encounter-type-eu-hdr | In-patient Encounter Type Value Set |
| medical-devices-eu-hdr | Medical Devices (SNOMED CT) |
| procedure-snomed-eu-hdr | Procedure codes: Snomed CT |
| sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes |
| be-vs-patient-relationship-type | BeVSPatientRelationshipType |
| bdr-procedurelist | Newborn Procedure List |
| 2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions |
| allergy-reaction-uv-ips | IPS Allergy Reaction |
| target-site-uv-ips | IPS Body Site |
| specimen-type | IPS Specimen Type |
| 2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) |
| 2.16.840.1.113883.11.22.58--20171212193352 | Topographical modifier (qualifier) |
| allergy-intolerance-substance-condition-uv-ips | IPS Allergy or Intolerance Substances |
| 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
| 2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products |
| 2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems |
| 2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method |
| cz-observationCode-vs | CZ Observation code |
| cz-procedure-type | CZ Procedure Type |
| media-view | Media View types - placeholder for cross-version extension |
| asagrade-vs | ASA Grade |
| ch-lab-bloodgroup-antibody-vs | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) |
| ch-lab-bloodgroup-immuno-hematology-vs | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) |
| AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment |
| ArterialAccessSite | Arterial Access Site |
| CABG | Coronary artery bypass grafting |
| CABGType | Coronary Artery Bypass Graft Type |
| CardiacArrest | Cardiac Arrest |
| CardiacCTAResults | Cardiac CTA Results |
| CardiacCatheter | SNOMED Cardiac Catheters |
| CardiacInstabilityType | Cardiac Instability Type |
| CardiacValves | Cardiac Valves |
| CerebrovascularDisease | Cerebrovascular Disease |
| ChestPainSymptomAssessment | Chest Pain Symptom Assessment |
| ChronicLungDisease | Chronic Lung Disease |
| ConcomitantProceduresPerformedType | Concomitant Procedures Performed Type |
| DiabetesMellitus | Diabetes Mellitus |
| Dyslipidemia | Dyslipidemia |
| ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type |
| ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method |
| ElectrocardiacAssessmentResults | Electrocardiac Assessment Results |
| FamilyPrematureCAD | Family History of Premature CAD |
| GraftVesselCABGVessel | Graft Vessel CABG Vessel |
| HeartFailure | Heart Failure codes from SNOMED |
| HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis |
| Hypertension | Hypertension |
| HypothermiaInduced | Induced Hypothermia Codes |
| InterventionTypes | Intervention Types |
| IntraAndPostEvents | Cath PCI qualified list of Events |
| LesionSegmentNumber | Lesion Segment Number |
| MyocardialInfarction | Myocardial Infarction |
| NewYorkHeartAssociation | New York Heart Association Assessment Scale |
| OrganDonor | SNOMED Valueset of Organ Donor codes |
| PCIIndications | Percutaneous Coronary Intervention Indication |
| PCIOperator | PCI Operator SNOMED codes |
| PackedRedBloodCells | Packed Red Blood Ceels |
| PercutaneousCoronaryIntervention | PCI |
| PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease |
| PriorCABG | Prior History of Coronary Artery Bypass Graft |
| PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results |
| PriorMyocardialInfarction | Prior Myocardial Infarction |
| SmokingStatus | Smoking Status |
| StentType | CathPCI List of Stent Types |
| TIMIFlow | TIMI Flow |
| ValvularRegurgitation | Valvular Regurgitation |
| VentricularSupport | VentricularSupport |
| VentricularSupportDeviceType | Ventricular Support Device Type |
| YesNo | Yes or No |
| sensitive-care-team-codes | ValueSet - Sensitive CareTeam Codes |
| sensitive-condition-codes | ValueSet - Sensitive Condition Codes |
| sensitive-medication-codes | ValueSet - Sensitive Medication Codes |
| sensitive-medication-request-codes | ValueSet - Sensitive MedicationRequest Codes |
| sensitive-observation-codes | ValueSet - Sensitive Observation Codes |
| ch-rad-order-caveat-condition | Caveat Condition |
| ch-rad-order-caveat-device | Caveat Device |
| ch-rad-order-caveat-qualifier-value | Qualifier Value |
| ch-rad-order-caveat-type | Type of Caveat |
| nhsn-pathogen-ranking | NHSNPathogenRanking |
| MeasSettingVS | Measurement Setting value set |
| bodyPositionVS | Body Position value set |
| bpMeasMethodVS | Blood Pressure Measurement Method value set |
| bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
| exertionPhaseVS | Exertion Phase value set |
| heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| sleepStatusVS | Sleep Status value set |
| condition-code-sct-tw | SNOMED CT診斷代碼值集 |
| health-professional-sct-tw | SNOMED CT + 臺灣醫事司醫事人員類別值集 |
| medical-department-sct-tw | 對應至 SNOMED CT之就醫科別 + 診療科別值集 |
| medication-path-sct-tw | SNOMED CT + 臺灣健保署給藥途徑值集 |
| serviceRequest-category | 臺灣衛福部資訊處ServiceRequest類型值集 |
| smoking-status-comprehensive-code | SNOMED CT 吸菸狀態綜合評估值集 |
| smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
| snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
| snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
| document-entry-class | DocumentEntry Class |
| document-entry-type | DocumentEntry Type |
| ethnicity | Ethnicity |
| specimen-type | Specimen Type |
| component-radiation-dose-summary-vs | Radiation Dose Summary component type |
| procedure-reported-type-rds-vs | Procedure Reported Type Value Set |
| ValueSet-apgar-timing | APGAR Score Timing |
| ValueSet-birth-attendant-titles | Birth Attendants Titles |
| ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
| ValueSet-delivery-routes | Delivery Routes |
| ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set |
| ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
| ValueSet-fetal-death-time-points | Fetal Death Time Points |
| ValueSet-fetal-presentations-max | Fetal Presentations - Max |
| ValueSet-fetal-presentations | Fetal Presentations |
| ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
| ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
| ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
| ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome |
| ValueSet-performed-not-performed-planned | Performed NotPerformed Planned |
| AxillaSurgeryVS | Axilla surgery ValueSet |
| ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
| ComplicationImpactVS | Impact of complication ValueSet |
| ComplicationTypeVS | Type of complication ValueSet |
| EducationLevelVS | Education level of patient ValueSet |
| EstrogenStatusVS | Estrogen receptor status ValueSet |
| GermlineMutationVS | Germline Mutation ValueSet |
| GradingVS | Grading of tumor ValueSet |
| HER2ReceptorStatusVS | HER2 receptor status ValueSet |
| HistologicalTypeVS | Histological type of the tumor ValueSet |
| HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
| InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
| LateralityNewCancerVS | Laterality of new cancer ValueSet |
| LateralityVS | Laterality of breast cancer ValueSet |
| LocationRadiotherapyVS | The location of radiotherapy ValueSet |
| MenopausalStatusVS | Menopausal status of patient ValueSet |
| PatientTreatPrefVS | Patient treatment preference ValueSet |
| ProgesteroneStatusVS | Progesterone receptor status ValueSet |
| RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
| RecurrenceMethodVS | Recurrence method ValueSet |
| ReoperationReasonVS | Reasoncode of the re-operation |
| ReoperationTypeVS | Type of re-operation |
| SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
| TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
| TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
| TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
| TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
| TargetedTherapyVS | Type of targeted therapy ValueSet |
| TherapyIntentVS | Intent of therapy ValueSet |
| TreatmentTypeVS | Type of treatments ValueSet |
| qicore-medication-dose-type | QICore SNOMED CT Dosage Codes |
| qicore-observation-body-position | QICore Observation Body Position |
| document-type-vs | Tipo de documento ValueSet |
| newborn-congenital-anomalies-vs | Tipos de doença congénita ValueSet |
| newbornriskassessment-vs | Tipos de risco para avaliação de recém-nascidos ValueSet |
| puerperium-vs | Tipos de outcome de puerpério ValueSet |
| risco-gravidez-vs | Risco de gravidez ValueSet |
| tipo-gravidez-vs | Tipo de gravidez ValueSet |
| tipo-parto-vs | Tipos de parto ValueSet |
| transport-type-vs | Tipos de transporte de recém-nascido ValueSet |
| vacinas-infancia-vs | Vacinas ValueSet |
| FoodAllergyVS | Food Allergies |
| us-core-condition-code-current | US Core Condition Codes Current |
| us-core-condition-code | US Core Condition Codes |
| us-core-goal-description | US Core Goal Codes |
| us-core-procedure-code | US Core Procedure Codes |
| us-core-servicerequest-category | US Core ServiceRequest Category Codes |
| hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT |
| cz-imaging-procedure-vs | CZ Imaging Procedure |
| close-contact-setting-vs | Close Contact Setting Value Set |
| covid-19-disease-severity-value-set | COVID-19 Disease Severity Value Set |
| covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set |
| covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set |
| covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set |
| covid19-det-notdet-vs | Detected, Not-detected value set |
| covid19-pos-neg-eqvs | Positive/Negative Value Set |
| covid19-pos-neg-ind-vs | COVID19 Positive, Negative, Indeterminate value set |
| covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set |
| covid19-pos-neg-inv-vs | COVID19 Positive Negative Invalid value set |
| covid19-pos-neg-susp-inv-vs | COVID19 Positive Negative Suspected Invalid value set |
| covid19-pos-neg-vs | Positive, Negative value set |
| covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set |
| covid19-react-nonreact-inv-vs | COVID19 Reactive, Non-reactive, Invalid value set |
| covid19-react-nonreact-vs | COVID19 Reactive Non-reactive value set |
| covid19-reporting-priority-vs | Reporting Priorities Value Set |
| covid19-signs-1nd-symptoms-value-set | COVID-19 Signs and Symptoms Value Set |
| covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set |
| covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set |
| covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set |
| covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set |
| covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set |
| covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set |
| covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set |
| covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set |
| covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set |
| covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set |
| covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set |
| det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set |
| det-notdet-inconclusive-invalid-vs | Detected, Not-detected, Inconclusive, Invalid value set |
| detected-not-detected-value-set | Detected, Not-detected Value Set |
| fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
| fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set |
| pregnancy-status-value-set | Pregnancy Status Value Set |
| present-absent-unknown-vs | Present, Absent, Unknown Value Set |
| reactive-non-reactive-value-set | Reactive - Non-reactive value set |
| smoking-status-value-set | Smoking Status Value Set |
| state-codes-vs | State Codes Value Set |
| yes-no-vs | Yes/No Value Set |
| CodigoMedicamentoVS | Codigo Medicamento |
| FormaFarmaceuticaVS | Identificación Formas Farmacéuticas |
| ViaAdminMedicamentoVS | Vías de Administración de Medicamentos |
| 2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) |
| abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set |
| abnormal-interpretation-value-set | Abnmormal Interpretation value set |
| lab-result-code-value-set | Lab Result Code value set |
| null-flavor-value-set | Null Flavor value set |
| ordinal-value-code-value-set | Ordinal Value Code value set |
| SEBaseAddressPersonVS | SE ValueSet for official address types |
| SEBaseSKRYrkeSpecialtyVS | SKR ValueSet for clinical specialties |
| SEBaseSKRYrkeVS | SKR ValueSet for occupations |
| menstrual-regularity-findings | Menstrual Regularity Findings |
| case-significance-vs | Case Significance Value Set |
| defining-relationship-type-vs | Defining Relationship Type Value Set |
| designation-acceptability-vs | Designation Acceptability Value Set |
| dialect-vs | Dialect Value Set |
| el-profile-set-operator-vs | EL Profile Set Operator Value Set |
| animal-breeds | animal breeds |
| animal-species | animal species |
| barrier | Barrier |
| condition-cause | Condition Cause Codes |
| condition-course | Condition Course Codes |
| condition-predecessor | Condition Predecessor Codes |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| feeding-device | Feeding Device Codes Value Set |
| focal-subject | Focal Subject Codes |
| medication-type | Medication Type VS |
| protective-factor | Protective Factor |
| specimen-additive-substance | Specimen Additive Substance Codes |
| ch-ig-example-sct | CH IG Example SNOMED CT |
| IMMZ.Z.DE1 | IMMZ.Z.DE1 ValueSet for BCG vaccines |
| IMMZ.Z.DE10 | IMMZ.Z.DE10 ValueSet for Meningococcal vaccines |
| IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines |
| IMMZ.Z.DE12 | IMMZ.Z.DE12 ValueSet for Pertussis-containing vaccines |
| IMMZ.Z.DE13 | IMMZ.Z.DE13 ValueSet for Pneumococcal vaccines |
| IMMZ.Z.DE14 | IMMZ.Z.DE14 ValueSet for Poliovirus-containing vaccines |
| IMMZ.Z.DE15 | IMMZ.Z.DE15 ValueSet for Rabies vaccines |
| IMMZ.Z.DE16 | IMMZ.Z.DE16 ValueSet for Rotavirus vaccines |
| IMMZ.Z.DE17 | IMMZ.Z.DE17 ValueSet for Rubella-containing vaccines |
| IMMZ.Z.DE18 | IMMZ.Z.DE18 ValueSet for Seasonal influenza vaccines |
| IMMZ.Z.DE2 | IMMZ.Z.DE2 ValueSet for Cholera vaccines |
| IMMZ.Z.DE20 | IMMZ.Z.DE20 ValueSet for TBE vaccines |
| IMMZ.Z.DE22 | IMMZ.Z.DE22 ValueSet for Varicella-containing vaccines |
| IMMZ.Z.DE23 | IMMZ.Z.DE23 ValueSet for Yellow fever vaccines |
| IMMZ.Z.DE24 | IMMZ.Z.DE24 ValueSet for DTP-containing vaccines |
| IMMZ.Z.DE26 | IMMZ.Z.DE26 ValueSet for COVID-19 vaccines |
| IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines |
| IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines |
| IMMZ.Z.DE5 | IMMZ.Z.DE5 ValueSet for Hepatitis A-containing vaccines |
| IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines |
| IMMZ.Z.DE7 | IMMZ.Z.DE7 ValueSet for HPV vaccines |
| IMMZ.Z.DE8 | IMMZ.Z.DE8 ValueSet for JE vaccines |
| IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines |
| IMMZ.Z.LiveAttenuated | IMMZ.Z.LiveAttenuated ValueSet for live attenuated vaccines |
| genetic-therapeutic-implications-vs | Genetic Therapeutic Implications |
| bodyLandmarkDescriptionVS | BodyLandmarkDescriptionvalueset |
| bodyLocationOrientationVS | BodyLocationOrientationvalueset |
| bodyLocationQualifierVS | BodyLocationQualifiervalueset |
| bodySideVS | BodySidevalueset |
| clockFacePositionVS | ClockFacePositionValueSet |
| courseVS | Coursevalueset |
| episodeVS | Episodevalueset |
| periwoundConditionVS | ReriwoundConditionvalueset |
| presentAbsentVS | PresentAbsentValueSet |
| pressureUlcerAssociationVS | PressureUlcerAssociationvalueset |
| qualitativeWoundDepthVS | QualitativeWoundDepthvalueset |
| recurrenceVS | Recurrencevalueset |
| surfaceOrientationVS | SurfaceOrientationvalueset |
| trendVS | Trendvalueset |
| underlyingAnatomicalStructureVS | UnderlyingAnatomicalStructurevalueset |
| woundAnatomicLocationVS | WoundAnatomicLocationvalueset |
| woundAssessmentInterpretationVS | WoundAssessmentInterpretationvalueset |
| woundBedAppearanceVS | WoundBedAppearanceValueSet |
| woundBedColorVS | Wound Bed Color value set |
| woundEdgeColorVS | WoundEdgeColorValueSet |
| woundEdgeDescriptionVS | WoundEdgeDescriptionValueSet |
| woundExudateAmountDescriptionVS | WoundExudateAmountDescriptionValueSet |
| woundExudateAppearanceVS | WoundExudateAppearanceValueSet |
| woundExudateColorVS | WoundExudateColorValueSet |
| woundExudateOdorVS | WoundExudateOdorValueSet |
| woundGradationVS | WoundGradationValueSet |
| woundInternalItemOrBodyStructureVisibleVS | WoundInternalItemOrBodyStructureVisiblevalueset |
| woundMeasurementDeviceVS | WoundMeasurementDeviceValueSet |
| woundShapeVS | Wound Shape value set |
| woundTypeEtiologyVS | WoundTypeEtiologyvalueset |
| woundTypeVS | CIMIWoundTypevalueset |
| yesNoVS | YesNoValueSet |
| ACPTreatmentCodelist | ACP behandelingen waardelijst |
| ProbleemNaamCodelist | Zorgviewer probleem naam waardelijst |
| SubjectRoleCodelist | Subject rol (beroepen) waardelijst |
| VerrichtingTypeCodelist | Zorgviewer verrichting type waardelijst |
| InfectiousDiseaseVS | Infectious Disease VS |
| pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| pcd-sleep-observation-value | Patient contributed data: sleep stage value |
| RIPT.Medical.Necessity.VS | Medical_Necessity_VS |
| RIPT.Reason.for.Interfacility.Transport.VS | Reason_for_Interfacility_Transport_VS |
| AllCOVID19RiskFactors | All COVID-19 Risk Factors |
| COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors |
| COVID19Antibody | COVID-19 Antibody |
| COVID19Complications | COVID-19 Complications |
| COVID19DXSNOMED | COVID-19 SNOMED |
| COVID19Exposures | COVID-19 Exposures |
| COVID19Organism | COVID-19 Organism |
| CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors |
| ConfirmedCOVID19Diagnoses | Confirmed COVID-19 Diagnosis Values |
| DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors |
| EventContext | Event Context |
| HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors |
| IsolationPrecautions | COVID-19 Isolation Precautions |
| KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors |
| NegativeResults | COVID-19 Not Detected |
| NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors |
| ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors |
| PositiveResults | COVID-19 Detected |
| PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors |
| Remdesivir | Remdesivir |
| SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors |
| SuspectedCOVID19Diagnoses | Suspected COVID19 Diagnoses |
| SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 |
| TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors |
| VentilatorDevices | Ventilator Devices |
| VentilatorProcedures | Ventilator Procedures |
| body-site | SNOMEDCT-健保重大傷病-身體部位值集 |
| document-entry-class | DocumentEntry Class |
| document-entry-type | DocumentEntry Type |
| ethnicity | Ethnicity |
| specimen-type | Specimen Type |
| Advance.Directives.VS | Advance Directives |
| Antepartum.Education.VS | Antepartum Education |
| Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
| Antepartum.History.of.Infection.VS | Antepartum History of Infection |
| Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
| Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
| Edema.VS | Edema observation |
| Fetal.Movement.VS | Fetal Movement |
| Fetal.Presentation.VS | Fetal Presentation |
| Presence.In.Urine.VS | Presence In Urine |
| Smoking.Status.VS | Smoking Status |
| fmc-allergy-code-vs | Fresenius Allergy Code Value Set |
| fmc-sexual-orientation-vs | Fresenius Sexual Orientation Value Set |
| ConditionDiagnosisSeverity | ConditionDiagnosisSeverity |
| DiagnosesSCT | DiagnosesSCT |
| EncounterReasonCodes | EncounterReasonCodes |
| ISiKKernTempSctVS | ISiK Kerntemperatur SnomedCT ValueSet |
| ISiKTerminPriority | ISiKTerminPriority |
| ProzedurenCodesSCT | ProzedurenCodesSCT |
| ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| SctRouteOfAdministration | SctRouteOfAdministration |
| vs-mii-icu-bodysite-observation-blutdruck | VS MII ICU BodySite Observation Blutdruck |
| vs-mii-icu-bodysite-observation-monitoring-und-vitaldaten | VS MII ICU BodySite Observation Monitoring und Vitaldaten |
| vs-mii-icu-code-monitoring-und-vitaldaten-snomed | VS MII ICU Code Monitoring und Vitaldaten [sct] |
| vs-mii-icu-method-observation-blutdruck | VS MII ICU Method Observation Blutdruck |
| mii-vs-mikrobio-aviditaet-snomedct | MII VS Mikrobio Aviditaet [SNOMED CT] |
| mii-vs-mikrobio-eucast-snomedct | MII VS Mikrobio EUCAST [SNOMED CT] |
| mii-vs-mikrobio-kultur-methode-snomedct | MII VS Mikrobio Kultur Methode[SNOMED CT] |
| mii-vs-mikrobio-mikroskopiemethoden-snomedct | MII VS Mikrobio Mikroskopiemethoden [SNOMED CT] |
| mii-vs-mikrobio-morphologie-snomedct | MII VS Mikrobio Morphologie [SNOMED CT] |
| mii-vs-mikrobio-mre-klasse-snomedct | MII VS Mikrobio MRE Klasse [SNOMED CT] |
| mii-vs-mikrobio-organismen-snomedct | MII VS Mikrobio Organismen [SNOMED CT] |
| mii-vs-mikrobio-positiv-negativ-snomedct | MII VS Mikrobio Positiv Negativ [SNOMED CT] |
| mii-vs-mikrobio-qualitative-labor-ergebnisse-snomedct | MII VS Mikrobio Qualitative Labor Ergebnisse [SNOMED CT] |
| mii-vs-mikrobio-voraussichtliche-empfindlichkeit-snomedct | MII VS Mikrobio Voraussichtliche Empfindlichkeit [SNOMED CT] |
| medicationreasoncode | Medication Reason Code |
| medication-repeat-pattern | Medication Repeat Pattern EHR |
| pharmaceuticalbiologicproductandsubstancecode | PharmaceuticalBiologicProductAndSubstanceCode |
| practitioner-specialty | Practitioner Specialty EHR |
| prescribedquantityunit | Prescribed Quantity Unit |
| prescriptiondosequantityunit | PrescriptionDoseQuantityUnit |
| procedure-body-part | Procedure Body Part EHR |
| procedure-contrast-used | Procedure Contrast Used EHR |
| procedure-laterality | Procedure Laterality EHR |
| procedure-specialty | Procedure Specialty EHR |
| procedure-type-sct | Procedure Type SNOMED CT EHR |
| routeofadministration | Route Of Administration |
| epa-plan-composition-code-vs | EPA Plan Composition Code ValueSet |
| epa-plan-observation-list-code-vs | EPA Observation List Code ValueSet |
| KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency |
| KBV_VS_MIO_DPE_Declaration_Type | Art der Erklärung |
| KBV_VS_MIO_NFD_Implant | Medizinprodukt |
| KBV_VS_MIO_NFD_Person_Institution | BAI_ART |
| KBV_VS_MIO_NFD_Procedure | Prozedur SNOMEDCT |
| KBV_VS_MIO_NFD_Reaction_Allergy | Manifestation |
| KBV_VS_MIO_NFD_Runaway_Risk | Weglaufgefährdung |
| KBV_VS_MIO_NFD_Allergy_Substance | Allergie Substanz |
| KBV_VS_MIO_NFD_Communication_Disorder | Kommunikationsstörung |
| delivery-method | DeliveryMethod |
| facet | Facet |
| healthcareservice-categories | HealthcareServiceCategories |
| qualified-expertise-role-type | QualifiedExpertiseRoleType |
| KLComplicationCodesSCT | KLComplicationCodesSCT |
| KLEvaluationTypeCodesSCT | KLEvaluationTypeCodesSCT |
| KLObservationCodes | KLObservationCodes |
| procedure-cohesion-category | 中醫處置值集 |
| treatment-region-sct-tw | SNOMED CT + 臺灣診療部位值集 |
| Wundgrund | Wundgrund (SNOMED) |
| Wundrand | Wundrand |
| Wundumgebung | Wundumgebung |
| Wundlokalisation | Lokalisation der Wunde (SNOMED) |
| Schmerzassessmentskalen | Scores für Schmerzen |
| Wundschmerz | Wundbezogener Schmerz (VAS, SNOMED) |
| Exsudatmenge | Exsudatmenge (SNOMED) |
| Exsudatfarbe | Exsudatfarbe (SNOMED) |
| Wundart | Wundarten (SNOMED) |
| WundVerband | Wundverband (SNOMED) |
| Ernaehrungsstatus | Ernährungsstatus |
| Hilfsmittel | Wundbezogene Hilfsmittel - Auswahl (SNOMED) |
| Immunstatus | Status Immunsystem (SNOMED) |
| Bewusstseinslevel_qualitativ | Bewusstseinslevel - qualitativ (SNOMED) |
| Bewusstseinslevel_quantitativ | Bewusstseinslevel - quantitativ (SNOMED) |
| EducationCode | Edukation Code |
| Laterality | PosiThera - Laterality |
| ProcedureCategory | Maßnahme - Kategorie |
| allergy-code | Allergie Code |
| contentVerbalAssessment | PosiThera - Inhalte verbaler Angaben |
| LowerLegBodyStructure | Location of Ulcer |
| mii-vs-patho-collection-method-snomed-ct | MII VS Patho Collection Method [SNOMED CT] |
| mii-vs-patho-container-type-snomed-ct | MII VS Patho Container Type [SNOMED CT] |
| mii-vs-patho-media-modality-snomed-ct | MII VS Patho Media Modality [SNOMED CT] |
| mii-vs-patho-problem-list-snomed-ct | MII VS Patho Problem List [SNOMED CT] |
| mii-vs-patho-processing-procedure-snomed-ct | MII VS Patho Processing Procedure [SNOMED CT] |
| mii-vs-patho-service-request-snomed-ct | MII VS Patho Service Request [SNOMED CT] |
| NICE-AdmitSource | NICE-AdmitSource |
| NICE-ConditionCodeList | NICE-ConditionCodeList |
| NICE-DischargeDisposition | NICE-DischargeDisposition |
| NICE-GeneralMeasurementCodeList | NICE-GeneralMeasurementCodeList |
| NICE-HospitalTypeCodelist | NICE-HospitalTypeCodelist |
| NICE-ProcedureCodeList | NICE-ProcedureCodeList |
| NICE-TreatmentCodelist | NICE-TreatmentCodelist |
| guardian-status | Guardian Status |
| person-relationship | Person Relationship |
| KBV_VS_Base_Allergy_Substance_SNOMED_CT | Allergie Substanz SNOMED CT® |
| KBV_VS_Base_Apgar_Score_Identifier_SNOMED_CT | Apgar Score SNOMED CT® |
| KBV_VS_Base_Apgar_Score_Value | Apgar Score Wert |
| KBV_VS_Base_Body_Weight_Method_SNOMED_CT | Körpergewicht Methode Datenerhebung SNOMED CT® |
| KBV_VS_Base_Device_SNOMED_CT | Gerät SNOMED CT® |
| KBV_VS_Base_Diagnosis_SNOMED_CT | Diagnose SNOMED CT® |
| KBV_VS_Base_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
| KBV_VS_Base_Drug_Therapy_Status_Codes_SNOMED_CT | Medikation Therapie Statuscodes SNOMED CT® |
| KBV_VS_Base_Glucose_Concentration_Interpretation | Glukosespiegel Interpretation |
| KBV_VS_Base_Glucose_Concentration_Method_SNOMED_CT | Glukosespiegel Methode SNOMED CT® |
| KBV_VS_Base_Glucose_Concentration_SNOMED_CT | Glukosespiegel SNOMED CT® |
| KBV_VS_Base_Head_Circumference_BodySite_SNOMED_CT | Head Circumference BodySite SNOMED CT® |
| KBV_VS_Base_Medication_Type | Arzneimittel/Rezeptur |
| KBV_VS_Base_Nursing_Professions | Pflegefachberufe SNOMED CT® |
| KBV_VS_Base_PRN_Medication_Reason_SNOMED_CT | Bedarfsmedikation Bedingung SNOMED CT® |
| KBV_VS_Base_Pain_Scale_SNOMED_CT | Schmerzskala SNOMED CT® |
| KBV_VS_Base_Practitioner_Speciality_SNOMED_CT | Behandelnder SNOMED CT® |
| KBV_VS_Base_Pregnancy_Status_Method_SNOMED_CT | Schwangerschaftsstatus Methode SNOMED CT® |
| KBV_VS_Base_Procedure_Categories_SNOMED_CT | Prozeduren Kategorie SNOMED CT® |
| KBV_VS_Base_Procedure_SNOMED_CT | Prozedur SNOMED CT® |
| KBV_VS_Base_Reaction_Allergy | Manifestation SNOMED CT® |
| KBV_VS_Base_Route_of_Administration_SNOMED_CT | Verabreichungsweg SNOMED CT® |
| KBV_VS_Base_Stage_Life | Stage Life SNOMED CT® |
| ppr-qualified-expertise-role-type | QualifiedExpertiseRoleType |
| service-category-eServices | Service Category-eServices |
| KBV_VS_Base_Apgar_Score_Identifier_Snomed | KBV_VS_Base_Apgar_Score_Identifier_Snomed |
| KBV_VS_Base_Body_Height_Snomed | Koerpergroesse |
| KBV_VS_Base_Body_Weight_Method_Snomed | Koerpergroesse |
| KBV_VS_Base_Body_Weight_Snomed | Koerpergroesse |
| KBV_VS_Base_Diagnose_Snomed_CT | SNOMED CT Diagnosen |
| KBV_VS_Base_Head_Circumference_BodySite_Snomed | Körperstelle Kopfumfang |
| KBV_VS_Base_Head_Circumference_Snomed | KBV_VS_Base_Head_Circumference_Snomed |
| KBV_VS_Base_Practitioner_Speciality_Addendum | Rolle des Behandelnden |
| KBV_VS_Base_Body_Temp_Snomed | KBV_VS_Base_Body_Temp_Snomed |
| KBV_VS_Base_Heart_Rate_Snomed | KBV_VS_Base_Heart_Rate_Snomed |
| species | Questionnaire Context Species |
| answerSetAcuteHBVD | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
| answerSetAcuteHCVD | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
| answerSetCauseDiagnosisMYTD | Anwort Anlass der Diagnose bei Tuberkulose |
| answerSetCoinfectionHDVD | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
| answerSetConservationCLOD | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
| answerSetConsumptionCLOD | Antwort zum Ort des Verzehrs bei Botulismus |
| answerSetDiagnosisCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
| answerSetFoodCLOD | Antwort zum verzehrten Lebensmittel bei Botulismus |
| answerSetFormBAND | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand" |
| answerSetFormCDFD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
| answerSetFormCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
| answerSetFormCLOD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus" |
| answerSetFormCORD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie" |
| answerSetFormMYBD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch" |
| answerSetFormYPSD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest" |
| answerSetInfectionAnimalWhereHUSD | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
| answerSetInfectionEnvironmentSettingCVDD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| answerSetInfectionEnvironmentSettingMYTD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose" |
| answerSetInfectionPathCJKD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)" |
| answerSetInfectionPathHAVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A" |
| answerSetInfectionPathHBVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B" |
| answerSetInfectionPathHCVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C" |
| answerSetInfectionPathHEVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E" |
| answerSetInfectionPathHUSD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| answerSetInfectionPathIZVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza" |
| answerSetInfectionPathMPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox" |
| answerSetInfectionPathOPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere" |
| answerSetInfectionPathWhoHUSD | Antwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| answerSetInfectionRiskAnimalHEVD | Antwort zu Tierkontakt bei Hepatitis E |
| answerSetInfectionRiskAnimalHUSD | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
| answerSetInfectionRiskAnimalRBVD | Antwort zu Tierkontakt bei Tollwut |
| answerSetInfectionRiskAnimalTTVD | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
| answerSetInfectionRiskCVDD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| answerSetInfectionRiskIZVD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza" |
| answerSetInfectionRiskJobHEVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E" |
| answerSetInfectionRiskJobHTVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
| answerSetInfectionRiskNEID | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung" |
| answerSetInfectionRiskOtherHEVD | Antwort zu Sonstiger Kontakt bei Hepatitis E |
| answerSetLocationLymphNodeSwellingMPXD | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
| answerSetLocationMucosalLesionsMPXD | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
| answerSetLocationSkinLesionsMPXD | Anwort Lokalisation der Hautläsionen bei Mpox |
| answerSetMajorSiteMYTD | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
| answerSetManufacturingCLOD | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
| answerSetMethodCDFD | Antwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
| answerSetMinorSiteMYTD | Anwort weiteres betroffenes Organ bei Tuberkulose |
| answerSetPathogenHFAD | Antwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber" |
| answerSetResultOfPrevTreatmentMYTD | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
| answerSetResultOfTreatmentMYTD | Anwort Behandlungsergebnis bei Tuberkulose |
| answerSetStadiumHBVD | Anwort Stadium der Infektion bei Hepatitis B |
| answerSetStadiumHCVD | Anwort Stadium der Infektion bei Hepatitis C |
| answerSetTransmissionKindHBVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B |
| answerSetTransmissionKindHCVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C |
| answerSetTrimester | Antwort zum Trimester |
| diagnosisHXXD | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Akute Virushepatitis" |
| diagnosisSXXD | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| evidenceBAND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Milzbrand" |
| evidenceBPSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Keuchhusten" |
| evidenceCLOD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Botulismus" |
| evidenceCORD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Diphtherie" |
| evidenceCVDD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| evidenceCVDDv1 | Coronavirus-Krankheit-2019 (COVID-19) -Symptom und -Manifestation Version 1 |
| evidenceDEND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Denguefieber" |
| evidenceEBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Ebolafieber" |
| evidenceGFVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Gelbfieber" |
| evidenceHAVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis A" |
| evidenceHBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis B" |
| evidenceHCVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis C" |
| evidenceHDVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis D" |
| evidenceHEVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis E" |
| evidenceHFAD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämorrhagisches Fieber" |
| evidenceHTVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
| evidenceHUSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| evidenceHXXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
| evidenceIZVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
| evidenceLSVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Lassafieber" |
| evidenceMBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Marburgfieber" |
| evidenceMPVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mumps" |
| evidenceMPXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mpox" |
| evidenceMSVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Masern" |
| evidenceNEID | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
| evidenceOPXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Orthopocken, andere" |
| evidencePKVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pocken" |
| evidencePOVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Poliomyelitis" |
| evidenceRBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Tollwut" |
| evidenceRUND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, konnatal" |
| evidenceRUVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, postnatal" |
| evidenceSPAD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus" |
| evidenceSSPD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
| evidenceSTYD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Typhus" |
| evidenceSXXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| evidenceVCHD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Cholera" |
| evidenceVZWD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Windpocken" |
| evidenceVZZD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Herpes Zoster" |
| evidenceYPSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pest" |
| vaccineBAND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand" |
| vaccineBPSD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten" |
| vaccineCDFD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
| vaccineCORD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie" |
| vaccineCVDD-SNOMED | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" als SNOMED-Code |
| vaccineDEND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber" |
| vaccineEBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber" |
| vaccineGFVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber" |
| vaccineHAVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A" |
| vaccineHBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B" |
| vaccineHDVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D" |
| vaccineHEVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E" |
| vaccineHXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
| vaccineIZVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
| vaccineMPVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps" |
| vaccineMPXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox" |
| vaccineMSVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern" |
| vaccineMYTD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose" |
| vaccineNEID | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
| vaccinePKVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken" |
| vaccinePOVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis" |
| vaccineRBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut" |
| vaccineRUVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal" |
| vaccineSSPD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
| vaccineSTYD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus" |
| vaccineSXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| vaccineTTVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht" |
| vaccineVCHD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera" |
| vaccineVZWD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken" |
| vaccineVZZD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster" |
| demog-alert-code | Demog Alert Code |
| encounter-department-type | Encounter Department Type |
| adverse-event-event-my-core | ValueSetAdverseEventEvent (MY Core) |
| allergy-manifestation-my-core | value-set-allergy-manifestation-my-core |
| allergy-negation-my-core | ValueSetAllergyNegation (MY Core) |
| child-identification-type-my-core | ValueSetChildIdentificationType (MY Core) |
| developmental-milestone-my-core | ValueSetDevelopmentalMilestone (MY Core) |
| glucose-level-my-core | ValueSetGlucoseLevel(MY Core) |
| observation-glucose-my-core | ValueSetObservationGlucose (MY Core) |
| observation-social-history-my-core | ValueSetObservationSocialHistory (MY Core) |
| procedure-category-my-core | ValueSetProcedureCategory (MY Core) |
| procedure-code-my-core | ValueSetProcedureCode (MY Core) |
| side-my-core | ValueSetSide (MY Core) |
| site-my-core | ValueSetSite (MY Core) |
| DiagnosesSCT | DiagnosesSCT |
| ProzedurenCodesSCT | ProzedurenCodesSCT |
| ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| mii-vs-bildgebung-diagnostic-report-coding | MII VS Bildgebung DiagnosticReport Coding |
| mii-vs-bildgebung-service-request-coding | MII VS Bildgebung ServiceRequest Coding |
| mii-vs-bildgebung-service-request-reason | MII VS Bildgebung ServiceRequest Reason |
| BeVSPopulationScreeningFollowUpAdvice | Population Screening Follow-up Advice Value Set |
| be-populationscreening-result-vs | PopulationScreening Result Value Set |
| be-vs-populationscreening-type | Population Screening Type Value Set |
| be-vspopulationscreening-body-site-location | PopulationScreening Body Site Value Set |
| 2.16.840.1.113883.2.4.3.11.60.42.11.3--20241004140515 | StatusCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.42.11.2--20241003115148 | VerrichtingCategorieCodelijst |
| nfdi4health-vs-mds-cd-common-chronic-disease-name-sct-local | NFDI4Health CD Common Chronic Disease Name [SNOMED CT, Local] |
| nfdi4health-vs-mds-ne-device-nci-snomedct-local | NFDI4Health NE Device [NCI, SNOMED CT, Local] |
| nfdi4health-vs-mds-ne-portion-size-snomedct-local | NFDI4Health NE Portion Size [SNOMED CT, Local] |
| nfdi4health-vs-mds-ne-reference-period-unit-sct | NFDI4Health NE Portion Size [SNOMED CT] |
| nfdi4health-vs-mds-role-name-type-snomed | NFDI4Health VS MDS Role Name Type [SNOMED] |
| nfdi4health-vs-mds-study-assessments-sct-nci | NFDI4Health VS MDS Study Assessments [SCT, NCI] |
| nfdi4health-vs-mds-study-centers-snomedct-local | NFDI4Health VS MDS Study Centers [SNOMED CT, local] |
| nfdi4health-vs-mds-study-data-sharing-plan-ds-sct-nci | NFDI4Health VS MDS Study Data Sharing Plan Datashield [SCT, NCI] |
| nfdi4health-vs-mds-study-diseases-generally-icd-sct | NFDI4Health VS MDS Study Groups Of Diseases Generally [ICD 10, SCT] |
| nfdi4health-vs-mds-study-ds-biosamples-sct-nci | NFDI4Health VS MDS Study Data Sources Biosamples [SCT, NCI] |
| nfdi4health-vs-mds-study-eligibility-gender-snomedct-local | NFDI4Health VS MDS Study Eligibility Criteria Genders [local, SNOMED CT] |
| nfdi4health-vs-mds-study-recruitment-register-nci-sct-local | NFDI4Health VS MDS Study Recruitment Register [NCI, SCT, Local] |
| nfdi4health-vs-mds-study-subject-snomedct | NFDI4Health VS MDS Study Subject [SNOMED CT] |
| nfdi4health-vs-mds-use-rights-label-spdx-smomed-local | NFDI4Health VS MDS Use Rights Label [SPDX, SNOMED, Local] |
| nfdi4health-vs-mds-yes-no-not-applicable-snomedct | NFDI4Health VS MDS Yes, No, Not Applicable [SNOMED CT] |
| KBV_VS_MIO_LAB_Body_Site | Körperstelle |
| KBV_VS_MIO_LAB_Device_Type | Gerät |
| KBV_VS_MIO_LAB_ELGA_Specimen_Type_SNOMED | ELGA Probenart SNOMED |
| KBV_VS_MIO_LAB_Specimen_Collection_Method | Probenentnahme-Methode |
| s4h-back-pain-location | S4hBackPainLocation |
| language-use | Language Use |
| personal-income-source | Personal Income Source |
| pre-existing-conditions | Pre-existing Conditions |
| service-termination-reason | Service Termination Reason |
| citizenshipStatus | Citizenship Status |
| sdohObservationCode | SDOH Observation Code |
| employment-status | Employment Status |
| highest-level-of-education-attained | Highest Level of Education Attained |
| sexual-orientation | Sexual Orientation |
| EkgAbleitungenVS | SNOMED CT codes der EKG Ableitungen |
| VitalSignDE-Atemfrequenz-SNOMED-CT | VitalSignDE_Atemfrequenz_SNOMED_CT |
| VitalSignDE-Herzfrequenz-SNOMED-CT | VitalSignDE_Herzfrequenz_SNOMED_CT |
| VitalSignDE-Koerpergewicht-SNOMED-CT | VitalSignDE_Koerpergewicht_SNOMED_CT |
| VitalSignDE-Koerpergroesse-SNOMED-CT | VitalSignDE_Koerpergroesse_SNOMED_CT |
| VitalSignDE-Koerpertemperatur-SNOMED-CT | VitalSignDE_Koerpertemperatur_SNOMED_CT |
| VitalSignDE-Kopfumfang-SNOMED-CT | VitalSignDE_Kopfumfang_SNOMED_CT |
| VitalSignDE-Sauerstoffsaettigung-SNOMED-CT | VitalSignDE_Sauerstoffsaettigung_SNOMED_CT |
| lebensphase-de | LebensphaseDe ValueSet |
| KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_Snomed | Art der Immunreaktion SCT2 |
| KBV_VS_MIO_Vaccination_Lab_ImmuneReaction_Test_Presence_Tuberculin | Tuberkulin-Test |
| KBV_VS_MIO_Vaccination_Lab_Titer_Immunity | Titer Immunität |
| KBV_VS_MIO_Vaccination_Practitioner_Speciality_Addendum | KBV_VS_MIO_Vaccination_Practitioner_Speciality_Addendum |
| KBV_VS_MIO_Vaccination_Prior_Disease | VaccinationrelevantDisease |
| KBV_VS_MIO_Vaccination_Source_of_Information | Source_of_Information |
| KBV_VS_MIO_Vaccination_TargetDisease | TargetDisease |
| KBV_VS_MIO_Vaccination_Vaccine_Brucella | Vaccine_Brucella |
| KBV_VS_MIO_Vaccination_Vaccine_Immunoglobulin_List | Immunglobulin |
| KBV_VS_MIO_Vaccination_Vaccine_List | Vaccine |
| DiagnosesSCT | DiagnosesSCT |
| ProzedurenCodesSCT | ProzedurenCodesSCT |
| ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| cimi-context-DeltaFlagVS | BC DeltaFlagVS ValueSet |
| cimi-context-PresenceContextVS | BC PresenceContextVS ValueSet |
| cimi-element-AnatomicalLocationVS | BC AnatomicalLocationVS ValueSet |
| oncology-BreastCancerDetectionVS | BC BreastCancerDetectionVS ValueSet |
| oncology-BreastCarcinomaHistologicTypeVS | BC BreastCarcinomaHistologicTypeVS ValueSet |
| oncology-BreastLymphNodeGroupVS | BC BreastLymphNodeGroupVS ValueSet |
| oncology-BreastSiteVS | BC BreastSiteVS ValueSet |
| oncology-BreastSpecimenCollectionMethodVS | BC BreastSpecimenCollectionMethodVS ValueSet |
| oncology-BreastSpecimenTypeVS | BC BreastSpecimenTypeVS ValueSet |
| oncology-DCISNuclearGradeVS | BC DCISNuclearGradeVS ValueSet |
| oncology-HER2FISHMethodVS | BC HER2FISHMethodVS ValueSet |
| oncology-Ki-67NuclearAntigenVS | BC Ki-67NuclearAntigenVS ValueSet |
| oncology-LymphNodeClinicalMethodVS | BC LymphNodeClinicalMethodVS ValueSet |
| oncology-LymphNodeInvolvementVS | BC LymphNodeInvolvementVS ValueSet |
| oncology-LymphNodeMobilityVS | BC LymphNodeMobilityVS ValueSet |
| oncology-LymphNodeSamplingMethodVS | BC LymphNodeSamplingMethodVS ValueSet |
| oncology-MorphologyBehaviorVS | BC MorphologyBehaviorVS ValueSet |
| oncology-StainingIntensityVS | BC StainingIntensityVS ValueSet |
| oncology-TumorMarginDescriptionVS | BC TumorMarginDescriptionVS ValueSet |
| shr-core-ClockDirectionVS | BC ClockDirectionVS ValueSet |
| shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet |
| shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet |
| shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet |
| all-snomed-codes | All Snomed Codes |
| body-site-laterlity | Body Site Laterality |
| HCIMLegalSituationCategory | HCIM LegalSituation Category |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.4--20200901000000 | RedenVanToepassenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.1--20200901000000 | SoortInterventieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.2--20200901000000 | SoortInterventieWvggzCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.3--20200901000000 | SoortInterventieWzdCodelijst |
| ActicoreTherapieTyp | Acticore Therapie-Typen |
| SHD-ReferralRequestType | SHD-ReferralRequestType |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.254--20200406100640 | a terme datum obv (23) |
| 2.16.840.1.113883.2.4.11.355--20220117102535 | AanUitKleden_GZ |
| 2.16.840.1.113883.2.4.11.265--20210525145536 | Aanvang Probleem |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.285--20200616133418 | Ademhaling |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.214--20160125115042 | Specificatie van de afwijking van placenta en/of vliezen en/of navelstreng (2.2) |
| 2.16.840.1.113883.2.4.11.19--20141222113040 | AmniotomieMoment |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.31--20140922095444 | Anemie (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.28--20140919141340 | Auto-immuun aandoening (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.40.2.2.2.1--20200901000000 | BehandelingCodelijst |
| 2.16.840.1.113883.2.4.11.317--20210322154057 | BeleidProfessioneelOnderzoek 3.2 |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.14.1--20200901000000 | BepalingsMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.341--20210225105013 | BetrokkenheidKinderarts |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.260--20200407134908 | Bevinding_Hart |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.323--20201124142938 | Bevindingen borsten 3.2 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.264--20200409090337 | Beweging |
| 2.16.840.1.113883.2.4.11.309--20210128112703 | Blood Group Antibodies 3.2 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.11--20140814133240 | Cardiovasculaire aandoeningen |
| 2.16.840.1.113883.2.4.11.175--20130422173433 | Cervical dilatation |
| 2.16.840.1.113883.2.4.11.175--20201210140135 | Cervical dilatation |
| 2.16.840.1.113883.2.4.11.158--20120317000000 | Cervix Effacement |
| 2.16.840.1.113883.2.4.11.158--20201210134951 | Cervix Effacement |
| 2.16.840.1.113883.2.4.11.198--20161026164418 | ChromosomaleAfwijkingen |
| 2.16.840.1.113883.2.4.11.230--20170201162016 | Compleetheid vliezen |
| 2.16.840.1.113883.2.4.11.160--20120317000000 | Completeness placenta |
| 2.16.840.1.113883.2.4.11.310--20210201115558 | ConclusieProfessioneelOnderzoek 3.2 |
| 2.16.840.1.113883.2.4.11.294--20200129150958 | ConclusieUterusContracties |
| 2.16.840.1.113883.2.4.11.315--20210222102852 | Conditie Sfincter (3.2) |
| 2.16.840.1.113883.2.4.11.368--20220210155748 | Conditie Perineum Observatie |
| 2.16.840.1.113883.2.4.11.354--20220110114406 | Conditie VrouwelijkeGeslachtsorganen |
| 2.16.840.1.113883.2.4.11.192--20140122110447 | Conditie perineum (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.301--20200901151615 | Conditie perineum (3.2) |
| 2.16.840.1.113883.2.4.11.196--20191010091229 | Congenitale afwijking |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.284--20200610131200 | ContactSoort |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.324--20201124152403 | Controle benen 3.2 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.322--20201124115905 | Controle borsten 3.2 |
| 2.16.840.1.113883.2.4.11.279--20191118174055 | ControleNavelstomp |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.290--20200622000000 | Controle perineum |
| 2.16.840.1.113883.2.4.11.295--20200129154254 | DeceleratiesCodelijst |
| 2.16.840.1.113883.2.4.11.357--20220117103812 | Douchen_GZ |
| 2.16.840.1.113883.2.4.11.321--20210412154013 | Echelon_3.2 |
| 2.16.840.1.113883.2.4.11.251--20181119182547 | Ernst van de aandoening |
| 2.16.840.1.113883.2.4.11.351--20211214145747 | Eten_GZ |
| 2.16.840.1.113883.2.4.11.297--20200129155847 | FIGO_ScoreCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.10--20201117115600 | Fase Perinatale Sterfte (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.1--20171231000000 | FecesContinentieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.207--20201112144120 | Leven voelen |
| 2.16.840.1.113883.2.4.11.296--20200129155035 | FoetaleHartslagVariabiliteit |
| 2.16.840.1.113883.2.4.11.298--20200129160647 | FoetaleMonitoringMethode |
| 2.16.840.1.113883.2.4.11.299--20200129162827 | FoetaleMonitoringMoment |
| 2.16.840.1.113883.2.4.11.227--20170201134622 | Foliumzuur gebruik |
| 2.16.840.1.113883.2.4.11.235--20170203161446 | Frequentie hartslag |
| 2.16.840.1.113883.2.4.11.226--20161216162923 | Fundusstand (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.246--20191028105919 | Fundusstand Kraamzorg |
| 2.16.840.1.113883.2.4.11.313--20210210164932 | Geboorte Placenta 3.2 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.37--20141020151252 | Groei afwijkend |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.16--20140814134544 | Gynaecologische aandoeningen |
| 2.16.840.1.113883.2.4.11.236--20170203161659 | Hartactie op basis van |
| 2.16.840.1.113883.2.4.11.159--20120317000000 | Hodge Planes |
| 2.16.840.1.113883.2.4.11.159--20210621112616 | Hodge Planes |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.274--20200512160326 | Huilgedrag baby |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.36--20141020145518 | Hypertensieve aandoening |
| 2.16.840.1.113883.2.4.11.223--20161202162349 | IUVD methode |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.320--20201112155937 | Indaling (3.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.204--20141021114554 | Infectie (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.15--20140814134341 | Infectieziekten |
| 2.16.840.1.113883.2.4.11.291--20200129144103 | IntensiteitUterusContracties |
| 2.16.840.1.113883.2.4.3.11.60.40.2.15.2.1--20200901000000 | IntentieBehandelingCodelijst |
| 2.16.840.1.113883.2.4.11.189--20140120142052 | Interventie begin baring (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.26--20140919115814 | Intra-uteriene behandeling (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.266--20200414155952 | KeuzeTest |
| 2.16.840.1.113883.2.4.11.20--20210222094051 | KleurVruchtwater |
| 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.2--20200901000000 | LateraliteitCodelijst |
| 2.16.840.1.113883.2.4.11.188--20140102000000 | Ligging |
| 2.16.840.1.113883.2.4.11.177--20131224000000 | LiggingBijGeboorte22 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.287--20200619144804 | Lochia |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.205--20141027141746 | Longaandoening |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.29--20140919144015 | Maag Darm Lever aandoening (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.282--20200526172902 | MeetMethode_GZ |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.258--20200406134703 | Methode_1e_trimester_SEO |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.226--20180816141641 | MicroorganismeCongInfectCodelijst_LNR |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.249--20191205111425 | MicroorganismeSepsisMeningCodelijst_LNR |
| 2.16.840.1.113883.2.4.11.353--20211214152957 | Mobiliteit_GZ |
| 2.16.840.1.113883.2.4.11.231--20170201164126 | Navelstreng vaten |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.14--20140814134140 | Neurologische aandoeningen |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.337--20201207162228 | ObservatieKind_Abdomen |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.339--20201208105521 | ObservatieKind_Extremiteiten |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.335--20201203120002 | ObservatieKind_Genitalia |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.326--20201201113630 | ObservatieKind_Hoofd-Hals |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.305--20200921120509 | ObservatieKind_Huid |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.340--20201208121209 | ObservatieKind_Neurologie |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.338--20201208102213 | ObservatieKind_Rug |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.328--20201201152903 | ObservatieKind_Thorax |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.27--20140919131821 | Oncologische aandoening (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.229--20181012134434 | Ondersteuning_Ontslag_Huis |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.255--20200406115120 | Onderzoektype |
| 2.16.840.1.113883.2.4.11.283--20200101130352 | OnsetCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.265--20200409144953 | Ontlasting zuigeling |
| 2.16.840.1.113883.2.4.11.369--20220214141440 | Opname Indicatie Kind (3.2) |
| 2.16.840.1.113883.2.4.11.322--20210506140617 | OrgaansysteemFoetus |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.17--20140814134642 | Orthopedische afwijkingen |
| 2.16.840.1.113883.2.4.11.272--20190925122834 | Ostium |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.20--20161123204523 | Overige interventies |
| 2.16.840.1.113883.2.4.11.195--20140102000000 | Partus stadium |
| 2.16.840.1.113883.2.4.11.202--20161123213413 | Pediatrische verwijsindicatie |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.342--20210225121553 | PlacentaCompleet (3.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.209--20141128125356 | Placentalokalisatie (2.2) |
| 2.16.840.1.113883.2.4.11.213--20160425122048 | Positie portio (2.2) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20191218092252 | Postpartum complicatie |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20210413094135 | Postpartum complicatie |
| 2.16.840.1.113883.2.4.11.172--20130320000000 | Presentation of fetus |
| 2.16.840.1.113883.2.4.11.172--20201210141721 | Presentation of fetus |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20171231000000 | ProbleemNaamCodelijst |
| 2.16.840.1.113883.2.4.11.337--20210628164200 | ProbleemNaam_AcuteOverdracht |
| 2.16.840.1.113883.2.4.11.328--20210520161536 | ProbleemNaam_Congenitale Afwijking Obstetrie |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.298--20200824133956 | ProbleemNaam CongenitaleAfwijking Pediatrie |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.299--20200824154514 | ProbleemNaam CongenitaleAfwijking Kraam |
| 2.16.840.1.113883.2.4.11.327--20210518144535 | ProbleemNaam_Geboortetrauma (Kraam) |
| 2.16.840.1.113883.2.4.11.326--20210518125239 | ProbleemNaam_Geboortetrauma (Obstetrie) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.296--20200811105755 | ProbleemNaam_Geboortetrauma (Pediatrie) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.313--20201027113825 | ProbleemNaam_Hb-pathie (3.2) |
| 2.16.840.1.113883.2.4.11.319--20210323153828 | ProbleemNaam_HuidBaby |
| 2.16.840.1.113883.2.4.11.358--20220117155944 | ProbleemNaam_InfectiesGezin |
| 2.16.840.1.113883.2.4.11.304--20200213111855 | ProbleemNaam_KindspecifiekMaternaal |
| 2.16.840.1.113883.2.4.11.289--20200127101358 | ProbleemNaam_Maternaal |
| 2.16.840.1.113883.2.4.11.325--20210518104806 | ProbleemNaam_Probleem Kind (Kraam) |
| 2.16.840.1.113883.2.4.11.324--20210518101158 | ProbleemNaam_Probleem Kind (Obstetrie) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.295--20200810122858 | ProbleemNaam_Problematiek Kind (Pediatrie) |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.231--20220120134819 | ProbleemNaam_Zintuigen (Neonatologie) |
| 2.16.840.1.113883.2.4.11.302--20200211092928 | ProbleemNaam_Zwangerschap |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20210329100741 | ProbleemTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.12--20191009125104 | Problematiek kind |
| 2.16.840.1.113883.2.4.11.153--20120829000000 | Categorie Reden overdracht |
| 2.16.840.1.113883.2.4.11.234--20170203161304 | Regelmaat hartslag |
| 2.16.840.1.113883.2.4.11.292--20200129145703 | RegelmatigheidUterusActiviteit |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.219--20161124113309 | Indicatie secundaire sectio |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.220--20180228115805 | SC Indicatie - primaire sectio |
| 2.16.840.1.113883.2.4.11.370--20220221143159 | SchedelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.13--20140814134002 | Schildklieraandoeningen |
| 2.16.840.1.113883.2.4.11.323--20210506154515 | Sonomarkers 3.2 |
| 2.16.840.1.113883.2.4.11.284--20200103125137 | SpugenCodelijst |
| 2.16.840.1.113883.2.4.11.174--20151019205620 | Stand |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20171231000000 | TabakGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.11.350--20211214144904 | ToiletGebruik_GZ |
| 2.16.840.1.113883.2.4.11.352--20211214151241 | Transfer_GZ |
| 2.16.840.1.113883.2.4.11.356--20220117103400 | TrappenLopen_GZ |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.310--20201006145809 | TweelingzwangerschapType |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.18--20140814143051 | Type operatie |
| 2.16.840.1.113883.2.4.11.182--20200811153819 | TypePartus |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.19--20140814144207 | Type stollingsprobleem |
| 2.16.840.1.113883.2.4.11.221--20161201112008 | Type verwijzing |
| 2.16.840.1.113883.2.4.11.348--20211101122336 | TypeVerwijzing_3.2 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.21--20160108110123 | Type vrouwelijke genitale verminking |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.275--20200513143542 | Type Biologische Relatie |
| 2.16.840.1.113883.2.4.11.250--20181119171538 | Type anticonceptie |
| 2.16.840.1.113883.2.4.11.349--20211214143820 | UiterlijkeVerzorging_GZ |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.14.1--20171231000000 | UrineContinentieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.291--20200623135655 | Urine baby |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.30--20200114155725 | Urogenitale aandoening (2.2) |
| 2.16.840.1.113883.2.4.11.293--20200129150222 | UterusActiviteitMethode |
| 2.16.840.1.113883.2.4.11.181--20140102000000 | VaginaleKunstverlossing22 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.253--20200401105232 | Verdenking Afwijking Hersenen |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.283--20200527093520 | Verdenking Afwijking Wervelkolom Ruggemerg |
| 2.16.840.1.113883.2.4.11.359--20220131105223 | Verdenking Afwijking Aangezicht |
| 2.16.840.1.113883.2.4.11.363--20220131112406 | Verdenking Afwijking Buikwand |
| 2.16.840.1.113883.2.4.11.362--20220131111328 | Verdenking Afwijking Diafragma |
| 2.16.840.1.113883.2.4.11.367--20220131120004 | Verdenking Afwijking Extremiteiten |
| 2.16.840.1.113883.2.4.11.364--20220131113252 | Verdenking Afwijking MaagDarm |
| 2.16.840.1.113883.2.4.11.360--20220131110025 | Verdenking Afwijking Nek/Huid |
| 2.16.840.1.113883.2.4.11.365--20220131114808 | Verdenking Afwijking NierenBlaasUrogenitalis |
| 2.16.840.1.113883.2.4.11.366--20220131115327 | Verdenking_Afwijking_SkeletSpierstelsel |
| 2.16.840.1.113883.2.4.11.361--20220131110815 | Verdenking Afwijking ThoraxLuchtwegen |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20171231000000 | VerrichtingAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.3--20171231000000 | VerrichtingLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4--20171231000000 | VerrichtingMethodeCodelijst |
| 2.16.840.1.113883.2.4.11.375--20220321094419 | VerrichtingTypeGeboortezorgCodelijst |
| 2.16.840.1.113883.2.4.11.333--20210615102522 | VerrichtingType_ChirurgischeIngrepen_3.2 |
| 2.16.840.1.113883.2.4.11.288--20200123134654 | VerrichtingType_Kindspecifiek |
| 2.16.840.1.113883.2.4.11.303--20200213102349 | VerrichtingType_Maternaal |
| 2.16.840.1.113883.2.4.11.329--20210525162006 | VerrichtingType_ProblematiekKind |
| 2.16.840.1.113883.2.4.11.307--20200226094046 | VerrichtingType_Zwangerschap |
| 2.16.840.1.113883.2.4.11.173--20201210140520 | Vliezen |
| 2.16.840.1.113883.2.4.11.249--20181119171103 | Vloeien |
| 2.16.840.1.113883.2.4.11.331--20210607115708 | VoedingSoort_GZ |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.319--20201112122448 | VoorgenomenPlaatsBaring (3.2) |
| 2.16.840.1.113883.2.4.11.228--20170201140644 | Voorgenomen voeding |
| 2.16.840.1.113883.2.4.11.191--20140121165337 | Vruchtwater |
| 2.16.840.1.113883.2.4.11.178--20131230000000 | WerkelijkePlaatsBaring22 |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.321--20201117110614 | Werkelijke plaats baring 3.2 |
| 2.16.840.1.113883.2.4.11.308--20210126165826 | WijzeBeginBaring_32 |
| 2.16.840.1.113883.2.4.11.248--20181119170402 | Wond |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20171231000000 | WondRandCodelijst |
| 2.16.840.1.113883.2.4.11.374--20220316115154 | ZorgVoorKindOnzekerheid |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.292--20200623140138 | ZorgVoorKindVaardigheid |
| 2.16.840.1.113883.2.4.3.11.60.90.77.11.308--20201006103803 | ZorgverlenerType (3.2) |
| bc-BirthObservation-code | bc-BirthObservation-code |
| bc-ChildObservation-code | bc-ChildObservation-code |
| bc-DeliveryObservation-code | bc-DeliveryObservation-code |
| bc-FetusObservation-code | bc-FetusObservation-code |
| bc-MaternalObservation-code | bc-MaternalObservation-code |
| bc-PregnancyObservation-code | bc-PregnancyObservation-code |
| bc-ProcedureObservation-code | bc-ProcedureObservation-code |
| dhdr-medication-repeat-pattern | Medication Repeat Pattern |
| ee-clinical-specialty | Clinical Specialty |
| ee-person-relationship | Person Relationship |
| KLComplicationCodesSCT | KLKomplikationskoderSCT |
| KLEvaluationTypeCodesSCT | KLVurderingTypekoderSCT |
| KLObservationCodes | KLObservationskoder |
| anatomicalsite | Anatomical Site |
| disease | Disease Code |
| generic | Vaccine Generic Code |
| repsource | Immunization Reporting Source |
| routeofadmin | Route Of Administration |
| tradename | Vaccine Tradename Code |
| no-colonoscopy-boston-bowel-preparation-scale | Colonoscopy Report Boston Bowel Preparation Scale |
| no-colonoscopy-complication | Colonoscopy Report Complications |
| no-colonoscopy-complication-consequence | Colonoscopy Report Complication Consequences |
| no-colonoscopy-current-medication | Colonoscopy Report Current Medication |
| no-colonoscopy-followup | Colonoscopy Report Follow Up |
| no-colonoscopy-medication | Colonoscopy Report Medication |
| no-colonoscopy-medication-krg | KRG Medication |
| no-colonoscopy-method-tissue-removal-biopsy | Colonoscopy Report Tissue Removal Method |
| no-colonoscopy-normal-abnormal | Colonoscopy Report Normal/Abnormal |
| no-colonoscopy-paris-polyp-classification | Colonoscopy Report Colonoscopy Paris Polyp Classification |
| no-colonoscopy-relevant-conditions | Colonoscopy Report Relevant Conditions |
| no-colonoscopy-sedation-level | Colonoscopy Report Sedation Level |
| no-colonoscopy-segment-lesion | Colonoscopy Report Segment Lesion |
| no-colonoscopy-segment-reached | Colonoscopy Report Segment Lesion |
| no-colonoscopy-type | Colonoscopy Type |
| no-coloscopy-segment-reached | Colonoscopy Report Segment Reached |
| no-procedure-performer-function | Conoloscopy Report Performer Function |
| no-colonoscopy-procedure-reason-gastronet | Colonoscopy Report Indication |
| ch-emed-epr-amount-quantity-unit-code | Amount Quantity Unit Codes |
| EaseOfRespirationVS | Ease of Respiration Value Set |
| anesthesia-sct | SNOMED CT Anesthesia值集 |
| mcode-cancer-stage-type | mCode Cancer Stage Type值集 |
| mcode-cancer-stage | mCode Cancer Stage值集 |
| physical-examination-sct | SNOMED CT Physical Examination值集 |
| KBV_VS_MIO_MR_AB0_System | AB0-System |
| KBV_VS_MIO_MR_AB0_System_First_Examination_After_Childbirth | AB0-System des Kindes im Wochenbett |
| KBV_VS_MIO_MR_Biometrics_I | Biometrie I |
| KBV_VS_MIO_MR_Biometrics_II_III | Biometrie II und III |
| KBV_VS_MIO_MR_Birth_Mode | Geburtsmodus |
| KBV_VS_MIO_MR_Breastfeeding_Behavior | Stillverhalten der Mutter |
| KBV_VS_MIO_MR_Catalogue_A | Anamneseerhebung bei Erstuntersuchung |
| KBV_VS_MIO_MR_Child_Position | Kindslage |
| KBV_VS_MIO_MR_Counselling | Beratung von Schwangeren |
| KBV_VS_MIO_MR_Direct_Coombstest | Direkter Coombstest |
| KBV_VS_MIO_MR_Examination_Interpretation | Interpretation der Messergebnisse hinsichtlich der Immunität |
| KBV_VS_MIO_MR_Examination_Result_Qualitative | Qualitative Beurteilung der Messergebnisse |
| KBV_VS_MIO_MR_Examination_Snomed | Laboruntersuchungen |
| KBV_VS_MIO_MR_Findings_Required_Control | Kontrollbedürftige Befunde |
| KBV_VS_MIO_MR_General_Information | Allgemeine Angaben zum Fötus beim ersten Ultraschallscreening |
| KBV_VS_MIO_MR_Heart_Sounds_Child | Herztöne des Kindes |
| KBV_VS_MIO_MR_Immunization_Status | Nachweise der prophylaktischen Impfungen |
| KBV_VS_MIO_MR_Localisation_Placenta | Lokalisation/Struktur der Plazenta |
| KBV_VS_MIO_MR_Morphology | Morphologie |
| KBV_VS_MIO_MR_Other_Ultrasound_Studies | Weitere Ultraschalluntersuchungen |
| KBV_VS_MIO_MR_Practitioner_Function_Addendum | Funktionen/Rollen des Behandelnden Ergänzung |
| KBV_VS_MIO_MR_Pregnancy_Information | Angaben zur Schwangerschaft beim Ultraschallscreening |
| KBV_VS_MIO_MR_Rhesus_System | Rhesus-System |
| KBV_VS_MIO_MR_Rhesus_System_Fetus | Rhesus-System des Fötus |
| KBV_VS_MIO_MR_Special_Findings | Befundkatalog Besondere Befunde |
| KBV_VS_MIO_MR_oGTT_Diagnosistest | Oraler Glucosetoleranztest (oGTT) Diagnosetest |
| KBV_VS_MIO_MR_oGTT_Pretest | Oraler Glucosetoleranztest (oGTT) Vortest |
| substance-codes | SNOMED CT Substance Codes |
| clinical-specialty | Clinical Specialty |
| eestkoste-liik | Eestkoste liik |
| mii-vs-molgen-familiaere-linie | MII VS MolGen Familiäre Linie |
| mii-vs-molgen-family-member-snomed | MII VS MolGen Family Member SNOMED |
| mii-vs-molgen-verwandtschaftsgrad | MII VS Mol Gen Verwandtschaftsgrad |
| mii-vs-molgen-verwandtschaftsverhaeltnis | MII VS MolGen Verwandtschaftsverhaeltnis |
| MaiaServiceRequestIntent | Maia Service Request Intent Value Set |
| adverse-event-event-id-core | ValueSetAdverseEventEvent (ID Core) |
| allergy-manifestation-id-core | value-set-allergy-manifestation-id-core |
| allergy-negation-id-core | ValueSetAllergyNegation (ID Core) |
| child-identification-type-id-core | ValueSetChildIdentificationType (ID Core) |
| glucose-level-id-core | ValueSetGlucoseLevel(ID Core) |
| observation-glucose-id-core | ValueSetObservationGlucose (ID Core) |
| observation-social-history-id-core | ValueSetObservationSocialHistory (ID Core) |
| HDBP0037-Microorganism | HDBP0037-Microorganism |
| HDBP0037-ResultFlags | HDBP0037-ResultFlags |
| HDBP0037-SpecimenMaterial | HDBP0037-SpecimenMaterial |
| HDBP0037-TestMethod | HDBP0037-TestMethod |
| HDBP0037-TestResult | HDBP0037-TestResult |
| 2.16.840.1.113883.2.4.3.11.60.131.11.2--20220301153357 | VaccinatieAanleidingWaardelijst |
| 2.16.840.1.113883.2.4.3.11.60.131.11.3--20220301175614 | ZiekteWaarTegenGevaccineerdWordtWaardelijst |
| 2.16.840.1.113883.2.4.3.11.60.131.11.4--20220301181306 | VaccinatieIndicatieWaardelijst |
| 2.16.840.1.113883.2.4.3.11.60.131.11.6--20240417113339 | ProductCodeSNOMEDCTCodeLijst |
| ecog-performance-status-snomed | ValueSet ECOG Performance Status SNOMED |
| histopathologisches-grading-snomed | ValueSet Histopathologisches Grading SNOMED |
| morphologie-snomed | ValueSet Morphologie SNOMED |
| topographie-snomed | ValueSet Topographie SNOMED |
| treatment-intent-vs | Treatment Intent Value Set |
| ClasseAsaMaitre | ClasseAsaMaitre |
| ColoscopieAnterieureEndo | ColoscopieAnterieureEndo |
| ColoscopieTypeEndo | ColoscopieTypeEndo |
| ComplicationEndo | ComplicationEndo |
| EchelleBostonEndo | EchelleBostonEndo |
| PractitionerRole | EndoPractitionerRole |
| IndicationColoscopieEndo | IndicationColoscopieEndo |
| InstrumentColoscopieEndo | InstrumentColoscopieEndo |
| IntervenantEndoscopiste | IntervenantEndoscopiste |
| IntervenantProcedureEndo | IntervenantProcedureEndo |
| IntervenantResident | IntervenantResident |
| InterventionNonPlanifieeEndo | InterventionNonPlanifieeEndo |
| LienUsagerEndo | LienUsagerEndo |
| MedicamentEndo | MedicamentEndo |
| MedicationUniteMesureEndo | MedicationUniteMesureEndo |
| ModalitePriseMedicationEndo | ModalitePriseMedicationEndo |
| MorphologiePolypeEndo | MorphologiePolypeEndo |
| ObservationStructureEndo | ObservationStructureEndo |
| OrigineDemandeEndo | OrigineDemandeEndo |
| practitioner-role | Practitioner role |
| PreparationColiqueEndo | PreparationColiqueEndo |
| ProcedureTypeEndo | ProcedureTypeEndo |
| RecommandationEndo | RecommandationEndo |
| ReferentEndo | ReferentEndo |
| RetroflexionEndo | RetroflexionEndo |
| SpecimenStatutEndo | SpecimenStatutEndo |
| StatutObservationEndo | StatutObservationEndo |
| StructureCorporelleEndo | StructureCorporelleEndo |
| SuiviPriseChargeEndo | SuiviPriseChargeEndo |
| TaillePolypeEndo | TaillePolypeEndo |
| TypeObservationEndo | TypeObservationEndo |
| VoieAdministrationEndo | VoieAdministrationEndo |
| c80-practice-codes | PracticeSettingCode |
| JDV-J148-ReferenceRangeAppliesTo-CISIS | JDV_J148-ReferenceRangeAppliesTo-CISIS |
| JDV-J149-BodySiteBP-ENS | JDV_J149-BodySiteBP-ENS |
| JDV-J161-Lateralite-CISIS | JDV_J161-Lateralite-CISIS |
| JDV-J276-SNOMED-UPNOS | JDV_J276-SNOMED-UPNOS |
| vs-mii-icu-bodysite-observation-beatmung | VS MII ICU BodySite Observation Beatmung |
| vs-mii-icu-bodysite-observation-blutdruck | VS MII ICU BodySite Observation Blutdruck |
| vs-mii-icu-bodysite-observation-extrakorporale-verfahren | VS MII ICU BodySite Observation extrakorporale Verfahren |
| vs-mii-icu-bodysite-observation-monitoring-und-vitaldaten | VS MII ICU BodySite Observation Monitoring und Vitaldaten |
| vs-mii-icu-category-procedure-beatmung-snomed | VS MII ICU Category Procedure Beatmung [SNOMED] |
| vs-mii-icu-code-extrakorporale-verfahren | VS MII ICU Code extrakorporale Verfahren |
| vs-mii-icu-code-monitoring-und-vitaldaten-snomed | VS MII ICU Code Monitoring und Vitaldaten [SNOMED] |
| vs-mii-icu-code-observation-beatmung-snomed | VS MII ICU Code Observation Beatmung [SNOMED] |
| vs-mii-icu-code-observation-bilanzen-snomed | VS MII ICU Code Observation Bilanzen [SNOMED] |
| vs-mii-icu-code-observation-extrakorporale-verfahren-snomed | VS MII ICU Code Observation extrakorporale Verfahren [SNOMED] |
| vs-mii-icu-code-procedure-beatmung-snomed | VS MII ICU Code Procedure Beatmung [SNOMED] |
| vs-mii-icu-devicemetric-extrakorporale-verfahren | VS MII ICU Category Procedure Beatmung [SNOMED] |
| vs-mii-icu-method-observation-blutdruck | VS MII ICU Method Observation Blutdruck |
| nxh-vs-act-procedure-code | NxhVSActProcedureCode |
| nxh-vs-snomed | NxhVSSnomed |
| nxh-vs-body-sites | NxhVSBodySites |
| nxh-vs-nxh-vs-care-observation-code | NxhVSCareObservationCodes |
| addiction-substance-use | Addiction-Substance Use |
| alcohol-anti-craving-medication | Alcohol Anti-Craving Medication |
| alcohol-anti-craving-medication-enrollment | Alcohol Anti-Craving Medication Enrollment |
| mha-disability-status | Disability Status |
| mha-disability-type | Disability Type |
| mha-organization-admission-discharge-reason | Discharge Reason |
| gambling-problem-identified | Gambling Problem Identified |
| gender-identity | Gender Identity |
| hcn-issuing-authority | HCN Issuing Authority |
| IndigenousIdentity | Indigenous Identity |
| opioid-agonist-medication-enrollment | Opioid Agonist Medication Enrollment |
| symptoms-of-clinical-concern | Symptoms Of Clinical Concern |
| mha-race | Race |
| religion-and-spiritual-affiliation | ReligionAndSpiritualAffiliation |
| transgender-identity | Transgender Identity |
| housing-status | Housing Status |
| snomedct-methodtype-values | SNOMED CT檢驗檢查方法種類值集 |
| Condition-KCD-8 | myhw-fhir-condition-kcd-8 |
| answerSetABVP | AnswerSet für Arboviren (sonstige) |
| answerSetACBP | AnswerSet für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| answerSetADEP | AnswerSet für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| answerSetADVP | AnswerSet für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| answerSetASTP | AnswerSet für Astroviren |
| answerSetBANP | AnswerSet für Bacillus anthracis |
| answerSetBOBP | AnswerSet für (Lyme-) Borreliose, Borrelia burgdorferi |
| answerSetBORP | AnswerSet für Borrelia recurrentis |
| answerSetBOVP | AnswerSet für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| answerSetBPSP | AnswerSet für Bordetella pertussis, Bordetella parapertussis |
| answerSetBRUP | AnswerSet für Brucella sp. |
| answerSetCAMP | AnswerSet für Campylobacter spp. (darmpathogen) |
| answerSetCAUP | AnswerSet für Candida auris; Meldepflicht nur für den direkten Nachweis |
| answerSetCHLP | AnswerSet für Chlamydia psittaci |
| answerSetCKVP | AnswerSet für Chikungunya-Virus |
| answerSetCLOP | AnswerSet für Clostridium botulinum oder Toxinnachweis |
| answerSetCLTP | AnswerSet für Tetanus, Clostridium tetani |
| answerSetCORP | AnswerSet für Corynebacterium spp. (Toxin bildend) |
| answerSetCOXP | AnswerSet für Coxiella burnetii |
| answerSetCRYP | AnswerSet für humanpathogene Cryptosporidium sp. |
| answerSetCVDP | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| answerSetCVSP | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus-1 (SARS-CoV-1) (2003) |
| answerSetCYMP | AnswerSet für Cytomegalie, Cytomegalievirus |
| answerSetDENP | AnswerSet für Denguevirus |
| answerSetEAHP | AnswerSet für Amoebiasis, Entamoeba histolytica |
| answerSetEBCP | AnswerSet für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| answerSetEBVP | AnswerSet für Ebolavirus |
| answerSetECOP | AnswerSet für Escherichia coli (sonstige darmpathogene Stämme) |
| answerSetEHCP | AnswerSet für Escherichia coli (enterohämorrhagische Stämme) (EHEC) |
| answerSetETVP | AnswerSet für Enteroviren |
| answerSetFRTP | AnswerSet für Francisella tularensis |
| answerSetFSVP | AnswerSet für FSME-Virus |
| answerSetGBSP | AnswerSet für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| answerSetGFVP | AnswerSet für Gelbfiebervirus |
| answerSetGILP | AnswerSet für Giardia lamblia |
| answerSetHAVP | AnswerSet für Hepatitis-A-Virus |
| answerSetHBVP | AnswerSet für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| answerSetHCVP | AnswerSet für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| answerSetHDVP | AnswerSet für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| answerSetHEVP | AnswerSet für Hepatitis-E-Virus |
| answerSetHFAP | AnswerSet für Andere Erreger hämorrhagischer Fieber |
| answerSetHINP | AnswerSet für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| answerSetHTVP | AnswerSet für Hantavirus |
| answerSetINVP | AnswerSet für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| answerSetLEGP | AnswerSet für Legionella sp. |
| answerSetLEPP | AnswerSet für humanpathogene Leptospira sp. |
| answerSetLISP | AnswerSet für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| answerSetLSVP | AnswerSet für Lassavirus |
| answerSetLaboratoryTest-SNOMED | SNOMED-AnswerSet für Labortest |
| answerSetMBVP | AnswerSet für Marburgvirus |
| answerSetMPMP | AnswerSet für Mycoplasmen |
| answerSetMPVP | AnswerSet für Mumpsvirus |
| answerSetMPXP | AnswerSet für Orthopockenviren (Mpoxvirus) |
| answerSetMRAP | AnswerSet für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| answerSetMRSP | AnswerSet für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| answerSetMSVP | AnswerSet für Masernvirus |
| answerSetMYLP | AnswerSet für Mycobacterium leprae |
| answerSetMYTP | AnswerSet für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| answerSetNCVP | AnswerSet für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| answerSetNEIP | AnswerSet für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| answerSetNOVP | AnswerSet für Norovirus |
| answerSetOPXP | AnswerSet für Orthopockenviren (sonstige Orthopockenviren) |
| answerSetPINP | AnswerSet für Parainfluenzavirus |
| answerSetPKVP | AnswerSet für Orthopockenviren (Variolavirus) |
| answerSetPLAP | AnswerSet für Plasmodium spp. (Malaria) |
| answerSetPOVP | AnswerSet für Poliovirus |
| answerSetPVBP | AnswerSet für Ringelröteln, Parvovirus B 19 |
| answerSetRBVP | AnswerSet für Rabiesvirus |
| answerSetRICP | AnswerSet für Rickettsia prowazekii |
| answerSetRSVP | AnswerSet für Respiratorisches-Synzytial-Virus |
| answerSetRTVP | AnswerSet für Rotavirus |
| answerSetRUVP | AnswerSet für Rubellavirus |
| answerSetResistance-SNOMED | SNOMED-AnswerSet für Resistenz |
| answerSetSALP | AnswerSet für Salmonella (sonstige) |
| answerSetSHIP | AnswerSet für Shigella sp. |
| answerSetSPAP | AnswerSet für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| answerSetSPNP | AnswerSet für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| answerSetSPYP | AnswerSet für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| answerSetSTYP | AnswerSet für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| answerSetTRIP | AnswerSet für Trichinella spiralis |
| answerSetVCHP | AnswerSet für Vibrio cholerae |
| answerSetVZVP | AnswerSet für Varizella-Zoster-Virus |
| answerSetWBKP | AnswerSet für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| answerSetWNVP | AnswerSet für West-Nil-Virus |
| answerSetYENP | AnswerSet für Yersinia spp. (darmpathogen) |
| answerSetYPSP | AnswerSet für Yersinia pestis |
| answerSetZKVP | AnswerSet für Zika-Virus |
| interpretation-SNOMED | SNOMED-Interpretation des Testergebnisses |
| materialABVP | Material für Arboviren (sonstige) |
| materialACBP | Material für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| materialADEP | Material für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| materialADVP | Material für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| materialASTP | Material für Astroviren |
| materialBANP | Material für Bacillus anthracis |
| materialBOBP | Material für (Lyme-) Borreliose, Borrelia burgdorferi |
| materialBORP | Material für Borrelia recurrentis |
| materialBOVP | Material für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| materialBPSP | Material für Bordetella pertussis, Bordetella parapertussis |
| materialBRUP | Material für Brucella sp. |
| materialCAMP | Material für Campylobacter spp. (darmpathogen) |
| materialCAUP | Material für Candida auris; Meldepflicht nur für den direkten Nachweis |
| materialCHLP | Material für Chlamydia psittaci |
| materialCKVP | Material für Chikungunya-Virus |
| materialCLOP | Material für Clostridium botulinum oder Toxinnachweis |
| materialCLTP | Material für Tetanus, Clostridium tetani |
| materialCORP | Material für Corynebacterium spp. (Toxin bildend) |
| materialCOXP | Material für Coxiella burnetii |
| materialCRYP | Material für humanpathogene Cryptosporidium sp. |
| materialCVDP | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| materialCVSP | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus-1 (SARS-CoV-1) (2003) |
| materialCYMP | Material für Cytomegalie, Cytomegalievirus |
| materialDENP | Material für Denguevirus |
| materialEAHP | Material für Amoebiasis, Entamoeba histolytica |
| materialEBCP | Material für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| materialEBVP | Material für Ebolavirus |
| materialECOP | Material für Escherichia coli (sonstige darmpathogene Stämme) |
| materialEHCP | Material für Escherichia coli (enterohämorrhagische Stämme) (EHEC) |
| materialETVP | Material für Enteroviren |
| materialFRTP | Material für Francisella tularensis |
| materialFSVP | Material für FSME-Virus |
| materialGBSP | Material für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| materialGFVP | Material für Gelbfiebervirus |
| materialGILP | Material für Giardia lamblia |
| materialHAVP | Material für Hepatitis-A-Virus |
| materialHBVP | Material für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| materialHCVP | Material für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| materialHDVP | Material für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| materialHEVP | Material für Hepatitis-E-Virus |
| materialHFAP | Material für Andere Erreger hämorrhagischer Fieber |
| materialHINP | Material für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| materialHTVP | Material für Hantavirus |
| materialINVP | Material für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| materialLEGP | Material für Legionella sp. |
| materialLEPP | Material für humanpathogene Leptospira sp. |
| materialLISP | Material für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| materialLSVP | Material für Lassavirus |
| materialMBVP | Material für Marburgvirus |
| materialMPMP | Material für Mycoplasmen |
| materialMPVP | Material für Mumpsvirus |
| materialMPXP | Material für Orthopockenviren (Mpoxvirus) |
| materialMRAP | Material für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| materialMRSP | Material für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| materialMSVP | Material für Masernvirus |
| materialMYLP | Material für Mycobacterium leprae |
| materialMYTP | Material für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| materialNCVP | Material für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| materialNEIP | Material für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| materialNOVP | Material für Norovirus |
| materialOPXP | Material für Orthopockenviren (sonstige Orthopockenviren) |
| materialPINP | Material für Parainfluenzavirus |
| materialPKVP | Material für Orthopockenviren (Variolavirus) |
| materialPLAP | Material für Plasmodium spp. (Malaria) |
| materialPOVP | Material für Poliovirus |
| materialPVBP | Material für Ringelröteln, Parvovirus B 19 |
| materialRBVP | Material für Rabiesvirus |
| materialRICP | Material für Rickettsia prowazekii |
| materialRSVP | Material für Respiratorisches-Synzytial-Virus |
| materialRTVP | Material für Rotavirus |
| materialRUVP | Material für Rubellavirus |
| materialSALP | Material für Salmonella (sonstige) |
| materialSHIP | Material für Shigella sp. |
| materialSPAP | Material für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| materialSPNP | Material für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| materialSPYP | Material für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| materialSTYP | Material für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| materialTRIP | Material für Trichinella spiralis |
| materialVCHP | Material für Vibrio cholerae |
| materialVZVP | Material für Varizella-Zoster-Virus |
| materialWBKP | Material für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| materialWNVP | Material für West-Nil-Virus |
| materialYENP | Material für Yersinia spp. (darmpathogen) |
| materialYPSP | Material für Yersinia pestis |
| materialZKVP | Material für Zika-Virus |
| method | Nachweismethode |
| reasonForTesting | Untersuchungsgrund |
| substanceBANP | Analyt-Set für Bacillus anthracis |
| substanceCLOP | Analyt-Set für Clostridium botulinum oder Toxinnachweis |
| substanceCLTP | Analyt-Set für Tetanus, Clostridium tetani |
| substanceCORP | Analyt-Set für Corynebacterium spp. (Toxin bildend) |
| substanceDENP | Analyt-Set für Denguevirus |
| substanceEHCP | Analyt-Set für Escherichia coli (enterohämorrhagische Stämme) (EHEC) |
| substanceHBVP | Analyt-Set für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| substanceHCVP | Analyt-Set für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| substancePLAP | Analyt-Set für Plasmodium spp. (Malaria) |
| substanceVCHP | Analyt-Set für Vibrio cholerae |
| fr-bp-measurement-method | Bp-measurement-method |
| Race | Race |
| anaesthesia-type | Anaesthesia Type |
| GenderIdentity | Gender Identity |
| hospital-service | Hospital Service |
| observation-types | Observation Types |
| procedure-complication | Procedure Complication |
| covid-19-detection-of-antibody | COVID-19 SNOMED CT Detection Of Antibody |
| covid-19-detection-of-antigen | COVID-19 SNOMED CT Detection Of Antigen |
| covid-19-detection-of-virus | COVID-19 SNOMED CT Detection of Virus |
| covid-19-snomed-test-vs | COVID-19 SNOMED CT Tests Value Set |
| mii-vs-diagnose-bodystructure-snomed | MII VS Diagnose BodyStructure SNOMED |
| diagnoses-sct | MII VS Diagnose Diagnose-Codes SNOMED |
| CareConnect-EmergencyCareDischargeStatus-1 | Care Connect Emergency Care Discharge Status |
| CareConnect-EncounterType-1 | Care Connect Encounter Type |
| CareConnect-ListCode-1 | Care Connect List Code |
| CareConnect-ReligiousAffiliation-1 | Care Connect Religious Affiliation |
| CareConnect-SourceOfReferral-1 | Care Connect Source of Referral |
| UEC-ConditionCode-1 | UEC Condition Code |
| UEC-ObservationCode-1 | UEC Observation Code |
| VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
| eimpf-medikationartanwendung | eImpf_MedikationArtAnwendung |
| elga-medicaldevices | ELGA_MedicalDevices |
| DiPagVerkehrsmittel | Digitale PatientenrechnungVerkehrsmittel |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20150401000000 | AfnameprocedureCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20150401000000 | AllergieCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.5.5--20150401000000 | DagdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20150401000000 | MateVanKritiekZijnCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20150401000000 | MonstermateriaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.21--20160617112039 | RedenMedicatieafspraak |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20150401000000 | ResultaatTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.3.11.2--20150401000000 | SpecifiekeStofCodeLijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20150401000000 | SymptoomCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20150401000000 | TestmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.3.11.1--20150401000000 | VeroorzakendeStofCodeLijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.8--20150401000000 | WaarschijnlijkheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.5.4--20150401000000 | WeekdagenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20150401000000 | WijzeVanBlootstellingCodelijst |
| CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty |
| CareConnect-AllergyCode-1 | Care Connect Allergy Code |
| CareConnect-AllergyExposureRoute-1 | Care Connect Allergy Exposure Route |
| CareConnect-AllergyManifestation-1 | Care Connect Allergy Manifestation |
| CareConnect-AllergySeverity-1 | Care Connect Allergy Severity |
| CareConnect-BodySite-1 | Care Connect Body Site |
| CareConnect-CareSettingType-1 | Care Connect Care Setting Type |
| CareConnect-CompositionSectionCode-1 | Care Connect Composition Section Code |
| CareConnect-ConditionCode-1 | Care Connect Condition Code |
| CareConnect-ConditionEpisodeSnCT-1 | Care Connect Condition Episode SnCT |
| CareConnect-DocumentType-1 | Care Connect Document Type |
| CareConnect-FindingCode-1 | Care Connect Finding Code |
| CareConnect-ImmunizationExplanationReason-2 | Care Connect Immunization Explanation Reason |
| CareConnect-ManufacturedMaterialSnCT-1 | Care Connect Manufactured Material SnCT |
| CareConnect-MedicationCode-1 | Care Connect Medication Code |
| CareConnect-MedicationDosageMethod-1 | Care Connect Medication Dosage Method |
| CareConnect-MedicationDosageRoute-1 | Care Connect Medication Dosage Route |
| CareConnect-MedicationForm-1 | Care Connect Medication Form |
| CareConnect-MedicationSupplyType-1 | Care Connect Medication Supply Type |
| CareConnect-ProcedureCode-1 | Care Connect Procedure Code |
| CareConnect-ReasonImmunizationNotAdministered-1 | Care Connect Reason Immunization Not Administered |
| CareConnect-ReportCodeSnCT-1 | Care Connect Report Code SnCT |
| CareConnect-SpecimenBodySite-1 | Care Connect Specimen Body Site |
| CareConnect-SpecimenType-1 | Care Connect Specimen Type |
| CareConnect-VaccinationProcedure-1 | Care Connect Vaccination Procedure |
| CareConnect-VaccineCode-1 | Care Connect Vaccine Code |
| CarePlanType-1 | Care Plan Type |
| CareSettingType-1 | Care Setting Type |
| DCH-AABRHearingTest-Outcome-1 | DCH AABR Hearing Test Outcome |
| DCH-AOAEHearingTest-Outcome-1 | DCH AOAE Hearing Test Outcome |
| DCH-APGARScoreObservation-1 | DCH APGAR Score Observation |
| DCH-ASQ3AssessmentToolType-1 | DCH ASQ 3 Assessment Tool Type |
| DCH-ASQSEAssessmentToolType-1 | DCH ASQ SE Assessment Tool Type |
| DCH-AdmissionReason-1 | DCH-AdmissionReason-1 |
| DCH-AlcoholUse-1 | DCH Alcohol Use |
| DCH-AssessmentScale-1 | DCH Assessment Scale |
| DCH-AttemptedDeliveryType-1 | DCH Attempted Delivery Type |
| DCH-BloodSpotOutcome-1 | DCH Blood Spot Outcome |
| DCH-BloodSpotOutcomeCFSnCT-1 | DCH Blood Spot Outcome CF SnCT |
| DCH-BloodSpotOutcomeCHTSnCT-1 | DCH Blood Spot Outcome CHT SnCT |
| DCH-BloodSpotOutcomeGA1SnCT-1 | DCH Blood Spot Outcome GA1 SnCT |
| DCH-BloodSpotOutcomeHCUSnCT-1 | DCH Blood Spot Outcome HCU SnCT |
| DCH-BloodSpotOutcomeIVASnCT-1 | DCH Blood Spot Outcome IVA SnCT |
| DCH-BloodSpotOutcomeMCADDSnCT-1 | DCH Blood Spot Outcome MCADD SnCT |
| DCH-BloodSpotOutcomeMSUDSnCT-1 | DCH Blood Spot Outcome MSUD SnCT |
| DCH-BloodSpotOutcomePKUSnCT-1 | DCH Blood Spot Outcome PKU SnCT |
| DCH-BloodSpotOutcomeSCDSnCT-1 | DCH Blood Spot Outcome SCD SnCT |
| DCH-ClinicalRiskFactorSnCT-1 | DCH Clinical Risk Factor SnCT |
| DCH-DevelopmentalSkill-1 | DCH Developmental Skill |
| DCH-DevelopmentalSkillObservation-1 | DCH Developmental Skill Observation |
| DCH-Diagnosis-Condition-1 | DCH Diagnosis Condition |
| DCH-DischargeDestinationEmergencyCare-1 | DCH Discharge Destination Emergency Care |
| DCH-DrugOrSubstanceUse-1 | DCH Drug Or Substance Use |
| DCH-EducationalAssessmentOutcome-1 | DCH Educational Assessment Outcome |
| DCH-ExaminationFindingOutcome-1 | DCH Examination Finding Outcome |
| DCH-ExaminationFindingProcedure-1 | DCH Examination Finding Procedure |
| DCH-FamilyHistory-1 | DCH Family History |
| DCH-FeedingMethod-1 | DCH Feeding Method |
| DCH-FinalDeliveryType-1 | DCH Final Delivery Type |
| DCH-HeadCircumferenceSnCT-1 | DCH Head Circumference SnCT |
| DCH-HearingScreeningOutcome-1 | DCH Hearing Screening Outcome |
| DCH-HouseholdAlcoholStatus-1 | DCH Household Alcohol Status |
| DCH-HouseholdSmokingStatus-1 | DCH Household Smoking Status |
| DCH-HouseholdSubstanceStatus-1 | DCH Household Substance Status |
| DCH-IdenticalTwinIndicator-1 | DCH Identical Twin Indicator |
| DCH-ImmunisationRoute-1 | DCH Immunisation Route |
| DCH-ImmunisationSite-1 | DCH Immunisation Site |
| DCH-IndividualRequirement-Cognitive-1 | DCH Individual Requirement - Cognitive |
| DCH-IndividualRequirement-CommunicationMethod-1 | DCH Individual Requirement - Communication Method |
| DCH-IndividualRequirement-CommunicationProfessional-1 | DCH Individual Requirement - Communication Professional |
| DCH-IndividualRequirement-CommunicationSupport-1 | DCH Individual Requirement - Communication Support |
| DCH-IndividualRequirement-ContactMethod-1 | DCH Individual Requirement - Contact Method |
| DCH-IndividualRequirement-GPOptOutIndicator-1 | DCH Individual Requirement - GP Opt Out Indicator |
| DCH-IndividualRequirement-InformationFormat-1 | DCH Individual Requirement - Information Format |
| DCH-IndividualRequirement-MobilityNeed-1 | DCH Individual Requirement - Mobility Need |
| DCH-InformationOrAdviceGiven-1 | DCH Information Or Advice Given |
| DCH-MaternalProblemsInPregnancy-FamilyHistory-1 | DCH Maternal Problems In Pregnancy Family History |
| DCH-NCMPWithdrawalReason-1 | DCH NCMP Withdrawal Reason |
| DCH-Occupation-1 | DCH Employment Status |
| DCH-OutcomeStatusEyes-1 | DCH Outcome Status Eyes |
| DCH-OutcomeStatusHeart-1 | DCH Outcome Status Heart |
| DCH-OutcomeStatusHips-1 | DCH Outcome Status Hips |
| DCH-OutcomeStatusTestes-1 | DCH Outcome Status Testes |
| DCH-PersonSmokingStatus-1 | DCH Person Smoking Status |
| DCH-PhysicalProblemAtBirth-1 | DCH Physical Problem At Birth |
| DCH-PresentingComplaintEmergencyCare-1 | DCH Presenting Complaint Emergency Care |
| DCH-Problem-Condition-1 | DCH Problem Condition |
| DCH-ProblemDuringDelivery-1 | DCH Problem During Delivery |
| DCH-ProcedureEmergencyCare-1 | DCH Procedure Emergency Care |
| DCH-PutToBreastIndicator-1 | DCH Put To Breast Indicator |
| DCH-ReasonForReferral-1 | DCH Reason For Referral |
| DCH-ReasonNotAdminsitered-1 | DCH Reason Not Adminsitered |
| DCH-ReferralSourceEmergencyCare-1 | DCH Referral Source Emergency Care |
| DCH-SafeguardingObservationCode-1 | DCH Safeguarding Observation Code |
| DCH-ServiceReferredTo-1 | DCH Service Referred To |
| DCH-SourceOfReferral-1 | DCH Source of Referral |
| DCH-SpecialEducationalNeed-1 | DCH Special Educational Need |
| DCH-Weight-1 | DCH Weight |
| DD4C-AssessmentScaleSimpleReferenceSetSnCT-1 | DD4C Assessment Scale Simple Reference Set |
| DD4C-LastingPowerAttorney-Code-1 | DD4C Lasting Power Attorney Code |
| DeviceType-1 | Device Type |
| DocumentType-1 | Document Type |
| EOL-AdvanceDecisionToRefuseTreatment-1 | EOL Advance Decision to Refuse Treatment |
| EOL-AwareOfDecisionSnCT-1 | EOL Prognosis Awareness SnCT |
| EOL-CPRStatus-Code-1 | EOL CPR Status Code |
| EOL-ConsentDecisionSnCT-1 | EOL Consent Decision SnCT |
| EOL-FunctionalStatusType-Code-1 | EOL Functional Status Type Code |
| EOL-IssueOfAnticipatoryMedicines-1 | EOL Issue of Anticipatory Medicines |
| EOL-PreferredPlaceDeath-Code-1 | EOL Preferred Place Death Code |
| EOL-Prognosis-Code-1 | EOL Prognosis Code |
| EOL-Register-Code-1 | End of Life Register Flag Code |
| ITK-ADRT-1 | ITK Advance Decision to Refuse Treatment |
| ITK-AccessibleInformation-1 | ITK Accessible Information |
| ITK-AllergyFlagCode-1 | Allergy Flag Code |
| ITK-Cognition-1 | ITK Cognition |
| ITK-FamilyHistoryIllness-1 | ITK Family History Illness |
| ITK-LPoA-1 | ITK Lasting Power of Attorney |
| ITK-Mobility-1 | ITK Mobility |
| ITK-OccupationalHistory-1 | ITK Occupational History |
| NIPE-Outcome-1 | NIPE Outcome |
| NRL-PracticeSetting-1 | NRL Practice Setting |
| NRL-RecordClass-1 | NRL Record Class |
| NRL-RecordType-1 | NRL Record Type |
| NRLS-RecordType-1 | NRLS Record Type |
| RARecord-AccessibleInformationCommunicationProfessional-1 | AccessibleInformation - Communication Professional |
| RARecord-AccessibleInformationCommunicationSupport-1 | Accessible Information - Communication Support |
| RARecord-AccessibleInformationSpecificContactMethod-1 | Accessible Information - Specific Contact Method |
| RARecord-AccessibleInformationSpecificInformationFormat-1 | Accessible Information - Specific Information Format |
| RARecord-AdditionalCommunicationSupport-1 | Additional Communication Support |
| RARecord-AdditionalSupport-1 | Additional Support |
| RARecord-BespokeReasonableAdjustment-1 | Bespoke Reasonable Adjustment |
| RARecord-CommunityLanguageSupport-1 | Community Language Support |
| RARecord-EnvironmentAdjustment-1 | Environment Adjustment |
| RARecord-FlagCode-1 | Reasonable Adjustments Record Flag Code |
| RARecord-IndividualCareRequirement-1 | Individual Care Requirement |
| ReasonForReferralSnCT-1 | Reason For Referral SnCT |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20220610000000 | ContainerTypeCodelijst |
| diagnostic-conclusion-code | Diagnostic Conclusion Codes |
| il-core-allergy-intolerance-code | IL Core Allergy Intolerance Code |
| il-core-allergy-intolerance-end-reason | IL Core Condition End Reason |
| il-core-body-position | IL Core Body Position |
| il-core-common-units-of-measure | IL Core Units Of Measure Codes |
| il-core-condition-category | IL Core Condition Category Codes |
| il-core-condition-code | IL Core Condition Code |
| il-core-doctor-to-doctor | IL Core Doctor To Doctor Codes |
| il-core-manifestation | IL Core Condition Codes |
| il-core-medication-code | ILCore Medication Code |
| il-core-medication-dose-form | IL Core Medication Dose Form |
| il-core-medication-statement-code | ILCore Medication statement Code |
| il-core-observation-code | IL Core Observation Codes |
| il-core-observation-value | IL Core Observation Value Codes |
| il-core-procedure-code | IL Core procedure Codes |
| il-core-route-code | IL Core Route Code |
| il-core-service-category | IL Core ServiceCategory |
| il-core-service-type | IL Core Service type |
| il-core-specimen-type | IL Core Specimen type |
| il-core-substance | IL Core Substance Codes |
| il-core-units-of-measure | IL Core Units Of Measure Codes |
| il-core-virtual-type | IL Core Virtual encounter Type Codes |
| immunization-body-site | Immunization Observation Body Site list |
| immunization-side-effect | Immunization side-effect codes |
| organization-type | Organization Type |
| reason-not-done | statusReason codes for Immunization profile |
| target-disease | Target Disease Codes |
| vaccine-code | Vaccine Codes |
| answerSetHFMP | AnswerSet für Hand-Fuß-Mund-Krankheit |
| materialHFMP | Material für Hand-Fuß-Mund-Krankheit |
| EkgAbleitungenVS | SNOMED CT codes der EKG Ableitungen |
| PHCVS | Pan-Canadian Health Concern Value Set |
| healthconditioncode | HealthConditionCode |
| indigenousidentitycode | Indigenous Identity Code |
| procedurecode | ProcedureCode |
| anatomicaloracquiredbodystructurecode | Anatomical Or Acquired Body Structure Code |
| genderidentityvaluecode | Gender Identity Value Set |
| genderusedvaluecode | Gender Used Value Set |
| passiveadministeredimmunizingagentcode | Passive Administered Immunizing Agent Code |
| passivehistoricalimmunizingagentcode | Passive Historical Immunizing Agent Code |
| pharmaceuticalbiologicproductcode | Pharmaceutical/Biologic Product Code |
| racializedgroupcode | Racialized Group Code |
| sexassignedatbirth | Sex assigned at Birth |
| sexualorientationcode | Sex Orientation Value Set |
| socialhistory | Social History |
| substancecode | Substance Code |
| vaccineadministeredtradenamecode | Vaccine Administered Trade Name Code |
| vaccinehistoricalnamecode | Vaccine Historical Name Code |
| vaccinepreventablediseasecode | Vaccine Preventable Disease Code |
| laterality | Health Hub Laterality |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000 | AfnameprocedureCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000 | AllergieCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000 | BestemmingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20200901000000 | BrandwondSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.12.6--20200901000000 | CommunicatieBijzonderhedenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.8.6--20200901000000 | ConditiesTijdensMetingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20200901000000 | ContainerTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20200901000000 | DecubitusCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20200901000000 | DefecatieKleurCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20200901000000 | DiastolischEindpuntCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20200901000000 | DieptegraadCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20200901000000 | DrinkBeperkingenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20200901000000 | DrinkenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000 | DrugsGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000 | DrugsOfGeneesmiddelSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20200901000000 | EetBeperkingenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20200901000000 | ErnstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20200901000000 | EtenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.1--20200901000000 | FecesContinentieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20200901000000 | HartslagMeetMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20200901000000 | HartslagRegelmatigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20200901000000 | HerkomstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20200901000000 | HoorFunctieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20200901000000 | HorenHulpmiddelTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20200901000000 | HoudingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20200901000000 | HoudingHandhavenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20200901000000 | HoudingVeranderenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.3--20200901000000 | InterpretatieFrequentieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20200901000000 | InterpretatieVlaggenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20200901000000 | InterventieSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.2--20200901000000 | LateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.1--20200901000000 | LocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20200901000000 | LocatieGehoorapparaatCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20200901000000 | LopenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20200901000000 | MateVanKritiekZijnCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20200901000000 | MeetLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20200901000000 | MeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20200901000000 | MicroorganismeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20200901000000 | MonstermateriaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20200901000000 | MorfologieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20200901000000 | OntwikkelingMotoriekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20200901000000 | OntwikkelingSociaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20200901000000 | OntwikkelingTaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20200901000000 | OntwikkelingVerstandelijkCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20200901000000 | PolsRegelmatigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.2.1--20200901000000 | PositieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20200901000000 | ProbleemNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20200901000000 | ProbleemStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20200901000000 | ProbleemTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20200901000000 | ProductTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20200901000000 | ProtheseTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.1--20200901000000 | RefractieMeetMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20200901000000 | ResultaatTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20200901000000 | SNAQrcHulpBijEtenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.6.2--20200901000000 | SOEPRegelNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20200901000000 | SchedelomvangMeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20200901000000 | SoortAandoeningCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20200901000000 | SoortHulpCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20200901000000 | SoortTabakGebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20200901000000 | SpecifiekeStofAllergeneStoffenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20200901000000 | StatusNaamSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20200901000000 | StatusWaardeSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20200901000000 | TeKledenLichaamsdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20200901000000 | TeWassenLichaamsdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20200901000000 | TekstUitslagTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20200901000000 | TemperatuurTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20200901000000 | TestmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20200901000000 | ToiletgebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20200901000000 | TraplopenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20200901000000 | UiterlijkeVerzorgingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20200901000000 | UitvoerenTransferCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20200901000000 | VerificatieStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20200901000000 | VeroorzakendeStofAllergeneStoffenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4--20200901000000 | VerrichtingMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20200901000000 | VerrichtingTypeDHDCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.7--20200901000000 | VerrichtingTypeGGZCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20200901000000 | VerzorgenTandenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.19.4--20200901000000 | VisusMeetHulpmiddelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.19.2--20200901000000 | VisusMetingTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20200901000000 | VoedingMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20200901000000 | VoedingSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20200901000000 | WijzeVanBlootstellingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20200901000000 | WondDrainTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20200901000000 | WondRandCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20200901000000 | WondSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.8.2--20200901000000 | WoningAanpassingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.8.3--20200901000000 | WoonOmstandigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20200901000000 | ZichKledenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20200901000000 | ZichWassenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20200901000000 | ZienHulpmiddelTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20200901000000 | ZindelijkheidFecesCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20200901000000 | ZindelijkheidUrineCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20200901000000 | ZorgBijMenstruatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.17.1.5--20200901000000 | ZorgverlenerRolCodelijst |
| CareConnect-AllergyCode-1 | Care Connect Allergy Code |
| CareConnect-AllergyExposureRoute-1 | Care Connect Allergy Exposure Route |
| CareConnect-AllergySeverity-1 | Care Connect Allergy Severity |
| CareConnect-CareSettingType-1 | Care Connect Care Setting Type |
| CareConnect-ListCode-1 | Care Connect List Code |
| CareConnect-ManufacturedMaterialSnCT-1 | Care Connect Manufactured Material SnCT |
| CareConnect-MedicationCode-1 | Care Connect Medication Code |
| CareConnect-MedicationDosageRoute-1 | Care Connect Medication Dosage Route |
| CareConnect-MedicationForm-1 | Care Connect Medication Form |
| CareConnect-ReligiousAffiliation-1 | Care Connect Religious Affiliation |
| RARecord-AdditionalNeed-1 | Additional Need |
| dk-core-SCTBasicObservation | DK Core SNOMED CT Basic Observation |
| dk-core-TechniquesSCTCodes | DK TechniquesSCTCodes |
| dk-core-servicerequest-codes | DK codes for ServiceRequest |
| sor-organization-type | DK SOR Organization Type |
| MeasSettingVS | Measurement Setting value set |
| bodyPositionVS | Body Position value set |
| bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set |
| bodyTempMeasMethodDeviceVS | Body Temperature Measurement Method Device value set |
| bodyWeightMeasurementAssociatedPrecondVS | Body Weight Measurement Associated Precondition value set |
| bpCuffSizeVS | Blood Pressure Cuff Size value set |
| bpMeasDeviceCSVS | Blood Pressure Measurement Device and Cuff Size value set |
| bpMeasDeviceVS | Blood Pressure Measurement Device value set |
| bpMeasMethodVS | Blood Pressure Measurement Method value set |
| bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoodinated value set |
| clothingWornDuringMeasureVS | Clothing Worn During Measure value set |
| definedLimitsVS | Defined Limits value set |
| exertionPhaseVS | Exertion Phase value set |
| heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| heightBodyPositionVS | Height Body Position value set |
| heightLengthMeasDeviceVS | Height Length Measurement Device value set |
| heightLengthMeasMethodVS | Height Length Measurement Method value set |
| respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set |
| respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set |
| sPO2BodyLocationVS | Oxygen Saturation Body Location value set |
| sensorDescriptionVS | Sensor Description value set |
| sleepStatusVS | Sleep Status value set |
| weightMeasurementDeviceVS | Weight Measurement Device value set |
| ClinicalInformationPresentVS | Klinische Informationen verfügbar |
| laterality-qualifier-lrub-vs | Laterality Qualifier Value Set |
| mcode-body-location-qualifier-vs | Body Location Qualifier Value Set |
| mcode-cancer-staging-system-vs | Cancer Staging System Value Set |
| otherInfos-condition-vs | Other Infors Condition |
| relapse-type-vs | Relapse type (Local/Distant/Combined) |
| vs-Gvhd-type-eu-pcsp | Gvhd condition |
| vs-ProstheticProcedureType-eu-pcsp | Prosthetic Surgical Procedure Type |
| vs-action-eu-pcsp | Surgical Actions |
| vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) |
| vs-amputationProcedureType-eu-pcsp | Amputation Surgical Procedure Type |
| vs-calcest-eu-pcsp | Calculated|Estimated |
| vs-colostomyProcedureType-eu-pcsp | Colostomy Surgical Procedure Type |
| vs-fromToPosteriorAnterior-eu-pcsp | Body Location Qualifier Value Set |
| vs-gastrostomyProcedureType-eu-pcsp | Gastrostomy Surgical Procedure Type |
| vs-hereditary-eu-pcsp | Hereditary Predispositions or Disease |
| vs-isotopes-eu-pcsp | Radiotherapy Isotopes |
| vs-radiotherapyDoseType-eu-pcsp | Radiotherapy Dose Type |
| vs-radiotherapyType-eu-pcsp | Radiotherapy Type |
| vs-sacrifiedOrgan-eu-pcsp | Sacrified Organs (surgery) |
| vs-sct-prophylaxis-cathegory-eu-pcsp | SCT Prophylaxis Cathegory |
| vs-sct-prophylaxis-type-eu-pcsp | SCT Prophylaxis Type |
| vs-sct-type-eu-pcsp | Stem Cell Transplantation type |
| additive | ValueSet - Additive |
| containertyp | ValueSet - Containertyp |
| probenart | ValueSet - Probenart |
| sct-body-structures | ValueSet - SNOMED CT Body Strutures |
| sct-lab-procedure | ValueSet - SNOMED CT Laboratory Procedure |
| mii-vs-mtb-molekulare-biomarker | MII VS Molekulare Biomarker |
| mii-vs-mtb-tumorausbreitung | MII VS Tumorausbreitung |
| mii-vs-mtb-who-grad-tumor-zns | MII VS WHO Grad Tumor ZNS |
| chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
| sct-services | Argonaut Snomed CT Services |
| specialty | Argonaut Scheduling Specialties |
| sect_CID_10.html | InterventionalDrug |
| sect_CID_100.html | QuantitativeDiagnosticImagingProcedure |
| sect_CID_1000.html | CTTransversePlaneReferenceBasis |
| sect_CID_10002.html | IrradiationEventType |
| sect_CID_10005.html | XRayRadiationDoseProcedureTypeReported |
| sect_CID_10006.html | XRayFilterMaterial |
| sect_CID_10009.html | Measured/Calculated |
| sect_CID_1001.html | AnatomicalReferenceBasis |
| sect_CID_10010.html | DoseMeasurementDevice |
| sect_CID_10013.html | CTAcquisitionType |
| sect_CID_10014.html | CTIVContrastImagingTechnique |
| sect_CID_10016.html | AnodeTargetMaterial |
| sect_CID_1002.html | AnatomicalReferenceBasisHead |
| sect_CID_10020.html | SourceofProjectionXRayDoseInformation |
| sect_CID_1003.html | AnatomicalReferenceBasisSpine |
| sect_CID_1004.html | AnatomicalReferenceBasisChest |
| sect_CID_10043.html | IntravenousExtravasationSymptom |
| sect_CID_10044.html | RadiosensitiveOrgan |
| sect_CID_10045.html | RadiopharmaceuticalPatientState |
| sect_CID_1005.html | AnatomicalReferenceBasisAbdomen/Pelvis |
| sect_CID_1006.html | AnatomicalReferenceBasisExtremity |
| sect_CID_10060.html | OrganforRadiationDoseEstimate |
| sect_CID_10066.html | AttenuatorCategory |
| sect_CID_10067.html | RadiationAttenuatorMaterial |
| sect_CID_10072.html | ReportedValueType |
| sect_CID_101.html | ImagingProcedure |
| sect_CID_108.html | DiagnosticImagingProcedurewithoutIVContrast |
| sect_CID_109.html | DiagnosticImagingProcedurewithIVContrast |
| sect_CID_11.html | AdministrationRoute |
| sect_CID_11002.html | AcousticCouplingMedium |
| sect_CID_11006.html | PhotoacousticImagedProperty |
| sect_CID_12.html | ImagingContrastAgent |
| sect_CID_1200.html | ContraindicationsForCTImaging |
| sect_CID_12001.html | UltrasoundProtocolType |
| sect_CID_12002.html | UltrasoundProtocolStageType |
| sect_CID_12008.html | OBGYNAmnioticSacMeasurement |
| sect_CID_1201.html | ContraindicationsForXAImaging |
| sect_CID_12020.html | FetalBiometryAnatomicSite |
| sect_CID_12021.html | FetalLongBoneAnatomicSite |
| sect_CID_12022.html | FetalCraniumAnatomicSite |
| sect_CID_12023.html | PelvisandUterusAnatomicSite |
| sect_CID_12024.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12025.html | OBGYNUltrasoundBeamPathUltrasoundBeamPath |
| sect_CID_12100.html | VascularUltrasoundReportDocumentTitle |
| sect_CID_12102.html | TemporalPeriodRelatingtoProcedureorTherapy |
| sect_CID_12103.html | VascularUltrasoundAnatomicLocation |
| sect_CID_12104.html | ExtracranialArtery |
| sect_CID_12105.html | IntracranialCerebralVessel |
| sect_CID_12106.html | IntracranialCerebralVessel(Unilateral) |
| sect_CID_12107.html | UpperExtremityArtery |
| sect_CID_12108.html | UpperExtremityVein |
| sect_CID_12109.html | LowerExtremityArtery |
| sect_CID_12110.html | LowerExtremityVein |
| sect_CID_12111.html | AbdominopelvicArtery(Paired) |
| sect_CID_12112.html | AbdominopelvicArtery(Unpaired) |
| sect_CID_12113.html | AbdominopelvicVein(Paired) |
| sect_CID_12114.html | AbdominopelvicVein(Unpaired) |
| sect_CID_12115.html | RenalVessel |
| sect_CID_12116.html | VesselSegmentModifier |
| sect_CID_12117.html | VesselBranchModifier |
| sect_CID_12118.html | MeasurementOrientation |
| sect_CID_12119.html | VascularUltrasoundProperty |
| sect_CID_12121.html | VascularIndex/Ratio |
| sect_CID_12122.html | OtherVascularProperty |
| sect_CID_12125.html | AbdominopelvicVessel |
| sect_CID_12130.html | OrganPart(NonLateralized) |
| sect_CID_12131.html | OrganPart(Lateralized) |
| sect_CID_12140.html | PelvicVasculatureAnatomicalLocation |
| sect_CID_12141.html | FetalVasculatureAnatomicalLocation |
| sect_CID_12200.html | EchocardiographyLeftVentricleMeasurement |
| sect_CID_12201.html | LeftVentricleLinearMeasurement |
| sect_CID_12203.html | LeftVentricleOtherMeasurement |
| sect_CID_12204.html | EchocardiographyRightVentricleMeasurement |
| sect_CID_12205.html | EchocardiographyLeftAtriumMeasurement |
| sect_CID_12207.html | EchocardiographyMitralValveMeasurement |
| sect_CID_12208.html | EchocardiographyTricuspidValveMeasurement |
| sect_CID_12209.html | EchocardiographyPulmonicValveMeasurement |
| sect_CID_12210.html | EchocardiographyPulmonaryArteryMeasurement |
| sect_CID_12211.html | EchocardiographyAorticValveMeasurement |
| sect_CID_12214.html | EchocardiographyPulmonaryVeinMeasurement |
| sect_CID_12218.html | EchocardiographyCongenitalAnomalyMeasurement |
| sect_CID_12219.html | PulmonaryVeinModifier |
| sect_CID_12221.html | FlowDirection |
| sect_CID_12222.html | OrificeFlowProperty |
| sect_CID_12223.html | EchocardiographyStrokeVolumeOrigin |
| sect_CID_12224.html | UltrasoundImageMode |
| sect_CID_12226.html | EchocardiographyImageView |
| sect_CID_12233.html | CardiacPhase |
| sect_CID_12234.html | RespirationState |
| sect_CID_12235.html | MitralValveAnatomicSite |
| sect_CID_12236.html | EchocardiographyAnatomicSite |
| sect_CID_12237.html | EchocardiographyAnatomicSiteModifier |
| sect_CID_12239.html | CardiacOutputProperty |
| sect_CID_12240.html | LeftVentricleAreaMeasurement |
| sect_CID_12241.html | TricuspidValveFindingSite |
| sect_CID_12242.html | AorticValveFindingSite |
| sect_CID_12243.html | LeftVentricleFindingSite |
| sect_CID_12244.html | CongenitalFindingSite |
| sect_CID_12246.html | CardiacUltrasoundIndicationforStudy |
| sect_CID_12247.html | Pediatric,FetalandCongenitalCardiacSurgicalIntervention |
| sect_CID_12248.html | CardiacUltrasoundSummaryCode |
| sect_CID_12249.html | CardiacUltrasoundFetalSummaryCode |
| sect_CID_12250.html | CardiacUltrasoundCommonLinearMeasurement |
| sect_CID_12251.html | CardiacUltrasoundLinearValveMeasurement |
| sect_CID_12252.html | CardiacUltrasoundCardiacFunction |
| sect_CID_12253.html | CardiacUltrasoundAreaMeasurement |
| sect_CID_12254.html | CardiacUltrasoundHemodynamicMeasurement |
| sect_CID_12257.html | CardiacUltrasoundLeftVentricleMeasurement |
| sect_CID_12258.html | CardiacUltrasoundRightVentricleMeasurement |
| sect_CID_12259.html | CardiacUltrasoundVentriclesMeasurement |
| sect_CID_12260.html | CardiacUltrasoundPulmonaryArteryMeasurement |
| sect_CID_12261.html | CardiacUltrasoundPulmonaryVein |
| sect_CID_12262.html | CardiacUltrasoundPulmonaryValveMeasurement |
| sect_CID_12263.html | CardiacUltrasoundVenousReturnPulmonaryMeasurement |
| sect_CID_12264.html | CardiacUltrasoundVenousReturnSystemicMeasurement |
| sect_CID_12265.html | CardiacUltrasoundAtriaandAtrialSeptumMeasurement |
| sect_CID_12266.html | CardiacUltrasoundMitralValveMeasurement |
| sect_CID_12267.html | CardiacUltrasoundTricuspidValveMeasurement |
| sect_CID_12268.html | CardiacUltrasoundAtrioventricularValveMeasurement |
| sect_CID_12269.html | CardiacUltrasoundInterventricularSeptumMeasurement |
| sect_CID_12270.html | CardiacUltrasoundAorticValveMeasurement |
| sect_CID_12271.html | CardiacUltrasoundOutflowTractMeasurement |
| sect_CID_12272.html | CardiacUltrasoundSemilunarValve,AnnulateandSinusMeasurement |
| sect_CID_12273.html | CardiacUltrasoundAorticSinotubularJunctionMeasurement |
| sect_CID_12274.html | CardiacUltrasoundAortaMeasurement |
| sect_CID_12275.html | CardiacUltrasoundCoronaryArteryMeasurement |
| sect_CID_12276.html | CardiacUltrasoundAortoPulmonaryConnectionMeasurement |
| sect_CID_12277.html | CardiacUltrasoundPericardiumandPleuraMeasurement |
| sect_CID_12279.html | CardiacUltrasoundFetalGeneralMeasurement |
| sect_CID_12280.html | CardiacUltrasoundTargetSite |
| sect_CID_12281.html | CardiacUltrasoundTargetSiteModifier |
| sect_CID_12282.html | CardiacUltrasoundVenousReturnSystemicFindingSite |
| sect_CID_12283.html | CardiacUltrasoundVenousReturnPulmonaryFindingSite |
| sect_CID_12284.html | CardiacUltrasoundAtriaandAtrialSeptumFindingSite |
| sect_CID_12285.html | CardiacUltrasoundAtrioventricularValveFindingSite |
| sect_CID_12286.html | CardiacUltrasoundInterventricularSeptumFindingSite |
| sect_CID_12287.html | CardiacUltrasoundVentricleFindingSite |
| sect_CID_12288.html | CardiacUltrasoundOutflowTractFindingSite |
| sect_CID_12289.html | CardiacUltrasoundSemilunarValve,AnnulusandSinusFindingSite |
| sect_CID_12290.html | CardiacUltrasoundPulmonaryArteryFindingSite |
| sect_CID_12291.html | CardiacUltrasoundAortaFindingSite |
| sect_CID_12292.html | CardiacUltrasoundCoronaryArteryFindingSite |
| sect_CID_12293.html | CardiacUltrasoundAortopulmonaryConnectionFindingSite |
| sect_CID_12294.html | CardiacUltrasoundPericardiumandPleuraFindingSite |
| sect_CID_12301.html | MeasurementSelectionReason |
| sect_CID_12302.html | EchoFindingObservationType |
| sect_CID_12303.html | EchoMeasurementType |
| sect_CID_12304.html | CardiovascularMeasuredProperty |
| sect_CID_12305.html | BasicEchoAnatomicSite |
| sect_CID_12306.html | EchoFlowDirection |
| sect_CID_12307.html | CardiacPhaseandTimePoint |
| sect_CID_12308.html | UltrasoundShearWaveMeasurement |
| sect_CID_12312.html | FetalEchocardiographyImageView |
| sect_CID_12321.html | ElastographySite |
| sect_CID_12322.html | ElastographyMeasurementSite |
| sect_CID_12323.html | UltrasoundRelevantPatientCondition |
| sect_CID_12325.html | LiverUltrasoundStudyIndication |
| sect_CID_12331.html | StructuralHeartProcedure |
| sect_CID_12332.html | StructuralHeartDevice |
| sect_CID_12339.html | StructuralHeartProcedureAnatomicSite |
| sect_CID_12341.html | IndicationforStructuralHeartProcedure |
| sect_CID_12342.html | BradycardiacAgent |
| sect_CID_13.html | ImagingContrastAgentIngredient |
| sect_CID_18.html | RadiopharmaceuticalIsotope |
| sect_CID_19.html | PatientOrientation |
| sect_CID_2.html | AnatomicModifier |
| sect_CID_20.html | PatientOrientationModifier |
| sect_CID_21.html | PatientEquipmentRelationship |
| sect_CID_210.html | QualitativeEvaluationModifierType |
| sect_CID_211.html | QualitativeEvaluationModifierValue |
| sect_CID_212.html | GenericAnatomicLocationModifier |
| sect_CID_218.html | QuantitativeImageFeature |
| sect_CID_219.html | GeometryGraphicalRepresentation |
| sect_CID_220.html | SignificanceLevel |
| sect_CID_221.html | MeasurementRangeConcept |
| sect_CID_222.html | Normality |
| sect_CID_223.html | NormalRangeValue |
| sect_CID_225.html | MeasurementUncertaintyConcept |
| sect_CID_226.html | PopulationStatisticalDescriptor |
| sect_CID_23.html | CranioCaudadAngulation |
| sect_CID_230.html | YesNo |
| sect_CID_231.html | YesNoOnly |
| sect_CID_240.html | PresentAbsent |
| sect_CID_241.html | PresentAbsentOnly |
| sect_CID_242.html | NormalAbnormal |
| sect_CID_244.html | Laterality |
| sect_CID_245.html | LateralitywithMedian |
| sect_CID_246.html | RelativeLaterality |
| sect_CID_247.html | LateralityLeftRightOnly |
| sect_CID_25.html | Radiopharmaceutical |
| sect_CID_250.html | PositiveNegative |
| sect_CID_251.html | ComplicationSeverity |
| sect_CID_252.html | SMLSizeDescriptor |
| sect_CID_26.html | NuclearMedicineProjection |
| sect_CID_27.html | BasicCardiacView |
| sect_CID_272.html | SpecificObservationSubjectClass |
| sect_CID_300.html | MultienergyRelevantMaterial |
| sect_CID_3003.html | HemodynamicWaveformSource |
| sect_CID_3010.html | CardiovascularAnatomicStructure |
| sect_CID_3011.html | ElectrophysiologyAnatomicLocation |
| sect_CID_3014.html | CoronaryArterySegment |
| sect_CID_3015.html | CoronaryArtery |
| sect_CID_3016.html | MajorCoronaryArtery |
| sect_CID_3019.html | CardiovascularAnatomicStructureModifier |
| sect_CID_3035.html | EEGAnnotation–NeurophysiologicEnumeration |
| sect_CID_3038.html | PatternEvent |
| sect_CID_3049.html | EEGProcedure |
| sect_CID_3050.html | PatientConsciousness |
| sect_CID_31.html | AbstractPrior |
| sect_CID_3101.html | CardiacProceduralStateValue |
| sect_CID_3102.html | Rest/StressState |
| sect_CID_3107.html | PETCardiologyRadiopharmaceutical |
| sect_CID_3108.html | NM/PETProcedure |
| sect_CID_3110.html | NuclearCardiologyProtocol |
| sect_CID_3111.html | NuclearCardiologyRadiopharmaceutical |
| sect_CID_3113.html | PerfusionDefectType |
| sect_CID_3115.html | StressImagingQualityIssue |
| sect_CID_3116.html | NMExtracardiacFinding |
| sect_CID_3118.html | LevelofRisk |
| sect_CID_3119.html | LVFunction |
| sect_CID_3120.html | PerfusionFinding |
| sect_CID_3121.html | PerfusionMorphology |
| sect_CID_3122.html | VentricularEnlargement |
| sect_CID_3200.html | StressTestProcedure |
| sect_CID_3201.html | IndicationsforStressTest |
| sect_CID_3202.html | ChestPain |
| sect_CID_3203.html | ExerciserDevice |
| sect_CID_3204.html | StressAgent |
| sect_CID_3205.html | IndicationsforPharmacologicalStressTest |
| sect_CID_3206.html | NoninvasiveCardiacImagingProcedure |
| sect_CID_3207.html | StressTestProcedurePhase |
| sect_CID_3208.html | ExerciseECGSummaryCode |
| sect_CID_3209.html | StressImagingSummaryCode |
| sect_CID_3210.html | SpeedofResponse |
| sect_CID_3211.html | BPResponse |
| sect_CID_3213.html | StressHemodynamicFinding |
| sect_CID_3215.html | PerfusionFindingMethod |
| sect_CID_3220.html | StressSymptom |
| sect_CID_3221.html | StressTestTerminationReason |
| sect_CID_3230.html | ECGFinding |
| sect_CID_3231.html | STSegmentFinding |
| sect_CID_3232.html | STSegmentLocation |
| sect_CID_3233.html | STSegmentMorphology |
| sect_CID_3234.html | EctopicBeatMorphology |
| sect_CID_3235.html | PerfusionComparisonFinding |
| sect_CID_3236.html | ToleranceComparisonFinding |
| sect_CID_3237.html | WallMotionComparisonFinding |
| sect_CID_3238.html | StressScoringScale |
| sect_CID_3241.html | HemodynamicMeasurementTechnique |
| sect_CID_3250.html | CatheterizationProcedurePhase |
| sect_CID_3254.html | ElectrophysiologyProcedurePhase |
| sect_CID_3261.html | StressProtocol |
| sect_CID_3262.html | ECGPatientStateValue |
| sect_CID_3271.html | HemodynamicPhysiologicalChallenge |
| sect_CID_3337.html | HemodynamicAnnotation |
| sect_CID_3403.html | PercutaneousEntry |
| sect_CID_3405.html | ProcedureActionValue |
| sect_CID_3411.html | IntracoronaryDevice |
| sect_CID_3413.html | AdverseOutcome |
| sect_CID_3414.html | ProcedureUrgency |
| sect_CID_3416.html | RespirationRhythm |
| sect_CID_3422.html | DeviceUseAction |
| sect_CID_3423.html | NumericDeviceCharacteristic |
| sect_CID_3425.html | InterventionParameter |
| sect_CID_3428.html | CardiovascularImagingProcedure |
| sect_CID_3429.html | CatheterizationDevice |
| sect_CID_3440.html | PeripheralPulseLocation |
| sect_CID_3441.html | PatientAssessment |
| sect_CID_3442.html | PeripheralPulseMethod |
| sect_CID_3451.html | CalibrationObject |
| sect_CID_3462.html | ChamberIdentification |
| sect_CID_3463.html | VentricleIdentification |
| sect_CID_3466.html | PlaneIdentification |
| sect_CID_3472.html | CardiacContractionPhase |
| sect_CID_3480.html | IVUSProcedurePhase |
| sect_CID_3481.html | IVUSDistanceMeasurement |
| sect_CID_3482.html | IVUSAreaMeasurement |
| sect_CID_3483.html | IVUSLongitudinalMeasurement |
| sect_CID_3485.html | IVUSVolumeMeasurement |
| sect_CID_3487.html | IntravascularVolumetricRegion |
| sect_CID_3488.html | Min/Max/Mean |
| sect_CID_3489.html | CalciumDistribution |
| sect_CID_3491.html | IVUSLesionMorphology |
| sect_CID_3492.html | VascularDissectionClassification |
| sect_CID_3494.html | IVUSNonMorphologicalFinding |
| sect_CID_3495.html | IVUSPlaqueComposition |
| sect_CID_3496.html | IVUSFiducialPoint |
| sect_CID_3497.html | IVUSArterialMorphology |
| sect_CID_3515.html | SpecimenCollection |
| sect_CID_3520.html | BloodSourceType |
| sect_CID_3531.html | OxygenAdministration |
| sect_CID_3553.html | CirculatorySupport |
| sect_CID_3554.html | Ventilation |
| sect_CID_3555.html | Pacing |
| sect_CID_3560.html | BloodPressureMethod |
| sect_CID_3600.html | RelativeTime |
| sect_CID_3602.html | HemodynamicPatientState |
| sect_CID_3604.html | ArterialLesionLocation |
| sect_CID_3606.html | ArterialSourceLocation |
| sect_CID_3607.html | VenousSourceLocation |
| sect_CID_3608.html | AtrialSourceLocation |
| sect_CID_3609.html | VentricularSourceLocation |
| sect_CID_3610.html | GradientSourceLocation |
| sect_CID_3611.html | PressureMeasurement |
| sect_CID_3614.html | NonmitralValveArea |
| sect_CID_3615.html | ValveArea |
| sect_CID_3616.html | HemodynamicPeriodMeasurement |
| sect_CID_3617.html | ValveFlow |
| sect_CID_3619.html | HemodynamicResistanceMeasurement |
| sect_CID_3620.html | HemodynamicRatio |
| sect_CID_3621.html | FractionalFlowReserve |
| sect_CID_3627.html | MeasurementType |
| sect_CID_3628.html | CardiacOutputMethod |
| sect_CID_3629.html | ProcedureIntent |
| sect_CID_3630.html | CardiovascularAnatomicLocation |
| sect_CID_3640.html | Hypertension |
| sect_CID_3641.html | HemodynamicAssessment |
| sect_CID_3642.html | DegreeFinding |
| sect_CID_3651.html | HemodynamicMeasurementPhase |
| sect_CID_3670.html | ECGProcedureType |
| sect_CID_3671.html | ReasonforECGStudy |
| sect_CID_3676.html | LeadMeasurementTechnique |
| sect_CID_3677.html | SummaryCodesECG |
| sect_CID_3700.html | CathDiagnosis |
| sect_CID_3701.html | CardiacValve/Tract |
| sect_CID_3703.html | WallMotion |
| sect_CID_3704.html | MyocardiumWallMorphologyFinding |
| sect_CID_3705.html | ChamberSize |
| sect_CID_3706.html | OverallContractility |
| sect_CID_3707.html | VSDDescription |
| sect_CID_3710.html | CoronaryDominance |
| sect_CID_3711.html | ValvularAbnormality |
| sect_CID_3712.html | VesselDescriptor |
| sect_CID_3713.html | TIMIFlowCharacteristic |
| sect_CID_3714.html | Thrombus |
| sect_CID_3715.html | LesionMargin |
| sect_CID_3716.html | Severity |
| sect_CID_3717.html | LeftVentricleMyocardialWall17SegmentModel |
| sect_CID_3718.html | MyocardialWallSegmentsinProjection |
| sect_CID_3719.html | CanadianClinicalClassification |
| sect_CID_3721.html | CardiovascularSurgery |
| sect_CID_3722.html | DiabeticTherapy |
| sect_CID_3723.html | MIType |
| sect_CID_3724.html | SmokingHistory |
| sect_CID_3726.html | CoronaryInterventionIndication |
| sect_CID_3727.html | CatheterizationIndication |
| sect_CID_3728.html | CathFinding |
| sect_CID_3729.html | AdmissionStatus |
| sect_CID_3736.html | NYHAClassification |
| sect_CID_3739.html | CathProcedureType |
| sect_CID_3740.html | ThrombolyticAdministration |
| sect_CID_3741.html | LabVisitMedicationAdministration |
| sect_CID_3742.html | PCIMedicationAdministration |
| sect_CID_3743.html | Clopidogrel/TiclopidineAdministration |
| sect_CID_3744.html | EFTestingMethod |
| sect_CID_3745.html | CalculationMethod |
| sect_CID_3746.html | PercutaneousEntrySite |
| sect_CID_3754.html | VascularComplication |
| sect_CID_3755.html | CathComplication |
| sect_CID_3756.html | CardiacPatientRiskFactor |
| sect_CID_3757.html | CardiacDiagnosticProcedure |
| sect_CID_3758.html | CardiovascularFamilyHistory |
| sect_CID_3760.html | HypertensionTherapy |
| sect_CID_3761.html | AntilipemicAgent |
| sect_CID_3762.html | AntiarrhythmicAgent |
| sect_CID_3764.html | MyocardialInfarctionTherapy |
| sect_CID_3769.html | ConcernType |
| sect_CID_3770.html | ProblemStatus |
| sect_CID_3772.html | HealthStatus |
| sect_CID_3773.html | UseStatus |
| sect_CID_3774.html | SocialHistory |
| sect_CID_3777.html | CardiovascularImplant |
| sect_CID_3778.html | Stage |
| sect_CID_3779.html | ImplantedDevice |
| sect_CID_3781.html | LeftVentricleMyocardialWall18SegmentModel |
| sect_CID_3782.html | LeftVentricleBasalWall6Segments |
| sect_CID_3783.html | LeftVentricleMidlevelWall6Segments |
| sect_CID_3784.html | LeftVentricleApicalWall4Segments |
| sect_CID_3785.html | LeftVentricleApicalWall6Segments |
| sect_CID_3802.html | PlaqueStructure |
| sect_CID_3805.html | StenosisType |
| sect_CID_3806.html | StenosisShape |
| sect_CID_3808.html | AneurysmType |
| sect_CID_3809.html | AssociatedCondition |
| sect_CID_3810.html | VascularMorphology |
| sect_CID_3813.html | StentFinding |
| sect_CID_3814.html | StentComposition |
| sect_CID_3815.html | SourceofVascularFinding |
| sect_CID_3817.html | VascularSclerosisType |
| sect_CID_3820.html | NoninvasiveVascularProcedure |
| sect_CID_3823.html | RespiratoryStatus |
| sect_CID_3826.html | HeartRhythm |
| sect_CID_3827.html | VesselSegment |
| sect_CID_3829.html | PulmonaryArtery |
| sect_CID_3831.html | StenosisLength |
| sect_CID_3832.html | StenosisGrade |
| sect_CID_3835.html | CardiacVolumeMeasurement |
| sect_CID_3837.html | FiducialFeature |
| sect_CID_3838.html | DiameterDerivation |
| sect_CID_3839.html | CoronaryVein |
| sect_CID_3840.html | PulmonaryVein |
| sect_CID_3843.html | MyocardialSubsegment |
| sect_CID_3850.html | ContrastBolusSubstance |
| sect_CID_4.html | AnatomicRegion |
| sect_CID_4005.html | PartialViewSectionforMammography |
| sect_CID_4009.html | DXAnatomyImaged |
| sect_CID_4010.html | DXView |
| sect_CID_4011.html | DXViewModifier |
| sect_CID_4012.html | ProjectionEponymousName |
| sect_CID_4013.html | AnatomicRegionforMammography |
| sect_CID_4014.html | ViewforMammography |
| sect_CID_4015.html | ViewModifierforMammography |
| sect_CID_4016.html | AnatomicRegionforIntraoralRadiography |
| sect_CID_4017.html | AnatomicRegionModifierforIntraoralRadiography |
| sect_CID_4018.html | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) |
| sect_CID_4019.html | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) |
| sect_CID_4020.html | PETRadionuclide |
| sect_CID_4021.html | PETRadiopharmaceutical |
| sect_CID_4025.html | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) |
| sect_CID_4026.html | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth |
| sect_CID_4028.html | CraniofacialAnatomicRegion |
| sect_CID_4029.html | DermatologyAnatomicSite |
| sect_CID_4030.html | CT,MRandPETAnatomyImaged |
| sect_CID_4031.html | CommonAnatomicRegion |
| sect_CID_4032.html | MRSpectroscopyMetabolite |
| sect_CID_4033.html | MRProtonSpectroscopyMetabolite |
| sect_CID_4040.html | EndoscopyAnatomicRegion |
| sect_CID_4042.html | XA/XRFAnatomyImaged |
| sect_CID_4050.html | DrugorContrastAgentCharacteristic |
| sect_CID_4051.html | GeneralDevice |
| sect_CID_4052.html | PhantomDevice |
| sect_CID_4061.html | HeadandNeckPrimaryAnatomicStructure |
| sect_CID_4062.html | VLView |
| sect_CID_4063.html | VLDentalView |
| sect_CID_4064.html | VLViewModifier |
| sect_CID_4065.html | VLDentalViewModifier |
| sect_CID_4066.html | OrthognathicFunctionalCondition |
| sect_CID_4067.html | OrthodonticFindingbyInspection |
| sect_CID_4068.html | OrthodonticObservableEntity |
| sect_CID_4069.html | DentalOcclusion |
| sect_CID_4070.html | OrthodonticTreatmentProgress |
| sect_CID_4071.html | GeneralPhotographyDevice |
| sect_CID_4072.html | DevicesforthePurposeofDentalPhotography |
| sect_CID_4200.html | OphthalmicImagingAgent |
| sect_CID_4201.html | PatientEyeMovementCommand |
| sect_CID_4202.html | OphthalmicPhotographyAcquisitionDevice |
| sect_CID_4203.html | OphthalmicPhotographyIllumination |
| sect_CID_4204.html | OphthalmicFilter |
| sect_CID_4205.html | OphthalmicLens |
| sect_CID_4206.html | OphthalmicChannelDescription |
| sect_CID_4207.html | OphthalmicImagePosition |
| sect_CID_4208.html | MydriaticAgent |
| sect_CID_4209.html | OphthalmicAnatomicStructureImaged |
| sect_CID_4210.html | OphthalmicTomographyAcquisitionDevice |
| sect_CID_4211.html | OphthalmicOCTAnatomicStructureImaged |
| sect_CID_4214.html | OphthalmicHorizontalDirection |
| sect_CID_4215.html | OphthalmicVerticalDirection |
| sect_CID_4216.html | OphthalmicVisualAcuityType |
| sect_CID_4220.html | VisualFixationQualityDuringAcquisition |
| sect_CID_4221.html | VisualFixationQualityProblem |
| sect_CID_4222.html | OphthalmicMacularGridProblem |
| sect_CID_4231.html | LensStatus |
| sect_CID_4232.html | VitreousStatus |
| sect_CID_4233.html | OphthalmicAxialLengthMeasurementsSegmentName |
| sect_CID_4234.html | RefractiveSurgeryType |
| sect_CID_4237.html | LensConstantType |
| sect_CID_4238.html | RefractiveErrorType |
| sect_CID_4253.html | VisualFieldStaticPerimetryFixationStrategy |
| sect_CID_4254.html | VisualFieldStaticPerimetryTestAnalysisResult |
| sect_CID_4255.html | VisualFieldIlluminationColor |
| sect_CID_4256.html | VisualFieldProcedureModifier |
| sect_CID_4266.html | OphthalmicAnatomicStructureReferencePoint |
| sect_CID_4273.html | RetinalSegmentationSurface |
| sect_CID_4275.html | AnteriorEyeSegmentationSurface |
| sect_CID_4402.html | HistoryofMalignantMelanoma |
| sect_CID_4403.html | HistoryofMelanomainSitu |
| sect_CID_4404.html | HistoryofNonMelanomaSkinCancer |
| sect_CID_4405.html | SkinDisorder |
| sect_CID_4406.html | PatientReportedLesionCharacteristic |
| sect_CID_4408.html | LesionVisualFinding |
| sect_CID_4409.html | SkinProcedure |
| sect_CID_4410.html | TopicalTreatment |
| sect_CID_4411.html | LesionColor |
| sect_CID_4412.html | SpecimenStainforConfocalMicroscopy |
| sect_CID_5.html | TransducerApproach |
| sect_CID_501.html | VolumetricViewDescription |
| sect_CID_502.html | VolumetricViewModifier |
| sect_CID_6.html | TransducerOrientation |
| sect_CID_60.html | ImagingAgentAdministrationAdverseEvent |
| sect_CID_6000.html | OverallBreastComposition |
| sect_CID_6001.html | OverallBreastCompositionfromBIRADS® |
| sect_CID_6002.html | ChangeSinceLastMammogramorPriorSurgery |
| sect_CID_6003.html | ChangeSinceLastMammogramorPriorSurgeryfromBIRADS® |
| sect_CID_6004.html | MammographyShapeCharacteristic |
| sect_CID_6005.html | ShapeCharacteristicfromBIRADS® |
| sect_CID_6006.html | MammographyMarginCharacteristic |
| sect_CID_6007.html | MarginCharacteristicfromBIRADS® |
| sect_CID_6008.html | DensityModifier |
| sect_CID_6009.html | DensityModifierfromBIRADS® |
| sect_CID_601.html | BiosafetyLevel |
| sect_CID_6010.html | MammographyCalcificationType |
| sect_CID_6011.html | CalcificationTypefromBIRADS® |
| sect_CID_6012.html | CalcificationDistributionModifier |
| sect_CID_6013.html | CalcificationDistributionModifierfromBIRADS® |
| sect_CID_6014.html | MammographySingleImageFinding |
| sect_CID_6015.html | SingleImageFindingfromBIRADS® |
| sect_CID_6016.html | MammographyCompositeFeature |
| sect_CID_6017.html | CompositeFeaturefromBIRADS® |
| sect_CID_6018.html | ClockfaceLocationorRegion |
| sect_CID_6019.html | ClockfaceLocationorRegionfromBIRADS® |
| sect_CID_602.html | BiosafetyControlReason |
| sect_CID_6020.html | QuadrantLocation |
| sect_CID_6021.html | QuadrantLocationfromBIRADS® |
| sect_CID_6022.html | Side |
| sect_CID_6023.html | SidefromBIRADS® |
| sect_CID_6024.html | Depth |
| sect_CID_6025.html | DepthfromBIRADS® |
| sect_CID_6026.html | MammographyAssessment |
| sect_CID_6027.html | AssessmentfromBIRADS® |
| sect_CID_6028.html | MammographyRecommendedFollowup |
| sect_CID_6029.html | RecommendedFollowupfromBIRADS® |
| sect_CID_603.html | AnimalRoomType |
| sect_CID_6030.html | MammographyPathologyCode |
| sect_CID_6031.html | BenignPathologyCodefromBIRADS® |
| sect_CID_6032.html | HighRiskLesionPathologyCodefromBIRADS® |
| sect_CID_6033.html | MalignantPathologyCodefromBIRADS® |
| sect_CID_6037.html | MammographyQuantitativeTemporalDifferenceType |
| sect_CID_6038.html | MammographyQualitativeTemporalDifferenceType |
| sect_CID_6039.html | NippleCharacteristic |
| sect_CID_6040.html | NonlesionObjectType |
| sect_CID_6043.html | MammographyCADAnalysisType |
| sect_CID_6050.html | BreastProcedureReported |
| sect_CID_6051.html | BreastProcedureReason |
| sect_CID_6052.html | BreastImagingReportSectionTitle |
| sect_CID_6053.html | BreastImagingReportElement |
| sect_CID_6054.html | BreastImagingFinding |
| sect_CID_6055.html | BreastClinicalFindingorIndicatedProblem |
| sect_CID_6056.html | AssociatedFindingforBreast |
| sect_CID_6057.html | DuctographyFindingforBreast |
| sect_CID_6058.html | ProcedureModifiersforBreast |
| sect_CID_6059.html | BreastImplantType |
| sect_CID_606.html | AnimalShelterType |
| sect_CID_6060.html | BreastBiopsyTechnique |
| sect_CID_6061.html | BreastImagingProcedureModifier |
| sect_CID_6062.html | InterventionalProcedureComplication |
| sect_CID_6063.html | InterventionalProcedureResult |
| sect_CID_6064.html | UltrasoundFindingforBreast |
| sect_CID_6065.html | InstrumentApproach |
| sect_CID_6067.html | FluidColor |
| sect_CID_6069.html | NottinghamCombinedHistologicGrade |
| sect_CID_6070.html | BloomRichardsonHistologicGrade |
| sect_CID_6071.html | HistologicGradingMethod |
| sect_CID_6072.html | BreastImplantFinding |
| sect_CID_6080.html | GynecologicalHormone |
| sect_CID_6081.html | BreastCancerRiskFactor |
| sect_CID_6082.html | GynecologicalProcedure |
| sect_CID_6083.html | ProceduresforBreast |
| sect_CID_6084.html | MammoplastyProcedure |
| sect_CID_6085.html | TherapiesforBreast |
| sect_CID_6086.html | MenopausalPhase |
| sect_CID_6087.html | GeneralRiskFactor |
| sect_CID_6088.html | OBGYNMaternalRiskFactor |
| sect_CID_6089.html | Substance |
| sect_CID_609.html | AnimalFeedingMethod |
| sect_CID_6091.html | RelativeFrequencyofEventValue |
| sect_CID_6092.html | Usage/ExposureQualitativeConcept |
| sect_CID_6096.html | PregnancyStatus |
| sect_CID_6097.html | SideofFamily |
| sect_CID_6099.html | RacialGroup |
| sect_CID_610.html | WaterType |
| sect_CID_6100.html | ChestComponentCategory |
| sect_CID_6102.html | ChestFindingorFeatureModifier |
| sect_CID_6103.html | AbnormalLinesFindingorFeature |
| sect_CID_6104.html | AbnormalOpacityFindingorFeature |
| sect_CID_6105.html | AbnormalLucencyFindingorFeature |
| sect_CID_6107.html | WidthDescriptor |
| sect_CID_6108.html | ChestAnatomicStructureAbnormalDistribution |
| sect_CID_6109.html | RadiographicAnatomyFindingorFeature |
| sect_CID_611.html | AnesthesiaCategoryCodeTypeforSmallAnimalAnesthesia |
| sect_CID_6110.html | LungAnatomyFindingorFeature |
| sect_CID_6111.html | BronchovascularAnatomyFindingorFeature |
| sect_CID_6112.html | PleuraAnatomyFindingorFeature |
| sect_CID_6113.html | MediastinumAnatomyFindingorFeature |
| sect_CID_6114.html | OsseousAnatomyFindingorFeature |
| sect_CID_6115.html | OsseousAnatomyModifier |
| sect_CID_6116.html | MuscularAnatomy |
| sect_CID_6117.html | VascularAnatomy |
| sect_CID_6118.html | SizeDescriptor |
| sect_CID_6119.html | ChestBorderShape |
| sect_CID_612.html | AnesthesiaCategoryCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_6120.html | ChestBorderDefinition |
| sect_CID_6121.html | ChestOrientationDescriptor |
| sect_CID_6122.html | ChestContentDescriptor |
| sect_CID_6124.html | LocationinChest |
| sect_CID_6125.html | GeneralChestLocation |
| sect_CID_6126.html | LocationinLung |
| sect_CID_6127.html | SegmentLocationinLung |
| sect_CID_6128.html | ChestDistributionDescriptor |
| sect_CID_6129.html | ChestSiteInvolvement |
| sect_CID_613.html | AnesthesiaInductionCodeTypeforSmallAnimalAnesthesia |
| sect_CID_6130.html | SeverityDescriptor |
| sect_CID_6132.html | ChestCalcificationDescriptor |
| sect_CID_6133.html | ChestQuantitativeTemporalDifferenceType |
| sect_CID_6134.html | ChestQualitativeTemporalDifferenceType |
| sect_CID_6137.html | CADAnalysisType |
| sect_CID_6138.html | ChestNonlesionObjectType |
| sect_CID_6139.html | NonlesionModifier |
| sect_CID_614.html | AnesthesiaInductionCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_6140.html | CalculationMethod |
| sect_CID_6142.html | CalculatedValue |
| sect_CID_6146.html | TimePointType |
| sect_CID_6148.html | MediastinumFindingorFeature |
| sect_CID_6149.html | MediastinumAnatomy |
| sect_CID_615.html | AnesthesiaMaintenanceCodeTypeforSmallAnimalAnesthesia |
| sect_CID_6159.html | MalignancyType |
| sect_CID_616.html | AnesthesiaMaintenanceCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_6160.html | BreastPrimaryTumorAssessmentFromAJCC |
| sect_CID_6161.html | PathologicalRegionalLymphNodeAssessmentforBreast |
| sect_CID_6162.html | AssessmentofMetastasisforBreast |
| sect_CID_6163.html | MenstrualCyclePhase |
| sect_CID_6165.html | BreastLinearMeasurement |
| sect_CID_6166.html | CADGeometrySecondaryGraphicalRepresentation |
| sect_CID_617.html | AirwayManagementMethodCodeTypeforSmallAnimalAnesthesia |
| sect_CID_6170.html | LobeofLung |
| sect_CID_6171.html | ZoneofLung |
| sect_CID_618.html | AirwayManagementMethodCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_619.html | AirwayManagementSubMethodCodeTypeforSmallAnimalAnesthesia |
| sect_CID_620.html | AirwayManagementSubMethodCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_6201.html | ColonFindingorFeature |
| sect_CID_6202.html | ColonFindingorFeatureModifier |
| sect_CID_6203.html | ColonNonlesionObjectType |
| sect_CID_6204.html | AnatomicNoncolonFinding |
| sect_CID_6205.html | ClockfaceLocationforColon |
| sect_CID_6206.html | RecumbentPatientOrientationforColon |
| sect_CID_6207.html | ColonQuantitativeTemporalDifferenceType |
| sect_CID_6209.html | ColonMorphologyDescriptor |
| sect_CID_621.html | MedicationTypeforSmallAnimalAnesthesia |
| sect_CID_6210.html | LocationinIntestinalTract |
| sect_CID_6211.html | ColonCADMaterialDescription |
| sect_CID_6212.html | CalculatedValueforColonFinding |
| sect_CID_622.html | MedicationTypeCodeTypefromAnesthesiaQualityInitiative |
| sect_CID_623.html | MedicationforSmallAnimalAnesthesia |
| sect_CID_624.html | InhalationalAnesthesiaAgentforSmallAnimalAnesthesia |
| sect_CID_625.html | InjectableAnesthesiaAgentforSmallAnimalAnesthesia |
| sect_CID_626.html | PremedicationAgentforSmallAnimalAnesthesia |
| sect_CID_627.html | NeuromuscularBlockingAgentforSmallAnimalAnesthesia |
| sect_CID_629.html | CarrierGasesforSmallAnimalAnesthesia |
| sect_CID_630.html | LocalAnestheticsforSmallAnimalAnesthesia |
| sect_CID_6300.html | ProstateAnatomy |
| sect_CID_6301.html | ProstateSectorAnatomyfromPIRADSv2 |
| sect_CID_6302.html | ProstateSectorAnatomyfromEuropeanConcensus16Sector(Minimal)Model |
| sect_CID_6303.html | ProstateSectorAnatomyfromEuropeanConcensus27Sector(Optimal)Model |
| sect_CID_6304.html | ProstateSectorAnatomyfromPIRADSv2.1 |
| sect_CID_631.html | ProcedurePhaseRequiringAnesthesia |
| sect_CID_6312.html | CrosssectionalScanPlaneOrientation |
| sect_CID_6313.html | HistoryofProstateDisease |
| sect_CID_6319.html | AbdominalInterventionType |
| sect_CID_632.html | SurgicalProcedurePhaseRequiringAnesthesia |
| sect_CID_6320.html | AbdominopelvicIntervention |
| sect_CID_6321.html | ProstateCancerDiagnosticProcedure |
| sect_CID_6322.html | ProstateCancerFamilyHistory |
| sect_CID_6323.html | ProstateCancerTherapy |
| sect_CID_6327.html | ProstateImagingIndication |
| sect_CID_6333.html | mpMRIAssessmentType |
| sect_CID_6334.html | mpMRIAssessmentTypefromPIRADS® |
| sect_CID_6335.html | mpMRIAssessmentValue |
| sect_CID_6336.html | MRIAbnormality |
| sect_CID_6337.html | mpMRIProstateAbnormalityfromPIRADS® |
| sect_CID_6338.html | mpMRIBenignProstateAbnormalityfromPIRADS® |
| sect_CID_6339.html | MRIShapeCharacteristic |
| sect_CID_634.html | AnimalHandlingPhase |
| sect_CID_6340.html | ProstateMRIShapeCharacteristicfromPIRADS® |
| sect_CID_6341.html | MRIMarginCharacteristic |
| sect_CID_6342.html | ProstateMRIMarginCharacteristicfromPIRADS® |
| sect_CID_6347.html | ProstateMRIExtraprostaticFinding |
| sect_CID_6348.html | ProstateMRIAssessmentofExtraprostaticAnatomicSite |
| sect_CID_635.html | HeatingMethod |
| sect_CID_6350.html | EndorectalCoilFillSubstance |
| sect_CID_636.html | TemperatureSensorDeviceComponentTypeforSmallAnimalProcedure |
| sect_CID_637.html | ExogenousSubstanceType |
| sect_CID_638.html | ExogenousSubstance |
| sect_CID_639.html | TumorGraftHistologicType |
| sect_CID_64.html | ImagingAgentAdministrationPatientState |
| sect_CID_6401.html | NonlesionObjectTypePhysicalObject |
| sect_CID_6402.html | NonlesionObjectTypeSubstance |
| sect_CID_6403.html | NonlesionObjectTypeTissue |
| sect_CID_6404.html | ChestNonlesionObjectTypePhysicalObject |
| sect_CID_6405.html | ChestNonlesionObjectTypeTissue |
| sect_CID_641.html | Virus |
| sect_CID_642.html | Cytokine |
| sect_CID_643.html | Toxin |
| sect_CID_644.html | ExogenousSubstanceAdministrationSite |
| sect_CID_645.html | ExogenousSubstanceOriginTissue |
| sect_CID_646.html | PreclinicalSmallAnimalImagingProcedure |
| sect_CID_65.html | ImagingAgentAdministrationPremedication |
| sect_CID_66.html | ImagingAgentAdministrationMedication |
| sect_CID_67.html | ImagingAgentAdministrationCompletionStatus |
| sect_CID_68.html | ImagingAgentAdministrationPharmaceuticalPresentationUnit |
| sect_CID_69.html | ImagingAgentAdministrationConsumable |
| sect_CID_7.html | UltrasoundBeamPath |
| sect_CID_70.html | Flush |
| sect_CID_7000.html | DiagnosticImagingReportDocumentTitle |
| sect_CID_7002.html | DiagnosticImagingReportElement |
| sect_CID_7026.html | RadiotherapeuticDoseMeasurementDevice |
| sect_CID_7027.html | SegmentedRadiotherapeuticDoseMeasurementDevice |
| sect_CID_7030.html | InstitutionalDepartment/Unit/Service |
| sect_CID_7039.html | PediatricSizeCategory |
| sect_CID_7040.html | BroselowLutenPediatricSizeCategory |
| sect_CID_7064.html | ModelUsage |
| sect_CID_7101.html | BrainAtlasFiducial |
| sect_CID_7110.html | FiducialCategory |
| sect_CID_7111.html | Fiducial |
| sect_CID_7112.html | RadiotherapyFiducial |
| sect_CID_7140.html | BrainStructureforVolumetricMeasurement |
| sect_CID_7150.html | SegmentationPropertyCategory |
| sect_CID_7151.html | SegmentationPropertyType |
| sect_CID_7152.html | CardiacStructureSegmentationType |
| sect_CID_7153.html | CNSSegmentationType |
| sect_CID_7154.html | AbdominalSegmentationType |
| sect_CID_7155.html | ThoracicSegmentationType |
| sect_CID_7156.html | VascularSegmentationType |
| sect_CID_7157.html | DeviceSegmentationType |
| sect_CID_7158.html | ArtifactSegmentationType |
| sect_CID_7159.html | LesionSegmentationType |
| sect_CID_7160.html | PelvicOrganSegmentationType |
| sect_CID_7161.html | PhysiologySegmentationType |
| sect_CID_7163.html | BreastSegmentationTypes |
| sect_CID_7165.html | AbstractSegmentationType |
| sect_CID_7166.html | CommonTissueSegmentationType |
| sect_CID_7167.html | PeripheralNervousSystemSegmentationType |
| sect_CID_7168.html | BrainLesionSegmentationTypeWithNecrosis |
| sect_CID_7169.html | BrainLesionSegmentationTypeWithoutNecrosis |
| sect_CID_7170.html | CouinaudLiverSegment |
| sect_CID_7171.html | LiverSegmentationType |
| sect_CID_7180.html | AbstractMultidimensionalImageModelComponentSemantic |
| sect_CID_7186.html | AbstractMultidimensionalImageModelQualitativeDimensionSampleSemantic |
| sect_CID_7191.html | TissueSegmentationPropertyType |
| sect_CID_7192.html | AnatomicalStructureSegmentationPropertyType |
| sect_CID_7193.html | PhysicalObjectSegmentationPropertyType |
| sect_CID_7194.html | MorphologicallyAbnormalStructureSegmentationPropertyType |
| sect_CID_7195.html | FunctionSegmentationPropertyType |
| sect_CID_7196.html | SpatialandRelationalConceptSegmentationPropertyType |
| sect_CID_7197.html | BodySubstanceSegmentationPropertyType |
| sect_CID_7198.html | SubstanceSegmentationPropertyType |
| sect_CID_7199.html | AnatomicallyLocalizedLesionSegmentationType |
| sect_CID_7230.html | AutomationofMeasurement |
| sect_CID_7300.html | ImplantMaterial |
| sect_CID_7301.html | InterventionType |
| sect_CID_7302.html | ImplantTemplateViewOrientation |
| sect_CID_7304.html | ImplantTargetAnatomy |
| sect_CID_7307.html | ImplantComponentType |
| sect_CID_7308.html | HumanHipImplantComponentType |
| sect_CID_7309.html | HumanTraumaImplantComponentType |
| sect_CID_7310.html | ImplantFixationMethod |
| sect_CID_74.html | ImagingAgentAdministrationConsumableCatheterType |
| sect_CID_7450.html | PersonRole |
| sect_CID_7451.html | FamilyMember |
| sect_CID_7452.html | OrganizationalRole |
| sect_CID_7453.html | PerformingRole |
| sect_CID_7454.html | AnimalTaxonomicRankValue |
| sect_CID_7458.html | PersonGenderIdentity |
| sect_CID_7464.html | GeneralRegionofInterestMeasurementModifier |
| sect_CID_7465.html | MeasurementDerivedFromMultipleROIMeasurements |
| sect_CID_7469.html | GenericIntensityandSizeMeasurement |
| sect_CID_7470.html | LinearMeasurement |
| sect_CID_7471.html | AreaMeasurement |
| sect_CID_7472.html | VolumeMeasurement |
| sect_CID_7480.html | Breed |
| sect_CID_7482.html | DXAnatomyImagedforAnimal |
| sect_CID_7483.html | CommonAnatomicRegionsforAnimal |
| sect_CID_7484.html | DXViewforAnimal |
| sect_CID_7486.html | MixedBreed |
| sect_CID_75.html | LowHighorEqual |
| sect_CID_7550.html | AngleMeasurement |
| sect_CID_76.html | PremedicationType |
| sect_CID_7600.html | LymphNodeAnatomicSite |
| sect_CID_7601.html | HeadandNeckCancerAnatomicSite |
| sect_CID_7602.html | VertebralAnatomicStructure |
| sect_CID_7603.html | Vertebra |
| sect_CID_7604.html | IntervertebralDisc |
| sect_CID_7701.html | FiberTractInBrainstem |
| sect_CID_7702.html | ProjectionandThalamicFiber |
| sect_CID_7703.html | AssociationFiber |
| sect_CID_7704.html | LimbicSystemTract |
| sect_CID_7705.html | CommissuralFiber |
| sect_CID_7706.html | CranialNerve |
| sect_CID_7707.html | SpinalCordFiber |
| sect_CID_7710.html | TractographyAnatomicSite |
| sect_CID_8.html | AngiographicInterventionalDevice |
| sect_CID_8101.html | ContainerType |
| sect_CID_8102.html | ContainerComponentType |
| sect_CID_8103.html | AnatomicPathologySpecimenType |
| sect_CID_8104.html | BreastTissueSpecimenType |
| sect_CID_8109.html | SpecimenCollectionProcedure |
| sect_CID_8110.html | SpecimenSamplingProcedure |
| sect_CID_8111.html | SpecimenPreparationProcedure |
| sect_CID_8112.html | SpecimenStain |
| sect_CID_8113.html | SpecimenPreparationStep |
| sect_CID_8114.html | SpecimenFixative |
| sect_CID_8115.html | SpecimenEmbeddingMedia |
| sect_CID_8121.html | MicroscopyLensType |
| sect_CID_8122.html | MicroscopyIlluminatorandSensorColor |
| sect_CID_8124.html | MicroscopyFilter |
| sect_CID_8125.html | MicroscopyIlluminatorType |
| sect_CID_8130.html | StainingProtocol |
| sect_CID_8131.html | PathologyImagingProtocol |
| sect_CID_8134.html | AnatomicStructure |
| sect_CID_8135.html | MicroscopyAnnotationPropertyType |
| sect_CID_8136.html | MicroscopyMeasurementType |
| sect_CID_9.html | ImageGuidedTherapeuticProcedure |
| sect_CID_9000.html | PhysicalQuantityDescriptor |
| sect_CID_91.html | FunctionalConditionPresentDuringAcquisition |
| sect_CID_92.html | JointPositionDuringAcquisition |
| sect_CID_9268.html | PatientPositionAcquisitionDevices |
| sect_CID_9271.html | RTImagePatientPositionAcquisitionDevices |
| sect_CID_9272.html | RTROIImageAcquisitionContext |
| sect_CID_93.html | JointPositioningMethod |
| sect_CID_9300.html | ProcedureDiscontinuationReason |
| sect_CID_9301.html | ModalityPPSDiscontinuationReason |
| sect_CID_94.html | PhysicalForceAppliedDuringAcquisition |
| sect_CID_9501.html | PrescriptionAnatomyCategory |
| sect_CID_9502.html | RTSegmentAnnotationCategory |
| sect_CID_9505.html | FixationorPositioningDevice |
| sect_CID_9513.html | FixationDevice |
| sect_CID_9514.html | AnatomicalStructureforRadiotherapy |
| sect_CID_9515.html | RTPatientSupportDevice |
| sect_CID_9516.html | RadiotherapyBolusDeviceType |
| sect_CID_9517.html | RadiotherapyBlockDeviceType |
| sect_CID_9520.html | SegmentedRTAccessoryDevice |
| sect_CID_9525.html | RadiationTherapyParticle |
| sect_CID_9526.html | IonTherapyParticle |
| sect_CID_9527.html | TeletherapyIsotope |
| sect_CID_9528.html | BrachytherapyIsotope |
| sect_CID_9534.html | RadiotherapyTarget |
| sect_CID_9536.html | RadiotherapyPrescribingandSegmentingPersonRole |
| sect_CID_9541.html | BeamLimitingDeviceType |
| sect_CID_9545.html | FixedBeamLimitingDeviceType |
| sect_CID_9555.html | RadiotherapyTreatmentPlanningPersonRole |
| sect_CID_9562.html | RadiotherapyTreatmentDeliveryPersonRole |
| sect_CID_9572.html | PatientShieldingDevice |
| sect_CID_9573.html | PatientTreatmentPreparationDevice |
| sect_CID_9577.html | PatientTreatmentPreparationProcedure |
| sect_CID_9579.html | RTSegmentMaterial |
| sect_CID_9580.html | RTSegmentationPropertyCategory |
| KBV_VS_MIO_ULB_Advance_Directive_Status | Information Persönliche Erklärung |
| KBV_VS_MIO_ULB_Allergies | Vorliegen Allergien |
| KBV_VS_MIO_ULB_Assessment_Scales | Assessment |
| KBV_VS_MIO_ULB_Behavior_Finding | Auffälliges Verhalten |
| KBV_VS_MIO_ULB_Bladder_Continence_Status | Harnkontinenz differenzierte Einschätzung |
| KBV_VS_MIO_ULB_Bowel_Continence_Status | Stuhlkontinenz differenzierte Einschätzung |
| KBV_VS_MIO_ULB_Cognitive_Awareness | Bewusstseinslage |
| KBV_VS_MIO_ULB_Constraint_Control_Seclusion | Freiheitsentziehende Maßnahmen |
| KBV_VS_MIO_ULB_Diagnosis_ICNP | Pflegeproblem/Pflegediagnose ICNP |
| KBV_VS_MIO_ULB_Disability | Einschränkung Funktionen |
| KBV_VS_MIO_ULB_Disability_Degree_Presence_Status | Grad Behinderung vorhanden |
| KBV_VS_MIO_ULB_Evacuation_Bladder_Content | Art der Harnableitung |
| KBV_VS_MIO_ULB_Evacuation_Intestinal_Contents | Art der Stuhlableitung |
| KBV_VS_MIO_ULB_Food_Administration_Form | Kostdarreichungsform |
| KBV_VS_MIO_ULB_Food_Type | Kostform |
| KBV_VS_MIO_ULB_Health_Care_Proxy_Type | Art der Erklärung |
| KBV_VS_MIO_ULB_Information_Legal_Guardian | Information gesetzliche Betreuung |
| KBV_VS_MIO_ULB_Information_Medication | Information Einnahme Medikamente |
| KBV_VS_MIO_ULB_Interventions_ICNP | Pflegerische Maßnahmen ICNP |
| KBV_VS_MIO_ULB_Isolation_Necessity | Isolation Notwendig |
| KBV_VS_MIO_ULB_Isolation_Type | Isolation Art |
| KBV_VS_MIO_ULB_Living_Condition | Wohnverhältnis |
| KBV_VS_MIO_ULB_Medical_Device | Medizinprodukt |
| KBV_VS_MIO_ULB_Medical_Product_Information | Information Medizinprodukt |
| KBV_VS_MIO_ULB_Nutrition | Ernährung |
| KBV_VS_MIO_ULB_Nutritional_Information | Hinweis Ernährung |
| KBV_VS_MIO_ULB_Orientation_Person | Orientierung Person |
| KBV_VS_MIO_ULB_Orientation_Place | Orientierung Ort |
| KBV_VS_MIO_ULB_Orientation_Situation | Orientierung Situation |
| KBV_VS_MIO_ULB_Orientation_Time | Orientierung Zeit |
| KBV_VS_MIO_ULB_Pain_Symptom | Schmerzsymptomatik |
| KBV_VS_MIO_ULB_Payment_Exemption | Zuzahlungsbefreiung |
| KBV_VS_MIO_ULB_Presence_Respiratory_Support | Vorliegen Atmungsunterstützung |
| KBV_VS_MIO_ULB_Problem_Presence | Vorliegen Problem |
| KBV_VS_MIO_ULB_Relatives_Involvement | Pflege durch Angehörige |
| KBV_VS_MIO_ULB_Relatives_Notification_Status | Benachrichtigung von An- und Zugehörigen |
| KBV_VS_MIO_ULB_Respiratory_Access | Art der Luftleitung |
| KBV_VS_MIO_ULB_Result_Qualitative | Ergebnis Qualitativ |
| KBV_VS_MIO_ULB_Risk | Risiko |
| KBV_VS_MIO_ULB_Risk_Presence | Vorliegen von Risiken |
| KBV_VS_MIO_ULB_Type_Of_Facility | Typ der Einrichtung |
| cyehr-vs-cypdisunitintakeresult | Cyprus EHR Value Set: CYPDIS Unit Intake Result |
| cyehr-vs-ehdsiadverseeventtype | Cyprus EHR Value Set: eHDSI Adverse Event Type |
| cyehr-vs-ehdsiallergennodrug | Cyprus EHR Value Set: eHDSI Allergen No Drug |
| cyehr-vs-ehdsibloodgroup | Cyprus EHR Value Set: eHDSI Blood Group |
| cyehr-vs-ehdsicodeprob | Cyprus EHR Value Set: eHDSI Code Prob |
| cyehr-vs-ehdsimedicaldevice | Cyprus EHR Value Set: eHDSI Medical Device |
| cyehr-vs-ehdsiprocedure | Cyprus EHR Value Set: eHDSI Procedure |
| cyehr-vs-ehdsireactionallergy | Cyprus EHR Value Set: eHDSI Reaction Allergy |
| cyehr-vs-ehdsiresolutionoutcome | Cyprus EHR Value Set: eHDSI Resolution Outcome |
| cyehr-vs-ehdsiseverity | Cyprus EHR Value Set: eHDSI Severity |
| cyehr-vs-ehdsisocialhistory | Cyprus EHR Value Set: eHDSI Social History |
| cyehr-vs-ehdsistatuscode | Cyprus EHR Value Set: eHDSI Status Code |
| cyehr-vs-ehdsivaccine | Cyprys EHR Value Set: eHDSI Vaccine |
| cyehr-vs-nursingcategories | Cyprus EHR Value Set: Nursing Categories |
| cyehr-vs-contactpersonlevel | Cyprus EHR Value Set: Contact Person Level |
| cyehr-vs-diet | Cyprus EHR Value Set: Diet |
| cyehr-vs-drugormedicationtype | Cyprus EHR Value Set: Drug Or Medication Type |
| cyehr-vs-drugusestatus | Cyprus EHR Value Set: Drug Use Status |
| cyehr-vs-findingrelatedtosleep | Cyprus EHR Value Set: Finding Related To Sleep |
| cyehr-vs-respiratoryrhythm | Cyprus EHR Value Set: Respiratory Rhythm |
| cyehr-vs-tobaccotype | Cyprus EHR Value Set: Tobacco Type |
| cyehr-vs-heartrhythm | Cyprus EHR Value Set: Heart Rhythm |
| cyehr-vs-alcoholstatus | Cyprus EHR Value Set: Alcohol Status |
| cyehr-vs-alcoholtypes | Cyprus EHR Value Set: Alcohol Types |
| CareConnect-AllergyManifestation-1 | Care Connect Allergy Manifestation |
| fr-core-vs-bp-method | FR Core ValueSet BP measurement method |
| fr-core-vs-height-body-position | FR Core ValueSet BodyPosition |
| device-kind | FHIR Device Types |
| edible-substance-type | Types of Edible Substances |
| gender-identity | Gender Identity |
| snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| v3-AllergyStatus | Allergy Status |
| v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
| v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
| v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10 | Seizure or Serious Neurologic Dysfunction (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100 | Third Degree Perineal Laceration (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101 | Fourth Degree Perineal Laceration (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102 | Ruptured Uterus (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103 | Unplanned Hysterectomy (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105 | Unplanned Operation (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106 | Attempted Forceps Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107 | Attempted Vacuum Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108 | Fetal Presentation at Birth- Breech (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109 | Fetal Presentation at Birth- Cephalic (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11 | Newborn Given Surfactant Replacement (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110 | Fetal Presentation at Birth- Other (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111 | Route and Method of Delivery - Spontaneous (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112 | Route and Method of Delivery - Forceps (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113 | Route and Method of Delivery - Vacuum (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114 | Route and Method of Delivery - Cesarean (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115 | Route Method of Delivery - Trial of Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116 | Route and Method of Delivery - Scheduled C (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119 | Problem Status Active (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125 | Cervical Cerclage (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127 | External Cephalic Version (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128 | Tocolysis (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129 | Premature Rupture (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130 | Precipitous Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131 | Prolonged Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136 | Prepregnancy Diabetes (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137 | Gestational Diabetes (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138 | Prepregnancy Hypertension (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139 | Gestational Hypertension (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14 | Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140 | Eclampsia (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141 | Preterm Birth (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142 | Poor Pregnancy Outcome History (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143 | Infertility Treatment (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145 | Artificial or Intrauterine Insemination (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146 | Assistive Reproductive Technology (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147 | Listeria (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149 | Neonatal Death (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15 | Physician (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150 | Hysterotomy Hysterectomy (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153 | Fetal Autopsy (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154 | Karyotype Determination (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16 | Doctor of Osteopathic Medicine (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166 | Group B Streptococcus (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167 | Cytomegalovirus (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168 | Parvovirus (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169 | Toxoplasmosis (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178 | Antibiotic Administration Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188 | ICU Care (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189 | Cleft Palate Alone (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190 | Transfer to Facility (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192 | Birth Place Hospital (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193 | Birth Place Home Intended (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194 | Birth Place Home Unintended (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196 | Birth Place Freestanding Birthing Center (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197 | Birth Place Clinic Office (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198 | NICU Care (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22 | Augmentation of Labor - Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24 | Chorioamnionitis During Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25 | Fever Greater Than 100.4 (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27 | Epidural Anesthesia - Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29 | Spinal Anesthesia - Procedure (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30 | Fetal Intolerance of Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31 | In-utero Resuscitation (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32 | Further Fetal Assessment (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33 | Operative Delivery (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34 | Induction of Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35 | Spontaneous Onset of Labor (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36 | Meconium Staining (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37 | Non-vertex presentation in active phase of (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39 | Immature Fetus (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40 | Inflammation Indication (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41 | Breastfed Infant (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53 | Anencephaly of the Newborn (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54 | Cyanotic Congenital Heart Disease (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55 | Congenital Diaphragmatic Hernia (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56 | Karyotype Confirmed (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57 | Suspected Chromosomal Disorder (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58 | Cleft Lip with or without Cleft Palate (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6 | Neonatal Sepsis (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60 | Cleft Lip without Cleft Palate (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61 | Down Syndrome (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62 | Gastroschisis of the Newborn (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63 | Hypospadias (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65 | Meningomyelocele/Spina Bifida - Newborn (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66 | Omphalocele of the Newborn (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9 | Significant Birth Injury (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93 | Chlamydia (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95 | Pregnant (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96 | Hepatitis B (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97 | Hepatitis C (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98 | Syphilis (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99 | Transfusion Whole Blood or Packed Red Bld (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11 | JCIH-EHDI Hearing Loss Risk Factors |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12 | JCIH-EHDI Hearing Loss Risk Factors - Procedures |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14 | JCIH-EHDI Newborn Hearing Loss Diagnosis |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15 | JCIH-EHDI Reason for no Hearing Loss Diagnosis |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16 | JCIH-EHDI Newborn Hearing Loss Referrals |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17 | JCIH-EHDI Newborn Hearing Procedure |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20 | JCIH-EHDI Procedure Declined |
| 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7 | JCIH-EHDI Reason for no Follow-up - Patient Reason |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1 | Autopsy Performed (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13 | Family History (HW) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14 | Mother Breastfeeding (HW) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19 | Associated Conditions (HW) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2 | Autopsy Not Performed (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6 | Death Certification (NCHS) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8 | Dietary Behavior (HW) |
| 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9 | Physical Activity Behavior (HW) |
| 1.3.6.1.4.1.33895.1.3.0.75 | Joint Commission Medical Reason |
| 2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP |
| 2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug (NCHS) |
| 2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| 2.16.840.1.113883.1.11.20.2 | Advance Directive Type Value Set |
| 2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.11 | Twin Placenta (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.13 | Infant Fetal Complications (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) |
| 2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) |
| 2.16.840.1.113883.11.20.9.34 | Patient Education |
| 2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) |
| 2.16.840.1.113883.11.20.9.41 | Tobacco Use |
| 2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type |
| 2.16.840.1.113883.11.20.9.60 | Priority Level (NCHS) |
| 2.16.840.1.113883.13.277 | Birth Defect Diagnosis |
| 2.16.840.1.113883.3.520.4.22 | Laterality (NAACCR) |
| 2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) |
| 2.16.840.1.113883.3.520.4.29 | NAACCR SNOMEDCT Cancer Reportability List |
| 2.16.840.1.113883.3.88.12.3221.6.2 | Allergy/Adverse Event Type Value Set |
| 2.16.840.1.113883.3.88.12.3221.6.8 | Problem Severity |
| 2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type Value Set |
| 2.16.840.1.113883.3.88.12.3221.7.4 | Problem Value Set |
| 2.16.840.1.113883.3.88.12.3221.8.19 | Medication Type Value Set |
| 2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| 2.16.840.1.113883.3.88.12.80.21 | Medication Vehicle Value Set |
| 2.16.840.1.113883.3.88.12.80.60 | Social History Type Value Set |
| 2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| 2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) |
| 2.16.840.1.114222.4.11.1009 | Microorganism |
| 2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) |
| 2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason |
| 2.16.840.1.114222.4.11.1014 | Modifier or Qualifier |
| 2.16.840.1.114222.4.11.1018 | Non Paint Lead Source |
| 2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related |
| 2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) |
| 2.16.840.1.114222.4.11.1026 | Pregnancy Trimester |
| 2.16.840.1.114222.4.11.1027 | Previous Vaccine History |
| 2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) |
| 2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) |
| 2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) |
| 2.16.840.1.114222.4.11.1036 | Referral Status (CRA) |
| 2.16.840.1.114222.4.11.1037 | Risk Category |
| 2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason |
| 2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) |
| 2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) |
| 2.16.840.1.114222.4.11.1057 | Vaccine Contraindications |
| 2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status |
| 2.16.840.1.114222.4.11.1067 | Body Substance |
| 2.16.840.1.114222.4.11.1068 | Event |
| 2.16.840.1.114222.4.11.1069 | Material |
| 2.16.840.1.114222.4.11.1074 | Animal |
| 2.16.840.1.114222.4.11.1075 | Physical Object |
| 2.16.840.1.114222.4.11.1076 | Situation with Explicit Context |
| 2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) |
| 2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) |
| 2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) |
| 2.16.840.1.114222.4.11.3025 | Case Confirmation Method |
| 2.16.840.1.114222.4.11.3026 | Case Detection Method |
| 2.16.840.1.114222.4.11.3027 | Case Transmission Mode |
| 2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) |
| 2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) |
| 2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) |
| 2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) |
| 2.16.840.1.114222.4.11.3036 | Reporting Source Type |
| 2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) |
| 2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) |
| 2.16.840.1.114222.4.11.3044 | Microbiology strain |
| 2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) |
| 2.16.840.1.114222.4.11.3048 | Lab Test Interpretation |
| 2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative |
| 2.16.840.1.114222.4.11.3058 | Cancer Type |
| 2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) |
| 2.16.840.1.114222.4.11.3060 | Immunosuppressed Condition |
| 2.16.840.1.114222.4.11.3062 | Transplant Organ |
| 2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) |
| 2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) |
| 2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) |
| 2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done |
| 2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) |
| 2.16.840.1.114222.4.11.3072 | Animal Type (FDD) |
| 2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) |
| 2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) |
| 2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) |
| 2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) |
| 2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) |
| 2.16.840.1.114222.4.11.3079 | Day Care Type (FDD) |
| 2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) |
| 2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) |
| 2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type |
| 2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) |
| 2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) |
| 2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) |
| 2.16.840.1.114222.4.11.3088 | Information Source |
| 2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) |
| 2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) |
| 2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) |
| 2.16.840.1.114222.4.11.3094 | Other Related Cases |
| 2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) |
| 2.16.840.1.114222.4.11.3096 | Pork Type (FDD) |
| 2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined |
| 2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) |
| 2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) |
| 2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) |
| 2.16.840.1.114222.4.11.3107 | Travel Mode |
| 2.16.840.1.114222.4.11.3108 | Travel Purpose |
| 2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) |
| 2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) |
| 2.16.840.1.114222.4.11.3112 | Underlying Conditions |
| 2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) |
| 2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) |
| 2.16.840.1.114222.4.11.3118 | Medication Treatment (FDD) |
| 2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) |
| 2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) |
| 2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) |
| 2.16.840.1.114222.4.11.3122 | Birth Location (VPD) |
| 2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) |
| 2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) |
| 2.16.840.1.114222.4.11.3126 | Genotype (Measles) |
| 2.16.840.1.114222.4.11.3127 | Genotype (Rubella) |
| 2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) |
| 2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) |
| 2.16.840.1.114222.4.11.3130 | Injury Type (VPD) |
| 2.16.840.1.114222.4.11.3131 | Lab Result (Pertussis) |
| 2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) |
| 2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) |
| 2.16.840.1.114222.4.11.3135 | Non-Live Birth Outcome (VPD) |
| 2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) |
| 2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) |
| 2.16.840.1.114222.4.11.3142 | Test Method EIA IgM |
| 2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) |
| 2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) |
| 2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) |
| 2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) |
| 2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) |
| 2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) |
| 2.16.840.1.114222.4.11.3160 | Microscopic Exam Type (TB) |
| 2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) |
| 2.16.840.1.114222.4.11.3162 | Risk Factors (TB) |
| 2.16.840.1.114222.4.11.3163 | Immigration Status |
| 2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason |
| 2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) |
| 2.16.840.1.114222.4.11.3203 | Treatment status |
| 2.16.840.1.114222.4.11.3204 | Non-Laboratory Intervention and Procedure |
| 2.16.840.1.114222.4.11.3209 | Exposure Location |
| 2.16.840.1.114222.4.11.3210 | Contact Type (Hepatitis B) |
| 2.16.840.1.114222.4.11.3211 | Material exposure type |
| 2.16.840.1.114222.4.11.3212 | Signs and Symptoms (Anthrax) |
| 2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) |
| 2.16.840.1.114222.4.11.3214 | Signs and Symptoms (TB) |
| 2.16.840.1.114222.4.11.3215 | Signs and Symptoms (Tularemia) |
| 2.16.840.1.114222.4.11.3220 | Disease Type (Anthrax) |
| 2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) |
| 2.16.840.1.114222.4.11.3222 | Disease Type (TB) |
| 2.16.840.1.114222.4.11.3223 | Disease Type (Tularemia) |
| 2.16.840.1.114222.4.11.3225 | Blood or body fluid exposure frequency |
| 2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure |
| 2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor |
| 2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) |
| 2.16.840.1.114222.4.11.3231 | Disease Type (STD) |
| 2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) |
| 2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms |
| 2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) |
| 2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) |
| 2.16.840.1.114222.4.11.3246 | Specimen (Flu) |
| 2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) |
| 2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) |
| 2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) |
| 2.16.840.1.114222.4.11.3254 | Employment Status (Flu) |
| 2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) |
| 2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) |
| 2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) |
| 2.16.840.1.114222.4.11.3258 | Change Pattern |
| 2.16.840.1.114222.4.11.3259 | Age Group (Flu) |
| 2.16.840.1.114222.4.11.3261 | Death Location (Flu) |
| 2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3265 | Positive Negative Unknown |
| 2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) |
| 2.16.840.1.114222.4.11.3275 | Relationship (Flu) |
| 2.16.840.1.114222.4.11.3282 | Specimen Collection Method |
| 2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) |
| 2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) |
| 2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) |
| 2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) |
| 2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) |
| 2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) |
| 2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) |
| 2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) |
| 2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) |
| 2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) |
| 2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) |
| 2.16.840.1.114222.4.11.3308 | Complications (Malaria) |
| 2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) |
| 2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) |
| 2.16.840.1.114222.4.11.3313 | Species (Malaria) |
| 2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) |
| 2.16.840.1.114222.4.11.3317 | Antimicrobial Susceptibility Test Method (IPD) |
| 2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) |
| 2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) |
| 2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) |
| 2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) |
| 2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) |
| 2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) |
| 2.16.840.1.114222.4.11.3359 | Evaluation Finding |
| 2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) |
| 2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) |
| 2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) |
| 2.16.840.1.114222.4.11.3411 | Body Region Tetanus (NETSS) |
| 2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) |
| 2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) |
| 2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) |
| 2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) |
| 2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) |
| 2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) |
| 2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) |
| 2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) |
| 2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) |
| 2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) |
| 2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) |
| 2.16.840.1.114222.4.11.3435 | Serotype (NETSS) |
| 2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease |
| 2.16.840.1.114222.4.11.3502 | Infectious Disease |
| 2.16.840.1.114222.4.11.3503 | Pneumonia Disease |
| 2.16.840.1.114222.4.11.3587 | Flu Activity Code |
| 2.16.840.1.114222.4.11.3594 | Campylobacter Organism |
| 2.16.840.1.114222.4.11.4000 | Lab Result (Amebiasis) |
| 2.16.840.1.114222.4.11.4001 | Lab Result (Anaplasma) |
| 2.16.840.1.114222.4.11.4002 | Lab Result (Anthrax) |
| 2.16.840.1.114222.4.11.4003 | Lab Result (Arbovirus) |
| 2.16.840.1.114222.4.11.4004 | Lab Result (Arenavirus) |
| 2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) |
| 2.16.840.1.114222.4.11.4006 | Lab Result (Bartonellosis) |
| 2.16.840.1.114222.4.11.4007 | Lab Result (Blastomycosis) |
| 2.16.840.1.114222.4.11.4008 | Lab Result (Botulism) |
| 2.16.840.1.114222.4.11.4009 | Lab Result (Brucellosis) |
| 2.16.840.1.114222.4.11.4010 | Lab Result (California serogroup virus) |
| 2.16.840.1.114222.4.11.4011 | Lab Result (Campylobacteriosis) |
| 2.16.840.1.114222.4.11.4012 | Lab Result (Chagas) |
| 2.16.840.1.114222.4.11.4013 | Lab Result (Chancroid) |
| 2.16.840.1.114222.4.11.4014 | Lab Result (Chlamydia trachomatis) |
| 2.16.840.1.114222.4.11.4015 | Lab Result (Cholera) |
| 2.16.840.1.114222.4.11.4016 | Lab Result (Clostridium perfringens) |
| 2.16.840.1.114222.4.11.4017 | Lab Result (Clostridium perfringens Epsilon Toxin) |
| 2.16.840.1.114222.4.11.4018 | Lab Result (Coccidioidomycosis) |
| 2.16.840.1.114222.4.11.4019 | Lab Result (Colorado Tick Fever) |
| 2.16.840.1.114222.4.11.4020 | Lab Result (Creutzfeldt-Jakob disease) |
| 2.16.840.1.114222.4.11.4021 | Lab Result (Cryptococcosis) |
| 2.16.840.1.114222.4.11.4022 | Lab Result (Cryptosporidiosis) |
| 2.16.840.1.114222.4.11.4023 | Lab Result (Cyclosporiasis) |
| 2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) |
| 2.16.840.1.114222.4.11.4025 | Lab Result (Dengue) |
| 2.16.840.1.114222.4.11.4026 | Lab Result (Diphtheria) |
| 2.16.840.1.114222.4.11.4027 | Lab Result (Eastern equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) |
| 2.16.840.1.114222.4.11.4029 | Lab Result (E. coli STEC) |
| 2.16.840.1.114222.4.11.4030 | Lab Result (Ehrlichia chaffeensis) |
| 2.16.840.1.114222.4.11.4031 | Lab Result (Ehrlichia ewingii) |
| 2.16.840.1.114222.4.11.4032 | Lab Result (Ehrlichiosis Anaplasmosis) |
| 2.16.840.1.114222.4.11.4033 | Lab Result (Genital Warts) |
| 2.16.840.1.114222.4.11.4034 | Lab Result (Giardiasis) |
| 2.16.840.1.114222.4.11.4035 | Lab Result (Glanders) |
| 2.16.840.1.114222.4.11.4036 | Lab Result (Gonorrhea) |
| 2.16.840.1.114222.4.11.4037 | Lab Result (Granuloma Inguinale) |
| 2.16.840.1.114222.4.11.4038 | Lab Result (Haemophilus influenzae) |
| 2.16.840.1.114222.4.11.4039 | Lab Result (Hansen's Disease) |
| 2.16.840.1.114222.4.11.4040 | Lab Result (Hantavirus Pulmonary Syndrome) |
| 2.16.840.1.114222.4.11.4041 | Lab Result (Hendra virus) |
| 2.16.840.1.114222.4.11.4042 | Lab Result (Hepatitis A) |
| 2.16.840.1.114222.4.11.4043 | Lab Result (Hepatitis B) |
| 2.16.840.1.114222.4.11.4044 | Lab Result (Hepatitis C) |
| 2.16.840.1.114222.4.11.4045 | Lab Result (Hepatitis D) |
| 2.16.840.1.114222.4.11.4046 | Lab Result (Hepatitis E) |
| 2.16.840.1.114222.4.11.4047 | Lab Result (Herpes Simplex) |
| 2.16.840.1.114222.4.11.4048 | Lab Result (Histoplasmosis) |
| 2.16.840.1.114222.4.11.4049 | Lab Result (HIV) |
| 2.16.840.1.114222.4.11.4050 | Lab Result (Influenza A virus, H1N1 2009 strain) |
| 2.16.840.1.114222.4.11.4051 | Lab Result (Jamestown Canyon virus) |
| 2.16.840.1.114222.4.11.4052 | Lab Result (Legionellosis) |
| 2.16.840.1.114222.4.11.4053 | Lab Result (Leptospirosis) |
| 2.16.840.1.114222.4.11.4054 | Lab Result (Listeriosis) |
| 2.16.840.1.114222.4.11.4055 | Lab Result (Lyme disease) |
| 2.16.840.1.114222.4.11.4056 | Lab Result (Lymphogranuloma Venereum) |
| 2.16.840.1.114222.4.11.4057 | Lab Result (Malaria) |
| 2.16.840.1.114222.4.11.4058 | Lab Result (Marburgvirus) |
| 2.16.840.1.114222.4.11.4059 | Lab Result (Measles) |
| 2.16.840.1.114222.4.11.4060 | Lab Result (Melioidosis) |
| 2.16.840.1.114222.4.11.4061 | Lab Result (Meningococcal Disease) |
| 2.16.840.1.114222.4.11.4062 | Lab Result (Monkeypox Orthopox) |
| 2.16.840.1.114222.4.11.4063 | Lab Result (MRSA) |
| 2.16.840.1.114222.4.11.4064 | Lab Result (Mumps) |
| 2.16.840.1.114222.4.11.4065 | Lab Result (Nipah Virus) |
| 2.16.840.1.114222.4.11.4066 | Lab Result (Nongonococcal Urethritis) |
| 2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) |
| 2.16.840.1.114222.4.11.4068 | Lab Result (Norovirus) |
| 2.16.840.1.114222.4.11.4069 | Lab Result RCMT (Pertussis) |
| 2.16.840.1.114222.4.11.4070 | Lab Result (Plague) |
| 2.16.840.1.114222.4.11.4071 | Lab Result (Polio) |
| 2.16.840.1.114222.4.11.4072 | Lab Result (Powassan virus) |
| 2.16.840.1.114222.4.11.4073 | Lab Result (Prion Disease) |
| 2.16.840.1.114222.4.11.4074 | Lab Result (Psittacosis) |
| 2.16.840.1.114222.4.11.4075 | Lab Result (Q Fever) |
| 2.16.840.1.114222.4.11.4076 | Lab Result (Rabies) |
| 2.16.840.1.114222.4.11.4077 | Lab Result (Relapsing Fever) |
| 2.16.840.1.114222.4.11.4078 | Lab Result (Respiratory Syncytial Virus) |
| 2.16.840.1.114222.4.11.4079 | Lab Result (Rickettsial infection, other) |
| 2.16.840.1.114222.4.11.4080 | Lab Result (Rift Valley Fever) |
| 2.16.840.1.114222.4.11.4081 | Lab Result (Rotavirus) |
| 2.16.840.1.114222.4.11.4082 | Lab Result RCMT (Rubella) |
| 2.16.840.1.114222.4.11.4083 | Lab Result (Salmonellosis) |
| 2.16.840.1.114222.4.11.4084 | Lab Result (SARS) |
| 2.16.840.1.114222.4.11.4085 | Lab Result (Shigella) |
| 2.16.840.1.114222.4.11.4086 | Lab Result (Smallpox) |
| 2.16.840.1.114222.4.11.4087 | Lab Result (Spotted fever rickettsiosis) |
| 2.16.840.1.114222.4.11.4088 | Lab Result (Staphylococcus aureus) |
| 2.16.840.1.114222.4.11.4089 | Lab Result (Staphylococcus aureus enterotoxin B) |
| 2.16.840.1.114222.4.11.4090 | Lab Result (Staphylococcus aureus food poisoning) |
| 2.16.840.1.114222.4.11.4091 | Lab Result (Staphylococcal TSS) |
| 2.16.840.1.114222.4.11.4092 | Lab Result (St. Louis encephalitis virus) |
| 2.16.840.1.114222.4.11.4093 | Lab Result (Streptococcus pneumoniae) |
| 2.16.840.1.114222.4.11.4094 | Lab Result (Streptococcal TSS) |
| 2.16.840.1.114222.4.11.4095 | Lab Result (Streptococcus, group A) |
| 2.16.840.1.114222.4.11.4096 | Lab Result (Streptococcus, group B) |
| 2.16.840.1.114222.4.11.4097 | Lab Result (Syphilis) |
| 2.16.840.1.114222.4.11.4098 | Lab Result (Tetanus) |
| 2.16.840.1.114222.4.11.4099 | Lab Result (Toxoplasmosis) |
| 2.16.840.1.114222.4.11.4100 | Lab Result (Trichinellosis) |
| 2.16.840.1.114222.4.11.4101 | Lab Result (Tuberculosis) |
| 2.16.840.1.114222.4.11.4102 | Lab Result (Tularemia) |
| 2.16.840.1.114222.4.11.4103 | Lab Result (Typhoid Fever) |
| 2.16.840.1.114222.4.11.4104 | Lab Result (Typhus group rickettsiosis) |
| 2.16.840.1.114222.4.11.4105 | Lab Result (Vaccinia) |
| 2.16.840.1.114222.4.11.4106 | Lab Result (Vancomycin resistant Enterococcus) |
| 2.16.840.1.114222.4.11.4107 | Lab Result (Varicella) |
| 2.16.840.1.114222.4.11.4108 | Lab Result (Vesicular Stomatitis) |
| 2.16.840.1.114222.4.11.4109 | Lab Result (Vibriosis, non-cholera) |
| 2.16.840.1.114222.4.11.4110 | Lab Result (Viral Hemorrhagic Fever) |
| 2.16.840.1.114222.4.11.4111 | Lab Result (VISA) |
| 2.16.840.1.114222.4.11.4112 | Lab Result (VRSA) |
| 2.16.840.1.114222.4.11.4113 | Lab Result (Western equine encephalitis virus) |
| 2.16.840.1.114222.4.11.4114 | Lab Result (West Nile virus) |
| 2.16.840.1.114222.4.11.4115 | Lab Result (Yellow Fever) |
| 2.16.840.1.114222.4.11.4116 | Lab Result (Yersiniosis) |
| 2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) |
| 2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) |
| 2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP |
| 2.16.840.1.114222.4.11.5004 | Specimen Reject Reason (SCT) (PHLIP) |
| 2.16.840.1.114222.4.11.5013 | Suspected Agent (PHLIP Sal) |
| 2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) |
| 2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP |
| 2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP |
| 2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP |
| 2.16.840.1.114222.4.11.5026 | Lab Test Result PHLIP Salmonella |
| 2.16.840.1.114222.4.11.5028 | Method Detail (PHLIP) |
| 2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) |
| 2.16.840.1.114222.4.11.6002 | Manner of Death (NCHS) |
| 2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) |
| 2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) |
| 2.16.840.1.114222.4.11.6027 | Smoking Status (PI) |
| 2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) |
| 2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) |
| 2.16.840.1.114222.4.11.6071 | Gonorrhea (NCHS) |
| 2.16.840.1.114222.4.11.6072 | Trachoma (NCHS) |
| 2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation |
| 2.16.840.1.114222.4.11.7104 | VPD Specimen Type |
| 2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method |
| 2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site |
| 2.16.840.1.114222.4.11.7108 | VPD Specimen Condition |
| 2.16.840.1.114222.4.11.7110 | VPD Specimen Reject Reason |
| 2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) |
| 2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) |
| 2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) |
| 2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) |
| 2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) |
| 2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) |
| 2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) |
| 2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) |
| 2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) |
| 2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) |
| 2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) |
| 2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) |
| 2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) |
| 2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) |
| 2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) |
| 2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) |
| 2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) |
| 2.16.840.1.114222.4.11.7140 | Autopsy Planned (NCHS) |
| 2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) |
| 2.16.840.1.114222.4.11.7143 | Steroids For Fetal Lung Maturation (NCHS) |
| 2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) |
| 2.16.840.1.114222.4.11.7154 | Fetal Presentation at Birth- Unknown (NCHS) |
| 2.16.840.1.114222.4.11.7156 | Assisted Ventilation (NCHS) |
| 2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) |
| 2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) |
| 2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) |
| 2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) |
| 2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) |
| 2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) |
| 2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) |
| 2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) |
| 2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) |
| 2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) |
| 2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) |
| 2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) |
| 2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) |
| 2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) |
| 2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) |
| 2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) |
| 2.16.840.1.114222.4.11.7189 | Specimen Source (STD) |
| 2.16.840.1.114222.4.11.7192 | HIV Status (STD) |
| 2.16.840.1.114222.4.11.7194 | Drugs Used (STD) |
| 2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) |
| 2.16.840.1.114222.4.11.7199 | Detection Method (STD) |
| 2.16.840.1.114222.4.11.7200 | Lab Results (STD) |
| 2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) |
| 2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) |
| 2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) |
| 2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) |
| 2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) |
| 2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) |
| 2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) |
| 2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) |
| 2.16.840.1.114222.4.11.7223 | Birth Status (NND) |
| 2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) |
| 2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) |
| 2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) |
| 2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) |
| 2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) |
| 2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) |
| 2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) |
| 2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) |
| 2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) |
| 2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) |
| 2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) |
| 2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) |
| 2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms |
| 2.16.840.1.114222.4.11.7257 | Abdominal Pain (CDS - EHR) |
| 2.16.840.1.114222.4.11.7258 | Weakness (CDS - EHR) |
| 2.16.840.1.114222.4.11.7259 | Fever (CDS - EHR) |
| 2.16.840.1.114222.4.11.7260 | Headache (CDS - EHR) |
| 2.16.840.1.114222.4.11.7261 | Hemorrhage (CDS - EHR) |
| 2.16.840.1.114222.4.11.7262 | Muscle Pain (CDS - EHR) |
| 2.16.840.1.114222.4.11.7263 | Vomiting (CDS - EHR) |
| 2.16.840.1.114222.4.11.7264 | Diarrhea (CDS - EHR) |
| 2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) |
| 2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) |
| 2.16.840.1.114222.4.11.7273 | Death Pronouncement Finding (NCHS) |
| 2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) |
| 2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) |
| 2.16.840.1.114222.4.11.7282 | Complications (Mumps) |
| 2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) |
| 2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) |
| 2.16.840.1.114222.4.11.7285 | Complications (Pertussis) |
| 2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) |
| 2.16.840.1.114222.4.11.7332 | Setting of Further Spread |
| 2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) |
| 2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) |
| 2.16.840.1.114222.4.11.7343 | Lab Result (Chikungunya virus) |
| 2.16.840.1.114222.4.11.7344 | Lab Result (Crimean-Congo hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7345 | Lab Result (Guanarito hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7346 | Lab Result (Junin hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7347 | Lab Result (Lassa fever) |
| 2.16.840.1.114222.4.11.7348 | Lab Result (Lujo virus) |
| 2.16.840.1.114222.4.11.7349 | Lab Result (Machupo hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7350 | Lab Result (Sabia virus hemorrhagic fever) |
| 2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) |
| 2.16.840.1.114222.4.11.7357 | Hysterectomy (NCHS) |
| 2.16.840.1.114222.4.11.7358 | Hysterotomy (NCHS) |
| 2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) |
| 2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) |
| 2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) |
| 2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) |
| 2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) |
| 2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) |
| 2.16.840.1.114222.4.11.7402 | Patient Residence (NCHS) |
| 2.16.840.1.114222.4.11.7403 | Injury or Poisoning (NCHS) |
| 2.16.840.1.114222.4.11.7405 | Co-morbid Conditions (NCHS) |
| 2.16.840.1.114222.4.11.7419 | Provider ED (NCHS) |
| 2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) |
| 2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs |
| 2.16.840.1.114222.4.11.7431 | Surfactant Replacement Therapy (NCHS) |
| 2.16.840.1.114222.4.11.7432 | Asthma (NCHS) |
| 2.16.840.1.114222.4.11.7433 | Condition Control (NCHS) |
| 2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) |
| 2.16.840.1.114222.4.11.7439 | Episode of Care (NCHS) |
| 2.16.840.1.114222.4.11.7440 | Hospital Discharge Status (NCHS) |
| 2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) |
| 2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) |
| 2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) |
| 2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) |
| 2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash |
| 2.16.840.1.114222.4.11.7454 | Character of Lesions |
| 2.16.840.1.114222.4.11.7458 | Transmission Mode (Zika) |
| 2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) |
| 2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) |
| 2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures |
| 2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) |
| 2.16.840.1.114222.4.11.7464 | Insect Repellant |
| 2.16.840.1.114222.4.11.7465 | Vector (Zika) |
| 2.16.840.1.114222.4.11.7466 | Complications (Zika) |
| 2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) |
| 2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks |
| 2.16.840.1.114222.4.11.7469 | Microcephaly Causes |
| 2.16.840.1.114222.4.11.7470 | Head Circumference Findings |
| 2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) |
| 2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) |
| 2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done |
| 2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done |
| 2.16.840.1.114222.4.11.7478 | Serotype (Dengue) |
| 2.16.840.1.114222.4.11.7479 | Lab Result (Zika virus) |
| 2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) |
| 2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) |
| 2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) |
| 2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) |
| 2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) |
| 2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) |
| 2.16.840.1.114222.4.11.7491 | Pregnancy Complications (Arbovirus) |
| 2.16.840.1.114222.4.11.7492 | Newborn Complications (Arbovirus) |
| 2.16.840.1.114222.4.11.7494 | Pregnancy Outcome |
| 2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) |
| 2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) |
| 2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) |
| 2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) |
| 2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) |
| 2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) |
| 2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) |
| 2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) |
| 2.16.840.1.114222.4.11.7526 | Method of Delivery VaginalSpon Finding (NCHS) |
| 2.16.840.1.114222.4.11.7527 | Method of Delivery Cesarean Finding (NCHS) |
| 2.16.840.1.114222.4.11.7528 | Method of Delivery Vaginal Forceps Finding (NCHS) |
| 2.16.840.1.114222.4.11.7529 | Method of Delivery Vaginal Vacuum Finding (NCHS) |
| 2.16.840.1.114222.4.11.7530 | Scheduled Cesarean Finding (NCHS) |
| 2.16.840.1.114222.4.11.7531 | Induction of Labor Finding (NCHS) |
| 2.16.840.1.114222.4.11.7532 | Augmentation of Labor Finding (NCHS) |
| 2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) |
| 2.16.840.1.114222.4.11.7540 | Blood Product |
| 2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) |
| 2.16.840.1.114222.4.11.7543 | Lab Result (Hantavirus Infection) |
| 2.16.840.1.114222.4.11.7544 | Outdoor Activities |
| 2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative |
| 2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) |
| 2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) |
| 2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) |
| 2.16.840.1.114222.4.11.7556 | Susceptibility Test Method (STD) |
| 2.16.840.1.114222.4.11.7557 | Susceptibility Test Interpretation (STD) |
| 2.16.840.1.114222.4.11.756 | Gender Identity |
| 2.16.840.1.114222.4.11.7563 | Sexual Orientation |
| 2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) |
| 2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) |
| 2.16.840.1.114222.4.11.7604 | Route Method of Delivery SpontaneousProcedure (NCHS) |
| 2.16.840.1.114222.4.11.7607 | Type of Testing at CDC |
| 2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) |
| 2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) |
| 2.16.840.1.114222.4.11.7610 | Gender Identity (STD) |
| 2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) |
| 2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) |
| 2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) |
| 2.16.840.1.114222.4.11.7617 | Organism (FDD) |
| 2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) |
| 2.16.840.1.114222.4.11.7622 | Positive Negative Not Done |
| 2.16.840.1.114222.4.11.7626 | Test Result (FDD) |
| 2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) |
| 2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) |
| 2.16.840.1.114222.4.11.7636 | Medical History (FDD) |
| 2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) |
| 2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) |
| 2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) |
| 2.16.840.1.114222.4.11.7647 | Typhoid Paratyphoid Serotype (FDD) |
| 2.16.840.1.114222.4.11.7648 | Yes No Not Tested (NND) |
| 2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) |
| 2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) |
| 2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) |
| 2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) |
| 2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) |
| 2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) |
| 2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) |
| 2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) |
| 2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) |
| 2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) |
| 2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) |
| 2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) |
| 2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) |
| 2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) |
| 2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) |
| 2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) |
| 2.16.840.1.114222.4.11.7675 | Specimen type (Trich) |
| 2.16.840.1.114222.4.11.7676 | Strain Type (Trich) |
| 2.16.840.1.114222.4.11.7677 | Form Status (RIBD) |
| 2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) |
| 2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) |
| 2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) |
| 2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) |
| 2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) |
| 2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) |
| 2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) |
| 2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) |
| 2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) |
| 2.16.840.1.114222.4.11.7690 | GAS Risk Factor (RIBD) |
| 2.16.840.1.114222.4.11.7692 | Rehab Type (RIBD) |
| 2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) |
| 2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) |
| 2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) |
| 2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) |
| 2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) |
| 2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) |
| 2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) |
| 2.16.840.1.114222.4.11.7701 | AR Test Method (RIBD) |
| 2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) |
| 2.16.840.1.114222.4.11.7703 | MIC Operator (RIBD) |
| 2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) |
| 2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) |
| 2.16.840.1.114222.4.11.7707 | Blood Type (RIBD) |
| 2.16.840.1.114222.4.11.7708 | Rupture Type (RIBD) |
| 2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) |
| 2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) |
| 2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) |
| 2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) |
| 2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) |
| 2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) |
| 2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) |
| 2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) |
| 2.16.840.1.114222.4.11.7720 | Water Source (RIBD) |
| 2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) |
| 2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) |
| 2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) |
| 2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) |
| 2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) |
| 2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) |
| 2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) |
| 2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) |
| 2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) |
| 2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) |
| 2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) |
| 2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) |
| 2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) |
| 2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) |
| 2.16.840.1.114222.4.11.7738 | Isolate Not Available (RIBD) |
| 2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) |
| 2.16.840.1.114222.4.11.7745 | Type of Radiology Study |
| 2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) |
| 2.16.840.1.114222.4.11.7747 | Diabetes Status |
| 2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) |
| 2.16.840.1.114222.4.11.7749 | Smoking Status |
| 2.16.840.1.114222.4.11.7750 | Diagnosis Type (TB) |
| 2.16.840.1.114222.4.11.7752 | Strength of Link (TB) |
| 2.16.840.1.114222.4.11.7753 | Directionality of Link (TB) |
| 2.16.840.1.114222.4.11.7754 | Treatment Administration Type (TB) |
| 2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) |
| 2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) |
| 2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) |
| 2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) |
| 2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) |
| 2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) |
| 2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) |
| 2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) |
| 2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) |
| 2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) |
| 2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) |
| 2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) |
| 2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) |
| 2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) |
| 2.16.840.1.114222.4.11.7779 | Condition Status (FDD) |
| 2.16.840.1.114222.4.11.7782 | Deli Meats (Listeria) |
| 2.16.840.1.114222.4.11.7783 | Deli Salads (Listeria) |
| 2.16.840.1.114222.4.11.7784 | Diet Type (Listeria) |
| 2.16.840.1.114222.4.11.7786 | Food (Listeria) |
| 2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) |
| 2.16.840.1.114222.4.11.7788 | Food Freshness (Listeria) |
| 2.16.840.1.114222.4.11.7789 | Fruit (Listeria) |
| 2.16.840.1.114222.4.11.7792 | Illness (Listeria) |
| 2.16.840.1.114222.4.11.7795 | Medical History (Listeria) |
| 2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) |
| 2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) |
| 2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) |
| 2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) |
| 2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) |
| 2.16.840.1.114222.4.11.7805 | Yes No None (Listeria) |
| 2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) |
| 2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) |
| 2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) |
| 2.16.840.1.114222.4.11.7810 | Provider Information Source (RIBD) |
| 2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) |
| 2.16.840.1.114222.4.11.7814 | Genotypic Test Result (CP-CRE) |
| 2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) |
| 2.16.840.1.114222.4.11.7817 | Type of Dairy Product (Listeria) |
| 2.16.840.1.114222.4.11.7818 | General Condition Status (TB) |
| 2.16.840.1.114222.4.11.7820 | Born in the United States (Listeria) |
| 2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) |
| 2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) |
| 2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) |
| 2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) |
| 2.16.840.1.114222.4.11.7833 | Complications (TBRD) |
| 2.16.840.1.114222.4.11.7836 | Organism (TBRD) |
| 2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) |
| 2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) |
| 2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) |
| 2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) |
| 2.16.840.1.114222.4.11.7843 | Organism (Lyme) |
| 2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) |
| 2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) |
| 2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) |
| 2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) |
| 2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) |
| 2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) |
| 2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) |
| 2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) |
| 2.16.840.1.114222.4.11.7867 | Test Result (C. auris) |
| 2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) |
| 2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) |
| 2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) |
| 2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) |
| 2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) |
| 2.16.840.1.114222.4.11.7878 | Exposure Source (CO) |
| 2.16.840.1.114222.4.11.7879 | Treatment Type (CO) |
| 2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) |
| 2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) |
| 2.16.840.1.114222.4.11.7886 | Treatment Location (CO) |
| 2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) |
| 2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) |
| 2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) |
| 2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) |
| 2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace |
| 2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) |
| 2.16.840.1.114222.4.11.7902 | GC specimen quality (ARLN) |
| 2.16.840.1.114222.4.11.7903 | GC beta-lactamase result (ARLN) |
| 2.16.840.1.114222.4.11.7911 | Clinical sample or isolate (ARLN) |
| 2.16.840.1.114222.4.11.7912 | Candida auris culture result (ARLN) |
| 2.16.840.1.114222.4.11.7913 | Candida auris PCR result (ARLN) |
| 2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) |
| 2.16.840.1.114222.4.11.7915 | Carbapenemase phenotypic result (ARLN) |
| 2.16.840.1.114222.4.11.7916 | CPO phenotypic method (ARLN) |
| 2.16.840.1.114222.4.11.7917 | CPO PCR method (ARLN) |
| 2.16.840.1.114222.4.11.7918 | CPO AST method (ARLN) |
| 2.16.840.1.114222.4.11.7919 | CPO PCR result (ARLN) |
| 2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) |
| 2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) |
| 2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) |
| 2.16.840.1.114222.4.11.7924 | Mother Infant Indicator (NND) |
| 2.16.840.1.114222.4.11.7925 | Type of Complication (STD) |
| 2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) |
| 2.16.840.1.114222.4.11.7927 | Dose Unit (STD) |
| 2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) |
| 2.16.840.1.114222.4.11.7929 | Medication Route (STD) |
| 2.16.840.1.114222.4.11.7930 | Route of Administration (STD) |
| 2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) |
| 2.16.840.1.114222.4.11.7934 | Microorganism (STD) |
| 2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) |
| 2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) |
| 2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) |
| 2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) |
| 2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) |
| 2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) |
| 2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) |
| 2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) |
| 2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) |
| 2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) |
| 2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) |
| 2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
| 2.16.840.1.114222.4.11.7955 | Location of Initial Diagnosis (Hansen) |
| 2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) |
| 2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) |
| 2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) |
| 2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) |
| 2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) |
| 2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) |
| 2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) |
| 2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) |
| 2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) |
| 2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) |
| 2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) |
| 2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) |
| 2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) |
| 2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) |
| 2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) |
| 2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) |
| 2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) |
| 2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) |
| 2.16.840.1.114222.4.11.7983 | Time of Day (Anthrax) |
| 2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) |
| 2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) |
| 2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) |
| 2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) |
| 2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) |
| 2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) |
| 2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) |
| 2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) |
| 2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) |
| 2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) |
| 2.16.840.1.114222.4.11.7998 | Severe Weather Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) |
| 2.16.840.1.114222.4.11.8000 | Test Results Anthrax |
| 2.16.840.1.114222.4.11.8001 | Time of Day (CDC) |
| 2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) |
| 2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) |
| 2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) |
| 2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) |
| 2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) |
| 2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) |
| 2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) |
| 2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) |
| 2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) |
| 2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) |
| 2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) |
| 2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) |
| 2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) |
| 2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) |
| 2.16.840.1.114222.4.11.8020 | Anthrax Vaccine Exposure (Anthrax) |
| 2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) |
| 2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) |
| 2.16.840.1.114222.4.11.8035 | Subject of Medication Received (Hansen) |
| 2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) |
| 2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) |
| 2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) |
| 2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) |
| 2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) |
| 2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) |
| 2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) |
| 2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) |
| 2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) |
| 2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) |
| 2.16.840.1.114222.4.11.8047 | Common-Source Outbreak (Hepatitis A) |
| 2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) |
| 2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) |
| 2.16.840.1.114222.4.11.8050 | Other Case Hepatitides (Hepatitis) |
| 2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) |
| 2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) |
| 2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) |
| 2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) |
| 2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) |
| 2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
| 2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) |
| 2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) |
| 2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) |
| 2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) |
| 2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) |
| 2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) |
| 2.16.840.1.114222.4.11.834 | Allergen |
| 2.16.840.1.114222.4.11.909 | Disease |
| 2.16.840.1.114222.4.11.928 | True False (TF) |
| 2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done |
| 2.16.840.1.114222.4.11.930 | Chest XRay Result |
| 2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason |
| 2.16.840.1.114222.4.11.941 | Susceptibility Result |
| 2.16.840.1.114222.4.11.946 | Specimen |
| 2.16.840.1.114222.4.11.950 | Passed Failed Unknown |
| 2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) |
| 2.16.840.1.114222.4.11.967 | Body site |
| 2.16.840.1.114222.4.11.968 | Case Classification Status |
| 2.16.840.1.114222.4.11.969 | Case investigation closure reason |
| 2.16.840.1.114222.4.11.970 | Case Investigation Status |
| 2.16.840.1.114222.4.11.972 | Case Verification (TB) |
| 2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) |
| 2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) |
| 2.16.840.1.114222.4.11.984 | Dwelling Type |
| 2.16.840.1.114222.4.11.985 | Employment Status |
| 2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose |
| 2.16.840.1.114222.4.11.991 | Environmental Investigation Reason |
| 2.16.840.1.114222.4.11.994 | General Condition Status |
| 2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) |
| 2.16.840.1.114222.4.11.996 | History Source (CRA) |
| 2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On |
| 2.16.840.1.114222.4.11.998 | HIV Status |
| 2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) |
| 6.1.4.1.19376.1.7.3.1.1.13.8.64 | Limb Reduction Defect (NCHS) |
| condition-severity | Condition/Diagnosis Severity |
| device-action | Procedure Device Action Codes |
| device-kind | FHIR Device Types |
| c80-facilitycodes | Facility Type Code Value Set |
| 2.16.840.1.113762.1.4.1021.32 | Gender Identity |
| performer-role | Procedure Performer Role Codes |
| procedure-category | Procedure Category Codes (SNOMED CT) |
| procedure-followup | Procedure Follow up Codes (SNOMED CT) |
| procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) |
| procedure-outcome | Procedure Outcome Codes (SNOMED CT) |
| referencerange-appliesto | Observation Reference Range Applies To Codes |
| servicerequest-orderdetail | Service Request Order Details Codes |
| us-core-encounter-type | US Core Encounter Type |
| us-core-servicerequest-category | US Core ServiceRequest Category Codes |
| KBV_VS_MIO_CMR_Bodysite_Hip | Hüftlateralität |
| KBV_VS_MIO_CMR_Examination_Number | Untersuchungsnummer U-Heft |
| KBV_VS_MIO_CMR_Foetal_Position | Kindslage aus Sicht d. Kindes |
| KBV_VS_MIO_CMR_Gender_Birth | Geschlecht |
| KBV_VS_MIO_CMR_Hearscreening_Method | Hörscreenigmethode |
| KBV_VS_MIO_CMR_Hearscreening_Result | Hörscreeningbefund Lokalisation |
| KBV_VS_MIO_CMR_Hip_History | Hüftanamnese |
| KBV_VS_MIO_CMR_Hip_Proceeding | Hüfte - weiteres Vorgehen |
| KBV_VS_MIO_CMR_Hip_Screening_Method | Hüftscreening Methode |
| KBV_VS_MIO_CMR_Newborn_Blood_Spot_Screening_Type | Typ der Blutabnahme |
| KBV_VS_MIO_CMR_Percentile_Body_Measure_Snomed | Perzentilkörpermaß SNOMED |
| KBV_VS_MIO_CMR_Practitioner_Speciality | Rolle des Behandelnden |
| KBV_VS_MIO_CMR_Pregnancy_History | Schwangerschaftsanamnese |
| KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Data_Absent_Reason | Gründe zur Ablehnung des Pulsoxymetriescreenings |
| KBV_VS_MIO_CMR_Pulse_Oxymetry_Screening_Measurement_Type | Typ der Pulsoxymetriemessung |
| KBV_VS_MIO_CMR_U1_Apgar_Score_Identifier | Apgar Score am Zeitpunkt |
| KBV_VS_MIO_CMR_U1_Apgar_Score_Value | Apgar-Score Wert |
| KBV_VS_MIO_CMR_U1_U3_Birthmode | Geburtsmodus |
| KBV_VS_MIO_CMR_U1_U3_Pulse_Oxymetry_Measurement | Auffälligkeit Sauerstoffsättigung |
| KBV_VS_MIO_CMR_U2_Consultation | U2 - Beratung |
| KBV_VS_MIO_CMR_U2_Current_Child_History | U2 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U2_Family_History | U2 - Familienanamnese |
| KBV_VS_MIO_CMR_U2_Physical_Exam_Head | U2 - Kopf |
| KBV_VS_MIO_CMR_U2_Physical_Exam_Mouth_Nose | U2 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U2_Physical_Exam_Musculoskeletal_System | U2 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U2_Physical_Exam_Skin | U2 - Haut |
| KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Abdomen_Genitals | U2, U3 - Abdomen, Genitale |
| KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Ears | U2, U3 - Ohren |
| KBV_VS_MIO_CMR_U2_U3_Physical_Exam_Eyes | U2, U3 - Augen |
| KBV_VS_MIO_CMR_U2_U4_Physical_Exam_Chest_Lung_Respiratory_Tract | U2, U3, U4 - Thorax, Lunge, Atemwege |
| KBV_VS_MIO_CMR_U2_U6_Physical_Exam_Heart_Blood_Circulation | U2, U3, U4, U5, U6 - Herz, Kreislauf |
| KBV_VS_MIO_CMR_U3_Consultation | U3 - Beratung |
| KBV_VS_MIO_CMR_U3_Current_Child_History | U3 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U3_Development_Assessment | U3 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U3_Family_History | U3 - Familienanamnese |
| KBV_VS_MIO_CMR_U3_Physical_Exam_Head | U3 - Kopf |
| KBV_VS_MIO_CMR_U3_Physical_Exam_Musculoskeletal_System | U3 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Mouth_Nose | U3, U4 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U3_U4_Physical_Exam_Skin | U3, U4 - Haut |
| KBV_VS_MIO_CMR_U3_U9_Age_Appropriate_Development | Altersgemäße Entwicklung |
| KBV_VS_MIO_CMR_U3_U9_Social_History | U3-U9 - Sozialanamnese |
| KBV_VS_MIO_CMR_U4_Consultation | U4 - Beratung |
| KBV_VS_MIO_CMR_U4_Current_Child_History | U4 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U4_Development_Assessment | U4 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U4_Physical_Exam_Abdomen_Genitals | U4 - Abdomen, Genitale |
| KBV_VS_MIO_CMR_U4_Physical_Exam_Head | U4 - Kopf |
| KBV_VS_MIO_CMR_U4_Physical_Exam_Musculoskeletal_System | U4 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U4_U5_Physical_Exam_Eyes | U4, U5 - Augen |
| KBV_VS_MIO_CMR_U5_Consultation | U5 - Beratung |
| KBV_VS_MIO_CMR_U5_Current_Child_History | U5 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U5_Development_Assessment | U5 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U5_Physical_Exam_Chest_Lung_Respiratory_Tract | U5 - Thorax, Lunge, Atemwege |
| KBV_VS_MIO_CMR_U5_Physical_Exam_Mouth_Nose | U5 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U5_Physical_Exam_Musculoskeletal_System | U5 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Abdomen_Genitals | U5, U6 - Abdomen, Genitale |
| KBV_VS_MIO_CMR_U5_U6_Physical_Exam_Head | U5, U6 - Kopf |
| KBV_VS_MIO_CMR_U5_U9_Physical_Exam_Skin | U5, U6, U7, U7a, U8, U9 - Haut |
| KBV_VS_MIO_CMR_U6_Consultation | U6 - Beratung |
| KBV_VS_MIO_CMR_U6_Current_Child_History | U6 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U6_Development_Assessment | U6 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U6_Physical_Exam_Eyes | U6 - Augen |
| KBV_VS_MIO_CMR_U6_Physical_Exam_Mouth_Nose | U6 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U6_Physical_Exam_Musculoskeletal_System | U6 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U6_U7_Physical_Exam_Chest_Lung_Respiratory_Tract | U6, U7 - Thorax, Lunge, Atemwege |
| KBV_VS_MIO_CMR_U7_Consultation | U7 - Beratung |
| KBV_VS_MIO_CMR_U7_Current_Child_History | U7 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U7_Development_Assessment | U7 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U7_Physical_Exam_Eyes | U7 - Augen |
| KBV_VS_MIO_CMR_U7_Physical_Exam_Mouth_Nose | U7 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U7_Physical_Exam_Musculoskeletal_System | U7 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U7_U7a_Physical_Exam_Abdomen_Genitals | U7, U7a - Abdomen, Genitale |
| KBV_VS_MIO_CMR_U7_U9_Physical_Exam_Heart_Blood_Circulation | U7, U7a, U8, U9 - Herz, Kreislauf |
| KBV_VS_MIO_CMR_U7a_Consultation | U7a - Beratung |
| KBV_VS_MIO_CMR_U7a_Current_Child_History | U7a - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U7a_Development_Assessment | U7a - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U7a_Physical_Exam_Mouth_Nose | U7a - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U7a_U9_Physical_Exam_Eyes | U7a, U8, U9 - Augen |
| KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Chest_Lung_Respiratory_Tract | U7a, U9 - Thorax, Lunge, Atemwege |
| KBV_VS_MIO_CMR_U7a_and_U9_Physical_Exam_Musculoskeletal_System | U7a, U9 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U8_Consultation | U8 - Beratung |
| KBV_VS_MIO_CMR_U8_Current_Child_History | U8 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U8_Development_Assessment | U8 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U8_Physical_Exam_Abdomen_Genitals | U8 - Abdomen, Genitale |
| KBV_VS_MIO_CMR_U8_Physical_Exam_Chest_Lung_Respiratory_Tract | U8 - Thorax, Lunge, Atemwege |
| KBV_VS_MIO_CMR_U8_Physical_Exam_Ears | U8 - Ohren |
| KBV_VS_MIO_CMR_U8_Physical_Exam_Musculoskeletal_System | U8 - Bewegungsapparat |
| KBV_VS_MIO_CMR_U8_U9_Physical_Exam_Mouth_Nose | U8, U9 - Mundhöhle, Kiefer, Nase |
| KBV_VS_MIO_CMR_U9_Consultation | U9 - Beratung |
| KBV_VS_MIO_CMR_U9_Current_Child_History | U9 - Aktuelle Anamnese des Kindes |
| KBV_VS_MIO_CMR_U9_Development_Assessment | U9 - Orient. Beurt. Entwicklung |
| KBV_VS_MIO_CMR_U9_Physical_Exam_Abdomen_Genitals | U9 - Abdomen, Genitale |
| KBV_VS_MIO_PC_PN_Examination_Number | Untersuchungsnummer Teilnahmekarte |
| practitionerspecialty | PractitionerSpecialtywithFrench |
| ClasseAsa | ClasseAsa |
| ClassificationDeParis | ClassificationDeParis |
| Complications | Complications |
| ConsentementReponse | ConsentementReponse |
| EchelleBostonScore | EchelleBostonScore |
| InaptConsentementPar | InaptConsentementPar |
| IndicationsEndoscopie | IndicationEndoscopie |
| InstrumentsUtilises | InstrumentsUtilises |
| IntervenantEndoscopiste | IntervenantEndoscopiste |
| IntervenantProcedure | IntervenantProcedure |
| IntervenantResident | IntervenantResident |
| LienUsagerEndo | LienUsagerEndo |
| ListeMedicamentsEndo | ListeMedicamentsEndo |
| MethodesAdministration | MethodesAdministration |
| Observations | Observations |
| PrecisionProvenanceExterne | PrecisionProvenanceExterne |
| PreparationColiqueLaxatifs | PreparationColiqueLaxatifs |
| ProceduresEffectuees | ProceduresEffectuees |
| ProceduresType | ProceduresType |
| ProceduresTypeSpecimentEnvoye | ProceduresTypeSpecimenEnvoye |
| Recommandations | Recommandations |
| RetroflexionEffectuee | RetroflexionEffectuee |
| StatutObservation | StatutObservation |
| StructuresCorporelles | StructuresCorporelles |
| SuiviPriseCharge | SuiviPriseCharge |
| TaillesPolype | TaillesPolype |
| TypeObservation | TypeObservation |
| allergy-intolerance-substance-condition-gps-uv-ips | Allergy intolerance substance condition (GPS) - IPS |
| allergy-reaction-gps-uv-ips | Allergy Reaction (GPS) - IPS |
| KBV_VS_MIO_EMP_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
| KBV_VS_MIO_EMP_Drug_Therapy_Status_SNOMED_CT | Medikation Statusgrund |
| vs-allergic-disposition-sct | Allergic Disposition SCT |
| vs-assessment-scales | Assessment Scales |
| vs-assessment | Assessment |
| vs-body-positioning-snomed | Body Positioning SNOMED CT |
| vs-drugs | Drugs |
| vs-observations | Observations |
| vs-procedures | Procedures |
| vs-radiologic-finding-sct | Radiologic Finding SCT |
| vs-substances-snomed | Substances SNOMED CT |
| ERGVerkehrsmittel | ERGVerkehrsmittel |
| covid-19-diseases | COVID-19 Diseases |
| covid-19-lab-result | COVID-19 Lab Result |
| covid-19-sample-origin | COVID-19 Sample Origin |
| sct-vaccines-covid-19 | SNOMED CT Vaccine List (COVID-19) |
| vaccines-covid-19 | Vaccine List (COVID-19) |
| ndhm-diagnosis-use | Diagnosis Use |
| ndhm-diagnostic-report-type | Diagnostic Report Type |
| ndhm-medicine-codes | Medicine Codes |
| ndhm-practitioner-role | Practitioner Role |
| ndhm-route-of-administration | Route Of Administration |
| ndhm-specimen-types | Specimen Types |
| ndhm-vaccine-codes | Vaccine Codes |
| ISiKTerminPriority | ISiKTerminPriority |
| mi-category-type | Medical Imaging Category Type |
| mi-procedure-bodypart-sct | Medical Imaging Procedure Body Part. |
| mi-procedure-contrast-used | Medical Imaging Procedure Contrast Used |
| mi-procedure-laterality-sct | Medical Imaging Procedure Laterality - SNOMED CT |
| mi-procedure-specialty | Medical Imaging Procedure Specialty |
| mi-procedure-type-sct | Medical Imaging SNOMED CT Procedure Type |
| cancer-type-code | Cancer type |
| sact-administration-site-code | Administration location |
| sact-location-medication-collection-code | Medication collection location |
| sact-support-factor-code | Support Factors |
| sact-support-factor-value-code | Possible values for Support Factors |
| sact-treatment-intent-code | Treatment intent |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20200901000000 | DagdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.55--20230119145802 | MedicatiegebruikStopTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.50--20221216102010 | StopTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20200901000000 | WeekdagCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.20.77.11.48--20230112155455 | WisselendDoseerschemaStopTypeCodelijst |
| be-vs-vaccination-bodysite | BeVSVaccinationBodySite |
| be-vs-vaccination-reason-code | BeVSVaccinationReasonCode |
| be-vs-vaccine-code | BeVSVaccineCode |
| device-kind | Argonaut Device Types |
| observation-ccdasmokingstatus | Smoking Status |
| observation-value-codes | Observation Value Codes (SNOMED-CT) |
| procedure-type | Argonaut ProcedureType |
| provider-role | Care Team Provider Roles |
| substance-sct | DAF SNOMED CT Substances Other Than Clinical Drugs |
| substance | Argonaut Substance-Reactant for Intolerance and Negation Codes |
| be-causativeagent | BeCausativeAgent |
| be-exposureroute | BeExposureRoute |
| be-noallergy | BeNoAllergy |
| be-riskmanifestation | BeRiskManifestation |
| be-vs-score | Score Value Set |
| referral-reason-code | ReferralReasonCode |
| Laterality2 | Health Hub Dk Core Laterality |
| delivery-method | Delivery Method |
| AbnormalClinicalFindings | Abnormal Clinical Findings Value Set |
| BiologicalSexes | Biological Sexes Value Set |
| Lateralities | Lateralities Value Set |
| PresenceValues | Presence Value Set |
| Severities | Severity Value Set |
| TestInterpretationValues | Test Interpretation Value Set |
| eHDSIAnimalSpecies | eHDSI Animal Species |
| eHDSIBloodGroup | eHDSI Blood Group |
| eHDSIBodySite | eHDSI Body Site |
| eHDSIBodySiteLaterality | eHDSI Body Site Laterality |
| eHDSIBodyStructureLocation | eHDSI Body Structure Location Qualifier |
| eHDSILabSpecimenType | eHDSI Laboratory Specimen Type |
| eHDSILabTechnique | eHDSI Laboratory Technique |
| eHDSIMedicalDevice | eHDSI Medical Device |
| eHDSIMicroorganism | eHDSI Microorganism |
| eHDSIMorphologicAbnormality | eHDSI Morphologic Abnormality |
| eHDSIPresenceAbsence | eHDSI Presence Absence |
| eHDSIReactionAllergy | eHDSI Reaction Allergy |
| abnahmeortKoerperstelleSNOMED | Abnahmeort |
| abnahmeortMorphologischeAnomalieSNOMED | Abnahmeort morphologische Anomalien |
| anforderungChlamydienSentinelSNOMED | Untersuchungsanlass Chlamydien-Sentinel |
| anforderungMasernSentinelSNOMED | Untersuchungsanlass Masern-Sentinel |
| anforderungSNOMED | Untersuchungsanlass Diagnose oder Screening |
| antwortNominalSNOMED | Ergebnis der Laboruntersuchung Nominal |
| antwortPathogenBakSNOMED | Ergebnis der Laboruntersuchung BAK |
| antwortPathogenBeschreibungMikroskopieSNOMED | Ergebnis der Laboruntersuchung Mikroskopie |
| antwortPathogenMykSNOMED | Ergebnis der Laboruntersuchung MYK |
| antwortPathogenParSNOMED | Ergebnis der Laboruntersuchung PAR |
| antwortPathogenVirSNOMED | Ergebnis der Laboruntersuchung VIR |
| antwortResistenzklassifikationSNOMED | Ergebnis der Laboruntersuchung MRE |
| interpretationSNOMED | Angabe der Interpretation mit SNOMED CT qualifier values |
| materialSNOMED | Probenmaterial |
| methodeSNOMED | Testmethoden |
| care-team-role-vs | Care Team role |
| consent-vs | Consent codes from Loinc and Snomed-ct |
| organization-type-vs | Organization type |
| body-parts | Body parts |
| ctcae-symptom-grades | CTCAE symptom grades |
| capsules | Capsule list |
| hobbies | Hobbies |
| list-codes | List codes |
| medication-performer-type | Medication performer types |
| melanoma-types | Types of melanoma |
| patient-goals | Patient goals |
| prescription-type | Prescription types |
| symptom-codes | Symptom codes |
| visit-types | Visit types |
| who-score | WHO score |
| Disease | |
| RouteOfAdmin | Route Of Administration |
| Tradename | |
| Generic | GenericImmunizingAgent |
| allergicconditioncode | Allergic Condition Code |
| allergyintolerancestatuscode | Allergy/Intolerance Status Code |
| drugormedicamentsubstancecode | Drug Or Medicament Substance Code |
| mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ |
| mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie |
| mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie |
| mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie |
| swissnoso-germ | Swissnoso Germ |
| vs-43file-refer-care-procedure | 43File: รหัสแสดงการให้การดูแลหรือปฐมพยาบาลผู้ป่วยขณะส่งต่อผู้ป่วย |
| vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
| vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
| vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
| vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
| vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย |
| vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
| vs-snomed-blood-abo | SNOMED CT Blood Group - ABO |
| vs-snomed-blood-rh | SNOMED CT Blood Group - Rh |
| vs-snomed-bloodgroup | SNOMED CT Blood Group |
| vs-snomed-int | SNOMED-CT International Release |
| device-kind | device-kind |
| device-settings-codes | device-settings-codes |
| observation-codes | observation-codes |
| KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type | KBV_VS_MIO_ZAEB_Preventive_Check_Up_Type |
| AdministrationAgreementStopType | AdministrationAgreementStopType |
| AdministrationDevice | AdministrationDevice |
| AlcoholUseStatus | AlcoholUseStatus |
| AlertName | AlertName |
| AllergyCategory | AllergyCategory |
| AllergyStatus | AllergyStatus |
| AsNeededCriterium | AsNeededCriterium |
| BathingOneself | BathingOneself |
| BodyPartToBeBathed | BodyPartToBeBathed |
| BodyPartToBeDressed | BodyPartToBeDressed |
| BurnwoundDepth | BurnwoundDepth |
| BurnwoundLaterality | BurnwoundLaterality |
| CausativeAgent | CausativeAgent |
| ChangingPosition | ChangingPosition |
| ClimbingStairs | ClimbingStairs |
| Clothing | Clothing |
| CollectionMethod | CollectionMethod |
| CommunicationDetails | CommunicationDetails |
| ConditionsDuringMeasurement | ConditionsDuringMeasurement |
| ContactType | ContactType |
| ContainerType | ContainerType |
| CriticalExtent | CriticalExtent |
| CuffType | CuffType |
| DASMethod | DASMethod |
| DeathIndicator | DeathIndicator |
| DecubitusCategory | DecubitusCategory |
| DefecationColor | DefecationColor |
| DentalHygiene | DentalHygiene |
| DepartmentSpecialty | DepartmentSpecialty |
| Depth | Depth |
| Destination | Destination |
| DevelopmentCognition | DevelopmentCognition |
| DevelopmentLinguistics | DevelopmentLinguistics |
| DevelopmentLocomotion | DevelopmentLocomotion |
| DevelopmentSocialChild | DevelopmentSocialChild |
| DeviatingBreathingPattern | DeviatingBreathingPattern |
| DeviceAnatomicalLocation | DeviceAnatomicalLocation |
| DiastolicEndpoint | DiastolicEndpoint |
| DressingOneself | DressingOneself |
| Drinking | Drinking |
| DrinkingLimitations | DrinkingLimitations |
| DrugUseStatus | DrugUseStatus |
| Eating | Eating |
| EatingLimitations | EatingLimitations |
| EstimatingMethod | EstimatingMethod |
| FamilyComposition | FamilyComposition |
| FamilyCompositionChild | FamilyCompositionChild |
| FecalContinence | FecalContinence |
| FeedingMethod | FeedingMethod |
| FeedingTubeType | FeedingTubeType |
| FeedingType | FeedingType |
| FrequencyQualifier | FrequencyQualifier |
| Gender | Gender |
| Grooming | Grooming |
| HeadCircumferenceMeasuringMethod | HeadCircumferenceMeasuringMethod |
| HealthProfessionalRole | HealthProfessionalRole |
| HearingAidType | HearingAidType |
| HearingFunction | HearingFunction |
| HeartRateMeasurementMethod | HeartRateMeasurementMethod |
| HeartbeatRegularity | HeartbeatRegularity |
| HomeAccessibility | HomeAccessibility |
| HomeAdaption | HomeAdaption |
| IndependentMedicationUse | IndependentMedicationUse |
| InfusionCatheterType | InfusionCatheterType |
| InterpretationHeartRate | InterpretationHeartRate |
| InterpretationMethod | InterpretationMethod |
| Intervention | Intervention |
| Laterality | Laterality |
| LifeStance | LifeStance |
| Location | Location |
| LumenLocation | LumenLocation |
| MaintainingPosition | MaintainingPosition |
| MaritalStatus | MaritalStatus |
| MeasuringLocation | MeasuringLocation |
| MeasuringMethod | MeasuringMethod |
| MeasuringPosition | MeasuringPosition |
| MedicationAdministrationReasonForDeviation | MedicationAdministrationReasonForDeviation |
| MedicationAdministrationStatus | MedicationAdministrationStatus |
| MedicationAgreementAdditionalInformation | MedicationAgreementAdditionalInformation |
| MedicationReason | MedicationReason |
| MedicationStopType | MedicationStopType |
| MenstrualCare | MenstrualCare |
| Microorganism | Microorganism |
| Morphology | Morphology |
| MultipleBirthIndicator | MultipleBirthIndicator |
| Municipality | Municipality |
| NameUsage | NameUsage |
| Origin | Origin |
| PainCourse | PainCourse |
| PainPattern | PainPattern |
| PainType | PainType |
| PerformNursingActivity | PerformNursingActivity |
| PharmaceuticalForm | PharmaceuticalForm |
| PlaceOfResidence | PlaceOfResidence |
| Position | Position |
| Postcode | Postcode |
| ProblemName | ProblemName |
| ProblemStatus | ProblemStatus |
| ProblemType | ProblemType |
| ProcedureMethod | ProcedureMethod |
| ProcedureType | ProcedureType |
| ProductCode | ProductCode |
| ProductType | ProductType |
| ProthesisType | ProthesisType |
| PulseRegularity | PulseRegularity |
| ReasonForUse | ReasonForUse |
| RefractionMeasurementMethod | RefractionMeasurementMethod |
| Relationship | Relationship |
| ResultFlags | ResultFlags |
| ResultType | ResultType |
| Rhythm | Rhythm |
| Role | Role |
| RouteOfAdministration | RouteOfAdministration |
| RouteOfExposure | RouteOfExposure |
| RouteOfMedicationAdministration | RouteOfMedicationAdministration |
| SOAPLineHeader | SOAPLineHeader |
| SmokingStatus | SmokingStatus |
| SpecimenMaterial | SpecimenMaterial |
| SpecimenSource | SpecimenSource |
| StatusName | StatusName |
| StatusValue | StatusValue |
| StomaType | StomaType |
| SubstanceCode | SubstanceCode |
| Symptom | Symptom |
| TemperatureType | TemperatureType |
| TestMethod | TestMethod |
| TextResultType | TextResultType |
| TimeOfDay | TimeOfDay |
| ToiletTrainednessFeces | ToiletTrainednessFeces |
| ToiletTrainednessUrine | ToiletTrainednessUrine |
| ToiletUse | ToiletUse |
| Transfer | Transfer |
| Treatment | Treatment |
| TreatmentDecision | TreatmentDecision |
| TypeOfDisorder | TypeOfDisorder |
| TypeOfDrugOrMedication | TypeOfDrugOrMedication |
| TypeOfHelp | TypeOfHelp |
| TypeOfHome | TypeOfHome |
| TypeOfIntervention | TypeOfIntervention |
| TypeOfLivingWill | TypeOfLivingWill |
| TypeOfSmokingOrTobacco | TypeOfSmokingOrTobacco |
| UrineCatheterType | UrineCatheterType |
| UrineContinence | UrineContinence |
| VaccineProduct | VaccineProduct |
| VerificationStatus | VerificationStatus |
| VisualAcuityMeasurementDevice | VisualAcuityMeasurementDevice |
| VisualAcuityType | VisualAcuityType |
| VisualAidType | VisualAidType |
| VisualFunction | VisualFunction |
| Walking | Walking |
| WeekDay | WeekDay |
| WoundDrainType | WoundDrainType |
| WoundEdge | WoundEdge |
| WoundType | WoundType |
| device-kind | DeviceKind |
| device-settings-codes | DeviceSettingsCodes |
| observation-codes | ObservationCodes |
| SNOMED-CT | SNOMEDCT |
| ndhm-alcohol-drinking-status | Alcohol Drinking Status |
| ndhm-benefit-type | Benefit Type |
| ndhm-benefitcategory | Benefit Category |
| ndhm-care-team-qualification | Care Team Qualification |
| ndhm-care-team-role | Care Team Role |
| ndhm-claim-type | Claim Type |
| ndhm-coverage-type | Coverage Type |
| ndhm-diagnostic-type | Diagnostic Type |
| ndhm-diet-type | Diet Type |
| ndhm-encounter-type | EncounterTypes |
| ndhm-general-assessment | General Assessment |
| ndhm-general-well-being | General Wellbeing |
| ndhm-lifestyle | Lifestyle |
| ndhm-mental-status | Mental Status |
| ndhm-productorservice | ProductorService |
| ndhm-tobacco-chewing-status | Tobacco Chewing Status |
| ndhm-tobacco-smoking-status | Tobacco Smoking Status |
| GPC-MedicationTradeFamily-1 | GPC Medication Trade Family |
| blood-gas-analysis-combined | Blood Gas Analysis Combined |
| diseases-combined | Diseases Combined |
| procedures-combined | Procedures Combined |
| apheresis-procedures | Apheresis-Procedures |
| cardiovascular-diseases | Cardiovascular-Diseases |
| chronic-kidney-diseases | Chronic Kidney Diseases |
| chronic-liver-diseases | Chronic-Liver-Diseases |
| chronic-lung-diseases | Chronic Lung Diseases |
| chronic-neurological-mental-diseases | Chronic Neurological Mental Diseases |
| complications-covid-19 | Complications of Covid-19 |
| condition-severity | Condition Severity |
| detected-not-detected-inconclusive | Detected Not-detected Inconclusive |
| diabetes-mellitus-diseases | Diabetes Mellitus Diseases |
| dialysis-procedures | Dialysis Procedures |
| discharge-disposition | Discharge Disposition |
| ethnic-groups | Ethnic Groups |
| gastrointestinal-ulcers | Gastrointestinal Ulcers |
| human-immunodeficiency-virus-infections | Human Immunodeficiency Virus Infections |
| known-exposure | Known Exposure to SARS-CoV-2 |
| malignant-neoplastic-diseases | Malignant Neoplastic Diseases |
| organs-for-transplant | Organs for Transplantation |
| pharmacological-therapy-snomed | Drug Therapy SNOMED |
| pregnancy-status | Pregnancy Status |
| radiology-findings | Radiology Findings |
| radiology-procedures | Radiology Procedures |
| respiratory-therapies-devices | Respiratory Therapy Devices |
| respiratory-therapies | Respiratory Therapies |
| resuscitation-status | Do-Not-Resuscitate-Order |
| rheumatological-immunological-diseases | Rheumatological Immunological Diseases |
| sars-cov-2-symptoms | SARS-CoV-2-Symptoms |
| stage-at-diagnosis | Stage at Diagnosis |
| therapeutic-intent | Therapeutic Intent |
| vaccines-snomed | Vaccines SNOMED |
| verification-status | ConditionVerificationStatus SNOMED |
| yes-no-unknown-other-na | Yes-No-Unknown-Other-Na |
| YesNoNullFlavor | Ja, Nein, Nicht ermittelbar, Nicht erhoben Antworten |
| BodyTemperatureSCTObservables | TemperatureSCTObservables |
| BodyheightSCTobservables | BodyheightSCTobservables |
| BodyweightSCTobservables | BodyweightSCTobservables |
| ConsciousnessSCTFindings | ConsciousnessSCTFindings |
| DiastolicBloodPressureSCTObservables | DiastolicBloodPressureSCTObservables |
| EQ5DSCTfindingsActivity | EQ5DSCTfindingsActivity |
| EQ5DSCTfindingsAnxiety | EQ5DSCTfindingsAnxiety |
| EQ5DSCTfindingsHygiene | EQ5DSCTfindingsHygiene |
| EQ5DSCTfindingsMobility | EQ5DSCTfindingsMobility |
| EQ5DSCTfindingsPain | EQ5DSCTfindingsPain |
| HeartRateSCTobservables | HeartRateSCTobservables |
| OxygenSaturationSCTobservables | OxygenSaturationSCTobservables |
| RespirationRateSCTObservables | RespirationRateSCTObservables |
| SCTUrinStix | SCTUrinStix |
| SystolicBloodPressureSCTObservables | SystolicBloodPressureSCTObservables |
| TechniqesSCTCodes | TechniqesSCTCodes |
| VRSSCTfindingsPain | VRSSCTfindingsPain |
| WHO5SCTfindingsActive3 | WHO5SCTfindingsActive3 |
| WHO5SCTfindingsCalm2 | WHO5SCTfindingsCalm2 |
| WHO5SCTfindingsHappy1 | WHO5SCTfindingsHappy1 |
| WHO5SCTfindingsInterest5 | WHO5SCTfindingsInterest5 |
| WHO5SCTfindingsRested4 | WHO5SCTfindingsRested4 |
| allergy-intolerance-substance-condition-uv-ips | Allergy intolerance substance condition - IPS |
| core-problem-finding-situation-event-gps-uv-ips | CORE Problem List Finding/Situation/Event (GPS) - IPS |
| medical-devices-uv-ips | Medical Devices - IPS |
| medication-example-uv-ips | Medications (example) - IPS |
| medication-snomed-uv-ips | Medications (SNOMED CT) - IPS |
| medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
| procedures-uv-ips | Procedures - IPS |
| result-coded-value-pathology-gps-uv-ips | Results Coded Values Pathology (GPS) - IPS |
| results-laboratory-blood-abo-rh-grp-gps-uv-ips | Results Laboratory ABO+RH Group (GPS) - IPS |
| results-laboratory-presence-absence-gps-uv-ips | Results Laboratory Presence/Absence (GPS) - IPS |
| results-organism-gps-uv-ips | Results Organism (GPS) - IPS |
| results-radiology-numobs-gps-dicom-uv-ips | Results Radiology Measurement Observation (GPS-DICOM) - IPS |
| results-radiology-txtobs-gps-dicom-loinc-uv-ips | Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS |
| results-specimen-collection-method-gps-uv-ips | Results Specimen Collection Method (GPS) - IPS |
| results-specimen-type-gps-uv-ips | Results Specimen Type (GPS) - IPS |
| snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| target-site-uv-ips | Target Site - IPS |
| targetDiseases-gps-uv-ips | Vaccine Target Diseases (GPS) - IPS |
| targetDiseases-uv-ips | Vaccine Target Diseases - IPS |
| vaccines-gps-uv-ips | Vaccines (GPS) - IPS |
| NHSDigital-CareSettingType | NHSDigital-CareSettingType |
| NHSDigital-ImmunizationExplanationReason | NHS Digital Immunization Explanation Reason |
| NHSDigital-VaccinationProcedure | Interim version of UK Core Vaccination Procedure. |
| NHSDigital-MedicationDispense-Code | Digital Medicine MedicationDispense Code |
| NHSDigital-MedicationRequest-Code | Digital Medicine MedicationRequest Code |
| NHSDigital-MedicationCode | NHS Digital Medication Code |
| NHSDigital-ReasonImmunizationNotAdministered | NHSDigital Reason Immunization Not Administered |
| NHSDigital-VaccineCode | NHS Digital Vaccine Code |
| NHSDigital-action-code | NHSDigital Action Code |
| NHSDigital-ServiceRequest-category | ServiceRequestCategory |
| DocumentCategory | NHSEnglandDocumentCategory |
| Document-Type | NHSEnglandDocumentType |
| covid-19-snomed-procedure-code-vs | COVID-19 SNOMED CT Procedure Code Value Set |
| procedures-intend | MII VS Prozedur Durchführungsabsicht [SNOMED CT] |
| procedures-category-sct | MII VS Prozedur OPS Kategorien [SNOMED CT] |
| procedures-sct | MII VS Prozedur Prozeduren [SNOMED CT] |
| DocumentEntry.classCode | DocumentEntry.classCode |
| DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| DocumentEntry.typeCode | DocumentEntry.typeCode |
| HCProfessional.hcProfession | HCProfessional.hcProfession |
| SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| screening-tests | Lung Cancer Screening Tests |
| lung-cancer-condition | lung-cancer-condition |
| preferred-place-of-death | Preferred place of death |
| practitioner-specialty | PractitionerSpecialty |
| service-category-eServices | Service Category-eServices |
| service-type-ocean | Service Type OCEAN |
| wait-time-service-type | WaitTime Service Type |
| allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS |
| allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS |
| covid-19-cond | COVID-19 related Condition codes |
| snomed-intl-ips | SNOMED CT® International Patient Set (IPS) |
| HighMediumLowVS | SCT: High - Medium - Low |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20150401000000 | AlcoholGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20150401000000 | AlertNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.2.1--20150401000000 | BehandelingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20150401000000 | DiastolischEindpuntCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20150401000000 | DrugGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20150401000000 | DrugsOfGeneesmiddelSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.2.4--20150401000000 | GeverifieerdBijCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20150401000000 | HartslagMeetMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20150401000000 | HartslagRegelmatigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20150401000000 | HoudingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20150401000000 | HulpmiddelAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20150401000000 | MeetLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20150401000000 | MeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20150401000000 | OrderStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20171231000000 | OrderStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20150401000000 | ProbleemNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20150401000000 | ProbleemTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2--20171231000000 | RedenMedicatieafspraakCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2--20171231000000 | RedenWijzigenOfStoppenGebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20150401000000 | SoortTabakGebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20150401000000 | StatusNaamSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20150401000000 | StatusWaardeSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20150401000000 | TabakGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20150401000000 | TekstUitslagTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20150401000000 | TemperatuurTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20150401000000 | VerrichtingAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20171231000000 | AfnameprocedureCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000 | AfwijkendAdemhalingspatroonCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000 | AlcoholGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000 | AlertNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20171231000000 | AllergieCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.2.1.1--20171231000000 | BehandelingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20171231000000 | BestemmingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.2--20171231000000 | BrandwondAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.4--20171231000000 | BrandwondLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20171231000000 | BrandwondSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20171231000000 | ContainerTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20171231000000 | DagdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.2--20171231000000 | DecubitusAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20171231000000 | DecubitusCategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.3--20171231000000 | DecubitusWondLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20171231000000 | DefecatieKleurCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20171231000000 | DiastolischEindpuntCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.2--20171231000000 | DiepteCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20171231000000 | DieptegraadCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20171231000000 | DrinkBeperkingenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20171231000000 | DrinkenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20171231000000 | DrugsGebruikStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20171231000000 | DrugsOfGeneesmiddelSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20171231000000 | EetBeperkingenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20171231000000 | ErnstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20171231000000 | EtenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.2.1.4--20171231000000 | GeverifieerdBijCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.13.1--20171231000000 | GezinssamenstellingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.16.1--20171231000000 | GezinssamenstellingKindCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20171231000000 | HartslagMeetMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20171231000000 | HartslagRegelmatigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20171231000000 | HerkomstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20171231000000 | HoorFunctieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20171231000000 | HorenHulpmiddelTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20171231000000 | HoudingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20171231000000 | HoudingHandhavenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20171231000000 | HoudingVeranderenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.2--20171231000000 | HuidAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.3--20171231000000 | HuidLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20171231000000 | HulpmiddelAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.1--20171231000000 | InfuuskatheterTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20171231000000 | InterpretatieVlaggenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20171231000000 | InterventieSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20171231000000 | LocatieGehoorapparaatCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20171231000000 | LopenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.2--20171231000000 | LumenLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20171231000000 | MateVanKritiekZijnCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.4--20171231000000 | MedischHulpmiddelLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20171231000000 | MeetLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20171231000000 | MeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.4--20171231000000 | MeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.2--20171231000000 | MetingNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20171231000000 | MicroorganismeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.11--20171231000000 | MonsterAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20171231000000 | MonstermateriaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20171231000000 | MorfologieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.3--20171231000000 | OnderzoekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000 | OntwikkelingMotoriekCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000 | OntwikkelingSociaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000 | OntwikkelingTaalCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000 | OntwikkelingVerstandelijkCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.2--20171231000000 | PijnAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.3--20171231000000 | PijnLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20171231000000 | PolsRegelmatigheidCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.5--20171231000000 | ProbleemAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.6--20171231000000 | ProbleemLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20171231000000 | ProbleemStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20171231000000 | ProbleemTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20171231000000 | ProductTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20171231000000 | ProtheseTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20171231000000 | ResultaatTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.1--20171231000000 | RitmeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20171231000000 | SNAQrcHulpBijEtenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20171231000000 | SchedelomvangMeetmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.10.3.1--20171231000000 | SondeTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20171231000000 | SoortAandoeningCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20171231000000 | SoortHulpCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.3.3--20171231000000 | SoortInterventieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20171231000000 | SoortTabakGebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20171231000000 | SpecifiekeStofAllergeneStoffenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20171231000000 | StatusNaamSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20171231000000 | StatusWaardeSnomedCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.2--20171231000000 | StomaAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000 | StomaLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000 | StomaTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000 | SymptoomCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000 | TeKledenLichaamsdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000 | TeWassenLichaamsdeelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000 | TekstUitslagTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000 | TemperatuurTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20171231000000 | TestmethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.4--20171231000000 | ToedieningHulpmiddelCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20171231000000 | ToiletgebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20171231000000 | TraplopenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20171231000000 | UiterlijkeVerzorgingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20171231000000 | UitvoerenTransferCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.14.2--20171231000000 | UrineKatheterTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20171231000000 | VerificatieStatusCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20171231000000 | VeroorzakendeStofAllergeneStoffenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.34.1--20171231000000 | VerrichtenVPKHandelingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20171231000000 | VerrichtingTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20171231000000 | VerzorgenTandenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.1--20171231000000 | VisueleFunctieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20171231000000 | VoedingMethodeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20171231000000 | VoedingSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20171231000000 | WeekdagCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20171231000000 | WijzeVanBlootstellingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.6--20171231000000 | WondAnatomischeLocatieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20171231000000 | WondDrainTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.8--20171231000000 | WondLateraliteitCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20171231000000 | WondSoortCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.35.1--20171231000000 | ZelfstandigMedicatiegebruikCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20171231000000 | ZichKledenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20171231000000 | ZichWassenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20171231000000 | ZienHulpmiddelTypeCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20171231000000 | ZindelijkheidFecesCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20171231000000 | ZindelijkheidUrineCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20171231000000 | ZorgBijMenstruatieCodelijst |
| animal-breeds | animal breeds |
| animal-species | animal species |
| barrier | Barrier |
| condition-cause | Condition Cause Codes |
| condition-course | Condition Course Codes |
| condition-predecessor | Condition Predecessor Codes |
| dataelement-sdcobjectclass | DataElement SDC Object Class |
| dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| feeding-device | Feeding Device Codes Value Set |
| focal-subject | Focal Subject Codes |
| protective-factor | Protective Factor |
| specimen-additive-substance | Specimen Additive Substance Codes |
| uds-plus-sex-codes | Uds Plus Sex Codes |
| DentalCare-ASAScore | DentalCare - ASA Score |
| DentalCare-OralHygieneFinding | DentalCare - Oral Hygiene Finding |
| il-hdp-condition-code | ILHDP Condition Code |
| IVR-VS-InfectPersPrecaution | IVR valueset infectiontransport precaution personnel |
| IVR-VS-ZUB | IVR valueset status change |
| IVR-VS-actRecovAid | IVR valueset Recovery Aid (.143.11.3) |
| IVR-VS-actRespiOwner | IVR valueset owner (.143.11.6) |
| IVR-VS-airway | IVR valueset airway (143.11.2) |
| IVR-VS-allergy | IVR valueset allergy (.143.11.7) |
| IVR-VS-ambulanceType | IVR Valueset ambulance type (143.11.28) |
| IVR-VS-bedding | IVR valueset transport bedding (.143.11.17) |
| IVR-VS-deathManner | IVR valueset manner of death (.143.11.41) |
| IVR-VS-diagType | IVR valueset diagnosis type (.143.11.16) |
| IVR-VS-event | IVR valueset event (.143.11.15) |
| IVR-VS-eyeForm | IVR valueset eye Form (.143.11.43) |
| IVR-VS-findingsAirway | IVR valueset findings airway (.143.11.39) |
| IVR-VS-formation | IVR valueset formation (.143.11.9) |
| IVR-VS-gcs-augenoeffnung | IVR valueset GCS Augenoeffnung (143.11.34) |
| IVR-VS-gcsMotoric | IVR valueset GCS motorische Reaktion (.143.11.35) |
| IVR-VS-gcsVerbal | IVR valueset GCS Verbale Kommunikation(.143.11.36) |
| IVR-VS-hospitalPriority | IVR valueset priority hospital |
| IVR-VS-idSource | IVR valueset identification source (143.11.29) |
| IVR-VS-intensity | IVR valueset intensity (.143.11.27) |
| IVR-VS-location | IVR valueset location (.143.11.23) |
| IVR-VS-locationType | IVR valueset location Type (.143.11.42) |
| IVR-VS-offender | IVR valueset offender (143.11.24) |
| IVR-VS-patient | IVR valueset patient |
| IVR-VS-personRole | IVR valueset role (.143.11.21) |
| IVR-VS-preTreatType | IVR valueset pre-treatment type (.143.11.13) |
| IVR-VS-preTreatment | IVR valueset pre-treatment (.143.11.14) |
| IVR-VS-pressureMethod | IVR valueset blood pressure method (.143.11.47) |
| IVR-VS-procAirType | IVR valueset procedure airway type (.143.11.40) |
| IVR-VS-pulesResult | IVR valueset pulse result (.143.11.49) |
| IVR-VS-pulseMethod | IVR valueset pulse method (.143.11.48) |
| IVR-VS-respirationObservation | IVR valueset Observation Respiration (.143.11.22) |
| IVR-VS-result | IVR valueset result (.143.11.44) |
| IVR-VS-sex | IVR Valueset sex (.143.11.31) |
| IVR-VS-size | IVR Valueset size |
| IVR-VS-symptom | IVR valueset symptom (.143.11.38) |
| IVR-VS-teamRole | IVR valueset role team (.143.11.8) |
| IVR-VS-transDesinfection | IVR valueset unit desinfection |
| IVR-VS-urgency-adequate | IVR valueset urgency adequate (143.11.37) |
| IVR-VS-valTxpe | IVR valueset valuables type (.143.11.33) |
| IVR-VS-ventilation | IVR valueset ventilation (.143.11.46) |
| IVR-VS-violenceForm | IVR valueset form of violence (143.11.25) |
| IVR-VS-violenceResult | IVR valueset result of violence (.143.11.26) |
| IVR-VS-woundTreat | IVR valueset wound treatment (.143.11.45) |
| yes-no-unknown | Yes/No/Unknown |
| mni-obs-bloodGroup | MedNet Interface (MNI) - Blood Group Observation ValueSet |
| mni-serviceRequestCode | MedNet Interface (MNI) - ServiceRequest Code ValueSet |
| body-site | SNOMED CT Body Structures |
| device-property-type-valueset | Device Property Type ValueSet |
| type-code-value-set | Type Code Value Set |
| 2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253 | CategorieCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.31--20231207101023 | DiagnoseNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.19--20231120131658 | ErnstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504 | StartRedenCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.34--20240501114150 | SymptoomErnstCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.35--20240501114333 | SymptoomNaamCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.16--20231120123250 | VerwachtRisicoBijBlootstellingCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019 | WijzeVanVaststellenCodelijst |
| BloodGlucoseMarkVS | BloodGlucoseMarkVS |
| BloodGlucoseUnit | BloodGlucoseUnit |
| CarbohydrateUnit | CarbohydrateUnit |
| CarbohydrateUnitSettingVS | CarbohydrateUnitSettingVS |
| CarbohydrateUnitVS | CarbohydrateUnitVS |
| DiabetesType | DiabetesType |
| DiabetesTypeVS | DiabetesTypeVS |
| DiaryEventVS | DiaryEventVS |
| EsystaEvaluationColorVS | EsystaEvaluationColorVS |
| EvaluationColor | EvaluationColor |
| EvaluationColorVS | EvaluationColorVS |
| InsulinPenMarkerColor | InsulinPenMarkerColor |
| InsulinPenMarkerColorVS | InsulinPenMarkerColorVS |
| InsulinType | InsulinType |
| InsulinTypeVS | InsulinTypeVS |
| MedicalFindingStageVS | MedicalFindingStageVS |
| MedicalFindingsVS | MedicalFindingsVS |
| epa-xds-event-code-vs | IHE XDS Event Code ValueSet für ePA |
| ti-medication-snomed-ct-vs | TI Arzneimittel SNOMED CT ValueSet |
| ti-medication-type-pharmaceutical-product-vs | TI Medication Type ValueSet for a Pharmaceutical Product |
| ti-medication-type-product-vs | TI Medication Type ValueSet for PZN-Medication |
| ti-medication-type-vs | TI Medication Type ValueSet |
| ti-medicine-form-snomed-ct-vs | Value Set Darreichungsform SNOMED CT |
| ti-substance-snomed-ct-vs | TI Substance SNOMED CT ValueSet |
| be-vs-patientwill-scope | BeVSPatientWillScope |
| sequencingReason | Grund der Sequenzierung |
| uploadStatus | Status des Sequenz-Uploads |
| BodyheightSCTobservablesChildren | HøjdeObservationskoderSCT |
| dataelement-sdccode | DataElement SDC Concept |
| mha-bornInCanadaResponse | Born in Canada Response |
| EducationLevelVS | Education level of patient ValueSet |
| ProcedureIntentVS | Procedure Intent Value Set |
| additivo-campione-it | Additivo Campione |
| campione-container-lab-it | Container Campione |
| results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
| results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
| results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
| tipo-campione-lab-it | Tipo campione |
| valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
| valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
| valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
| adultcheck-code | 成人預防保健疾病史代碼集值 |
| adultcheck-lifecode | 成人預防保健生活史代碼集值 |
| KBV_VS_MIO_TELE_Clinical_Course | Verlauf |
| KBV_VS_MIO_TELE_Procedure_And_Recommendations | Weiteres Procedere und Empfehlung |
| KBV_VS_MIO_TELE_Results_Type | Befundtyp |
| KBV_VS_MIO_TELE_SNOMED_CT_Drug_Therapy_Status_Codes | Medikation Therapie Statuscodes SNOMED CT® |
| KBV_VS_MIO_TELE_Type_Of_Medical_History | Art der Anamnese |
| chronic-condition-set | ChronicConditions |
| covapp-symptoms-group-1 | Symptoms |
| covapp-symptoms-group-2 | Symptoms |
| vs-ventilation-observable-sct | Ventilation Observable SCT |
| CareConnect-ACVPU-1 | Care Connect ACVPU |
| CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty |
| CareConnect-InspiredOxygen-1 | Care Connect Inspired Oxygen |
| CareConnect-SaturatedOxygenSp02Scale-1 | Care Connect Saturated Oxygen Sp02 Scale |
| CareConnect-ObservationMethod-1 | Care Connect Observation Method |
| CareConnect-ObservationType-1 | Care Connect Observation Type |
| materialWBGP | Material für Meldepflicht für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit |
| KBV_VS_MIO_KHE_Initiated_Services_SNOMED_CT | Veranlasste Leistungen |
| KBV_VS_MIO_KHE_Results_Type | Befundtyp |
| Laborergebnis-semiquantitativ | MII VS Labor Laborergbenis Semiquantitativ |
| Laborergebnis-qualitativ | MII VS Labor Laborergebnis Qualitativ |
| QuelleKlinischesBezugsdatum | MII VS Labor Quelle klinisches Bezugsdatum |
| targetDisease | Vaccine Target Disease |
| 1.2.91.13925.17760.1280649 | Sneezing and Itching Grouping |
| 1.2.91.13925.17760.15972546 | Conditions Indicating Appropriate Sinonasal Imaging |
| 1.2.91.13925.17760.16432390 | Cerumen Impaction |
| 1.2.91.13925.17760.16929355 | Allergic Rhinitis Grouping |
| 1.2.91.13925.17760.18316962 | Severe Asthma |
| 1.2.91.13925.17760.23618223 | Hearing Aids Grouping |
| 1.3.6.1.4.1.33895.1.3.0.45 | Comfort Measures |
| 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain |
| 1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 | pain medication action plan |
| 1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring |
| 1.3.6.1.4.1.6997.4.1.2.234.999.4.7 | malignant neoplasms and cancer pain |
| 1.3.6.1.4.1.6997.4.1.2.234.999.4.9 | malignancy or cancer related pain |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 | Cerumen on Otoscopy |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 | Hearing Loss |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 | Tinnitus |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 | Ear Congestion |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 | Ear Pruritus |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 | Otalgia |
| 1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 | Initial Encounter with Otolaryngologist or undefined clinician |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 | Cerumen Impaction |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 | Head and Neck Anatomic Locations |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 | Ear Canal Stenosis |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 | Exostoses |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 | Non intact Tympanic Membrane |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 | Hearing Aids |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 | DO NOT USE |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 | Irrigation |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 | Otoscopy performed on exam |
| 1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 | Otolaryngologist as a Clinician or Service |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 | Dermatologic Diseases of the Ear |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 | Keratoses Obturans |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 | Tympanoplasty |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 | Myringoplasty |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 | Mastoidectomy |
| 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 | Ear Surgery, Other |
| 1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 | Sleep Apnea |
| 1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 | Allergic Rhinitis |
| 1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 | Uncontrolled or severe asthma |
| 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 | Rhinosinusitis |
| 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 | Nasal Polyposis |
| 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 | Suspected Nasal Neoplasm |
| 1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 | Sneezing as a finding |
| 1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 | Pruritus Unspecified or Other Location |
| 1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 | Clinicians who perform allergy testing |
| 1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 | Radiography of face, head or neck |
| 1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 | Eustachian Tube Dysfunction |
| 1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 | Immunotherapy that is not Identified as Subcutaneous |
| 1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 | Immunotherapy |
| 1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 | Clostridium difficile infection |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 | Ileus due to infection |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 | Vomiting potentially due to CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 | Toxic Megacolon in adults |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 | Abdominal Distension |
| 1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 | Septic Shock due to C. Diff |
| 1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 | History of CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 | Consult Infectious Disease |
| 1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 | Abdominal Xrays for CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 | CT of abdomen with contrast for fulminant CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 | Surgical consult for CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 | Fecal microbiota transplantation |
| 1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 | Hospitalist |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 | Positive result indicator |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 | Body Temperature |
| 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 | Diarrhea Potentially due to CDI |
| 1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 | Inpatient Setting |
| 2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance |
| 2.16.840.1.113762.1.4.1010.2 | Clinical Substance |
| 2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug |
| 2.16.840.1.113762.1.4.1018.240 | SNOMED CT CORE Problem List |
| 2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| 2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core |
| 2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement |
| 2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex |
| 2.16.840.1.113762.1.4.1021.14 | Published test VS |
| 2.16.840.1.113762.1.4.1021.33 | Sexual Orientation |
| 2.16.840.1.113762.1.4.1021.40 | MDP Test Intensional |
| 2.16.840.1.113762.1.4.1021.56 | Medical Reason Not Done SCT |
| 2.16.840.1.113762.1.4.1029.120 | Phototherapy |
| 2.16.840.1.113762.1.4.1029.121 | Phototherapy |
| 2.16.840.1.113762.1.4.1029.123 | Neonatal Jaundice |
| 2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice |
| 2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use |
| 2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use |
| 2.16.840.1.113762.1.4.1029.129 | Fetal Conditions |
| 2.16.840.1.113762.1.4.1029.130 | Fetal Conditions |
| 2.16.840.1.113762.1.4.1029.132 | Congenital Malformations |
| 2.16.840.1.113762.1.4.1029.133 | Congenital Malformations |
| 2.16.840.1.113762.1.4.1029.135 | Social Indications |
| 2.16.840.1.113762.1.4.1029.136 | Social Indications |
| 2.16.840.1.113762.1.4.1029.138 | Neonatal Severe Birth Trauma |
| 2.16.840.1.113762.1.4.1029.139 | Neonatal Severe Birth Trauma |
| 2.16.840.1.113762.1.4.1029.141 | Neonatal Severe Hypoxia or Asphyxia |
| 2.16.840.1.113762.1.4.1029.142 | Neonatal Severe Hypoxia or Asphyxia |
| 2.16.840.1.113762.1.4.1029.144 | Neonatal Severe Shock and Resuscitation |
| 2.16.840.1.113762.1.4.1029.145 | Neonatal Severe Shock and Resuscitation |
| 2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications |
| 2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications |
| 2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection |
| 2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection |
| 2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications |
| 2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications |
| 2.16.840.1.113762.1.4.1029.156 | Neonatal Severe Shock and Resuscitation Procedures |
| 2.16.840.1.113762.1.4.1029.157 | Neonatal Severe Shock and Resuscitation Procedures |
| 2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures |
| 2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures |
| 2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures |
| 2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures |
| 2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia |
| 2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia |
| 2.16.840.1.113762.1.4.1029.168 | Neonatal Moderate Birth Trauma |
| 2.16.840.1.113762.1.4.1029.169 | Neonatal Moderate Birth Trauma |
| 2.16.840.1.113762.1.4.1029.171 | Neonatal Moderate Respiratory Complications |
| 2.16.840.1.113762.1.4.1029.172 | Neonatal Moderate Respiratory Complications |
| 2.16.840.1.113762.1.4.1029.174 | Neonatal Moderate Respiratory Complications Procedures |
| 2.16.840.1.113762.1.4.1029.175 | Neonatal Moderate Respiratory Complications Procedures |
| 2.16.840.1.113762.1.4.1029.177 | Neonatal Moderate Birth Trauma with LOS |
| 2.16.840.1.113762.1.4.1029.178 | Neonatal Moderate Birth Trauma with LOS |
| 2.16.840.1.113762.1.4.1029.180 | Neonatal Moderate Respiratory Complications with LOS |
| 2.16.840.1.113762.1.4.1029.181 | Neonatal Moderate Respiratory Complications with LOS |
| 2.16.840.1.113762.1.4.1029.186 | Neonatal Moderate Respiratory complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.187 | Neonatal Moderate Respiratory complications with LOS Procedures |
| 2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal |
| 2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal |
| 2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean |
| 2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean |
| 2.16.840.1.113762.1.4.1029.196 | Neonatal Moderate Infection with LOS |
| 2.16.840.1.113762.1.4.1029.197 | Neonatal Moderate Infection with LOS |
| 2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit |
| 2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit |
| 2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration |
| 2.16.840.1.113762.1.4.1029.213 | Blood Transfusion |
| 2.16.840.1.113762.1.4.1029.220 | Aortic Aneurysm |
| 2.16.840.1.113762.1.4.1029.228 | Heart Failure Cardiac Arrest Related to Procedure or Surgery |
| 2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration |
| 2.16.840.1.113762.1.4.1029.246 | Blood Transfusion |
| 2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm |
| 2.16.840.1.113762.1.4.1029.250 | Hysterectomy |
| 2.16.840.1.113762.1.4.1029.252 | Tracheostomy |
| 2.16.840.1.113762.1.4.1029.254 | Ventilation |
| 2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures |
| 2.16.840.1.113762.1.4.1029.344 | Aortic Aneurysm |
| 2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm |
| 2.16.840.1.113762.1.4.1029.358 | Hysterectomy |
| 2.16.840.1.113762.1.4.1029.359 | Tracheostomy |
| 2.16.840.1.113762.1.4.1029.360 | Ventilation |
| 2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother |
| 2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage |
| 2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed |
| 2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed |
| 2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 |
| 2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 |
| 2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures |
| 2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 |
| 2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility |
| 2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT |
| 2.16.840.1.113762.1.4.1032.102 | Suicide Attempt |
| 2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT |
| 2.16.840.1.113762.1.4.1032.14 | Cirrhosis |
| 2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome |
| 2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT |
| 2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test |
| 2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results |
| 2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT |
| 2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 |
| 2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy |
| 2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional |
| 2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis |
| 2.16.840.1.113762.1.4.1032.268 | HPV Negative Results |
| 2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT |
| 2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 |
| 2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures |
| 2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS |
| 2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 |
| 2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 |
| 2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 |
| 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping |
| 2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain |
| 2.16.840.1.113762.1.4.1032.48 | Anxiety |
| 2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing |
| 2.16.840.1.113762.1.4.1032.52 | Anxiety |
| 2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing |
| 2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral |
| 2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance |
| 2.16.840.1.113762.1.4.1032.9 | Hypertension |
| 2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes |
| 2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis |
| 2.16.840.1.113762.1.4.1034.464 | Cluster Headache |
| 2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) |
| 2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine |
| 2.16.840.1.113762.1.4.1034.642 | No pain with headache |
| 2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) |
| 2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) |
| 2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) |
| 2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) |
| 2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment |
| 2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache |
| 2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation |
| 2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy |
| 2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy |
| 2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation |
| 2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton |
| 2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy |
| 2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy |
| 2.16.840.1.113762.1.4.1045.59 | Delivery Procedures |
| 2.16.840.1.113762.1.4.1045.67 | PCI |
| 2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation |
| 2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton |
| 2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED |
| 2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder |
| 2.16.840.1.113762.1.4.1046.279 | Triage |
| 2.16.840.1.113762.1.4.1046.283 | Emergency Department Location |
| 2.16.840.1.113762.1.4.1046.284 | Emergency Department Location |
| 2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders |
| 2.16.840.1.113762.1.4.1046.286 | Decision to Transfer |
| 2.16.840.1.113762.1.4.1047.10 | Breastfeeding |
| 2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia |
| 2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis |
| 2.16.840.1.113762.1.4.1047.12 | Liver Disease |
| 2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis |
| 2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease |
| 2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease |
| 2.16.840.1.113762.1.4.1047.42 | Liver Disease |
| 2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA |
| 2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses |
| 2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina |
| 2.16.840.1.113762.1.4.1047.502 | Overweight or Obese |
| 2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading |
| 2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension |
| 2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) |
| 2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate |
| 2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment |
| 2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage |
| 2.16.840.1.113762.1.4.1047.553 | Uveitis |
| 2.16.840.1.113762.1.4.1047.560 | Tonometry |
| 2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage |
| 2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections |
| 2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections |
| 2.16.840.1.113762.1.4.1047.587 | Lost to follow up |
| 2.16.840.1.113762.1.4.1047.588 | Uveitis |
| 2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam |
| 2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam |
| 2.16.840.1.113762.1.4.1047.615 | Physical Disability |
| 2.16.840.1.113762.1.4.1047.616 | Financial difficulty |
| 2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam |
| 2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina |
| 2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses |
| 2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA |
| 2.16.840.1.113762.1.4.1047.73 | Breastfeeding |
| 2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia |
| 2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care |
| 2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) |
| 2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED |
| 2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT |
| 2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions |
| 2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short |
| 2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT |
| 2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents |
| 2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT |
| 2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure |
| 2.16.840.1.113762.1.4.1078.1050 | Knee pain |
| 2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT |
| 2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT |
| 2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT |
| 2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence |
| 2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT |
| 2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm |
| 2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT |
| 2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT |
| 2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT |
| 2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT |
| 2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis |
| 2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT |
| 2.16.840.1.113762.1.4.1078.1084 | Tic disorder |
| 2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT |
| 2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia |
| 2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT |
| 2.16.840.1.113762.1.4.1078.1092 | Blepharospasm |
| 2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT |
| 2.16.840.1.113762.1.4.1078.1095 | Strabismus |
| 2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT |
| 2.16.840.1.113762.1.4.1078.1098 | Overactive bladder |
| 2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT |
| 2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT |
| 2.16.840.1.113762.1.4.1078.1101 | Movement disorders |
| 2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT |
| 2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis |
| 2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT |
| 2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits |
| 2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT |
| 2.16.840.1.113762.1.4.1078.111 | CKD stage4above |
| 2.16.840.1.113762.1.4.1078.1111 | Cardiac CT |
| 2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT |
| 2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI |
| 2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT |
| 2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery |
| 2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT |
| 2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT |
| 2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT |
| 2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis |
| 2.16.840.1.113762.1.4.1078.124 | DKD |
| 2.16.840.1.113762.1.4.1078.147 | HFrEF SCT |
| 2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD |
| 2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation |
| 2.16.840.1.113762.1.4.1078.175 | Asthma |
| 2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment |
| 2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease |
| 2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT |
| 2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure |
| 2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy |
| 2.16.840.1.113762.1.4.1078.260 | UACR SCT |
| 2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT |
| 2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT |
| 2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT |
| 2.16.840.1.113762.1.4.1078.459 | Liver cancer |
| 2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy SCT |
| 2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine |
| 2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine |
| 2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component |
| 2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine |
| 2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy |
| 2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT |
| 2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure |
| 2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT |
| 2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT |
| 2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity |
| 2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT |
| 2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis |
| 2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT |
| 2.16.840.1.113762.1.4.1078.536 | Vasospastic disease |
| 2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT |
| 2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine |
| 2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT |
| 2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease |
| 2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT |
| 2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping |
| 2.16.840.1.113762.1.4.1078.549 | Bleeding disorder |
| 2.16.840.1.113762.1.4.1078.561 | conditions_migraine |
| 2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT |
| 2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine |
| 2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT |
| 2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT |
| 2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease |
| 2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT |
| 2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites |
| 2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT |
| 2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia |
| 2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT |
| 2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT |
| 2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White |
| 2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT |
| 2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma |
| 2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT |
| 2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT |
| 2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT |
| 2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT |
| 2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT |
| 2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT |
| 2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT |
| 2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT |
| 2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT |
| 2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT |
| 2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT |
| 2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT |
| 2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT |
| 2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT |
| 2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT |
| 2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED |
| 2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED |
| 2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT |
| 2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT |
| 2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT |
| 2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT |
| 2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT |
| 2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT |
| 2.16.840.1.113762.1.4.1078.738 | Pneumonia |
| 2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT |
| 2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism |
| 2.16.840.1.113762.1.4.1078.745 | Influenza SCT |
| 2.16.840.1.113762.1.4.1078.747 | Influenza |
| 2.16.840.1.113762.1.4.1078.749 | COVID19 SCT |
| 2.16.840.1.113762.1.4.1078.750 | COVID19 |
| 2.16.840.1.113762.1.4.1078.753 | RSV SCT |
| 2.16.840.1.113762.1.4.1078.754 | RSV |
| 2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT |
| 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate |
| 2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT |
| 2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure |
| 2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT |
| 2.16.840.1.113762.1.4.1078.763 | Dyspnea |
| 2.16.840.1.113762.1.4.1078.765 | Confusion SCT |
| 2.16.840.1.113762.1.4.1078.766 | Confusion |
| 2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT |
| 2.16.840.1.113762.1.4.1078.769 | Drowsiness |
| 2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT |
| 2.16.840.1.113762.1.4.1078.772 | Cyanosis |
| 2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT |
| 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation |
| 2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT |
| 2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain |
| 2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT |
| 2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT |
| 2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain |
| 2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain |
| 2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT |
| 2.16.840.1.113762.1.4.1078.800 | Knee joint surgery |
| 2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT |
| 2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis |
| 2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT |
| 2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT |
| 2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee |
| 2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee |
| 2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT |
| 2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis |
| 2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT |
| 2.16.840.1.113762.1.4.1078.815 | Hip joint surgery |
| 2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT |
| 2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT |
| 2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip |
| 2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip |
| 2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT |
| 2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions |
| 2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED |
| 2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT |
| 2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease |
| 2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes |
| 2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT |
| 2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction |
| 2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT |
| 2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) |
| 2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT |
| 2.16.840.1.113762.1.4.1078.889 | Gastroparesis |
| 2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT |
| 2.16.840.1.113762.1.4.1078.894 | Peripheral edema |
| 2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance |
| 2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT |
| 2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD |
| 2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT |
| 2.16.840.1.113762.1.4.1078.916 | Anxiety |
| 2.16.840.1.113762.1.4.1078.918 | Stress_SCT |
| 2.16.840.1.113762.1.4.1078.92 | ASCVD |
| 2.16.840.1.113762.1.4.1078.920 | Stress |
| 2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT |
| 2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT |
| 2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT |
| 2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT |
| 2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT |
| 2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT |
| 2.16.840.1.113762.1.4.1078.940 | Crohn disease |
| 2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT |
| 2.16.840.1.113762.1.4.1078.943 | Celiac disease |
| 2.16.840.1.113762.1.4.1078.95 | Albuminuria |
| 2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT |
| 2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED |
| 2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED |
| 2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT |
| 2.16.840.1.113762.1.4.1078.973 | MASLD SCT |
| 2.16.840.1.113762.1.4.1078.974 | MASLD |
| 2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED |
| 2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED |
| 2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED |
| 2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED |
| 2.16.840.1.113762.1.4.1078.99 | BMI SCT |
| 2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED |
| 2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED |
| 2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED |
| 2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT |
| 2.16.840.1.113762.1.4.1095.101 | Hospice Status |
| 2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT |
| 2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT |
| 2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT |
| 2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT |
| 2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT |
| 2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT |
| 2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT |
| 2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment |
| 2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment |
| 2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening |
| 2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure |
| 2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening |
| 2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished |
| 2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished |
| 2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping |
| 2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT |
| 2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT |
| 2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping |
| 2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT |
| 2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis |
| 2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis |
| 2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping |
| 2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping |
| 2.16.840.1.113762.1.4.1095.60 | Edible Substances |
| 2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT |
| 2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping |
| 2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT |
| 2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT |
| 2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT |
| 2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT |
| 2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping |
| 2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment |
| 2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT |
| 2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping |
| 2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT |
| 2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping |
| 2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping |
| 2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning |
| 2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result |
| 2.16.840.1.113762.1.4.1095.91 | Dietitian Referral |
| 2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan |
| 2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| 2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) |
| 2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source |
| 2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen |
| 2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication |
| 2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication |
| 2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose |
| 2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form |
| 2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course |
| 2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval |
| 2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication |
| 2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen |
| 2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation |
| 2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications |
| 2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices |
| 2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications |
| 2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization |
| 2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition |
| 2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders |
| 2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education |
| 2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management |
| 2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review |
| 2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion |
| 2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost |
| 2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations |
| 2.16.840.1.113762.1.4.1096.123 | Status of Recommendations |
| 2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents |
| 2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability |
| 2.16.840.1.113762.1.4.1096.126 | Status of Interventions |
| 2.16.840.1.113762.1.4.1096.127 | Status of Disease Control |
| 2.16.840.1.113762.1.4.1096.128 | Status of Compliance |
| 2.16.840.1.113762.1.4.1096.129 | Occupations of Providers |
| 2.16.840.1.113762.1.4.1096.130 | Environments of Care |
| 2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index |
| 2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use |
| 2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use |
| 2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet |
| 2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise |
| 2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior |
| 2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet |
| 2.16.840.1.113762.1.4.1096.139 | Status of Care Goal |
| 2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use |
| 2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations |
| 2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs |
| 2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event |
| 2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting |
| 2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations |
| 2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs |
| 2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use |
| 2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication |
| 2.16.840.1.113762.1.4.1096.151 | Encounter Type |
| 2.16.840.1.113762.1.4.1096.152 | Encounter Class |
| 2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity |
| 2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management |
| 2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation |
| 2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation |
| 2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation |
| 2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management |
| 2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration |
| 2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications |
| 2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits |
| 2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure |
| 2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination |
| 2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering |
| 2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning |
| 2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation |
| 2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food |
| 2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental |
| 2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason |
| 2.16.840.1.113762.1.4.1096.182 | Encounter Reason |
| 2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related |
| 2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies |
| 2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions |
| 2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions |
| 2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus |
| 2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination |
| 2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo |
| 2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome |
| 2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession |
| 2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare |
| 2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType |
| 2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass |
| 2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation |
| 2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange |
| 2.16.840.1.113762.1.4.1096.214 | PharmacyEducation |
| 2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus |
| 2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom |
| 2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication |
| 2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation |
| 2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms |
| 2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure |
| 2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set |
| 2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions |
| 2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings |
| 2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication |
| 2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness |
| 2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred |
| 2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost |
| 2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem |
| 2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford |
| 2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings |
| 2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review |
| 2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy |
| 2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events |
| 2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence |
| 2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers |
| 2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present |
| 2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease |
| 2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required |
| 2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy |
| 2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management |
| 2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy |
| 2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low |
| 2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments |
| 2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management |
| 2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales |
| 2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring |
| 2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations |
| 2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers |
| 2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services |
| 2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High |
| 2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication |
| 2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication |
| 2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication |
| 2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose |
| 2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form |
| 2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course |
| 2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval |
| 2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication |
| 2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring |
| 2.16.840.1.113762.1.4.1099.12 | Medication Route |
| 2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status |
| 2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) |
| 2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status |
| 2.16.840.1.113762.1.4.1099.30 | Care Team Member Function |
| 2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) |
| 2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type |
| 2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason |
| 2.16.840.1.113762.1.4.1099.50 | Transport vehicle type |
| 2.16.840.1.113762.1.4.1099.53 | Sex |
| 2.16.840.1.113762.1.4.1099.54 | Specimen type |
| 2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis |
| 2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT |
| 2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction |
| 2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months |
| 2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months |
| 2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory |
| 2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening |
| 2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening |
| 2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy |
| 2.16.840.1.113762.1.4.1108.182 | Eclampsia |
| 2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension |
| 2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy |
| 2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter |
| 2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter |
| 2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy |
| 2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion |
| 2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia |
| 2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion |
| 2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms |
| 2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms |
| 2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy |
| 2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus |
| 2.16.840.1.113762.1.4.1110.16 | Uterine Rupture |
| 2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage |
| 2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage |
| 2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit |
| 2.16.840.1.113762.1.4.1110.24 | Uterine Horn |
| 2.16.840.1.113762.1.4.1110.25 | Metroplasty |
| 2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa |
| 2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa |
| 2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service |
| 2.16.840.1.113762.1.4.1110.41 | Statin Allergen |
| 2.16.840.1.113762.1.4.1110.42 | Statin Allergen |
| 2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition |
| 2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis |
| 2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other |
| 2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps |
| 2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices |
| 2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings |
| 2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation |
| 2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation |
| 2.16.840.1.113762.1.4.1111.126 | Hospital Settings |
| 2.16.840.1.113762.1.4.1111.143 | Observation Services |
| 2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer |
| 2.16.840.1.113762.1.4.1111.164 | Admit Inpatient |
| 2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder |
| 2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED |
| 2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis |
| 2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) |
| 2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED |
| 2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain |
| 2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT |
| 2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality |
| 2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping |
| 2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures |
| 2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures |
| 2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping |
| 2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT |
| 2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c |
| 2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 |
| 2.16.840.1.113762.1.4.1116.102 | N Stage pN1a |
| 2.16.840.1.113762.1.4.1116.103 | N Stage pN1b |
| 2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi |
| 2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b |
| 2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a |
| 2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 |
| 2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b |
| 2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a |
| 2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 |
| 2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d |
| 2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c |
| 2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b |
| 2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a |
| 2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 |
| 2.16.840.1.113762.1.4.1116.120 | N Stage N2C |
| 2.16.840.1.113762.1.4.1116.121 | T Stage T3c |
| 2.16.840.1.113762.1.4.1116.122 | T Stage T3b |
| 2.16.840.1.113762.1.4.1116.123 | T Stage T3a |
| 2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 |
| 2.16.840.1.113762.1.4.1116.125 | T Stage T2c |
| 2.16.840.1.113762.1.4.1116.126 | T Stage T2b |
| 2.16.840.1.113762.1.4.1116.127 | T Stage T2a |
| 2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 |
| 2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c |
| 2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b |
| 2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a |
| 2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 |
| 2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic |
| 2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 |
| 2.16.840.1.113762.1.4.1116.142 | Cancer Stage III |
| 2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA |
| 2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB |
| 2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC |
| 2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV |
| 2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA |
| 2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB |
| 2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC |
| 2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status |
| 2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status |
| 2.16.840.1.113762.1.4.1116.185 | Breast Cancer |
| 2.16.840.1.113762.1.4.1116.191 | Cancer Stage II |
| 2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA |
| 2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB |
| 2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer |
| 2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA |
| 2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB |
| 2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC |
| 2.16.840.1.113762.1.4.1116.291 | Positive Result |
| 2.16.840.1.113762.1.4.1116.292 | Negative Result |
| 2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C |
| 2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission |
| 2.16.840.1.113762.1.4.1116.439 | T Category |
| 2.16.840.1.113762.1.4.1116.440 | N Category |
| 2.16.840.1.113762.1.4.1116.441 | M Category |
| 2.16.840.1.113762.1.4.1116.442 | TNM Stage Group |
| 2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer |
| 2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C |
| 2.16.840.1.113762.1.4.1116.555 | Gender Female |
| 2.16.840.1.113762.1.4.1116.556 | Gender Male |
| 2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a |
| 2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b |
| 2.16.840.1.113762.1.4.1116.95 | M Stage M0 |
| 2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 |
| 2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a |
| 2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b |
| 2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings |
| 2.16.840.1.113762.1.4.1130.11 | Sleep Apnea |
| 2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults |
| 2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff |
| 2.16.840.1.113762.1.4.1130.15 | Body Temperature |
| 2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI |
| 2.16.840.1.113762.1.4.1130.17 | Abdominal Distension |
| 2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI |
| 2.16.840.1.113762.1.4.1130.19 | Ileus due to infection |
| 2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection |
| 2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis |
| 2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders |
| 2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders |
| 2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders |
| 2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder |
| 2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens |
| 2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity |
| 2.16.840.1.113762.1.4.1142.30 | C2S Inhalants |
| 2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders |
| 2.16.840.1.113762.1.4.1142.42 | C2S Opioids |
| 2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance Use Disorder |
| 2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders |
| 2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders |
| 2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories |
| 2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders |
| 2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity |
| 2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value |
| 2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1065 | Consciousness [Decreased Level] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1091 | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1092 | Congenital heart disease (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1093 | Hearing impairment (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1095 | Microcephaly (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1096 | Developmental delay (SNOMED) |
| 2.16.840.1.113762.1.4.1146.112 | Tetanus (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1145 | Resistant Lab Result Value |
| 2.16.840.1.113762.1.4.1146.115 | Mumps (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1156 | Staphylococcus aureus (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1197 | Cervical Lymphadenitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1207 | CRE (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1212 | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1213 | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1214 | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1224 | Therapeutic Response to Medication [Improved] |
| 2.16.840.1.113762.1.4.1146.1225 | Altered Mental Status (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1230 | Eschar (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1231 | Hypotension (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1233 | Localized Edema (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1237 | Tachycardia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1239 | RCKMS Conditions (SNOMED) |
| 2.16.840.1.113762.1.4.1146.124 | Poliomyelitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1240 | Maternal Condition Puerperium (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1242 | Non pestis Yersiniosis Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1244 | Blastomycosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1246 | Blastomycosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1269 | Tuberculosis [Latent Infection] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1274 | Histoplasmosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1294 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1295 | Seizure [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.130 | Influenza (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1309 | RSV (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1314 | Wheezing (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1325 | Tobacco Use and Exposure (Social History) |
| 2.16.840.1.113762.1.4.1146.1335 | Hospitalized [Inpatient] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1336 | Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1337 | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1349 | Cerebrospinal Fluid (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.135 | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1350 | Endocervical (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1351 | Tissue (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1352 | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) |
| 2.16.840.1.113762.1.4.1146.1353 | Urethral Swab (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1355 | Wound (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.136 | Invasive Pneumococcal Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1369 | Serum (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1379 | Fish Poisoning (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1388 | Occupational Asthma (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1389 | Asthma (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1391 | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1393 | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1405 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1407 | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1418 | Alpha gal syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1422 | Ptosis of Eyelid [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1424 | Constipation [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1426 | Intubation [Respiratory Tract] (Procedure) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1430 | Infant Botulism (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1446 | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1447 | MRSA (Disorders (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1449 | Staphylococcus aureus infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.145 | Varicella (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1514 | Mercury Exposure and Toxicity (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1532 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1534 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1538 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1551 | Meningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) |
| 2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2383 | Absence of Skin Lesions (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2384 | Neuralgia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2386 | Peripheral Nerve Thickening (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2387 | Nerve (Specimen Type) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2407 | Firearm Injury (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2415 | Cranial Nerve Involvement (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2416 | Unusual Change in Behavior (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2417 | Radiculitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2418 | Subarachnoid Hemorrhage (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2420 | Discitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2423 | Respiratory Insufficiency [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2425 | Conjunctival Suffusion (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2430 | Pleural effusion (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2432 | Abdominal swelling (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2434 | Neck swelling (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2436 | Diaphoresis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2438 | Edema (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2442 | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2443 | Influenza A (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2444 | Influenza B (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2445 | Influenza [Unspecified] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2452 | Influenza (unspecified influenza virus in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2453 | Influenza (influenza B virus in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2463 | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2464 | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2470 | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2471 | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2473 | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2474 | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2475 | Aortic valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2479 | Microtia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2480 | Anotia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2482 | Anophthalmia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2484 | Microphthalmia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2486 | Atrial septal defect (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2488 | Fetal Aortic valve stenosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2489 | Congenital Posterior Urethral Valves (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2491 | Bladder Exstrophy (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2493 | Encephalocele (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2496 | Choanal Atresia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2498 | Cloacal Exstrophy (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2500 | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2502 | Trisomy 13 (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2504 | Fetal Trisomy 13 (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2506 | Galactosemia (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2516 | Hypospadias (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2518 | Trisomy 18 (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2519 | Fetal Trisomy 18 (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2527 | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.2528 | Ventricular septal defect (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.2531 | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value |
| 2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) |
| 2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) |
| 2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) |
| 2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.362 | Hansen’s Disease (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.365 | Silicosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.460 | HIV Infection or AIDS (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.48 | Salmonellosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.494 | Ehrlichiosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.505 | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.516 | Brucellosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.534 | Smallpox (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.542 | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.580 | Arboviral Disease [Other] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.586 | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.6 | Diphtheria (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.606 | Tuberculosis (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.632 | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.650 | Jaundice (SNOMED) |
| 2.16.840.1.113762.1.4.1146.660 | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.663 | Erythema Nodosum (SNOMED) |
| 2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) |
| 2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) |
| 2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) |
| 2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) |
| 2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) |
| 2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) |
| 2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) |
| 2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) |
| 2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) |
| 2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) |
| 2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) |
| 2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) |
| 2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) |
| 2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) |
| 2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) |
| 2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) |
| 2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) |
| 2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) |
| 2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) |
| 2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) |
| 2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) |
| 2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) |
| 2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) |
| 2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) |
| 2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) |
| 2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.918 | Spondylitis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) |
| 2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.963 | Arboviral Disease [Other] (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) |
| 2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) |
| 2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) |
| 2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) |
| 2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) |
| 2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue |
| 2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| 2.16.840.1.113762.1.4.1147.122 | Inpatient Falls |
| 2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site |
| 2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site |
| 2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site |
| 2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site |
| 2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast |
| 2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities |
| 2.16.840.1.113762.1.4.1147.171 | Inpatient Falls |
| 2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) |
| 2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump |
| 2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care |
| 2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care |
| 2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care |
| 2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial |
| 2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care |
| 2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care |
| 2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care |
| 2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care |
| 2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care |
| 2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care |
| 2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care |
| 2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care |
| 2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care |
| 2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care |
| 2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care |
| 2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care |
| 2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care |
| 2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care |
| 2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care |
| 2.16.840.1.113762.1.4.1151.56 | Active Tuberculosis for Urology Care |
| 2.16.840.1.113762.1.4.1151.58 | Bladder Cancer Staging Tis for Urology Care |
| 2.16.840.1.113762.1.4.1151.8 | Tuberculosis Diagnosis Prior to Urology Care |
| 2.16.840.1.113762.1.4.1151.9 | Leukemia Diagnosis Prior to Urology Care |
| 2.16.840.1.113762.1.4.1160.13 | Preventative Clinical Encounters |
| 2.16.840.1.113762.1.4.1160.16 | Intensive Lifestyle Interventions |
| 2.16.840.1.113762.1.4.1160.17 | Intensive lifestyle interventions |
| 2.16.840.1.113762.1.4.1160.23 | Outpatient Clinical Encounters |
| 2.16.840.1.113762.1.4.1160.24 | Outpatient Clinical Encounters |
| 2.16.840.1.113762.1.4.1160.25 | Reason for No Intensive Lifestyle Intervention |
| 2.16.840.1.113762.1.4.1160.28 | Type 2 Diabetes Diagnoses |
| 2.16.840.1.113762.1.4.1160.29 | Type 2 Diabetes Diagnoses |
| 2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode |
| 2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode |
| 2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension |
| 2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension |
| 2.16.840.1.113762.1.4.1160.85 | Renal Colic |
| 2.16.840.1.113762.1.4.1160.86 | Renal Colic |
| 2.16.840.1.113762.1.4.1160.9 | Preventative Clinical Encounters |
| 2.16.840.1.113762.1.4.1164.50 | Urinary retention |
| 2.16.840.1.113762.1.4.1164.52 | Urinary retention |
| 2.16.840.1.113762.1.4.1164.66 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1164.67 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1166.1 | Pregnancy Status |
| 2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED |
| 2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits |
| 2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED |
| 2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED |
| 2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED |
| 2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses |
| 2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits |
| 2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses |
| 2.16.840.1.113762.1.4.1166.138 | IUD Surveillance |
| 2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures |
| 2.16.840.1.113762.1.4.1166.140 | IUD Devices |
| 2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices |
| 2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures |
| 2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures |
| 2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT |
| 2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures |
| 2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices |
| 2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures |
| 2.16.840.1.113762.1.4.1166.17 | Contraceptive Type |
| 2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices |
| 2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures |
| 2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance |
| 2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason |
| 2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures |
| 2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures |
| 2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures |
| 2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures |
| 2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance |
| 2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures |
| 2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance |
| 2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices |
| 2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures |
| 2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance |
| 2.16.840.1.113762.1.4.1166.209 | Yes and No Answers |
| 2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method |
| 2.16.840.1.113762.1.4.1166.210 | Pap Smear Results |
| 2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention |
| 2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role |
| 2.16.840.1.113762.1.4.1166.3 | Organism Detection |
| 2.16.840.1.113762.1.4.1166.31 | English Proficiency |
| 2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices |
| 2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings |
| 2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures |
| 2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures |
| 2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings |
| 2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined |
| 2.16.840.1.113762.1.4.1170.15 | Intervention for Positive Transportation Insecurity Screen |
| 2.16.840.1.113762.1.4.1170.16 | Intervention for Positive Food Insecurity Screen |
| 2.16.840.1.113762.1.4.1170.19 | Intervention for Positive Food Insecurity Screen |
| 2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery |
| 2.16.840.1.113762.1.4.1170.20 | Intervention for Positive Homelessness Screen |
| 2.16.840.1.113762.1.4.1170.21 | Intervention for Positive Housing Instability Screen |
| 2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders |
| 2.16.840.1.113762.1.4.1170.29 | Bed Assigned |
| 2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group |
| 2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation |
| 2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation |
| 2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation |
| 2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation |
| 2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation |
| 2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics |
| 2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen |
| 2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen |
| 2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen |
| 2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen |
| 2.16.840.1.113762.1.4.1170.57 | Non Invasive Oxygen Therapy Device Codes |
| 2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event |
| 2.16.840.1.113762.1.4.1170.8 | Intervention for Positive Utility Insecurity Screen |
| 2.16.840.1.113762.1.4.1176.58 | Food Insecurity Screening Positive |
| 2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication |
| 2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication |
| 2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 |
| 2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 |
| 2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 |
| 2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 |
| 2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 |
| 2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 |
| 2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 |
| 2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 |
| 2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 |
| 2.16.840.1.113762.1.4.1178.118 | SNOMED CT Atrial Fibrillation |
| 2.16.840.1.113762.1.4.1178.121 | AHA GWTG Atrial Fibrillation |
| 2.16.840.1.113762.1.4.1178.123 | SNOMED CT Hyperlipidemia |
| 2.16.840.1.113762.1.4.1178.125 | AHA GWTG Hyperlipidemia |
| 2.16.840.1.113762.1.4.1178.126 | SNOMED CT Hypertriglyceridemia |
| 2.16.840.1.113762.1.4.1178.129 | AHA GWTG Hypertriglyceridemia |
| 2.16.840.1.113762.1.4.1178.130 | SNOMED CT Gestational Diabetes |
| 2.16.840.1.113762.1.4.1178.132 | AHA GWTG Gestational Diabetes |
| 2.16.840.1.113762.1.4.1178.133 | SNOMED CT Hyperglycemia |
| 2.16.840.1.113762.1.4.1178.135 | AHA GWTG Hyperglycemia |
| 2.16.840.1.113762.1.4.1178.136 | SNOMED CT Nonobstructive CAD |
| 2.16.840.1.113762.1.4.1178.138 | AHA GWTG Nonobstructive coronary artery disease |
| 2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User |
| 2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab |
| 2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation |
| 2.16.840.1.113762.1.4.1178.32 | Heart Transplant |
| 2.16.840.1.113762.1.4.1178.33 | Heart Transplant |
| 2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy |
| 2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation |
| 2.16.840.1.113762.1.4.1178.5 | Hypothyroidism |
| 2.16.840.1.113762.1.4.1178.52 | Cardiac Pacer |
| 2.16.840.1.113762.1.4.1178.53 | Cardiac Pacer |
| 2.16.840.1.113762.1.4.1178.55 | Heart Transplant Complications |
| 2.16.840.1.113762.1.4.1178.56 | Heart Transplant Complications |
| 2.16.840.1.113762.1.4.1178.57 | Left Ventricular Assist Device Complications |
| 2.16.840.1.113762.1.4.1178.58 | Left Ventricular Assist Device Complications |
| 2.16.840.1.113762.1.4.1178.6 | Hypothyroidism |
| 2.16.840.1.113762.1.4.1178.60 | Left Ventricular Assist Device Placement |
| 2.16.840.1.113762.1.4.1178.61 | Left Ventricular Assist Device Placement |
| 2.16.840.1.113762.1.4.1178.67 | Diastolic Heart Failure |
| 2.16.840.1.113762.1.4.1178.68 | Diastolic Heart Failure |
| 2.16.840.1.113762.1.4.1178.69 | Allergy to SGLT2 Inhibitors |
| 2.16.840.1.113762.1.4.1178.70 | Intolerance to SGLT2 Inhibitors |
| 2.16.840.1.113762.1.4.1178.71 | Intolerance to MRA Therapy |
| 2.16.840.1.113762.1.4.1178.74 | Mitral Stenosis |
| 2.16.840.1.113762.1.4.1178.75 | Mitral Stenosis |
| 2.16.840.1.113762.1.4.1178.77 | Mechanical Prosthetic Heart Valve |
| 2.16.840.1.113762.1.4.1178.78 | Mechanical Prosthetic Heart Valve |
| 2.16.840.1.113762.1.4.1178.8 | Anorexia Nervosa |
| 2.16.840.1.113762.1.4.1178.83 | Systolic Heart Failure |
| 2.16.840.1.113762.1.4.1178.84 | Systolic Heart Failure |
| 2.16.840.1.113762.1.4.1178.9 | Anorexia Nervosa |
| 2.16.840.1.113762.1.4.1178.96 | AHA GWTG Long COVID19 |
| 2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT |
| 2.16.840.1.113762.1.4.1181.1 | Wound internal item and/or body structure visible value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.11 | Wound exudate appearance value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.12 | Wound exudate color value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.13 | Exudate odor value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.16 | Skin temperature value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.17 | Skin color enumerated value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.18 | Skin turgor value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.19 | Skin and mucous membrane integrity value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.2 | Periwound condition value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.20 | Skin moisture value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.3 | Wound Type Etiology value set |
| 2.16.840.1.113762.1.4.1181.4 | Wound episode value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.6 | Wound bed appearance value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.60 | Wound type reference set |
| 2.16.840.1.113762.1.4.1181.7 | Wound bed color value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.74 | Nonverbal pain indicators reference set |
| 2.16.840.1.113762.1.4.1181.76 | Pain associated signs and symptoms reference set |
| 2.16.840.1.113762.1.4.1181.77 | Pain body location reference set |
| 2.16.840.1.113762.1.4.1181.8 | Wound edge description value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1181.80 | Pain quality reference set |
| 2.16.840.1.113762.1.4.1181.81 | Pain speed of onset reference set |
| 2.16.840.1.113762.1.4.1181.9 | Presence absence value set (foundation metadata concept) |
| 2.16.840.1.113762.1.4.1186.2 | Common drug classes for allergy and intolerance documentation |
| 2.16.840.1.113762.1.4.1186.3 | Common dietary substances for allergy and intolerance documentation |
| 2.16.840.1.113762.1.4.1186.4 | Common environmental substances for allergy and intolerance documentation |
| 2.16.840.1.113762.1.4.1186.5 | Common refutations for substance causes for allergy and intolerance documentation |
| 2.16.840.1.113762.1.4.1186.7 | Common substances for allergy and intolerance documentation |
| 2.16.840.1.113762.1.4.1186.8 | Common substances for allergy and intolerance documentation including refutations |
| 2.16.840.1.113762.1.4.1190.11 | NHSNCriterionOfDiagnosisCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.13 | NHSNInfectionConditionCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO |
| 2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route |
| 2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route |
| 2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) |
| 2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration |
| 2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition |
| 2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia |
| 2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy |
| 2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder |
| 2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease |
| 2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia |
| 2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy |
| 2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp |
| 2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma |
| 2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus |
| 2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness |
| 2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp |
| 2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp |
| 2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED |
| 2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens |
| 2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens |
| 2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions |
| 2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures |
| 2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests |
| 2.16.840.1.113762.1.4.1206.51 | VTE Symptoms |
| 2.16.840.1.113762.1.4.1206.53 | Provider Types |
| 2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) |
| 2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) |
| 2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 |
| 2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 |
| 2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds |
| 2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 |
| 2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding |
| 2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED |
| 2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure |
| 2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure |
| 2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure |
| 2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep |
| 2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder |
| 2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease |
| 2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder |
| 2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition |
| 2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation |
| 2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device |
| 2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location |
| 2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder |
| 2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder |
| 2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT |
| 2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment |
| 2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT |
| 2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment |
| 2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT |
| 2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease |
| 2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder |
| 2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder |
| 2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder |
| 2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder |
| 2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.178 | Wound Disorder |
| 2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder |
| 2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder |
| 2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT |
| 2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer |
| 2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder |
| 2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason |
| 2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT |
| 2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder |
| 2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure |
| 2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History |
| 2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder |
| 2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder |
| 2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition |
| 2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level |
| 2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder |
| 2.16.840.1.113762.1.4.1219.31 | Sleep Apnea or Breathing Related Sleep Disorder |
| 2.16.840.1.113762.1.4.1219.34 | Diabetes Mellitus Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.35 | Diabetes Mellitus Disorder |
| 2.16.840.1.113762.1.4.1219.36 | Restrictive Lung Disease SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.38 | Restrictive Lung Disease |
| 2.16.840.1.113762.1.4.1219.39 | Chest Wall Deformity Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.41 | Chest Wall Deformity Disorder |
| 2.16.840.1.113762.1.4.1219.42 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.44 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder |
| 2.16.840.1.113762.1.4.1219.45 | Chronic Respiratory Failure Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.47 | Chronic Respiratory Failure Disorder |
| 2.16.840.1.113762.1.4.1219.48 | Ventilator Therapy Qualifying Condition |
| 2.16.840.1.113762.1.4.1219.5 | Chronic Obstructive Lung Disease SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.6 | Chronic Obstructive Lung Disease (COPD) |
| 2.16.840.1.113762.1.4.1219.64 | Urinary Incontinence Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.66 | Urinary Incontinence Disorder |
| 2.16.840.1.113762.1.4.1219.67 | Chronic Urinary Retention Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.69 | Chronic Urinary Retention Disorder |
| 2.16.840.1.113762.1.4.1219.70 | Urinary Incontinence or Chronic Urinary Retention Disorder |
| 2.16.840.1.113762.1.4.1219.8 | Hypoxemia Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.81 | Organ Transplant History Significant to Immunosuppressive Therapy |
| 2.16.840.1.113762.1.4.1219.86 | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.88 | Hyperglycemia or Hypoglycemia Disorder |
| 2.16.840.1.113762.1.4.1219.9 | Hypoxemia Disorder |
| 2.16.840.1.113762.1.4.1219.90 | Organ Transplant Procedure Significant to Immunosuppressive Therapy |
| 2.16.840.1.113762.1.4.1219.91 | Pulmonary Hypertension Disorder SNOMEDCT |
| 2.16.840.1.113762.1.4.1219.93 | Pulmonary Hypertension Disorder |
| 2.16.840.1.113762.1.4.1219.95 | Physical Therapy Procedure SNOMED CT |
| 2.16.840.1.113762.1.4.1219.96 | Occupational Therapy Procedure SNOMED CT |
| 2.16.840.1.113762.1.4.1219.97 | Speech Language Therapy Procedure SNOMED CT |
| 2.16.840.1.113762.1.4.1219.99 | Physical Therapy Procedure |
| 2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) |
| 2.16.840.1.113762.1.4.1221.149 | Abortion, All (SNOMED CT) |
| 2.16.840.1.113762.1.4.1221.150 | Abortion, All |
| 2.16.840.1.113762.1.4.1221.156 | Abortion, Elective |
| 2.16.840.1.113762.1.4.1221.165 | Abortion, Elective |
| 2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management |
| 2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management |
| 2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage |
| 2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage |
| 2.16.840.1.113762.1.4.1221.173 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling |
| 2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance |
| 2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance |
| 2.16.840.1.113762.1.4.1221.187 | Infertility, Female |
| 2.16.840.1.113762.1.4.1221.188 | Infertility, Female |
| 2.16.840.1.113762.1.4.1221.190 | Infertility, Male |
| 2.16.840.1.113762.1.4.1221.191 | Infertility, Male |
| 2.16.840.1.113762.1.4.1221.192 | Infertility, All |
| 2.16.840.1.113762.1.4.1221.194 | Gender Identity |
| 2.16.840.1.113762.1.4.1221.195 | Intersex Surgery, History |
| 2.16.840.1.113762.1.4.1221.196 | Intersex Surgery, Non specific |
| 2.16.840.1.113762.1.4.1221.197 | Intersex Surgery, Female to Male |
| 2.16.840.1.113762.1.4.1221.199 | Intersex Surgery, Female to Male |
| 2.16.840.1.113762.1.4.1221.200 | Intersex Surgery, Male to Female Sex |
| 2.16.840.1.113762.1.4.1221.202 | Intersex Surgery, Male to Female Sex |
| 2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All |
| 2.16.840.1.113762.1.4.1221.205 | Stillbirth |
| 2.16.840.1.113762.1.4.1221.208 | Sexual Orientation |
| 2.16.840.1.113762.1.4.1222.100 | Sleep Apnea Disorders SCT |
| 2.16.840.1.113762.1.4.1222.102 | Sleep Apnea Disorders |
| 2.16.840.1.113762.1.4.1222.103 | PostTraumatic Stress Disorder PTSD |
| 2.16.840.1.113762.1.4.1222.105 | PostTraumatic Stress Disorder PTSD SCT |
| 2.16.840.1.113762.1.4.1222.1203 | Medication Literacy |
| 2.16.840.1.113762.1.4.1222.1213 | Elder and Child Abuse SCT |
| 2.16.840.1.113762.1.4.1222.1229 | Education Level SCT |
| 2.16.840.1.113762.1.4.1222.1281 | Elder and Child Abuse |
| 2.16.840.1.113762.1.4.1222.1375 | Tinnitus |
| 2.16.840.1.113762.1.4.1222.1377 | Brain Fog |
| 2.16.840.1.113762.1.4.1222.1378 | Depression Symptoms |
| 2.16.840.1.113762.1.4.1222.1379 | Mood Swings |
| 2.16.840.1.113762.1.4.1222.1380 | Anxiety |
| 2.16.840.1.113762.1.4.1222.1381 | Lightheadedness |
| 2.16.840.1.113762.1.4.1222.1382 | Stress |
| 2.16.840.1.113762.1.4.1222.1383 | Grief and Suffering |
| 2.16.840.1.113762.1.4.1222.1384 | Insomnia and Other Sleep Difficulties |
| 2.16.840.1.113762.1.4.1222.1385 | Impaired Sense of Taste |
| 2.16.840.1.113762.1.4.1222.1386 | Pink Eye Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1388 | Pink Eye Diagnosis |
| 2.16.840.1.113762.1.4.1222.1392 | Lymphadenopathy Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1394 | Lymphadenopathy Diagnosis |
| 2.16.840.1.113762.1.4.1222.1395 | Visual Changes |
| 2.16.840.1.113762.1.4.1222.1396 | Impaired Sense of Smell |
| 2.16.840.1.113762.1.4.1222.1398 | Fatigue |
| 2.16.840.1.113762.1.4.1222.1399 | Chills |
| 2.16.840.1.113762.1.4.1222.1400 | Fever |
| 2.16.840.1.113762.1.4.1222.1401 | Functional and Mobility Impairment |
| 2.16.840.1.113762.1.4.1222.1403 | Orthostatic Intolerance |
| 2.16.840.1.113762.1.4.1222.1405 | Cough |
| 2.16.840.1.113762.1.4.1222.1406 | Dyspnea |
| 2.16.840.1.113762.1.4.1222.1409 | Wheezing |
| 2.16.840.1.113762.1.4.1222.1413 | Sinonasal Congestion |
| 2.16.840.1.113762.1.4.1222.1414 | Respiratory Distress |
| 2.16.840.1.113762.1.4.1222.1415 | Edema |
| 2.16.840.1.113762.1.4.1222.1419 | Weight Changes |
| 2.16.840.1.113762.1.4.1222.1422 | Immunologic Changes |
| 2.16.840.1.113762.1.4.1222.1424 | Pain |
| 2.16.840.1.113762.1.4.1222.1425 | Arthralgia |
| 2.16.840.1.113762.1.4.1222.1426 | Chest Pain |
| 2.16.840.1.113762.1.4.1222.1427 | Headache |
| 2.16.840.1.113762.1.4.1222.1428 | Myalgia |
| 2.16.840.1.113762.1.4.1222.1429 | Back Pain |
| 2.16.840.1.113762.1.4.1222.1430 | Pain in Extremities |
| 2.16.840.1.113762.1.4.1222.1431 | Pain in Throat |
| 2.16.840.1.113762.1.4.1222.1432 | Palpitations |
| 2.16.840.1.113762.1.4.1222.1433 | Tachycardia |
| 2.16.840.1.113762.1.4.1222.1434 | Bleeding |
| 2.16.840.1.113762.1.4.1222.1435 | Abdominal Pain |
| 2.16.840.1.113762.1.4.1222.1436 | Diarrhea |
| 2.16.840.1.113762.1.4.1222.1437 | Gastroesophageal Reflux |
| 2.16.840.1.113762.1.4.1222.1438 | Nausea |
| 2.16.840.1.113762.1.4.1222.1439 | Vomiting |
| 2.16.840.1.113762.1.4.1222.1440 | Constipation |
| 2.16.840.1.113762.1.4.1222.1441 | Difficulty Swallowing |
| 2.16.840.1.113762.1.4.1222.1443 | Loss of Appetite |
| 2.16.840.1.113762.1.4.1222.1444 | Paresthesia |
| 2.16.840.1.113762.1.4.1222.1445 | Rash |
| 2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) |
| 2.16.840.1.113762.1.4.1222.1447 | Itching |
| 2.16.840.1.113762.1.4.1222.1448 | Menstrual Cycle Irregularities |
| 2.16.840.1.113762.1.4.1222.1449 | Lower Urinary Tract Symptoms |
| 2.16.840.1.113762.1.4.1222.1450 | Urinary Incontinence |
| 2.16.840.1.113762.1.4.1222.1451 | Dizziness |
| 2.16.840.1.113762.1.4.1222.1453 | Hair Loss |
| 2.16.840.1.113762.1.4.1222.1455 | Disability Severity |
| 2.16.840.1.113762.1.4.1222.1456 | Hypercoagulability |
| 2.16.840.1.113762.1.4.1222.1457 | Post Exertional Malaise |
| 2.16.840.1.113762.1.4.1222.1458 | Chronic Pain |
| 2.16.840.1.113762.1.4.1222.1459 | Neurogenic Pain |
| 2.16.840.1.113762.1.4.1222.1460 | Impaired Hearing |
| 2.16.840.1.113762.1.4.1222.1461 | Parkinsonia Like Symptoms |
| 2.16.840.1.113762.1.4.1222.1462 | Bronchiectasis Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1463 | Bronchiectasis Diagnosis |
| 2.16.840.1.113762.1.4.1222.1464 | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1466 | Chronic obstructive pulmonary disease (COPD) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1467 | Interstitial lung disease Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1469 | Interstitial lung disease Diagnosis |
| 2.16.840.1.113762.1.4.1222.1470 | Asthma Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1472 | Asthma Diagnosis |
| 2.16.840.1.113762.1.4.1222.1473 | Fibromyalgia Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1475 | Fibromyalgia Diagnosis |
| 2.16.840.1.113762.1.4.1222.1477 | Herpes zoster Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1478 | Herpes zoster |
| 2.16.840.1.113762.1.4.1222.1479 | Pulmonary embolism Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1481 | Pulmonary embolism Diagnosis |
| 2.16.840.1.113762.1.4.1222.1482 | Hypertension, Pulmonary Hypertension SCT |
| 2.16.840.1.113762.1.4.1222.1484 | Hypertension, Pulmonary Hypertension |
| 2.16.840.1.113762.1.4.1222.1485 | Language and Speech Problems |
| 2.16.840.1.113762.1.4.1222.1486 | Postural tachycardia syndrome (POTS) Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1488 | Postural tachycardia syndrome (POTS) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1489 | Functional disorder of gastrointestinal tract Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1491 | Functional disorder of gastrointestinal tract Diagnosis |
| 2.16.840.1.113762.1.4.1222.1492 | Autonomic dysfunction |
| 2.16.840.1.113762.1.4.1222.1496 | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1498 | Mast Cell Activation Syndrome (MCAS) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1500 | Debility or Frailty SCT |
| 2.16.840.1.113762.1.4.1222.1502 | Debility or Frailty |
| 2.16.840.1.113762.1.4.1222.1503 | Ehlers Danlos syndrome (EDS) Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1505 | Ehlers Danlos syndrome (EDS) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1506 | Malnutrition Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1508 | Narcolepsy Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1510 | Narcolepsy |
| 2.16.840.1.113762.1.4.1222.1514 | Small Fiber Neuropathy Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1516 | Small Fiber Neuropathy Diagnosis |
| 2.16.840.1.113762.1.4.1222.1517 | Malnutrition Diagnosis |
| 2.16.840.1.113762.1.4.1222.1518 | Neuropathy Diagnosis |
| 2.16.840.1.113762.1.4.1222.1519 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1521 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1522 | Congestive heart failure Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1524 | Congestive heart failure Diagnosis |
| 2.16.840.1.113762.1.4.1222.1526 | Cognitive disorder SCT |
| 2.16.840.1.113762.1.4.1222.1527 | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT |
| 2.16.840.1.113762.1.4.1222.1530 | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis |
| 2.16.840.1.113762.1.4.1222.1531 | Hypertension, Persistent SCT |
| 2.16.840.1.113762.1.4.1222.1532 | Acute Renal Failure Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1534 | Acute Renal Failure Diagnosis |
| 2.16.840.1.113762.1.4.1222.1535 | Complication due to Diabetes Mellitus Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1537 | Complication due to Diabetes Mellitus Diagnosis |
| 2.16.840.1.113762.1.4.1222.1538 | Coronary Revascularization History SCT |
| 2.16.840.1.113762.1.4.1222.1540 | Coronary Revascularization History |
| 2.16.840.1.113762.1.4.1222.1541 | Heart Failure Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1543 | Heart Failure Diagnosis |
| 2.16.840.1.113762.1.4.1222.1547 | Hypertension, Primary and Secondary Diagnosis |
| 2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1549 | Cerebrovascular Disease Diagnosis |
| 2.16.840.1.113762.1.4.1222.1550 | Migraine Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1552 | Migraine Diagnosis |
| 2.16.840.1.113762.1.4.1222.1553 | Chronic Tension type Headache Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1555 | Chronic Tension type Headache Diagnosis |
| 2.16.840.1.113762.1.4.1222.1556 | Low Back Pain SCT |
| 2.16.840.1.113762.1.4.1222.1558 | Low Back Pain |
| 2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1561 | Metabolic Syndrome Diagnosis |
| 2.16.840.1.113762.1.4.1222.1563 | Hypertension, Persistent |
| 2.16.840.1.113762.1.4.1222.1564 | Pregnancy SCT |
| 2.16.840.1.113762.1.4.1222.1566 | Pregnancy |
| 2.16.840.1.113762.1.4.1222.157 | Chronic Kidney Disease All Stages (1 through 5) SNOMED |
| 2.16.840.1.113762.1.4.1222.159 | Chronic Kidney Disease All Stages (1 through 5) |
| 2.16.840.1.113762.1.4.1222.1595 | Acute COVID 19 Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1599 | Cardiomyopathy Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1601 | Atherosclerotic Cardiovascular Disease SCT |
| 2.16.840.1.113762.1.4.1222.1603 | Neuropathy Diagnosis SCT |
| 2.16.840.1.113762.1.4.1222.1606 | Left Ventricular Hypertrophy |
| 2.16.840.1.113762.1.4.1222.22 | Alcohol Use Disorder SCT |
| 2.16.840.1.113762.1.4.1222.24 | Alcohol Use Disorder |
| 2.16.840.1.113762.1.4.1222.25 | Peripheral Vascular Disease SCT |
| 2.16.840.1.113762.1.4.1222.27 | Peripheral Vascular Disease |
| 2.16.840.1.113762.1.4.1222.28 | Hepatitis C Condition SCT |
| 2.16.840.1.113762.1.4.1222.30 | Hepatitis C Conditions |
| 2.16.840.1.113762.1.4.1222.31 | Diabetic Neuropathy SCT |
| 2.16.840.1.113762.1.4.1222.33 | Diabetic Neuropathy Conditions |
| 2.16.840.1.113762.1.4.1222.36 | Obesity Conditions |
| 2.16.840.1.113762.1.4.1222.37 | Obesity SCT |
| 2.16.840.1.113762.1.4.1222.4 | Chronic Kidney Disease Type or Cause SCT |
| 2.16.840.1.113762.1.4.1222.41 | Tuberculosis (Disorders) SCT |
| 2.16.840.1.113762.1.4.1222.417 | Prediabetes (Borderline Diabetes) |
| 2.16.840.1.113762.1.4.1222.419 | Prediabetes (Borderline Diabetes) |
| 2.16.840.1.113762.1.4.1222.420 | Maturity Onset Diabetes of the Young (MODY) |
| 2.16.840.1.113762.1.4.1222.43 | Tuberculosis Disorders |
| 2.16.840.1.113762.1.4.1222.45 | Hypoalbuminemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.47 | Hypoalbuminemia Conditions |
| 2.16.840.1.113762.1.4.1222.48 | Hyperkalemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.481 | Diabetic Coma |
| 2.16.840.1.113762.1.4.1222.482 | Diabetic Coma |
| 2.16.840.1.113762.1.4.1222.491 | Diabetic Peripheral Angiopathy |
| 2.16.840.1.113762.1.4.1222.492 | Diabetic Peripheral Angiopathy |
| 2.16.840.1.113762.1.4.1222.496 | Cataract of the Eye |
| 2.16.840.1.113762.1.4.1222.498 | Cataract of the Eye |
| 2.16.840.1.113762.1.4.1222.499 | Rubeosis Iridis |
| 2.16.840.1.113762.1.4.1222.50 | Hyperkalemia Conditions |
| 2.16.840.1.113762.1.4.1222.501 | Rubeosis Iridis |
| 2.16.840.1.113762.1.4.1222.507 | Emotional Distress caused by Chronic Condition |
| 2.16.840.1.113762.1.4.1222.508 | Emotional Distress caused by Chronic Condition |
| 2.16.840.1.113762.1.4.1222.51 | Anemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.512 | Hypoglycemic Event |
| 2.16.840.1.113762.1.4.1222.513 | Hypoglycemic Event |
| 2.16.840.1.113762.1.4.1222.514 | Hypoglycemia Unawareness |
| 2.16.840.1.113762.1.4.1222.516 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| 2.16.840.1.113762.1.4.1222.517 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| 2.16.840.1.113762.1.4.1222.519 | Ketoacidosis |
| 2.16.840.1.113762.1.4.1222.520 | Ketoacidosis |
| 2.16.840.1.113762.1.4.1222.522 | Diabetic Foot |
| 2.16.840.1.113762.1.4.1222.523 | Diabetic Foot |
| 2.16.840.1.113762.1.4.1222.525 | Diabetic Foot Ulcer |
| 2.16.840.1.113762.1.4.1222.526 | Diabetic Foot Ulcer |
| 2.16.840.1.113762.1.4.1222.529 | Charcot Foot |
| 2.16.840.1.113762.1.4.1222.53 | Anemia Conditions |
| 2.16.840.1.113762.1.4.1222.531 | Charcot Foot |
| 2.16.840.1.113762.1.4.1222.533 | Cellulitis |
| 2.16.840.1.113762.1.4.1222.535 | Diabetic Hand or Diabetic Cheiroarthropathy |
| 2.16.840.1.113762.1.4.1222.539 | Necrobiosis Lipoidica (Skin Lesions) |
| 2.16.840.1.113762.1.4.1222.540 | Necrobiosis Lipoidica (Skin Lesions) |
| 2.16.840.1.113762.1.4.1222.542 | Gangrene |
| 2.16.840.1.113762.1.4.1222.543 | Gangrene |
| 2.16.840.1.113762.1.4.1222.545 | Dupuytren's Contracture |
| 2.16.840.1.113762.1.4.1222.546 | Dupuytren's Contracture |
| 2.16.840.1.113762.1.4.1222.548 | Scleroderma or Thick Skin Syndrome |
| 2.16.840.1.113762.1.4.1222.549 | Scleroderma or Thick Skin Syndrome |
| 2.16.840.1.113762.1.4.1222.555 | Acanthosis Nigricans |
| 2.16.840.1.113762.1.4.1222.556 | Acanthosis Nigricans |
| 2.16.840.1.113762.1.4.1222.557 | Eruptive Xanthomatosis |
| 2.16.840.1.113762.1.4.1222.559 | Periodontitis |
| 2.16.840.1.113762.1.4.1222.560 | Periodontitis |
| 2.16.840.1.113762.1.4.1222.562 | Amputated Limb (Not Traumatic) |
| 2.16.840.1.113762.1.4.1222.563 | Amputated Limb (Not Traumatic) |
| 2.16.840.1.113762.1.4.1222.565 | Hypertension, Essential or Primary SCT |
| 2.16.840.1.113762.1.4.1222.568 | Hypertension, Secondary SCT |
| 2.16.840.1.113762.1.4.1222.571 | Hypertension Stage |
| 2.16.840.1.113762.1.4.1222.579 | Cardiomyopathy |
| 2.16.840.1.113762.1.4.1222.58 | Hypercalcemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications |
| 2.16.840.1.113762.1.4.1222.581 | American Heart Association Heart Failure Stage |
| 2.16.840.1.113762.1.4.1222.584 | Atherosclerotic Cardiovascular Disease |
| 2.16.840.1.113762.1.4.1222.586 | Gout |
| 2.16.840.1.113762.1.4.1222.587 | Psoriatic Arthritis |
| 2.16.840.1.113762.1.4.1222.588 | Reactive Arthritis |
| 2.16.840.1.113762.1.4.1222.591 | Cannabis Use |
| 2.16.840.1.113762.1.4.1222.592 | Hearing Impairment |
| 2.16.840.1.113762.1.4.1222.6 | Chronic Kidney Disease Type or Cause |
| 2.16.840.1.113762.1.4.1222.60 | Hypercalcemia Conditions |
| 2.16.840.1.113762.1.4.1222.607 | Angina |
| 2.16.840.1.113762.1.4.1222.608 | Angina |
| 2.16.840.1.113762.1.4.1222.61 | Hypocalcemia Conditions |
| 2.16.840.1.113762.1.4.1222.610 | Unstable Angina |
| 2.16.840.1.113762.1.4.1222.611 | Unstable Angina |
| 2.16.840.1.113762.1.4.1222.613 | Ischemic Heart Disease |
| 2.16.840.1.113762.1.4.1222.614 | Ischemic Heart Disease |
| 2.16.840.1.113762.1.4.1222.615 | Left Ventricular Hypertrophy SCT |
| 2.16.840.1.113762.1.4.1222.618 | Stroke |
| 2.16.840.1.113762.1.4.1222.620 | Transient Ischemic Attack |
| 2.16.840.1.113762.1.4.1222.621 | Transient Ischemic Attack |
| 2.16.840.1.113762.1.4.1222.626 | Aneurysm |
| 2.16.840.1.113762.1.4.1222.627 | Aneurysm |
| 2.16.840.1.113762.1.4.1222.63 | Hypocalcemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.635 | Aortic Disease |
| 2.16.840.1.113762.1.4.1222.636 | Aortic Disease |
| 2.16.840.1.113762.1.4.1222.638 | Carotid Stenosis |
| 2.16.840.1.113762.1.4.1222.639 | Carotid Stenosis |
| 2.16.840.1.113762.1.4.1222.64 | Hyperphosphatemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.641 | Intracranial Stenosis |
| 2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis |
| 2.16.840.1.113762.1.4.1222.644 | Pulmonary Edema |
| 2.16.840.1.113762.1.4.1222.645 | Pulmonary Edema |
| 2.16.840.1.113762.1.4.1222.647 | Osteoarthritis (Oa) |
| 2.16.840.1.113762.1.4.1222.648 | Osteoarthritis (Oa) |
| 2.16.840.1.113762.1.4.1222.650 | Rheumatoid Arthritis (Ra) |
| 2.16.840.1.113762.1.4.1222.651 | Rheumatoid Arthritis (Ra) |
| 2.16.840.1.113762.1.4.1222.653 | Infectious Arthritis |
| 2.16.840.1.113762.1.4.1222.654 | Infectious Arthritis |
| 2.16.840.1.113762.1.4.1222.656 | Temporomandibular Disorder Diagnosis |
| 2.16.840.1.113762.1.4.1222.659 | Irritable Bowel Syndrome |
| 2.16.840.1.113762.1.4.1222.66 | Hyperphosphatemia Conditions |
| 2.16.840.1.113762.1.4.1222.660 | Irritable Bowel Syndrome |
| 2.16.840.1.113762.1.4.1222.662 | Neuropathic Pain (Neuralgia) |
| 2.16.840.1.113762.1.4.1222.663 | Neuropathic Pain (Neuralgia) |
| 2.16.840.1.113762.1.4.1222.665 | Neuromas |
| 2.16.840.1.113762.1.4.1222.666 | Neuromas |
| 2.16.840.1.113762.1.4.1222.668 | Phantom Pain |
| 2.16.840.1.113762.1.4.1222.669 | Phantom Pain |
| 2.16.840.1.113762.1.4.1222.67 | Hematuria Conditions |
| 2.16.840.1.113762.1.4.1222.671 | Entrapment Neuropathy |
| 2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy |
| 2.16.840.1.113762.1.4.1222.674 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| 2.16.840.1.113762.1.4.1222.675 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| 2.16.840.1.113762.1.4.1222.677 | Psychotic Depression |
| 2.16.840.1.113762.1.4.1222.678 | Psychotic Depression |
| 2.16.840.1.113762.1.4.1222.680 | Post Partum Depression |
| 2.16.840.1.113762.1.4.1222.681 | Post Partum Depression |
| 2.16.840.1.113762.1.4.1222.683 | Seasonal Affective Disorder |
| 2.16.840.1.113762.1.4.1222.684 | Seasonal Affective Disorder |
| 2.16.840.1.113762.1.4.1222.686 | Psychological Trauma |
| 2.16.840.1.113762.1.4.1222.687 | Psychological Trauma |
| 2.16.840.1.113762.1.4.1222.689 | Grief or Loss |
| 2.16.840.1.113762.1.4.1222.69 | Hematuria Conditions SCT |
| 2.16.840.1.113762.1.4.1222.690 | Grief or Loss |
| 2.16.840.1.113762.1.4.1222.692 | Suicide Risk |
| 2.16.840.1.113762.1.4.1222.693 | Suicide Risk |
| 2.16.840.1.113762.1.4.1222.695 | Vaping |
| 2.16.840.1.113762.1.4.1222.696 | Vaping |
| 2.16.840.1.113762.1.4.1222.699 | Tobacco Use or Exposure |
| 2.16.840.1.113762.1.4.1222.70 | Metabolic Acidosis Conditions |
| 2.16.840.1.113762.1.4.1222.701 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.702 | Binge Drinking |
| 2.16.840.1.113762.1.4.1222.705 | Drug Misuse |
| 2.16.840.1.113762.1.4.1222.707 | Drug Misuse |
| 2.16.840.1.113762.1.4.1222.709 | Sensory Status |
| 2.16.840.1.113762.1.4.1222.714 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| 2.16.840.1.113762.1.4.1222.715 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| 2.16.840.1.113762.1.4.1222.717 | Urinary Incontinence |
| 2.16.840.1.113762.1.4.1222.718 | Urinary Incontinence |
| 2.16.840.1.113762.1.4.1222.72 | Metabolic Acidosis Conditions SCT |
| 2.16.840.1.113762.1.4.1222.720 | Urinary Urgency |
| 2.16.840.1.113762.1.4.1222.721 | Urinary Urgency |
| 2.16.840.1.113762.1.4.1222.723 | Urinary Frequency |
| 2.16.840.1.113762.1.4.1222.724 | Urinary Frequency |
| 2.16.840.1.113762.1.4.1222.726 | Nocturia |
| 2.16.840.1.113762.1.4.1222.727 | Nocturia |
| 2.16.840.1.113762.1.4.1222.729 | Pelvic Organ Prolapse |
| 2.16.840.1.113762.1.4.1222.73 | Hyperlipidemia Conditions |
| 2.16.840.1.113762.1.4.1222.730 | Pelvic Organ Prolapse |
| 2.16.840.1.113762.1.4.1222.732 | Erectile Dysfunction |
| 2.16.840.1.113762.1.4.1222.733 | Erectile Dysfunction |
| 2.16.840.1.113762.1.4.1222.735 | Interstitial Cystitis or Bladder Pain Syndrome |
| 2.16.840.1.113762.1.4.1222.736 | Interstitial Cystitis or Bladder Pain Syndrome |
| 2.16.840.1.113762.1.4.1222.738 | Recurrent Urinary Tract Infections |
| 2.16.840.1.113762.1.4.1222.739 | Recurrent Urinary Tract Infections |
| 2.16.840.1.113762.1.4.1222.741 | Hypertriglyceridemia |
| 2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia |
| 2.16.840.1.113762.1.4.1222.744 | Hypothyroidism |
| 2.16.840.1.113762.1.4.1222.745 | Hypothyroidism |
| 2.16.840.1.113762.1.4.1222.747 | Menopause |
| 2.16.840.1.113762.1.4.1222.748 | Menopause |
| 2.16.840.1.113762.1.4.1222.75 | Hyperlipidemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.750 | Testicular Hypofunction |
| 2.16.840.1.113762.1.4.1222.751 | Testicular Hypofunction |
| 2.16.840.1.113762.1.4.1222.753 | Primary Aldosteronism |
| 2.16.840.1.113762.1.4.1222.754 | Primary Aldosteronism |
| 2.16.840.1.113762.1.4.1222.756 | Restless Leg Syndrome |
| 2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome |
| 2.16.840.1.113762.1.4.1222.76 | Chronic Pain Conditions |
| 2.16.840.1.113762.1.4.1222.760 | Claudication |
| 2.16.840.1.113762.1.4.1222.761 | Claudication |
| 2.16.840.1.113762.1.4.1222.762 | Angioedema |
| 2.16.840.1.113762.1.4.1222.764 | Angioedema |
| 2.16.840.1.113762.1.4.1222.769 | Nonalcoholic Fatty Liver Disease |
| 2.16.840.1.113762.1.4.1222.770 | Nonalcoholic Fatty Liver Disease |
| 2.16.840.1.113762.1.4.1222.772 | Thalassemia |
| 2.16.840.1.113762.1.4.1222.773 | Thalassemia |
| 2.16.840.1.113762.1.4.1222.78 | Chronic Pain SCT |
| 2.16.840.1.113762.1.4.1222.79 | Arthritis Disorders SCT |
| 2.16.840.1.113762.1.4.1222.800 | Temporomandibular Disorder Diagnosis |
| 2.16.840.1.113762.1.4.1222.81 | Arthritis Disorders |
| 2.16.840.1.113762.1.4.1222.82 | Preeclampsia Disorders SCT |
| 2.16.840.1.113762.1.4.1222.84 | Preeclampsia Disorders |
| 2.16.840.1.113762.1.4.1222.840 | Spinal Cord Compression |
| 2.16.840.1.113762.1.4.1222.841 | Spinal Cord Compression |
| 2.16.840.1.113762.1.4.1222.843 | Alcohol Use (Revised 2021) |
| 2.16.840.1.113762.1.4.1222.845 | Alcohol Use |
| 2.16.840.1.113762.1.4.1222.85 | Hyperuricemia Conditions |
| 2.16.840.1.113762.1.4.1222.87 | Hyperuricemia Conditions SCT |
| 2.16.840.1.113762.1.4.1222.88 | Vitamin D Deficiency Conditions SCT |
| 2.16.840.1.113762.1.4.1222.90 | Vitamin D Deficiency Conditions |
| 2.16.840.1.113762.1.4.1222.91 | Alkaline Phosphatase Deficiency Conditions SCT |
| 2.16.840.1.113762.1.4.1222.93 | Alkaline Phosphatase Deficiency Conditions |
| 2.16.840.1.113762.1.4.1222.95 | Uremic Pruritus Conditions SCT |
| 2.16.840.1.113762.1.4.1222.96 | Uremic Pruritus Conditions |
| 2.16.840.1.113762.1.4.1222.97 | Insomnia Disorders |
| 2.16.840.1.113762.1.4.1222.99 | Insomnia Disorders SCT |
| 2.16.840.1.113762.1.4.1225.5 | Glaucoma SNOMED |
| 2.16.840.1.113762.1.4.1226.1 | Scleritis |
| 2.16.840.1.113762.1.4.1226.3 | Scleritis |
| 2.16.840.1.113762.1.4.1228.6 | Outpatient Encounter Locations |
| 2.16.840.1.113762.1.4.1234.60 | Guillain Barre Syndrome, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.61 | Febrile seizure, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.62 | Encephalomyelitis and encephalitis, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.63 | Disseminated Intravascular Coagulation, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.64 | Deep Vein Thrombosis, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.65 | Bells Palsy, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.66 | Appendicitis, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.67 | Anaphylaxis, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.68 | Acute Myocardial Infarction, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.69 | Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.7 | Anaphylaxis, SNOMED codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.70 | Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting |
| 2.16.840.1.113762.1.4.1234.8 | Appendicitis, SNOMED codes for AE reporting |
| 2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition |
| 2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.173 | Systolic Blood Pressure_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.18 | Annual Physical SNOMED CN5 |
| 2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD |
| 2.16.840.1.113762.1.4.1235.184 | Acute Inpatient_CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.188 | ED Visit_CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.191 | Pregnancy_CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED |
| 2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 |
| 2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED |
| 2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping |
| 2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED |
| 2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED |
| 2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.298 | FIT DNA_SNOMED |
| 2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED |
| 2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED |
| 2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping |
| 2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED |
| 2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping |
| 2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.321 | Absence of Cervix Diagnosis_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.322 | Absence of Cervix Diagnosis_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping |
| 2.16.840.1.113762.1.4.1235.340 | AFib (Atrial Fibrillation)_SNOMED |
| 2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED |
| 2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.360 | Allergy List_SNOMED |
| 2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED |
| 2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping |
| 2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED |
| 2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping |
| 2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED |
| 2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping |
| 2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED |
| 2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping |
| 2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED |
| 2.16.840.1.113762.1.4.1235.378 | IVF_Grouping |
| 2.16.840.1.113762.1.4.1235.382 | Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.384 | Family History Hypertension (HTN)_SNOMED |
| 2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED |
| 2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.409 | Birth Event_SNOMED |
| 2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED |
| 2.16.840.1.113762.1.4.1235.429 | Vitals Body Height SnoMed |
| 2.16.840.1.113762.1.4.1235.430 | Vitals Body Height |
| 2.16.840.1.113762.1.4.1235.434 | Anxiety_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED |
| 2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED |
| 2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.499 | Active Pregnancy_SNOMED |
| 2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED |
| 2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.504 | Prediabetes_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED |
| 2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED |
| 2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED |
| 2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED |
| 2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED |
| 2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED |
| 2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED |
| 2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.524 | UTI_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED |
| 2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED |
| 2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED |
| 2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event |
| 2.16.840.1.113762.1.4.1235.548 | Depression_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.557 | CABG_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.566 | Essential HTN_HD_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition |
| 2.16.840.1.113762.1.4.1235.587 | COPD_Clinical_Grouping_Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED |
| 2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping |
| 2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED |
| 2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping |
| 2.16.840.1.113762.1.4.1235.598 | Allergy Iodine_SNOMED |
| 2.16.840.1.113762.1.4.1235.599 | Allergy to contrast_SNOMED |
| 2.16.840.1.113762.1.4.1235.601 | Allergy to contrast_Grouping |
| 2.16.840.1.113762.1.4.1235.602 | Contrast induced nephropathy_SNOMED |
| 2.16.840.1.113762.1.4.1235.604 | Contrast induced nephropathy_Grouping |
| 2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant |
| 2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED |
| 2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED |
| 2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED |
| 2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI |
| 2.16.840.1.113762.1.4.1235.618 | b.well Herpes Zoster Vaccine CN_HD |
| 2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED |
| 2.16.840.1.113762.1.4.1235.622 | b.well Herpes Zoster Vaccine CN_HD_2dose |
| 2.16.840.1.113762.1.4.1235.625 | b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED |
| 2.16.840.1.113762.1.4.1235.626 | b.well Herpes Zoster Vaccine CN_HD_Exclusions |
| 2.16.840.1.113762.1.4.1235.627 | b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED |
| 2.16.840.1.113762.1.4.1235.631 | b.well Adult RSV Vaccine CN_SNOMED |
| 2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED |
| 2.16.840.1.113762.1.4.1235.637 | LP(a) Test |
| 2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN |
| 2.16.840.1.113762.1.4.1235.639 | BWellAdultTetanusVaccineCN_SNOMED |
| 2.16.840.1.113762.1.4.1235.642 | b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED |
| 2.16.840.1.113762.1.4.1235.643 | b.well Adult Tetanus Vaccine CN_Exclusions |
| 2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy |
| 2.16.840.1.113762.1.4.1235.646 | bwell COVID Vaccine CN_Allergy |
| 2.16.840.1.113762.1.4.1235.647 | bwell Covid Vaccine CN_Allergy_SNOMED |
| 2.16.840.1.113762.1.4.1235.93 | Cardiomyopathy Dilated SNOMED |
| 2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition |
| 2.16.840.1.113762.1.4.1235.98 | Cardiomyopathy Hypertrophic SNOMED |
| 2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue |
| 2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List |
| 2.16.840.1.113762.1.4.1237.2 | SNOMED Organisms |
| 2.16.840.1.113762.1.4.1240.1 | Mental Status Observation |
| 2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason |
| 2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation |
| 2.16.840.1.113762.1.4.1240.3 | Sex |
| 2.16.840.1.113762.1.4.1240.8 | Medication Adherence |
| 2.16.840.1.113762.1.4.1242.2 | Sickle Cell Disease |
| 2.16.840.1.113762.1.4.1242.4 | Depression |
| 2.16.840.1.113762.1.4.1247.1 | Food Insecurity Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals |
| 2.16.840.1.113762.1.4.1247.101 | Less Than High School Education Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.103 | Less Than High School Education Diagnoses |
| 2.16.840.1.113762.1.4.1247.106 | Transportation Insecurity Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.107 | Financial Insecurity Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.108 | Financial Insecurity Diagnoses |
| 2.16.840.1.113762.1.4.1247.109 | Financial Insecurity Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests |
| 2.16.840.1.113762.1.4.1247.110 | Medical Cost Burden Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.111 | Health Insurance Coverage Status Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.112 | Health Literacy Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.114 | Health Literacy Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.115 | Health Literacy Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.116 | Health Literacy Diagnoses |
| 2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals |
| 2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures |
| 2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests |
| 2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals |
| 2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals |
| 2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures |
| 2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests |
| 2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests |
| 2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures |
| 2.16.840.1.113762.1.4.1247.137 | Cognitive disorder Diagnosis |
| 2.16.840.1.113762.1.4.1247.14 | Homelessness Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.145 | Less Than High School Education Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.148 | Health Insurance Coverage Status Diagnoses |
| 2.16.840.1.113762.1.4.1247.149 | Health Insurance Coverage Status Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.150 | Material Hardship Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.152 | Medical Cost Burden Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.153 | Medical Cost Burden Diagnoses |
| 2.16.840.1.113762.1.4.1247.154 | Medical Cost Burden Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.158 | Homelessness Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.159 | Homelessness Goals |
| 2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals |
| 2.16.840.1.113762.1.4.1247.160 | Housing Instability Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals |
| 2.16.840.1.113762.1.4.1247.162 | Transportation Insecurity Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals |
| 2.16.840.1.113762.1.4.1247.164 | Veteran Status Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.17 | Food Insecurity Diagnoses |
| 2.16.840.1.113762.1.4.1247.18 | Homelessness Diagnoses |
| 2.16.840.1.113762.1.4.1247.19 | Homelessness Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures |
| 2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests |
| 2.16.840.1.113762.1.4.1247.213 | Health Insurance Coverage Status Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals |
| 2.16.840.1.113762.1.4.1247.215 | Veteran Status Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.217 | Digital Literacy Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.219 | Digital Literacy Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.22 | Housing Instability Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.220 | Digital Literacy Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.224 | Digital Literacy Diagnoses |
| 2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals |
| 2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures |
| 2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests |
| 2.16.840.1.113762.1.4.1247.229 | Digital Access Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.231 | Digital Access Diagnoses |
| 2.16.840.1.113762.1.4.1247.232 | Digital Access Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.233 | Digital Access Goals |
| 2.16.840.1.113762.1.4.1247.234 | Digital Access Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures |
| 2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests |
| 2.16.840.1.113762.1.4.1247.24 | Housing Instability Diagnoses |
| 2.16.840.1.113762.1.4.1247.241 | Utility Insecurity Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.243 | Utility Insecurity Diagnoses |
| 2.16.840.1.113762.1.4.1247.244 | Utility Insecurity Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals |
| 2.16.840.1.113762.1.4.1247.246 | Utility Insecurity Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures |
| 2.16.840.1.113762.1.4.1247.25 | Transportation Insecurity Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests |
| 2.16.840.1.113762.1.4.1247.255 | Incarceration Status Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.256 | Incarceration Status Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals |
| 2.16.840.1.113762.1.4.1247.258 | Incarceration Status Diagnoses |
| 2.16.840.1.113762.1.4.1247.259 | Incarceration Status Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.26 | Transportation Insecurity Diagnoses |
| 2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures |
| 2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests |
| 2.16.840.1.113762.1.4.1247.262 | Language Access Diagnoses |
| 2.16.840.1.113762.1.4.1247.264 | Language Access Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.265 | Language Access Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.266 | Language Access Goals |
| 2.16.840.1.113762.1.4.1247.267 | Language Access Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.268 | Language Access Procedures |
| 2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests |
| 2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures |
| 2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests |
| 2.16.840.1.113762.1.4.1247.29 | Financial Insecurity Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals |
| 2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests |
| 2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures |
| 2.16.840.1.113762.1.4.1247.34 | Material Hardship Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.35 | Material Hardship Diagnoses |
| 2.16.840.1.113762.1.4.1247.36 | Material Hardship Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.37 | Material Hardship Goals |
| 2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests |
| 2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures |
| 2.16.840.1.113762.1.4.1247.4 | Food Insecurity Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.41 | Unemployment Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.42 | Unemployment Diagnoses |
| 2.16.840.1.113762.1.4.1247.43 | Housing Instability Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures |
| 2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests |
| 2.16.840.1.113762.1.4.1247.46 | Inadequate Housing Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.48 | Inadequate Housing Diagnoses |
| 2.16.840.1.113762.1.4.1247.49 | Inadequate Housing Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.5 | Social Determinants of Health General Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals |
| 2.16.840.1.113762.1.4.1247.51 | Inadequate Housing Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures |
| 2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests |
| 2.16.840.1.113762.1.4.1247.54 | Less Than High School Education Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.55 | Less Than High School Education Goals |
| 2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures |
| 2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests |
| 2.16.840.1.113762.1.4.1247.58 | Unemployment Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures |
| 2.16.840.1.113762.1.4.1247.6 | Food Insecurity Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests |
| 2.16.840.1.113762.1.4.1247.62 | Elder Abuse Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.63 | Elder Abuse Diagnoses |
| 2.16.840.1.113762.1.4.1247.64 | Elder Abuse Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals |
| 2.16.840.1.113762.1.4.1247.66 | Elder Abuse Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures |
| 2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests |
| 2.16.840.1.113762.1.4.1247.69 | Unemployment Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures |
| 2.16.840.1.113762.1.4.1247.70 | Unemployment Goals |
| 2.16.840.1.113762.1.4.1247.71 | Social Determinants of Health Goals |
| 2.16.840.1.113762.1.4.1247.72 | Stress Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.73 | Stress Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.75 | Stress Diagnoses |
| 2.16.840.1.113762.1.4.1247.76 | Veteran Status Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.78 | Veteran Status Diagnoses |
| 2.16.840.1.113762.1.4.1247.79 | Social Connection Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.81 | Social Connection Diagnoses |
| 2.16.840.1.113762.1.4.1247.82 | Intimate Partner Violence Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1247.84 | Intimate Partner Violence Diagnoses |
| 2.16.840.1.113762.1.4.1247.85 | Stress Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.86 | Stress Goals |
| 2.16.840.1.113762.1.4.1247.87 | Stress Procedures |
| 2.16.840.1.113762.1.4.1247.88 | Social Connection Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1247.89 | Social Connection Goals |
| 2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures |
| 2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests |
| 2.16.840.1.113762.1.4.1247.92 | Stress Service Requests |
| 2.16.840.1.113762.1.4.1247.93 | Social Connection Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures |
| 2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests |
| 2.16.840.1.113762.1.4.1247.96 | Intimate Partner Violence Interventions SNOMED CT |
| 2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures |
| 2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests |
| 2.16.840.1.113762.1.4.1247.99 | Intimate Partner Violence Goals SNOMED CT |
| 2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation |
| 2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation |
| 2.16.840.1.113762.1.4.1248.138 | COVID19 |
| 2.16.840.1.113762.1.4.1248.140 | COVID 19 |
| 2.16.840.1.113762.1.4.1248.178 | Intubation |
| 2.16.840.1.113762.1.4.1248.179 | Intubation |
| 2.16.840.1.113762.1.4.1248.180 | Tracheostomy Procedures |
| 2.16.840.1.113762.1.4.1248.181 | Tracheostomy Procedures |
| 2.16.840.1.113762.1.4.1248.182 | Head and Neck Surgeries with High Risk Airway Compromise |
| 2.16.840.1.113762.1.4.1248.187 | Routes of Administration for Opioid Antagonists |
| 2.16.840.1.113762.1.4.1248.19 | High Risk Procedures for AKI |
| 2.16.840.1.113762.1.4.1248.197 | Hospital Based Dialysis Services |
| 2.16.840.1.113762.1.4.1248.199 | Hospital Based Dialysis Services |
| 2.16.840.1.113762.1.4.1248.200 | Nephrectomy |
| 2.16.840.1.113762.1.4.1248.207 | General and Neuraxial Anesthesia |
| 2.16.840.1.113762.1.4.1248.208 | General and Neuraxial Anesthesia |
| 2.16.840.1.113762.1.4.1248.209 | Non Invasive Oxygen Therapy by Nasal Cannula or Mask |
| 2.16.840.1.113762.1.4.1248.211 | Continuous and Bilevel Positive Airway Pressure |
| 2.16.840.1.113762.1.4.1248.213 | Non Invasive Oxygen Therapy |
| 2.16.840.1.113762.1.4.1248.214 | Non Invasive Oxygen Therapy Devices |
| 2.16.840.1.113762.1.4.1248.217 | ASA physical status class |
| 2.16.840.1.113762.1.4.1248.220 | Smoking status |
| 2.16.840.1.113762.1.4.1248.238 | Neuromuscular Disorder |
| 2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder |
| 2.16.840.1.113762.1.4.1248.240 | Degenerative Neurological Disorder |
| 2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder |
| 2.16.840.1.113762.1.4.1248.243 | Heart and Lung Transplants |
| 2.16.840.1.113762.1.4.1248.246 | Lung Resections and Excisions |
| 2.16.840.1.113762.1.4.1248.248 | Chest Wall Procedures |
| 2.16.840.1.113762.1.4.1248.250 | Maxillary Procedures |
| 2.16.840.1.113762.1.4.1248.251 | Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise |
| 2.16.840.1.113762.1.4.1248.253 | Anesthesia Requiring Monitored Care |
| 2.16.840.1.113762.1.4.1248.255 | Anesthesia Requiring Monitored Care |
| 2.16.840.1.113762.1.4.1248.271 | Undetectable Lab Result Value |
| 2.16.840.1.113762.1.4.1248.272 | Undetectable Lab Result Value |
| 2.16.840.1.113762.1.4.1248.275 | Bariatric Procedures |
| 2.16.840.1.113762.1.4.1248.33 | Obstetrics and VTE Obstetrics |
| 2.16.840.1.113762.1.4.1248.350 | Tuberculosis for Urology Care |
| 2.16.840.1.113762.1.4.1248.351 | Tuberculosis for Urology Care |
| 2.16.840.1.113762.1.4.1248.357 | Cystectomy for Urology Care |
| 2.16.840.1.113762.1.4.1248.358 | Cystectomy for Urology Care |
| 2.16.840.1.113762.1.4.1248.362 | Immunocompromised Conditions |
| 2.16.840.1.113762.1.4.1248.363 | Immunocompromised Conditions |
| 2.16.840.1.113762.1.4.1248.365 | Mixed Histology Urothelial Cell Carcinoma for Urology Care |
| 2.16.840.1.113762.1.4.1248.367 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1248.368 | Morbid Obesity |
| 2.16.840.1.113762.1.4.1248.369 | Unavailability of Bacillus Calmette Guerin for Urology Care |
| 2.16.840.1.113762.1.4.1248.371 | Urinary Retention |
| 2.16.840.1.113762.1.4.1248.372 | Urinary Retention |
| 2.16.840.1.113762.1.4.1248.374 | Face to Face Interaction |
| 2.16.840.1.113762.1.4.1248.375 | Face to Face Interaction |
| 2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation |
| 2.16.840.1.113762.1.4.1248.85 | Elective Inpatient Encounter |
| 2.16.840.1.113762.1.4.1251.10 | Tricuspid Valve Regurgitation |
| 2.16.840.1.113762.1.4.1251.12 | Hypertension |
| 2.16.840.1.113762.1.4.1251.2 | Valvular Heart Disease |
| 2.16.840.1.113762.1.4.1251.22 | Acute Kidney Injury |
| 2.16.840.1.113762.1.4.1251.23 | Anemia |
| 2.16.840.1.113762.1.4.1251.24 | Cardiac Arrhythmias |
| 2.16.840.1.113762.1.4.1251.25 | Attention Deficit and Hyperactivity Disorder |
| 2.16.840.1.113762.1.4.1251.26 | Cerebrovascular Disease |
| 2.16.840.1.113762.1.4.1251.27 | Seizure Disorder |
| 2.16.840.1.113762.1.4.1251.28 | Proteinuria |
| 2.16.840.1.113762.1.4.1251.29 | Thyroid Hormone Disorder |
| 2.16.840.1.113762.1.4.1251.30 | Thromboembolic Disease |
| 2.16.840.1.113762.1.4.1251.31 | Parkinson's Disease and Parkinsonism |
| 2.16.840.1.113762.1.4.1251.32 | Upper GI Diseases |
| 2.16.840.1.113762.1.4.1251.33 | Failure to Thrive |
| 2.16.840.1.113762.1.4.1251.34 | Osteoporosis |
| 2.16.840.1.113762.1.4.1251.35 | Mood Disorders |
| 2.16.840.1.113762.1.4.1251.36 | Dyslipidemia |
| 2.16.840.1.113762.1.4.1251.37 | Heart Failure |
| 2.16.840.1.113762.1.4.1251.38 | Coronary Artery Disease |
| 2.16.840.1.113762.1.4.1251.39 | Chronic Kidney Disease |
| 2.16.840.1.113762.1.4.1251.40 | Chronic Obstructive Pulmonary Disease |
| 2.16.840.1.113762.1.4.1251.41 | Diabetes Mellitus |
| 2.16.840.1.113762.1.4.1260.100 | MMR Proficient |
| 2.16.840.1.113762.1.4.1260.102 | Face To Face Interaction |
| 2.16.840.1.113762.1.4.1260.112 | Urothelial Cancer Histologies |
| 2.16.840.1.113762.1.4.1260.113 | Malignant Tumor Behavior |
| 2.16.840.1.113762.1.4.1260.114 | Localized Bladder Cancer Stage SNOMED |
| 2.16.840.1.113762.1.4.1260.116 | Localized Bladder Cancer Staging |
| 2.16.840.1.113762.1.4.1260.117 | Advanced Bladder Cancer Stage |
| 2.16.840.1.113762.1.4.1260.118 | Localized Bladder Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.119 | Localized Bladder Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.120 | Localized Bladder Cancer N Stage |
| 2.16.840.1.113762.1.4.1260.121 | Localized Bladder Cancer M Stage |
| 2.16.840.1.113762.1.4.1260.122 | Advanced Bladder Cancer M Stage |
| 2.16.840.1.113762.1.4.1260.126 | Locoregional Urothelial Cancer SNOMED |
| 2.16.840.1.113762.1.4.1260.127 | Locoregional Urothelial Cancer |
| 2.16.840.1.113762.1.4.1260.129 | FGFR3 Gene Interpretation Positive SNOMED |
| 2.16.840.1.113762.1.4.1260.13 | HER2 Negative |
| 2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.134 | FGFR3 Gene Interpretation Negative SNOMED |
| 2.16.840.1.113762.1.4.1260.137 | FGFR3 Gene Interpretation Negative |
| 2.16.840.1.113762.1.4.1260.139 | Tumor Behavior |
| 2.16.840.1.113762.1.4.1260.140 | Physcological Support for Cancer |
| 2.16.840.1.113762.1.4.1260.141 | Referral For Pain From Cancer |
| 2.16.840.1.113762.1.4.1260.142 | Cancer Pain Education |
| 2.16.840.1.113762.1.4.1260.143 | Telehealth Encounters |
| 2.16.840.1.113762.1.4.1260.144 | Pain Assessment Score |
| 2.16.840.1.113762.1.4.1260.146 | Telehealth Encounters SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.149 | Telehealth Encounters All |
| 2.16.840.1.113762.1.4.1260.150 | Chemo Admin SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.153 | Chemotherapy Administration All |
| 2.16.840.1.113762.1.4.1260.156 | Radiation Treatment SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.157 | Radiation Treatment All |
| 2.16.840.1.113762.1.4.1260.159 | Telephone Visits SNOMED |
| 2.16.840.1.113762.1.4.1260.161 | Telephone Visits All |
| 2.16.840.1.113762.1.4.1260.165 | Referral for Depression Adult |
| 2.16.840.1.113762.1.4.1260.166 | Referrals for Adolescent Depression |
| 2.16.840.1.113762.1.4.1260.167 | Follow Ups for Adolescent Depression |
| 2.16.840.1.113762.1.4.1260.168 | FollowUps for Adult Depression |
| 2.16.840.1.113762.1.4.1260.169 | Depression Screen Declined for Medical Reason |
| 2.16.840.1.113762.1.4.1260.17 | Metastatic Breast Cancer |
| 2.16.840.1.113762.1.4.1260.170 | Physical Therapy Evaluations SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.172 | Physical Therapies Evaluations |
| 2.16.840.1.113762.1.4.1260.18 | Stage IA |
| 2.16.840.1.113762.1.4.1260.183 | Locally Advanced NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.185 | Localized NSCLC Stage Group SNOMED |
| 2.16.840.1.113762.1.4.1260.187 | Plan of Care |
| 2.16.840.1.113762.1.4.1260.188 | Documentation of Plan of Care |
| 2.16.840.1.113762.1.4.1260.189 | Pain Present |
| 2.16.840.1.113762.1.4.1260.19 | Stage IB |
| 2.16.840.1.113762.1.4.1260.192 | Localized NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.193 | Advanced NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.194 | NSCLC M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.195 | NSCLC T Stage |
| 2.16.840.1.113762.1.4.1260.196 | NSCLC N Stage |
| 2.16.840.1.113762.1.4.1260.197 | SCLC and rarer lung cancer histology |
| 2.16.840.1.113762.1.4.1260.199 | EGFR Gene Interpretation Positive SNOMED |
| 2.16.840.1.113762.1.4.1260.20 | Stage IIA |
| 2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive |
| 2.16.840.1.113762.1.4.1260.204 | EGFR Generic Molecular Variant SNOMED |
| 2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM |
| 2.16.840.1.113762.1.4.1260.209 | Radiation Treatment Management SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.21 | Stage IIB |
| 2.16.840.1.113762.1.4.1260.210 | Radiation Treatment Management Codes |
| 2.16.840.1.113762.1.4.1260.215 | Radiation Treatment Delivery SNOMED |
| 2.16.840.1.113762.1.4.1260.216 | Radiation Treatment Delivery |
| 2.16.840.1.113762.1.4.1260.22 | Stage IIIA |
| 2.16.840.1.113762.1.4.1260.220 | MET Positive gene interpretation |
| 2.16.840.1.113762.1.4.1260.23 | Stage IIIB |
| 2.16.840.1.113762.1.4.1260.236 | ROS1 Negative (geneinterpretation) SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.238 | ROS1 Negative (geneinterpretation) SNOMEDCT,NCI |
| 2.16.840.1.113762.1.4.1260.239 | ROS1 Positive (geneinterpretation) |
| 2.16.840.1.113762.1.4.1260.24 | Stage IIIC |
| 2.16.840.1.113762.1.4.1260.241 | ROS1 Gene Rearrangement |
| 2.16.840.1.113762.1.4.1260.242 | RET Test (HGNC) |
| 2.16.840.1.113762.1.4.1260.243 | RET Positive (Genei interpretation ) |
| 2.16.840.1.113762.1.4.1260.244 | RET Gene Rearrangement |
| 2.16.840.1.113762.1.4.1260.245 | RET Negative (geneinterpretaion) SNOMED |
| 2.16.840.1.113762.1.4.1260.247 | RET Negative (geneinterpretaion) SNOMEDCT,NCI |
| 2.16.840.1.113762.1.4.1260.255 | NSCLC_Tumor_resection SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.257 | NSCLC_Tumor_resection SNOMEDCT CPT |
| 2.16.840.1.113762.1.4.1260.259 | ALK Positive (geneinterpretation) SNOMED |
| 2.16.840.1.113762.1.4.1260.261 | ALK Positive (geneinterpretation) SNOMEDCT NCI |
| 2.16.840.1.113762.1.4.1260.262 | ALK Negative (geneinterpretation) SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.264 | ALK Negative (geneinterpretation) SNOMEDCT NCI |
| 2.16.840.1.113762.1.4.1260.265 | Locoregional Sites |
| 2.16.840.1.113762.1.4.1260.266 | NSCLC N2 Stage |
| 2.16.840.1.113762.1.4.1260.267 | NSCLC N1 Stage |
| 2.16.840.1.113762.1.4.1260.268 | NSCLC N0 Stage |
| 2.16.840.1.113762.1.4.1260.269 | NSCLC T3_T4 Stage |
| 2.16.840.1.113762.1.4.1260.27 | Genetic Test Finding |
| 2.16.840.1.113762.1.4.1260.270 | NSCLC T2 Stage |
| 2.16.840.1.113762.1.4.1260.271 | NSCLC T1 Stage |
| 2.16.840.1.113762.1.4.1260.272 | Locally_Advanced_Metastatic_NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.273 | Localized_Inclusion_NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.274 | Localized_Exclusion_NSCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.276 | Extensive SCLC Stage Group SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.278 | Extensive SCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.279 | Localized SCLC Stage Group |
| 2.16.840.1.113762.1.4.1260.280 | SCLC M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.281 | SCLC T Stage |
| 2.16.840.1.113762.1.4.1260.282 | SCLC N Stage |
| 2.16.840.1.113762.1.4.1260.283 | SCLC histology (to include those patients) |
| 2.16.840.1.113762.1.4.1260.288 | BRAF Positive (geneinterpretation) |
| 2.16.840.1.113762.1.4.1260.294 | Metastatic_Solid_Cancer_Stage Group SNOMED CT |
| 2.16.840.1.113762.1.4.1260.295 | Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT |
| 2.16.840.1.113762.1.4.1260.296 | Localized_Solid_Cancer_Stage Group SNOMED CT |
| 2.16.840.1.113762.1.4.1260.297 | Solid cancer M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.298 | Solid Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.299 | Solid Cancer N Stage |
| 2.16.840.1.113762.1.4.1260.302 | HER2_IHC_Positive |
| 2.16.840.1.113762.1.4.1260.303 | HER2 Negative (geneinterpretation/Labtestvalue) SNOMED |
| 2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) |
| 2.16.840.1.113762.1.4.1260.31 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.313 | Localized_Solid_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.315 | Locally_Advanced_Solid_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.317 | Metastatic_Solid_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.32 | HER2 Positive |
| 2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes |
| 2.16.840.1.113762.1.4.1260.322 | RET test_Solid_cancer (HGNC) |
| 2.16.840.1.113762.1.4.1260.323 | RET Positive_Solid_Cancer (geneinterpretation) |
| 2.16.840.1.113762.1.4.1260.324 | RET Negative_Solid_Cancer (geneinterpretation) |
| 2.16.840.1.113762.1.4.1260.33 | Metastatic Breast Cancer |
| 2.16.840.1.113762.1.4.1260.331 | Metastatic_Breast_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.332 | Locally_Advanced_Breast_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.333 | Localized_Breast_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.334 | Breast cancer M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.335 | Breast Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.336 | Breast Cancer N Stage |
| 2.16.840.1.113762.1.4.1260.337 | Metastatic Sites All Breast SNOMEDCT |
| 2.16.840.1.113762.1.4.1260.340 | Metastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10) |
| 2.16.840.1.113762.1.4.1260.345 | PTEN_geneinterpretation |
| 2.16.840.1.113762.1.4.1260.347 | PI3KCA_geneinterpretation |
| 2.16.840.1.113762.1.4.1260.349 | AKTI_geneinterpretation |
| 2.16.840.1.113762.1.4.1260.35 | All Metastatic Sites |
| 2.16.840.1.113762.1.4.1260.351 | Progesterone_receptor_geneinterpretation |
| 2.16.840.1.113762.1.4.1260.353 | Estrogen_receptor_geneinterpretation |
| 2.16.840.1.113762.1.4.1260.355 | Progesterone_receptor_labinterpretation |
| 2.16.840.1.113762.1.4.1260.357 | Estrogen_receptor_labinterpretation |
| 2.16.840.1.113762.1.4.1260.358 | NSCLC M0 Stage |
| 2.16.840.1.113762.1.4.1260.36 | All Metastatic Sites |
| 2.16.840.1.113762.1.4.1260.362 | HER2_IHC_Negative |
| 2.16.840.1.113762.1.4.1260.368 | HER2_Fish_test_Negative |
| 2.16.840.1.113762.1.4.1260.369 | HER2_IHC_Equivocal |
| 2.16.840.1.113762.1.4.1260.37 | Locoregional Breast Cancer |
| 2.16.840.1.113762.1.4.1260.370 | HER2 Positive_PM_results |
| 2.16.840.1.113762.1.4.1260.375 | Metastatic_Thyroid_Stage Group |
| 2.16.840.1.113762.1.4.1260.377 | RET Gene mutation |
| 2.16.840.1.113762.1.4.1260.378 | Locally_Advanced_Localized_Thyroid_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.379 | Thyroid cancer M1_Stage |
| 2.16.840.1.113762.1.4.1260.380 | Thyroid_cancer_M0_Stage |
| 2.16.840.1.113762.1.4.1260.381 | Thyroid_cancer_T_Stage |
| 2.16.840.1.113762.1.4.1260.382 | Thyroid_cancer_T1_T2_T3_Stage |
| 2.16.840.1.113762.1.4.1260.383 | Thyroid_cancer_T4_Stage |
| 2.16.840.1.113762.1.4.1260.384 | Thyroid_cancer_N1b_Stage&Above |
| 2.16.840.1.113762.1.4.1260.385 | Thyroid_cancer_N_Stage |
| 2.16.840.1.113762.1.4.1260.386 | Medullary_thyroid_histology |
| 2.16.840.1.113762.1.4.1260.388 | RET Positive |
| 2.16.840.1.113762.1.4.1260.389 | NSCLC N3 Stage |
| 2.16.840.1.113762.1.4.1260.393 | Metastatic_CRC_Cancer_Stage Group |
| 2.16.840.1.113762.1.4.1260.394 | Locally_Advanced_Localized_CRC_Stage Group |
| 2.16.840.1.113762.1.4.1260.395 | CRC cancer M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.396 | CRC Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.397 | CRC Cancer N Stage |
| 2.16.840.1.113762.1.4.1260.399 | KRAS_negative |
| 2.16.840.1.113762.1.4.1260.40 | Locoregional Breast Cancer |
| 2.16.840.1.113762.1.4.1260.406 | Locally_Advanced_CRC_Stage Group |
| 2.16.840.1.113762.1.4.1260.407 | Localized_CRC_Stage Group |
| 2.16.840.1.113762.1.4.1260.408 | CRC cancer M0_Stage |
| 2.16.840.1.113762.1.4.1260.409 | CRC_Cancer_T1_Stage |
| 2.16.840.1.113762.1.4.1260.410 | CRC_Cancer_T2_Stage |
| 2.16.840.1.113762.1.4.1260.411 | CRC_Cancer_T3_Stage |
| 2.16.840.1.113762.1.4.1260.412 | CRC_Cancer_T4_Stage |
| 2.16.840.1.113762.1.4.1260.413 | CRC Cancer N1 Stage |
| 2.16.840.1.113762.1.4.1260.414 | CRC Cancer N2 Stage |
| 2.16.840.1.113762.1.4.1260.415 | CRC Cancer N2b Stage |
| 2.16.840.1.113762.1.4.1260.418 | KRAS_positive |
| 2.16.840.1.113762.1.4.1260.428 | Localized_Endometerial_Stage Group SNOMED |
| 2.16.840.1.113762.1.4.1260.431 | Endometrial_Sarcoma_Tumor_Histology_exc |
| 2.16.840.1.113762.1.4.1260.432 | Endometrial cancer M Stage (metastatic) |
| 2.16.840.1.113762.1.4.1260.433 | Endometrial_M0_Stage |
| 2.16.840.1.113762.1.4.1260.449 | Endometrial_ Cancer N Stage |
| 2.16.840.1.113762.1.4.1260.451 | Endometrial_N0_Stage |
| 2.16.840.1.113762.1.4.1260.453 | Endometrial_N1_N2_Stage |
| 2.16.840.1.113762.1.4.1260.455 | Endometrial_T1_T3_Stage |
| 2.16.840.1.113762.1.4.1260.456 | Endometrial_T3_Stage |
| 2.16.840.1.113762.1.4.1260.458 | Endometrial_T4_Stage |
| 2.16.840.1.113762.1.4.1260.459 | Endometrial Cancer T Stage |
| 2.16.840.1.113762.1.4.1260.460 | Localized_Endometerial_Stage Group_SNOMED/NCIM |
| 2.16.840.1.113762.1.4.1260.461 | Metastatic Sites All CRC |
| 2.16.840.1.113762.1.4.1260.464 | Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10) |
| 2.16.840.1.113762.1.4.1260.466 | NTRK_Gene_rearrangment |
| 2.16.840.1.113762.1.4.1260.468 | NTRK_Positive |
| 2.16.840.1.113762.1.4.1260.469 | NTRK_test_gene |
| 2.16.840.1.113762.1.4.1260.50 | MSI High |
| 2.16.840.1.113762.1.4.1260.502 | All Metastatic sites Endometrial SNOMED |
| 2.16.840.1.113762.1.4.1260.505 | All Metastatic sites Endometrial |
| 2.16.840.1.113762.1.4.1260.506 | Create CRC_Cancer_T4a_Stage |
| 2.16.840.1.113762.1.4.1260.507 | Create CRC_Cancer_T4b_Stage |
| 2.16.840.1.113762.1.4.1260.510 | InactiveFollowup |
| 2.16.840.1.113762.1.4.1260.55 | MSI High |
| 2.16.840.1.113762.1.4.1260.56 | Early and Limited Stage |
| 2.16.840.1.113762.1.4.1260.58 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.60 | MMR Deficient |
| 2.16.840.1.113762.1.4.1260.61 | Stage IIB or lower and limited |
| 2.16.840.1.113762.1.4.1260.62 | Stage III or higher |
| 2.16.840.1.113762.1.4.1260.63 | Stage III or higher |
| 2.16.840.1.113762.1.4.1260.65 | Staging Unknown |
| 2.16.840.1.113762.1.4.1260.67 | Staging Unknown |
| 2.16.840.1.113762.1.4.1260.70 | Tumor Histology |
| 2.16.840.1.113762.1.4.1260.78 | Advanced or Unresectable Colorectal Cancer Staging |
| 2.16.840.1.113762.1.4.1260.79 | 0 to IIIB Colorectal Cancer Staging |
| 2.16.840.1.113762.1.4.1260.80 | Colorectal Cancer M1 Stage |
| 2.16.840.1.113762.1.4.1260.83 | RAS Gene Interpretation Negative SNOMED |
| 2.16.840.1.113762.1.4.1260.85 | RAS Gene Negative |
| 2.16.840.1.113762.1.4.1260.86 | RAS Gene Interpretation Positive SNOMED |
| 2.16.840.1.113762.1.4.1260.88 | RAS Gene Positive |
| 2.16.840.1.113762.1.4.1260.90 | Patient Reason |
| 2.16.840.1.113762.1.4.1260.92 | MSI Low SNOMED |
| 2.16.840.1.113762.1.4.1260.95 | MSI Low |
| 2.16.840.1.113762.1.4.1260.97 | MMR Proficient SNOMED |
| 2.16.840.1.113762.1.4.1264.1 | Inpatient Pneumonia Diagnosis |
| 2.16.840.1.113762.1.4.1264.20 | SNOMEDCT Abnormal Finding on Chest Imaging |
| 2.16.840.1.113762.1.4.1264.21 | Abnormal Finding on Chest Imaging |
| 2.16.840.1.113762.1.4.1264.22 | SNOMEDCT Pneumonia Definition |
| 2.16.840.1.113762.1.4.1264.37 | SNOMEDCT Transplant, Stem Cell and Solid |
| 2.16.840.1.113762.1.4.1264.38 | Transplant, Stem Cell and Solid |
| 2.16.840.1.113762.1.4.1264.42 | MRSA Organism or Substance in Lab Results |
| 2.16.840.1.113762.1.4.1267.1 | Problem Type |
| 2.16.840.1.113762.1.4.1267.11 | Information Source for Medication Adherence |
| 2.16.840.1.113762.1.4.1267.15 | Yes or No SCT |
| 2.16.840.1.113762.1.4.1267.16 | Answer Set with Yes No and Unknowns |
| 2.16.840.1.113762.1.4.1267.22 | Route of Administration of Therapeutic Agents |
| 2.16.840.1.113762.1.4.1267.23 | Encounter Type |
| 2.16.840.1.113762.1.4.1267.24 | Specimen Condition SCT |
| 2.16.840.1.113762.1.4.1267.26 | Healthcare Facility type (SCT) |
| 2.16.840.1.113762.1.4.1267.28 | Social History Type |
| 2.16.840.1.113762.1.4.1267.3 | Smoking status comprehensive |
| 2.16.840.1.113762.1.4.1267.31 | Healthcare Service Location Type Combined |
| 2.16.840.1.113762.1.4.1267.5 | Smoking Status Pack Years SCT |
| 2.16.840.1.113762.1.4.1267.6 | Smoking Status Type |
| 2.16.840.1.113762.1.4.1267.9 | Information Source for Medication Adherence SCT |
| 2.16.840.1.113762.1.4.1272.11 | Transplant Diagnoses |
| 2.16.840.1.113762.1.4.1272.14 | Transplant Diagnoses SNOMED CT |
| 2.16.840.1.113762.1.4.1272.2 | Moderate Injuries (SNOMEDCT) |
| 2.16.840.1.113762.1.4.1272.3 | Diabetes |
| 2.16.840.1.113762.1.4.1272.5 | Diabetes |
| 2.16.840.1.113762.1.4.1272.6 | Immobility |
| 2.16.840.1.113762.1.4.1272.7 | Smoking status |
| 2.16.840.1.113762.1.4.1282.1 | Drug Intervention Not Indicated/Contraindicated |
| 2.16.840.1.113762.1.4.1282.2 | Procedure Not Indicated/Contraindicated |
| 2.16.840.1.113762.1.4.1290.5 | Septic Shock |
| 2.16.840.1.113883.1.11.20.12 | HealthStatus |
| 2.16.840.1.113883.1.11.20.2.6 | Wound Type |
| 2.16.840.1.113883.1.11.20.2.7 | Nutritional Status |
| 2.16.840.1.113883.1.11.20.2.9 | Nutrition Recommendations |
| 2.16.840.1.113883.1.11.20.2 | Advance Directive Type Code |
| 2.16.840.1.113883.10.20.15.2.5.12 | Therapeutic Response to Medication |
| 2.16.840.1.113883.10.20.22.5.300 | Transmission Based Precaution Types |
| 2.16.840.1.113883.10.20.22.5.304 | Organism |
| 2.16.840.1.113883.10.20.22.5.306 | Infectious Disease |
| 2.16.840.1.113883.10.20.5.9.24 | NHSNVascularSpecimenCollectionSite |
| 2.16.840.1.113883.10.20.5.9.30 | NHSNLOS/MENDischargeDisposition |
| 2.16.840.1.113883.10.20.5.9.40 | NHSN COVID19 Case Classification |
| 2.16.840.1.113883.10.20.5.9.50 | NHSNGenotypicTestInterpretation |
| 2.16.840.1.113883.11.20.9.29 | DIRQuantityMeasurementTypeCodes |
| 2.16.840.1.113883.11.20.9.34 | Patient Education |
| 2.16.840.1.113883.11.20.9.35 | Pressure Ulcer Stage |
| 2.16.840.1.113883.11.20.9.36 | Pressure Point |
| 2.16.840.1.113883.11.20.9.37 | TargetSite Qualifiers |
| 2.16.840.1.113883.11.20.9.38 | Smoking Status |
| 2.16.840.1.113883.11.20.9.41 | Tobacco Use |
| 2.16.840.1.113883.11.20.9.44 | Mental and Functional Status Response |
| 2.16.840.1.113883.11.20.9.46 | Ability |
| 2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type |
| 2.16.840.1.113883.11.20.9.50 | Sensory Status Problem Type |
| 2.16.840.1.113883.11.20.9.51 | Healthcare Agent Qualifier |
| 2.16.840.1.113883.11.20.9.52 | Encounter SCT |
| 2.16.840.1.113883.11.20.9.55 | Goal Achievement |
| 2.16.840.1.113883.11.20.9.56 | Referral Types |
| 2.16.840.1.113883.11.20.9.58 | Wound Characteristic |
| 2.16.840.1.113883.11.20.9.60 | Priority Level |
| 2.16.840.1.113883.11.20.9.61 | Care Model |
| 2.16.840.1.113883.11.20.9.69.1.2 | Advance Care Planning Services SCT |
| 2.16.840.1.113883.11.20.9.69.1.3 | Advance Care Planning Services Grouping |
| 2.16.840.1.113883.11.20.9.69.17 | Obligation or Prohibition Instruction Type |
| 2.16.840.1.113883.11.20.9.69.7 | Obligation or Prohibition Instruction Type |
| 2.16.840.1.113883.11.20.9.80 | Pregnancy Status Determination Method |
| 2.16.840.1.113883.11.20.9.86 | Pregnancy Outcome |
| 2.16.840.1.113883.11.20.9.87 | Postpartum Status |
| 2.16.840.1.113883.11.20.9.88 | Pregnancy Related Findings |
| 2.16.840.1.113883.11.20.9.89 | D(Rh) Type |
| 2.16.840.1.113883.11.20.9.90 | D(Rh) Sensitized |
| 2.16.840.1.113883.13.10 | NHSNASAClassCode |
| 2.16.840.1.113883.13.16 | NHSNPathogenCode |
| 2.16.840.1.113883.13.2 | NHSNSpinalFusionApproachCode |
| 2.16.840.1.113883.13.20 | NHSNInfectionTypeCode |
| 2.16.840.1.113883.13.9 | NHSNWoundClassCode |
| 2.16.840.1.113883.17.4077.2.1018 | Closed Head and Facial Trauma |
| 2.16.840.1.113883.3.117.1.7.1.136 | Perforation of Uterus |
| 2.16.840.1.113883.3.117.1.7.1.137 | Uterine Window |
| 2.16.840.1.113883.3.117.1.7.1.138 | Uterine Rupture |
| 2.16.840.1.113883.3.117.1.7.1.202 | Atrial Fibrillation or Flutter |
| 2.16.840.1.113883.3.117.1.7.1.203 | Atrial Ablation |
| 2.16.840.1.113883.3.117.1.7.1.204 | Carotid Intervention |
| 2.16.840.1.113883.3.117.1.7.1.207 | Discharged to Health Care Facility for Hospice Care |
| 2.16.840.1.113883.3.117.1.7.1.209 | Discharged to Home for Hospice Care |
| 2.16.840.1.113883.3.117.1.7.1.212 | Hemorrhagic Stroke |
| 2.16.840.1.113883.3.117.1.7.1.214 | Intermittent pneumatic compression devices |
| 2.16.840.1.113883.3.117.1.7.1.222 | Intravenous route |
| 2.16.840.1.113883.3.117.1.7.1.223 | Subcutaneous route |
| 2.16.840.1.113883.3.117.1.7.1.230 | Venous foot pumps |
| 2.16.840.1.113883.3.117.1.7.1.235 | Hemorrhagic Stroke |
| 2.16.840.1.113883.3.117.1.7.1.239 | Carotid Intervention |
| 2.16.840.1.113883.3.117.1.7.1.243 | Atrial Ablation |
| 2.16.840.1.113883.3.117.1.7.1.246 | Atrial Fibrillation or Flutter |
| 2.16.840.1.113883.3.117.1.7.1.247 | Ischemic Stroke |
| 2.16.840.1.113883.3.117.1.7.1.25 | Single Live Birth |
| 2.16.840.1.113883.3.117.1.7.1.252 | Ischemic Stroke Embolism |
| 2.16.840.1.113883.3.117.1.7.1.255 | General Surgery |
| 2.16.840.1.113883.3.117.1.7.1.256 | Graduated compression stockings |
| 2.16.840.1.113883.3.117.1.7.1.257 | Gynecological Surgery |
| 2.16.840.1.113883.3.117.1.7.1.258 | Hip Fracture Surgery |
| 2.16.840.1.113883.3.117.1.7.1.259 | Hip Replacement Surgery |
| 2.16.840.1.113883.3.117.1.7.1.26 | Single Live Born Newborn Born in Hospital |
| 2.16.840.1.113883.3.117.1.7.1.260 | Intracranial Neurosurgery |
| 2.16.840.1.113883.3.117.1.7.1.261 | Knee Replacement Surgery |
| 2.16.840.1.113883.3.117.1.7.1.263 | Obstetrical or Pregnancy Related Conditions |
| 2.16.840.1.113883.3.117.1.7.1.264 | Obstetrics VTE |
| 2.16.840.1.113883.3.117.1.7.1.27 | Dietary Intake Other than Human Milk |
| 2.16.840.1.113883.3.117.1.7.1.272 | Urological Surgery |
| 2.16.840.1.113883.3.117.1.7.1.279 | Venous Thromboembolism |
| 2.16.840.1.113883.3.117.1.7.1.281 | Labor |
| 2.16.840.1.113883.3.117.1.7.1.282 | Cesarean Birth |
| 2.16.840.1.113883.3.117.1.7.1.286 | Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation |
| 2.16.840.1.113883.3.117.1.7.1.288 | Medical Induction of Labor |
| 2.16.840.1.113883.3.117.1.7.1.292 | Emergency Department Visit |
| 2.16.840.1.113883.3.117.1.7.1.294 | Decision to Admit to Hospital Inpatient |
| 2.16.840.1.113883.3.117.1.7.1.295 | Decision to Admit to Hospital Inpatient |
| 2.16.840.1.113883.3.117.1.7.1.298 | Psychiatric/Mental Health Diagnosis |
| 2.16.840.1.113883.3.117.1.7.1.299 | Psychiatric/Mental Health Diagnosis |
| 2.16.840.1.113883.3.117.1.7.1.30 | Human Milk |
| 2.16.840.1.113883.3.117.1.7.1.308 | Left Against Medical Advice |
| 2.16.840.1.113883.3.117.1.7.1.309 | Patient Expired |
| 2.16.840.1.113883.3.117.1.7.1.310 | Gynecological Surgery |
| 2.16.840.1.113883.3.117.1.7.1.315 | Knee Replacement Surgery |
| 2.16.840.1.113883.3.117.1.7.1.319 | Hip Replacement Surgery |
| 2.16.840.1.113883.3.117.1.7.1.323 | Hip Fracture Surgery |
| 2.16.840.1.113883.3.117.1.7.1.33 | Galactosemia |
| 2.16.840.1.113883.3.117.1.7.1.330 | Venous Thromboembolism |
| 2.16.840.1.113883.3.117.1.7.1.333 | Urological Surgery |
| 2.16.840.1.113883.3.117.1.7.1.337 | Obstetrical or Pregnancy Related Conditions |
| 2.16.840.1.113883.3.117.1.7.1.340 | Obstetrics VTE |
| 2.16.840.1.113883.3.117.1.7.1.346 | Intracranial Neurosurgery |
| 2.16.840.1.113883.3.117.1.7.1.348 | General or Neuraxial Anesthesia |
| 2.16.840.1.113883.3.117.1.7.1.35 | Galactosemia |
| 2.16.840.1.113883.3.117.1.7.1.365 | General Surgery |
| 2.16.840.1.113883.3.117.1.7.1.369 | Cesarean Birth |
| 2.16.840.1.113883.3.117.1.7.1.37 | Parenteral Nutrition |
| 2.16.840.1.113883.3.117.1.7.1.38 | Parenteral Nutrition |
| 2.16.840.1.113883.3.117.1.7.1.384 | Medical Induction of Labor |
| 2.16.840.1.113883.3.117.1.7.1.395 | Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation |
| 2.16.840.1.113883.3.117.1.7.1.400 | Low Risk |
| 2.16.840.1.113883.3.117.1.7.1.401 | Delivery Procedures |
| 2.16.840.1.113883.3.117.1.7.1.418 | Classical Cesarean Birth |
| 2.16.840.1.113883.3.117.1.7.1.421 | Classical Cesarean Birth |
| 2.16.840.1.113883.3.117.1.7.1.422 | Myomectomy |
| 2.16.840.1.113883.3.117.1.7.1.424 | Nonelective Inpatient Encounter |
| 2.16.840.1.113883.3.117.1.7.1.473 | Medical Reason For Not Providing Treatment |
| 2.16.840.1.113883.3.117.1.7.1.75 | Neonatal Intensive Care Unit |
| 2.16.840.1.113883.3.117.1.7.1.87 | Discharge To Acute Care Facility |
| 2.16.840.1.113883.3.117.1.7.1.93 | Patient Refusal |
| 2.16.840.1.113883.3.1434.1047 | Skin Melanoma pT1 |
| 2.16.840.1.113883.3.1444.3.102 | Breast Cancer |
| 2.16.840.1.113883.3.1444.3.106 | High Fiber Supplement or Diet Education |
| 2.16.840.1.113883.3.1444.3.110 | Pancreatic Cancer |
| 2.16.840.1.113883.3.1444.3.111 | Audio Visual Telehealth Encounter |
| 2.16.840.1.113883.3.1444.3.112 | Telephone Encounter |
| 2.16.840.1.113883.3.1444.3.115 | Referral to Hospice Care |
| 2.16.840.1.113883.3.1444.3.116 | Referral to Palliative Care |
| 2.16.840.1.113883.3.1444.3.117 | Assessment Scale for Dyspnea |
| 2.16.840.1.113883.3.1444.3.118 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.3.119 | Enrollment in Hospice Care |
| 2.16.840.1.113883.3.1444.3.120 | Palliative Care |
| 2.16.840.1.113883.3.1444.3.121 | Advance Directive Including Durable Power of Attorney or Instructional |
| 2.16.840.1.113883.3.1444.3.207 | Epithelial Ovarian Cancer |
| 2.16.840.1.113883.3.1444.3.208 | Primary Peritoneal Cancer |
| 2.16.840.1.113883.3.1444.3.209 | Fallopian Tube Cancer |
| 2.16.840.1.113883.3.1444.3.215 | Colorectal Cancer |
| 2.16.840.1.113883.3.1444.3.217 | Cancer Stage I |
| 2.16.840.1.113883.3.1444.3.240 | Pathological N Stage N3c |
| 2.16.840.1.113883.3.1444.3.258 | Indication for Dexamethasone |
| 2.16.840.1.113883.3.1444.3.260 | Indication for Olanzapine |
| 2.16.840.1.113883.3.1444.3.265 | As Needed PRN |
| 2.16.840.1.113883.3.1444.5.211 | High Fiber Supplement or Diet Education |
| 2.16.840.1.113883.3.1444.5.214 | Pancreatic Cancer |
| 2.16.840.1.113883.3.1444.5.215 | Audio Visual Telehealth Encounter |
| 2.16.840.1.113883.3.1444.5.216 | Telephone Encounter |
| 2.16.840.1.113883.3.1444.5.218 | Dyspnea Assessment |
| 2.16.840.1.113883.3.1444.5.219 | Nausea or Vomiting Assessment |
| 2.16.840.1.113883.3.1444.5.220 | Karnofsky Performance Status |
| 2.16.840.1.113883.3.1444.5.221 | Referral to Hospice Care |
| 2.16.840.1.113883.3.1444.5.222 | Referral to Palliative Care |
| 2.16.840.1.113883.3.1444.5.223 | Palliative Care |
| 2.16.840.1.113883.3.1444.5.224 | Enrollment in Hospice Care |
| 2.16.840.1.113883.3.1444.5.225 | Advance Directive Including Durable Power of Attorney or Instructional |
| 2.16.840.1.113883.3.1444.5.232 | Epithelial Ovarian Cancer |
| 2.16.840.1.113883.3.1444.5.233 | Primary Peritoneal Cancer |
| 2.16.840.1.113883.3.1444.5.240 | Cancer Stage 4 |
| 2.16.840.1.113883.3.1444.5.241 | Cancer Stage M1 |
| 2.16.840.1.113883.3.1444.5.247 | Indication for Dexamethasone |
| 2.16.840.1.113883.3.1444.5.249 | Indication for Olanzapine |
| 2.16.840.1.113883.3.3157.2000.2 | Percutaneous Coronary Intervention SNOMEDCT |
| 2.16.840.1.113883.3.3157.2000.5 | Percutaneous Coronary Intervention |
| 2.16.840.1.113883.3.3157.4009 | Malignant Intracranial Neoplasm |
| 2.16.840.1.113883.3.3157.4016 | STEMI |
| 2.16.840.1.113883.3.3157.4017 | STEMI |
| 2.16.840.1.113883.3.3157.4024 | Cerebral Vascular Lesion |
| 2.16.840.1.113883.3.3157.4025 | Cerebral Vascular Lesion |
| 2.16.840.1.113883.3.3157.4026 | Closed Head and Facial Trauma |
| 2.16.840.1.113883.3.3157.4028 | Aortic Dissection or Ruptured Aortic Aneurysm |
| 2.16.840.1.113883.3.3157.4030 | Acute Peptic Ulcer |
| 2.16.840.1.113883.3.3157.4031 | Acute Peptic Ulcer |
| 2.16.840.1.113883.3.3157.4033 | Dementia and Related Intracranial Pathologies |
| 2.16.840.1.113883.3.3157.4035 | Active Bleeding or Bleeding Diathesis, Excluding Menses |
| 2.16.840.1.113883.3.3157.4036 | Active Bleeding or Bleeding Diathesis, Excluding Menses |
| 2.16.840.1.113883.3.3157.4043 | Dementia and Related Intracranial Pathologies |
| 2.16.840.1.113883.3.3157.4044 | Aortic Dissection or Ruptured Aortic Aneurysm |
| 2.16.840.1.113883.3.3157.4047 | Cardiopulmonary Emergency |
| 2.16.840.1.113883.3.3157.4048 | Cardiopulmonary Emergency |
| 2.16.840.1.113883.3.3157.4049 | Mechanical Circulatory Assist Device |
| 2.16.840.1.113883.3.3157.4052 | Mechanical Circulatory Assist Device |
| 2.16.840.1.113883.3.3157.4054 | Pregnant State |
| 2.16.840.1.113883.3.3157.4055 | Pregnant State |
| 2.16.840.1.113883.3.3157.4056 | Major Surgical Procedure |
| 2.16.840.1.113883.3.3566.2.1006 | Chronic Stable Angina |
| 2.16.840.1.113883.3.3566.3.1002 | Chronic Stable Angina |
| 2.16.840.1.113883.3.464.1003.1002 | Hospice Encounter |
| 2.16.840.1.113883.3.464.1003.1003 | Hospice Encounter |
| 2.16.840.1.113883.3.464.1003.1004 | Nutrition Services |
| 2.16.840.1.113883.3.464.1003.1006 | Nutrition Services |
| 2.16.840.1.113883.3.464.1003.101.11.1215 | Referral |
| 2.16.840.1.113883.3.464.1003.101.11.1216 | Face-to-Face Interaction |
| 2.16.840.1.113883.3.464.1003.101.11.1228 | Detoxification Visit |
| 2.16.840.1.113883.3.464.1003.101.11.1261 | Nursing Facility Visit |
| 2.16.840.1.113883.3.464.1003.101.11.1262 | Care Services in Long Term Residential Facility |
| 2.16.840.1.113883.3.464.1003.101.11.1264 | Office Visit |
| 2.16.840.1.113883.3.464.1003.101.11.1265 | Home Healthcare Services |
| 2.16.840.1.113883.3.464.1003.101.11.1266 | Outpatient Consultation |
| 2.16.840.1.113883.3.464.1003.101.11.1284 | Outpatient Encounter |
| 2.16.840.1.113883.3.464.1003.101.11.1286 | Palliative Encounter |
| 2.16.840.1.113883.3.464.1003.101.11.1287 | Telephone Visits |
| 2.16.840.1.113883.3.464.1003.101.12.1001 | Office Visit |
| 2.16.840.1.113883.3.464.1003.101.12.1008 | Outpatient Consultation |
| 2.16.840.1.113883.3.464.1003.101.12.1010 | Emergency Department Evaluation and Management Visit |
| 2.16.840.1.113883.3.464.1003.101.12.1012 | Nursing Facility Visit |
| 2.16.840.1.113883.3.464.1003.101.12.1014 | Care Services in Long Term Residential Facility |
| 2.16.840.1.113883.3.464.1003.101.12.1016 | Home Healthcare Services |
| 2.16.840.1.113883.3.464.1003.101.12.1046 | Referral |
| 2.16.840.1.113883.3.464.1003.101.12.1048 | Face-to-Face Interaction |
| 2.16.840.1.113883.3.464.1003.101.12.1059 | Detoxification Visit |
| 2.16.840.1.113883.3.464.1003.101.12.1080 | Telephone Visits |
| 2.16.840.1.113883.3.464.1003.101.12.1087 | Outpatient Encounter |
| 2.16.840.1.113883.3.464.1003.101.12.1090 | Palliative Care Encounter |
| 2.16.840.1.113883.3.464.1003.1011 | Multiple Myeloma |
| 2.16.840.1.113883.3.464.1003.1013 | Premature Menopause |
| 2.16.840.1.113883.3.464.1003.1014 | Multiple Myeloma |
| 2.16.840.1.113883.3.464.1003.1015 | Premature Menopause |
| 2.16.840.1.113883.3.464.1003.102.11.1031 | Acute Pharyngitis |
| 2.16.840.1.113883.3.464.1003.102.11.1034 | Acute Tonsillitis |
| 2.16.840.1.113883.3.464.1003.102.11.1059 | Upper Respiratory Infection |
| 2.16.840.1.113883.3.464.1003.102.11.1066 | Comorbid Conditions for Respiratory Conditions |
| 2.16.840.1.113883.3.464.1003.102.12.1011 | Acute Pharyngitis |
| 2.16.840.1.113883.3.464.1003.102.12.1012 | Acute Tonsillitis |
| 2.16.840.1.113883.3.464.1003.102.12.1017 | Competing Conditions for Respiratory Conditions |
| 2.16.840.1.113883.3.464.1003.102.12.1022 | Upper Respiratory Infection |
| 2.16.840.1.113883.3.464.1003.102.12.1025 | Comorbid Conditions for Respiratory Conditions |
| 2.16.840.1.113883.3.464.1003.1021 | Amenorrhea |
| 2.16.840.1.113883.3.464.1003.1022 | Amenorrhea |
| 2.16.840.1.113883.3.464.1003.1028 | Unilateral Oophorectomy Left |
| 2.16.840.1.113883.3.464.1003.1029 | Unilateral Oophorectomy Left |
| 2.16.840.1.113883.3.464.1003.103.12.1001 | Diabetes |
| 2.16.840.1.113883.3.464.1003.103.12.1020 | Type 1 Diabetes |
| 2.16.840.1.113883.3.464.1003.1031 | Unilateral Oophorectomy Right |
| 2.16.840.1.113883.3.464.1003.1032 | Unilateral Oophorectomy Right |
| 2.16.840.1.113883.3.464.1003.1034 | Unilateral Oophorectomy, Unspecified Laterality |
| 2.16.840.1.113883.3.464.1003.1035 | Unilateral Oophorectomy, Unspecified Laterality |
| 2.16.840.1.113883.3.464.1003.1038 | Eating Disorders |
| 2.16.840.1.113883.3.464.1003.1039 | Eating Disorders |
| 2.16.840.1.113883.3.464.1003.104.11.1029 | Essential Hypertension |
| 2.16.840.1.113883.3.464.1003.104.12.1011 | Essential Hypertension |
| 2.16.840.1.113883.3.464.1003.1042 | Major Transplant |
| 2.16.840.1.113883.3.464.1003.1046 | Evidence of Bilateral Oophorectomy |
| 2.16.840.1.113883.3.464.1003.1048 | Evidence of Bilateral Oophorectomy |
| 2.16.840.1.113883.3.464.1003.105.11.1010 | Mental Health Diagnoses |
| 2.16.840.1.113883.3.464.1003.105.11.1017 | Major Depression |
| 2.16.840.1.113883.3.464.1003.105.11.1060 | Major Depression In Remission |
| 2.16.840.1.113883.3.464.1003.105.11.1163 | Schizophrenia or Psychotic Disorder |
| 2.16.840.1.113883.3.464.1003.105.11.1178 | Pervasive Developmental Disorder |
| 2.16.840.1.113883.3.464.1003.105.11.1207 | Mental Behavioral and Neurodevelopmental Disorders |
| 2.16.840.1.113883.3.464.1003.105.11.1211 | Schizophrenia |
| 2.16.840.1.113883.3.464.1003.105.11.1213 | Seizure Disorder |
| 2.16.840.1.113883.3.464.1003.105.11.1215 | REM |
| 2.16.840.1.113883.3.464.1003.105.11.1217 | Benzodiazepine Withdrawal |
| 2.16.840.1.113883.3.464.1003.105.11.1219 | Alcohol Withdrawal |
| 2.16.840.1.113883.3.464.1003.105.11.1221 | General Anxiety |
| 2.16.840.1.113883.3.464.1003.105.12.1004 | Mental Health Diagnoses |
| 2.16.840.1.113883.3.464.1003.105.12.1007 | Major Depression |
| 2.16.840.1.113883.3.464.1003.105.12.1104 | Schizophrenia or Psychotic Disorder |
| 2.16.840.1.113883.3.464.1003.105.12.1152 | Pervasive Developmental Disorder |
| 2.16.840.1.113883.3.464.1003.105.12.1203 | Mental Behavioral and Neurodevelopmental Disorders |
| 2.16.840.1.113883.3.464.1003.105.12.1205 | Schizophrenia |
| 2.16.840.1.113883.3.464.1003.105.12.1206 | Seizure Disorder |
| 2.16.840.1.113883.3.464.1003.105.12.1207 | REM Sleep Behavior Disorder |
| 2.16.840.1.113883.3.464.1003.105.12.1208 | Benzodiazepine Withdrawal |
| 2.16.840.1.113883.3.464.1003.105.12.1209 | Alcohol Withdrawal |
| 2.16.840.1.113883.3.464.1003.105.12.1210 | Generalized Anxiety Disorder |
| 2.16.840.1.113883.3.464.1003.106.11.1001 | Substance Use Disorder |
| 2.16.840.1.113883.3.464.1003.106.11.1012 | Substance Use Disorder Treatment |
| 2.16.840.1.113883.3.464.1003.106.12.1001 | Substance Use Disorder |
| 2.16.840.1.113883.3.464.1003.106.12.1005 | Substance Use Disorder Treatment |
| 2.16.840.1.113883.3.464.1003.108.11.1001 | Malignant Neoplasm of Colon |
| 2.16.840.1.113883.3.464.1003.108.11.1025 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue |
| 2.16.840.1.113883.3.464.1003.108.11.1053 | Colonoscopy |
| 2.16.840.1.113883.3.464.1003.108.12.1001 | Malignant Neoplasm of Colon |
| 2.16.840.1.113883.3.464.1003.108.12.1009 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue |
| 2.16.840.1.113883.3.464.1003.108.12.1020 | Colonoscopy |
| 2.16.840.1.113883.3.464.1003.109.11.1024 | Kidney Transplant |
| 2.16.840.1.113883.3.464.1003.109.11.1028 | Dialysis Services |
| 2.16.840.1.113883.3.464.1003.109.12.1012 | Kidney Transplant |
| 2.16.840.1.113883.3.464.1003.109.12.1013 | Dialysis Services |
| 2.16.840.1.113883.3.464.1003.110.11.1066 | DTaP Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1068 | Hepatitis A |
| 2.16.840.1.113883.3.464.1003.110.11.1078 | Measles |
| 2.16.840.1.113883.3.464.1003.110.11.1086 | Measles, Mumps and Rubella (MMR) Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1087 | Mumps |
| 2.16.840.1.113883.3.464.1003.110.11.1098 | Rubella |
| 2.16.840.1.113883.3.464.1003.110.11.1105 | Varicella Zoster |
| 2.16.840.1.113883.3.464.1003.110.11.1107 | Varicella Zoster Vaccine (VZV) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1110 | Hepatitis A Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1112 | Hepatitis B Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1116 | Child Influenza Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1118 | Inactivated Polio Vaccine (IPV) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1124 | Genital Herpes |
| 2.16.840.1.113883.3.464.1003.110.11.1133 | Pneumococcal Conjugate Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1148 | Rotavirus Vaccine (2 Dose Schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1149 | Rotavirus Vaccine (3 Dose Schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1151 | Advanced Illness |
| 2.16.840.1.113883.3.464.1003.110.11.1156 | HiB Vaccine (3 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1157 | HiB Vaccine (4 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.11.1159 | Competing Conditions for Respiratory Conditions |
| 2.16.840.1.113883.3.464.1003.110.12.1022 | DTaP Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1024 | Hepatitis A |
| 2.16.840.1.113883.3.464.1003.110.12.1031 | Measles, Mumps and Rubella (MMR) Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1032 | Mumps |
| 2.16.840.1.113883.3.464.1003.110.12.1037 | Rubella |
| 2.16.840.1.113883.3.464.1003.110.12.1039 | Varicella Zoster |
| 2.16.840.1.113883.3.464.1003.110.12.1040 | Varicella Zoster Vaccine (VZV) Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1041 | Hepatitis A Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1042 | Hepatitis B Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1044 | Child Influenza Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1045 | Inactivated Polio Vaccine (IPV) Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1046 | Pneumococcal Conjugate Vaccine Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1047 | Rotavirus Vaccine (3 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1048 | Rotavirus Vaccine (2 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1049 | Genital Herpes |
| 2.16.840.1.113883.3.464.1003.110.12.1053 | Measles |
| 2.16.840.1.113883.3.464.1003.110.12.1082 | Advanced Illness |
| 2.16.840.1.113883.3.464.1003.110.12.1084 | Hib Vaccine (3 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.110.12.1086 | Hib Vaccine (4 dose schedule) Administered |
| 2.16.840.1.113883.3.464.1003.111.11.1023 | Complications of Pregnancy, Childbirth and the Puerperium |
| 2.16.840.1.113883.3.464.1003.111.11.1030 | Procedures for Sexual Activity |
| 2.16.840.1.113883.3.464.1003.111.11.1032 | Diagnosis for Sexual Activity |
| 2.16.840.1.113883.3.464.1003.111.12.1012 | Complications of Pregnancy, Childbirth and the Puerperium |
| 2.16.840.1.113883.3.464.1003.111.12.1016 | Congenital or Acquired Absence of Cervix |
| 2.16.840.1.113883.3.464.1003.111.12.1017 | Procedures Used to Indicate Sexual Activity |
| 2.16.840.1.113883.3.464.1003.111.12.1018 | Diagnoses Used to Indicate Sexual Activity |
| 2.16.840.1.113883.3.464.1003.112.11.1025 | Absence of Cervix |
| 2.16.840.1.113883.3.464.1003.113.11.1074 | Osteoporosis Without Current Fracture |
| 2.16.840.1.113883.3.464.1003.113.11.1078 | History of hip fracture in parent |
| 2.16.840.1.113883.3.464.1003.113.11.1081 | Rheumatoid Arthritis |
| 2.16.840.1.113883.3.464.1003.113.11.1085 | Osteogenesis Imperfecta |
| 2.16.840.1.113883.3.464.1003.113.11.1088 | Ankylosing Spondylitis |
| 2.16.840.1.113883.3.464.1003.113.11.1091 | Psoriatic Arthritis |
| 2.16.840.1.113883.3.464.1003.113.11.1094 | Ehlers Danlos Syndrome |
| 2.16.840.1.113883.3.464.1003.113.11.1097 | Marfan's Syndrome |
| 2.16.840.1.113883.3.464.1003.113.11.1100 | Osteopenia |
| 2.16.840.1.113883.3.464.1003.113.11.1201 | Osteoporosis With Current Fracture |
| 2.16.840.1.113883.3.464.1003.113.11.1309 | Frailty Diagnosis |
| 2.16.840.1.113883.3.464.1003.113.11.1311 | Frailty Symptom |
| 2.16.840.1.113883.3.464.1003.113.12.1005 | Rheumatoid Arthritis |
| 2.16.840.1.113883.3.464.1003.113.12.1038 | Osteoporosis Without Current Fracture |
| 2.16.840.1.113883.3.464.1003.113.12.1040 | History of hip fracture in parent |
| 2.16.840.1.113883.3.464.1003.113.12.1044 | Osteogenesis Imperfecta |
| 2.16.840.1.113883.3.464.1003.113.12.1045 | Ankylosing Spondylitis |
| 2.16.840.1.113883.3.464.1003.113.12.1046 | Psoriatic Arthritis |
| 2.16.840.1.113883.3.464.1003.113.12.1047 | Ehlers Danlos Syndrome |
| 2.16.840.1.113883.3.464.1003.113.12.1048 | Marfan's Syndrome |
| 2.16.840.1.113883.3.464.1003.113.12.1049 | Osteopenia |
| 2.16.840.1.113883.3.464.1003.113.12.1050 | Osteoporosis With Current Fracture |
| 2.16.840.1.113883.3.464.1003.113.12.1074 | Frailty Diagnosis |
| 2.16.840.1.113883.3.464.1003.113.12.1075 | Frailty Symptom |
| 2.16.840.1.113883.3.464.1003.114.11.1021 | Narcolepsy |
| 2.16.840.1.113883.3.464.1003.114.11.1024 | Neurologic impairment |
| 2.16.840.1.113883.3.464.1003.114.12.1011 | Narcolepsy |
| 2.16.840.1.113883.3.464.1003.114.12.1012 | Neurologic impairment |
| 2.16.840.1.113883.3.464.1003.115.11.1248 | Retinal or Dilated Eye Exam |
| 2.16.840.1.113883.3.464.1003.115.12.1088 | Retinal or Dilated Eye Exam |
| 2.16.840.1.113883.3.464.1003.1155 | Substance Use Disorder Short Acting Medication Administration |
| 2.16.840.1.113883.3.464.1003.1157 | Substance Use Disorder Short Acting Medication Administration |
| 2.16.840.1.113883.3.464.1003.1163 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine |
| 2.16.840.1.113883.3.464.1003.1164 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine |
| 2.16.840.1.113883.3.464.1003.1165 | Hospice Diagnosis |
| 2.16.840.1.113883.3.464.1003.1166 | Hospice Diagnosis |
| 2.16.840.1.113883.3.464.1003.1167 | Palliative Care Diagnosis |
| 2.16.840.1.113883.3.464.1003.1168 | Palliative Care Diagnosis |
| 2.16.840.1.113883.3.464.1003.117.11.1023 | Cushings Syndrome |
| 2.16.840.1.113883.3.464.1003.117.11.1026 | Lupus |
| 2.16.840.1.113883.3.464.1003.117.11.1033 | Hyperthyroidism |
| 2.16.840.1.113883.3.464.1003.117.11.1034 | Hyperparathyroidism |
| 2.16.840.1.113883.3.464.1003.117.12.1009 | Cushings Syndrome |
| 2.16.840.1.113883.3.464.1003.117.12.1010 | Lupus |
| 2.16.840.1.113883.3.464.1003.117.12.1015 | Hyperthyroidism |
| 2.16.840.1.113883.3.464.1003.117.12.1016 | Hyperparathyroidism |
| 2.16.840.1.113883.3.464.1003.1178 | Lower Body Fractures Excluding Ankle and Foot |
| 2.16.840.1.113883.3.464.1003.118.11.1042 | Counseling for Physical Activity |
| 2.16.840.1.113883.3.464.1003.118.11.1220 | Frailty Device SNOMED |
| 2.16.840.1.113883.3.464.1003.118.12.1035 | Counseling for Physical Activity |
| 2.16.840.1.113883.3.464.1003.118.12.1300 | Frailty Device |
| 2.16.840.1.113883.3.464.1003.1180 | Malignant Neoplasms of Lower and Unspecified Limbs |
| 2.16.840.1.113883.3.464.1003.1182 | Mechanical Complications Excluding Upper Body |
| 2.16.840.1.113883.3.464.1003.1184 | Partial Arthroplasty of Hip |
| 2.16.840.1.113883.3.464.1003.1189 | Removal, Revision and Supplement Procedures of the Lower Body and Spine |
| 2.16.840.1.113883.3.464.1003.1194 | Malignant Neoplasms |
| 2.16.840.1.113883.3.464.1003.1196 | Atherosclerosis of the Extremities |
| 2.16.840.1.113883.3.464.1003.1198 | Atherosclerosis of the Extremities |
| 2.16.840.1.113883.3.464.1003.1199 | Lower Extremity Neurological Assessment Result or Finding |
| 2.16.840.1.113883.3.464.1003.120.11.1001 | Disorders of the Immune System |
| 2.16.840.1.113883.3.464.1003.120.11.1005 | HIV 1 |
| 2.16.840.1.113883.3.464.1003.120.11.1008 | HIV 2 |
| 2.16.840.1.113883.3.464.1003.120.11.1012 | Severe Combined Immunodeficiency |
| 2.16.840.1.113883.3.464.1003.120.12.1001 | Disorders of the Immune System |
| 2.16.840.1.113883.3.464.1003.120.12.1003 | HIV |
| 2.16.840.1.113883.3.464.1003.120.12.1007 | Severe Combined Immunodeficiency |
| 2.16.840.1.113883.3.464.1003.1200 | Lower Extremity Neurological Tests |
| 2.16.840.1.113883.3.464.1003.1201 | Lower Extremity Visual Inspection Result or Finding |
| 2.16.840.1.113883.3.464.1003.1202 | Lower Extremity Visual Inspection Test |
| 2.16.840.1.113883.3.464.1003.1203 | Monofilament Test Result or Finding |
| 2.16.840.1.113883.3.464.1003.1204 | Monofilament Tests |
| 2.16.840.1.113883.3.464.1003.1205 | Pedal Pulse Result or Finding |
| 2.16.840.1.113883.3.464.1003.1206 | Peripheral Neuropathy |
| 2.16.840.1.113883.3.464.1003.1207 | Peripheral Neuropathy |
| 2.16.840.1.113883.3.464.1003.1209 | Amputation of Bilateral Feet |
| 2.16.840.1.113883.3.464.1003.121.11.1011 | Consultant Report |
| 2.16.840.1.113883.3.464.1003.121.12.1006 | Consultant Report |
| 2.16.840.1.113883.3.464.1003.1211 | Amputation of Bilateral Feet |
| 2.16.840.1.113883.3.464.1003.1212 | Amputation of Left Foot |
| 2.16.840.1.113883.3.464.1003.1214 | Amputation of Left Foot |
| 2.16.840.1.113883.3.464.1003.1215 | Amputation of Right Foot |
| 2.16.840.1.113883.3.464.1003.1217 | Amputation of Right Foot |
| 2.16.840.1.113883.3.464.1003.1218 | Amputation of Unspecified Foot |
| 2.16.840.1.113883.3.464.1003.1219 | Amputation of Unspecified Foot |
| 2.16.840.1.113883.3.464.1003.122.11.1003 | Ambulatory |
| 2.16.840.1.113883.3.464.1003.122.12.1003 | Ambulatory |
| 2.16.840.1.113883.3.464.1003.1220 | Foot Assessment With Abnormal Result or Finding |
| 2.16.840.1.113883.3.464.1003.1221 | Foot Assessment With Abnormal Result or Finding |
| 2.16.840.1.113883.3.464.1003.1222 | Acquired Absence of Bilateral feet |
| 2.16.840.1.113883.3.464.1003.1223 | Acquired Absence of Bilateral feet |
| 2.16.840.1.113883.3.464.1003.1224 | Acquired Absence of Left Foot |
| 2.16.840.1.113883.3.464.1003.1226 | Acquired Absence of Left Foot |
| 2.16.840.1.113883.3.464.1003.1227 | Acquired Absence of Right Foot |
| 2.16.840.1.113883.3.464.1003.1229 | Acquired Absence of Right Foot |
| 2.16.840.1.113883.3.464.1003.1230 | Lower Body Fractures Excluding Ankle and Foot |
| 2.16.840.1.113883.3.464.1003.1231 | Malignant Neoplasms of Lower and Unspecified Limbs |
| 2.16.840.1.113883.3.464.1003.1232 | Mechanical Complications Excluding Upper Body |
| 2.16.840.1.113883.3.464.1003.1233 | Partial Arthroplasty of Hip |
| 2.16.840.1.113883.3.464.1003.1235 | Removal, Revision and Supplement Procedures of the Lower Body and Spine |
| 2.16.840.1.113883.3.464.1003.1239 | Foot Ulcer |
| 2.16.840.1.113883.3.464.1003.1241 | Foot Ulcer |
| 2.16.840.1.113883.3.464.1003.1242 | Referral for Foot Care |
| 2.16.840.1.113883.3.464.1003.1243 | Therapeutic Footwear |
| 2.16.840.1.113883.3.464.1003.1244 | Foot Deformity |
| 2.16.840.1.113883.3.464.1003.1246 | Foot Deformity |
| 2.16.840.1.113883.3.464.1003.125.11.1004 | Fluoride Varnish Application for Children |
| 2.16.840.1.113883.3.464.1003.125.11.1007 | Dental Caries |
| 2.16.840.1.113883.3.464.1003.125.12.1002 | Fluoride Varnish Application for Children |
| 2.16.840.1.113883.3.464.1003.125.12.1004 | Dental Caries |
| 2.16.840.1.113883.3.464.1003.1273 | Diabetes |
| 2.16.840.1.113883.3.464.1003.195.11.1004 | Counseling for Nutrition |
| 2.16.840.1.113883.3.464.1003.195.12.1003 | Counseling for Nutrition |
| 2.16.840.1.113883.3.464.1003.198.11.1005 | Bilateral Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.11.1017 | Flexible Sigmoidoscopy |
| 2.16.840.1.113883.3.464.1003.198.11.1027 | Hysterectomy with No Residual Cervix |
| 2.16.840.1.113883.3.464.1003.198.11.1035 | Total Colectomy |
| 2.16.840.1.113883.3.464.1003.198.11.1061 | Gastric Bypass Surgery |
| 2.16.840.1.113883.3.464.1003.198.11.1080 | Primary THA Procedure |
| 2.16.840.1.113883.3.464.1003.198.11.1085 | History of bilateral mastectomy |
| 2.16.840.1.113883.3.464.1003.198.11.1086 | Status Post Left Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.11.1087 | Status Post Right Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.11.1090 | Unilateral Mastectomy, Unspecified Laterality |
| 2.16.840.1.113883.3.464.1003.198.11.1132 | Unilateral Mastectomy Left |
| 2.16.840.1.113883.3.464.1003.198.11.1133 | Unilateral Mastectomy Right |
| 2.16.840.1.113883.3.464.1003.198.11.1148 | Palliative Intervention |
| 2.16.840.1.113883.3.464.1003.198.12.1005 | Bilateral Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.12.1006 | Primary THA Procedure |
| 2.16.840.1.113883.3.464.1003.198.12.1010 | Flexible Sigmoidoscopy |
| 2.16.840.1.113883.3.464.1003.198.12.1014 | Hysterectomy with No Residual Cervix |
| 2.16.840.1.113883.3.464.1003.198.12.1019 | Total Colectomy |
| 2.16.840.1.113883.3.464.1003.198.12.1050 | Gastric Bypass Surgery |
| 2.16.840.1.113883.3.464.1003.198.12.1068 | History of bilateral mastectomy |
| 2.16.840.1.113883.3.464.1003.198.12.1069 | Status Post Left Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.12.1070 | Status Post Right Mastectomy |
| 2.16.840.1.113883.3.464.1003.198.12.1071 | Unilateral Mastectomy, Unspecified Laterality |
| 2.16.840.1.113883.3.464.1003.198.12.1075 | Major Transplant |
| 2.16.840.1.113883.3.464.1003.198.12.1133 | Unilateral Mastectomy Left |
| 2.16.840.1.113883.3.464.1003.198.12.1134 | Unilateral Mastectomy Right |
| 2.16.840.1.113883.3.464.1003.198.12.1135 | Palliative Care Intervention |
| 2.16.840.1.113883.3.464.1003.199.11.1064 | Anaphylactic Reaction to DTaP Vaccine |
| 2.16.840.1.113883.3.464.1003.199.11.1065 | Chronic Liver Disease |
| 2.16.840.1.113883.3.464.1003.199.11.1068 | Chronic Malnutrition |
| 2.16.840.1.113883.3.464.1003.199.11.1100 | Malabsorption Syndromes |
| 2.16.840.1.113883.3.464.1003.199.11.1106 | Intussusception |
| 2.16.840.1.113883.3.464.1003.199.12.1031 | Anaphylactic Reaction to DTaP Vaccine |
| 2.16.840.1.113883.3.464.1003.199.12.1035 | Chronic Liver Disease |
| 2.16.840.1.113883.3.464.1003.199.12.1036 | Chronic Malnutrition |
| 2.16.840.1.113883.3.464.1003.199.12.1050 | Malabsorption Syndromes |
| 2.16.840.1.113883.3.464.1003.199.12.1056 | Intussusception |
| 2.16.840.1.113883.3.464.1004.2446 | Lower Extremity Visual Inspection Test |
| 2.16.840.1.113883.3.464.1004.2447 | Pedal Pulse Result or Finding |
| 2.16.840.1.113883.3.464.1004.2448 | Monofilament Test Result or Finding |
| 2.16.840.1.113883.3.464.1004.2449 | Monofilament Tests |
| 2.16.840.1.113883.3.464.1004.2450 | Lower Extremity Neurological Assessment Result or Finding |
| 2.16.840.1.113883.3.464.1004.2451 | Lower Extremity Neurological Tests |
| 2.16.840.1.113883.3.464.1004.2452 | Lower Extremity Visual Inspection Result or Finding |
| 2.16.840.1.113883.3.526.2.1037 | Chronic Kidney Disease, Stage 5 |
| 2.16.840.1.113883.3.526.2.1049 | Patient Provider Interaction |
| 2.16.840.1.113883.3.526.2.1068 | Dementia and Mental Degenerations |
| 2.16.840.1.113883.3.526.2.1072 | Radiation Treatment Management |
| 2.16.840.1.113883.3.526.2.1079 | Cancer |
| 2.16.840.1.113883.3.526.2.1081 | Chemotherapy Administration |
| 2.16.840.1.113883.3.526.2.120 | Coronary Artery Disease No MI |
| 2.16.840.1.113883.3.526.2.1244 | Renal Failure Due to ACE Inhibitor |
| 2.16.840.1.113883.3.526.2.1256 | Allergy to ACE Inhibitor or ARB |
| 2.16.840.1.113883.3.526.2.1257 | Intolerance to ACE Inhibitor or ARB |
| 2.16.840.1.113883.3.526.2.1333 | Allergy to Beta Blocker Therapy |
| 2.16.840.1.113883.3.526.2.1334 | Intolerance to Beta Blocker Therapy |
| 2.16.840.1.113883.3.526.2.1353 | Limited Life Expectancy |
| 2.16.840.1.113883.3.526.2.1377 | Level of Severity of Retinopathy Findings |
| 2.16.840.1.113883.3.526.2.1381 | Macular Edema Findings Present |
| 2.16.840.1.113883.3.526.2.1401 | Cognitive Assessment |
| 2.16.840.1.113883.3.526.2.1509 | Acute and Subacute Iridocyclitis |
| 2.16.840.1.113883.3.526.2.1521 | Burn Confined to Eye and Adnexa |
| 2.16.840.1.113883.3.526.2.1524 | Cataract Secondary to Ocular Disorders |
| 2.16.840.1.113883.3.526.2.1527 | Cataract Surgery |
| 2.16.840.1.113883.3.526.2.1530 | Cataract Congenital |
| 2.16.840.1.113883.3.526.2.1532 | Cataract Mature or Hypermature |
| 2.16.840.1.113883.3.526.2.1535 | Cataract Posterior Polar |
| 2.16.840.1.113883.3.526.2.1538 | Certain Types of Iridocyclitis |
| 2.16.840.1.113883.3.526.2.1542 | Chronic Iridocyclitis |
| 2.16.840.1.113883.3.526.2.1544 | Cloudy Cornea |
| 2.16.840.1.113883.3.526.2.1549 | Corneal Edema |
| 2.16.840.1.113883.3.526.2.1550 | Disorders of Cornea Including Corneal Opacity |
| 2.16.840.1.113883.3.526.2.1562 | Glaucoma |
| 2.16.840.1.113883.3.526.2.1564 | Hereditary Corneal Dystrophies |
| 2.16.840.1.113883.3.526.2.1571 | Hypotony of Eye |
| 2.16.840.1.113883.3.526.2.1574 | Injury to Optic Nerve and Pathways |
| 2.16.840.1.113883.3.526.2.1577 | Central Corneal Ulcer |
| 2.16.840.1.113883.3.526.2.1582 | Open Wound of Eyeball |
| 2.16.840.1.113883.3.526.2.1587 | Pathologic Myopia |
| 2.16.840.1.113883.3.526.2.1590 | Posterior Lenticonus |
| 2.16.840.1.113883.3.526.2.1601 | Retrolental Fibroplasias |
| 2.16.840.1.113883.3.526.2.1613 | Traumatic Cataract |
| 2.16.840.1.113883.3.526.2.1615 | Uveitis |
| 2.16.840.1.113883.3.526.2.1618 | Vascular Disorders of Iris and Ciliary Body |
| 2.16.840.1.113883.3.526.2.1621 | Visual Field Defects |
| 2.16.840.1.113883.3.526.2.1628 | Amblyopia |
| 2.16.840.1.113883.3.526.2.1634 | Choroidal Degenerations |
| 2.16.840.1.113883.3.526.2.1637 | Choroidal Detachment |
| 2.16.840.1.113883.3.526.2.1640 | Choroidal Hemorrhage and Rupture |
| 2.16.840.1.113883.3.526.2.1643 | Degeneration of Macula and Posterior Pole |
| 2.16.840.1.113883.3.526.2.1646 | Degenerative Disorders of Globe |
| 2.16.840.1.113883.3.526.2.1649 | Diabetic Macular Edema |
| 2.16.840.1.113883.3.526.2.1655 | Disorders of Optic Chiasm |
| 2.16.840.1.113883.3.526.2.1658 | Disorders of Visual Cortex |
| 2.16.840.1.113883.3.526.2.1661 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis |
| 2.16.840.1.113883.3.526.2.1664 | Focal Chorioretinitis and Focal Retinochoroiditis |
| 2.16.840.1.113883.3.526.2.1667 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes |
| 2.16.840.1.113883.3.526.2.1670 | Hereditary Choroidal Dystrophies |
| 2.16.840.1.113883.3.526.2.1673 | Hereditary Retinal Dystrophies |
| 2.16.840.1.113883.3.526.2.1679 | Nystagmus and Other Irregular Eye Movements |
| 2.16.840.1.113883.3.526.2.168 | Cardiac Surgery |
| 2.16.840.1.113883.3.526.2.1682 | Optic Atrophy |
| 2.16.840.1.113883.3.526.2.1685 | Optic Neuritis |
| 2.16.840.1.113883.3.526.2.1688 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis |
| 2.16.840.1.113883.3.526.2.1691 | Other Background Retinopathy and Retinal Vascular Changes |
| 2.16.840.1.113883.3.526.2.1697 | Other Disorders of Optic Nerve |
| 2.16.840.1.113883.3.526.2.1703 | Other Endophthalmitis |
| 2.16.840.1.113883.3.526.2.1709 | Prior Penetrating Keratoplasty |
| 2.16.840.1.113883.3.526.2.1715 | Purulent Endophthalmitis |
| 2.16.840.1.113883.3.526.2.1718 | Retinal Detachment with Retinal Defect |
| 2.16.840.1.113883.3.526.2.1721 | Retinal Vascular Occlusion |
| 2.16.840.1.113883.3.526.2.1724 | Other Proliferative Retinopathy |
| 2.16.840.1.113883.3.526.2.1730 | Separation of Retinal Layers |
| 2.16.840.1.113883.3.526.2.1731 | Visual Acuity 20/40 or Better |
| 2.16.840.1.113883.3.526.2.1767 | Morgagnian Cataract |
| 2.16.840.1.113883.3.526.2.1770 | Macular Scar of Posterior Polar |
| 2.16.840.1.113883.3.526.2.1771 | Ophthalmological Services |
| 2.16.840.1.113883.3.526.2.1772 | Annual Wellness Visit |
| 2.16.840.1.113883.3.526.2.1773 | Speech and Hearing Evaluation |
| 2.16.840.1.113883.3.526.2.1774 | Occupational Therapy Evaluation |
| 2.16.840.1.113883.3.526.2.1775 | Behavioral Neuropsych Assessment |
| 2.16.840.1.113883.3.526.2.1776 | Psych Visit Diagnostic Evaluation |
| 2.16.840.1.113883.3.526.2.1777 | Psych Visit Psychotherapy |
| 2.16.840.1.113883.3.526.2.1778 | Psychoanalysis |
| 2.16.840.1.113883.3.526.2.1779 | Group Psychotherapy |
| 2.16.840.1.113883.3.526.2.1780 | Psych Visit for Family Psychotherapy |
| 2.16.840.1.113883.3.526.2.1782 | Physical Therapy Evaluation |
| 2.16.840.1.113883.3.526.2.185 | Hypotension |
| 2.16.840.1.113883.3.526.2.186 | Arrhythmia |
| 2.16.840.1.113883.3.526.2.187 | Atrioventricular Block |
| 2.16.840.1.113883.3.526.2.1912 | Major Depressive Disorder Active |
| 2.16.840.1.113883.3.526.2.1924 | Cardiac Pacer in Situ |
| 2.16.840.1.113883.3.526.2.408 | Bradycardia |
| 2.16.840.1.113883.3.526.2.422 | Tobacco User |
| 2.16.840.1.113883.3.526.2.425 | Tobacco Use Cessation Counseling |
| 2.16.840.1.113883.3.526.2.469 | Bilateral Oophorectomy |
| 2.16.840.1.113883.3.526.2.483 | Chemotherapy |
| 2.16.840.1.113883.3.526.2.511 | Tobacco Non User |
| 2.16.840.1.113883.3.526.2.532 | Pregnancy |
| 2.16.840.1.113883.3.526.2.58 | Initial Myocardial Infarction |
| 2.16.840.1.113883.3.526.2.590 | End Stage Renal Disease |
| 2.16.840.1.113883.3.526.2.61 | Asthma |
| 2.16.840.1.113883.3.526.2.74 | Primary Open Angle Glaucoma |
| 2.16.840.1.113883.3.526.2.80 | Diabetic Retinopathy |
| 2.16.840.1.113883.3.526.2.859 | Left Ventricular Systolic Dysfunction |
| 2.16.840.1.113883.3.526.2.860 | Moderate or Severe |
| 2.16.840.1.113883.3.526.2.861 | Moderate or Severe LVSD |
| 2.16.840.1.113883.3.526.2.92 | Prostate Cancer |
| 2.16.840.1.113883.3.526.3.1002 | Chronic Kidney Disease, Stage 5 |
| 2.16.840.1.113883.3.526.3.1005 | Dementia and Mental Degenerations |
| 2.16.840.1.113883.3.526.3.1007 | Medical Reason |
| 2.16.840.1.113883.3.526.3.1008 | Patient Reason |
| 2.16.840.1.113883.3.526.3.1010 | Cancer |
| 2.16.840.1.113883.3.526.3.1011 | Occupational Therapy Evaluation |
| 2.16.840.1.113883.3.526.3.1012 | Patient Provider Interaction |
| 2.16.840.1.113883.3.526.3.1018 | Psych Visit for Family Psychotherapy |
| 2.16.840.1.113883.3.526.3.1022 | Physical Therapy Evaluation |
| 2.16.840.1.113883.3.526.3.1023 | Behavioral or Neuropsych Assessment |
| 2.16.840.1.113883.3.526.3.1026 | Radiation Treatment Management |
| 2.16.840.1.113883.3.526.3.1027 | Chemotherapy Administration |
| 2.16.840.1.113883.3.526.3.1090 | Moderate or Severe LVSD |
| 2.16.840.1.113883.3.526.3.1091 | Left Ventricular Systolic Dysfunction |
| 2.16.840.1.113883.3.526.3.1092 | Moderate or Severe |
| 2.16.840.1.113883.3.526.3.1140 | Patient Reason for ACE Inhibitor or ARB Decline |
| 2.16.840.1.113883.3.526.3.1141 | Psychoanalysis |
| 2.16.840.1.113883.3.526.3.1151 | Renal Failure Due to ACE Inhibitor |
| 2.16.840.1.113883.3.526.3.1170 | Tobacco User |
| 2.16.840.1.113883.3.526.3.1177 | Allergy to Beta Blocker Therapy |
| 2.16.840.1.113883.3.526.3.1178 | Intolerance to Beta Blocker Therapy |
| 2.16.840.1.113883.3.526.3.1187 | Group Psychotherapy |
| 2.16.840.1.113883.3.526.3.1189 | Tobacco Non User |
| 2.16.840.1.113883.3.526.3.1193 | Cardiac Pacer |
| 2.16.840.1.113883.3.526.3.1211 | Allergy to ACE Inhibitor or ARB |
| 2.16.840.1.113883.3.526.3.1212 | Intolerance to ACE Inhibitor or ARB |
| 2.16.840.1.113883.3.526.3.1240 | Annual Wellness Visit |
| 2.16.840.1.113883.3.526.3.1241 | Acute and Subacute Iridocyclitis |
| 2.16.840.1.113883.3.526.3.1259 | Limited Life Expectancy |
| 2.16.840.1.113883.3.526.3.1283 | Level of Severity of Retinopathy Findings |
| 2.16.840.1.113883.3.526.3.1285 | Ophthalmological Services |
| 2.16.840.1.113883.3.526.3.1320 | Macular Edema Findings Present |
| 2.16.840.1.113883.3.526.3.1332 | Cognitive Assessment |
| 2.16.840.1.113883.3.526.3.1409 | Burn Confined to Eye and Adnexa |
| 2.16.840.1.113883.3.526.3.1410 | Cataract Secondary to Ocular Disorders |
| 2.16.840.1.113883.3.526.3.1411 | Cataract Surgery |
| 2.16.840.1.113883.3.526.3.1412 | Cataract Congenital |
| 2.16.840.1.113883.3.526.3.1413 | Cataract Mature or Hypermature |
| 2.16.840.1.113883.3.526.3.1414 | Cataract Posterior Polar |
| 2.16.840.1.113883.3.526.3.1415 | Certain Types of Iridocyclitis |
| 2.16.840.1.113883.3.526.3.1416 | Chronic Iridocyclitis |
| 2.16.840.1.113883.3.526.3.1417 | Cloudy Cornea |
| 2.16.840.1.113883.3.526.3.1418 | Corneal Edema |
| 2.16.840.1.113883.3.526.3.1419 | Disorders of Cornea Including Corneal Opacity |
| 2.16.840.1.113883.3.526.3.1423 | Glaucoma |
| 2.16.840.1.113883.3.526.3.1424 | Hereditary Corneal Dystrophies |
| 2.16.840.1.113883.3.526.3.1426 | Hypotony of Eye |
| 2.16.840.1.113883.3.526.3.1427 | Injury to Optic Nerve and Pathways |
| 2.16.840.1.113883.3.526.3.1428 | Central Corneal Ulcer |
| 2.16.840.1.113883.3.526.3.1430 | Open Wound of Eyeball |
| 2.16.840.1.113883.3.526.3.1432 | Pathologic Myopia |
| 2.16.840.1.113883.3.526.3.1433 | Posterior Lenticonus |
| 2.16.840.1.113883.3.526.3.1438 | Retrolental Fibroplasias |
| 2.16.840.1.113883.3.526.3.1443 | Traumatic Cataract |
| 2.16.840.1.113883.3.526.3.1444 | Uveitis |
| 2.16.840.1.113883.3.526.3.1445 | Vascular Disorders of Iris and Ciliary Body |
| 2.16.840.1.113883.3.526.3.1446 | Visual Field Defects |
| 2.16.840.1.113883.3.526.3.1448 | Amblyopia |
| 2.16.840.1.113883.3.526.3.1450 | Choroidal Degenerations |
| 2.16.840.1.113883.3.526.3.1451 | Choroidal Detachment |
| 2.16.840.1.113883.3.526.3.1452 | Choroidal Hemorrhage and Rupture |
| 2.16.840.1.113883.3.526.3.1453 | Degeneration of Macula and Posterior Pole |
| 2.16.840.1.113883.3.526.3.1454 | Degenerative Disorders of Globe |
| 2.16.840.1.113883.3.526.3.1455 | Diabetic Macular Edema |
| 2.16.840.1.113883.3.526.3.1457 | Disorders of Optic Chiasm |
| 2.16.840.1.113883.3.526.3.1458 | Disorders of Visual Cortex |
| 2.16.840.1.113883.3.526.3.1459 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis |
| 2.16.840.1.113883.3.526.3.1460 | Focal Chorioretinitis and Focal Retinochoroiditis |
| 2.16.840.1.113883.3.526.3.1461 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes |
| 2.16.840.1.113883.3.526.3.1462 | Hereditary Choroidal Dystrophies |
| 2.16.840.1.113883.3.526.3.1463 | Hereditary Retinal Dystrophies |
| 2.16.840.1.113883.3.526.3.1465 | Nystagmus and Other Irregular Eye Movements |
| 2.16.840.1.113883.3.526.3.1466 | Optic Atrophy |
| 2.16.840.1.113883.3.526.3.1467 | Optic Neuritis |
| 2.16.840.1.113883.3.526.3.1468 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis |
| 2.16.840.1.113883.3.526.3.1469 | Other Background Retinopathy and Retinal Vascular Changes |
| 2.16.840.1.113883.3.526.3.1471 | Other Disorders of Optic Nerve |
| 2.16.840.1.113883.3.526.3.1473 | Other Endophthalmitis |
| 2.16.840.1.113883.3.526.3.1475 | Prior Penetrating Keratoplasty |
| 2.16.840.1.113883.3.526.3.1477 | Purulent Endophthalmitis |
| 2.16.840.1.113883.3.526.3.1478 | Retinal Detachment with Retinal Defect |
| 2.16.840.1.113883.3.526.3.1479 | Retinal Vascular Occlusion |
| 2.16.840.1.113883.3.526.3.1480 | Other Proliferative Retinopathy |
| 2.16.840.1.113883.3.526.3.1482 | Separation of Retinal Layers |
| 2.16.840.1.113883.3.526.3.1483 | Visual Acuity 20/40 or Better |
| 2.16.840.1.113883.3.526.3.1491 | Major Depressive Disorder Active |
| 2.16.840.1.113883.3.526.3.1492 | Psych Visit Diagnostic Evaluation |
| 2.16.840.1.113883.3.526.3.1496 | Psych Visit Psychotherapy |
| 2.16.840.1.113883.3.526.3.1530 | Speech and Hearing Evaluation |
| 2.16.840.1.113883.3.526.3.1558 | Morgagnian Cataract |
| 2.16.840.1.113883.3.526.3.1559 | Macular Scar of Posterior Polar |
| 2.16.840.1.113883.3.526.3.1563 | Underweight |
| 2.16.840.1.113883.3.526.3.1568 | Follow Up for Adult Depression |
| 2.16.840.1.113883.3.526.3.1569 | Follow Up for Adolescent Depression |
| 2.16.840.1.113883.3.526.3.1570 | Referral for Adolescent Depression |
| 2.16.840.1.113883.3.526.3.1571 | Referral for Adult Depression |
| 2.16.840.1.113883.3.526.3.1576 | Outpatient Encounters for Preventive Care |
| 2.16.840.1.113883.3.526.3.1578 | Follow Up Within 4 Weeks |
| 2.16.840.1.113883.3.526.3.1580 | Referral to Primary Care or Alternate Provider |
| 2.16.840.1.113883.3.526.3.1581 | Lifestyle Recommendation |
| 2.16.840.1.113883.3.526.3.1582 | Patient Declined |
| 2.16.840.1.113883.3.526.3.1583 | Referral or Counseling for Alcohol Consumption |
| 2.16.840.1.113883.3.526.3.1584 | Hospice Care Ambulatory |
| 2.16.840.1.113883.3.526.3.319 | Prostate Cancer |
| 2.16.840.1.113883.3.526.3.326 | Primary Open Angle Glaucoma |
| 2.16.840.1.113883.3.526.3.327 | Diabetic Retinopathy |
| 2.16.840.1.113883.3.526.3.353 | End Stage Renal Disease |
| 2.16.840.1.113883.3.526.3.362 | Asthma |
| 2.16.840.1.113883.3.526.3.366 | Arrhythmia |
| 2.16.840.1.113883.3.526.3.367 | Atrioventricular Block |
| 2.16.840.1.113883.3.526.3.368 | Cardiac Pacer in Situ |
| 2.16.840.1.113883.3.526.3.369 | Coronary Artery Disease No MI |
| 2.16.840.1.113883.3.526.3.370 | Hypotension |
| 2.16.840.1.113883.3.526.3.371 | Cardiac Surgery |
| 2.16.840.1.113883.3.526.3.376 | Heart Failure |
| 2.16.840.1.113883.3.526.3.378 | Pregnancy |
| 2.16.840.1.113883.3.526.3.398 | Prostate Cancer Treatment |
| 2.16.840.1.113883.3.526.3.399 | Salvage Therapy |
| 2.16.840.1.113883.3.526.3.403 | Initial Myocardial Infarction |
| 2.16.840.1.113883.3.526.3.412 | Bradycardia |
| 2.16.840.1.113883.3.526.3.451 | Pain Warranting Further Investigation for Prostate Cancer |
| 2.16.840.1.113883.3.526.3.471 | Bilateral Oophorectomy |
| 2.16.840.1.113883.3.526.3.485 | Chemotherapy |
| 2.16.840.1.113883.3.526.3.509 | Tobacco Use Cessation Counseling |
| 2.16.840.1.113883.3.600.1.1525 | Follow Up for Above Normal BMI |
| 2.16.840.1.113883.3.600.1.1526 | Follow Up for Above Normal BMI |
| 2.16.840.1.113883.3.600.1.1527 | Referrals Where Weight Assessment May Occur |
| 2.16.840.1.113883.3.600.1.1528 | Follow Up for Below Normal BMI |
| 2.16.840.1.113883.3.600.1.1551 | Follow Up for Below Normal BMI |
| 2.16.840.1.113883.3.600.1.1578 | Palliative Care |
| 2.16.840.1.113883.3.600.1.1579 | Palliative or Hospice Care |
| 2.16.840.1.113883.3.600.1.1610 | Referrals Where Weight Assessment May Occur |
| 2.16.840.1.113883.3.600.1.1751 | Encounter to Evaluate BMI |
| 2.16.840.1.113883.3.600.1.1834 | Encounter to Document Medications |
| 2.16.840.1.113883.3.600.1.1917 | Encounter to Document Medications |
| 2.16.840.1.113883.3.600.1.886 | Encounter to Evaluate BMI |
| 2.16.840.1.113883.3.600.1475 | Referral to Primary Care or Alternate Provider |
| 2.16.840.1.113883.3.600.1508 | Lifestyle Recommendation |
| 2.16.840.1.113883.3.600.1510 | Weight Reduction Recommended |
| 2.16.840.1.113883.3.600.1511 | Dietary Recommendations |
| 2.16.840.1.113883.3.600.1515 | Dietary Recommendations |
| 2.16.840.1.113883.3.600.1518 | Recommendation to Increase Physical Activity |
| 2.16.840.1.113883.3.600.1537 | Follow Up Within 4 Weeks |
| 2.16.840.1.113883.3.600.1914 | Encounter to Screen for Depression |
| 2.16.840.1.113883.3.600.1916 | Encounter to Screen for Depression |
| 2.16.840.1.113883.3.600.1918 | Encounter to Screen for Blood Pressure |
| 2.16.840.1.113883.3.600.1920 | Encounter to Screen for Blood Pressure |
| 2.16.840.1.113883.3.600.2387 | Overweight or Obese |
| 2.16.840.1.113883.3.600.2388 | Underweight |
| 2.16.840.1.113883.3.600.2395 | Finding of Hypertension |
| 2.16.840.1.113883.3.600.259 | Diagnosis of Hypertension |
| 2.16.840.1.113883.3.600.263 | Diagnosis of Hypertension |
| 2.16.840.1.113883.3.600.467 | Follow Up for Adolescent Depression |
| 2.16.840.1.113883.3.600.468 | Follow Up for Adult Depression |
| 2.16.840.1.113883.3.600.537 | Referral for Adolescent Depression |
| 2.16.840.1.113883.3.600.538 | Referral for Adult Depression |
| 2.16.840.1.113883.3.600.791 | Patient Declined |
| 2.16.840.1.113883.3.600.805 | Weight Reduction Recommended |
| 2.16.840.1.113883.3.600.810 | Recommendation to Increase Physical Activity |
| 2.16.840.1.113883.3.600.823 | Referral or Counseling for Alcohol Consumption |
| 2.16.840.1.113883.3.666.5.1250 | Major Surgical Procedure |
| 2.16.840.1.113883.3.666.5.1743 | General or Neuraxial Anesthesia |
| 2.16.840.1.113883.3.666.5.1940 | Immunocompromised Conditions |
| 2.16.840.1.113883.3.666.5.2262 | CABG Surgeries |
| 2.16.840.1.113883.3.666.5.2343 | Immunocompromised Conditions |
| 2.16.840.1.113883.3.666.5.3011 | Acute Myocardial Infarction |
| 2.16.840.1.113883.3.666.5.3024 | Acute Myocardial Infarction |
| 2.16.840.1.113883.3.666.5.307 | Encounter Inpatient |
| 2.16.840.1.113883.3.666.5.335 | Bone Marrow Transplant |
| 2.16.840.1.113883.3.666.5.336 | Bone Marrow Transplant |
| 2.16.840.1.113883.3.666.5.694 | CABG Surgeries |
| 2.16.840.1.113883.3.666.5.737 | PCI |
| 2.16.840.1.113883.3.666.5.747 | Endotracheal Intubation |
| 2.16.840.1.113883.3.67.1.101.1.128 | Bipolar Disorder |
| 2.16.840.1.113883.3.67.1.101.1.246 | Personality Disorder Emotionally Labile |
| 2.16.840.1.113883.3.67.1.101.1.249 | Personality Disorder Emotionally Labile |
| 2.16.840.1.113883.3.67.1.101.1.254 | Dysthymia |
| 2.16.840.1.113883.3.67.1.101.1.257 | Dysthymia |
| 2.16.840.1.113883.3.67.1.101.1.262 | Deceased |
| 2.16.840.1.113883.3.67.1.101.1.269 | Hepatitis B |
| 2.16.840.1.113883.3.67.1.101.1.272 | Hepatitis B |
| 2.16.840.1.113883.3.67.1.101.1.273 | Live Birth or Delivery |
| 2.16.840.1.113883.3.67.1.101.1.275 | Live Birth or Delivery |
| 2.16.840.1.113883.3.67.1.101.1.278 | Delivery - Diagnosis |
| 2.16.840.1.113883.3.67.1.101.1.44 | Bipolar Disorder |
| 2.16.840.1.113883.3.67.1.101.1.82 | Delivery |
| 2.16.840.1.113883.3.67.1.101.11.721 | Deceased |
| 2.16.840.1.113883.3.8420.2.1001 | Strabismic Amblyopia |
| 2.16.840.1.113883.3.8420.2.1003 | Refractive Amblyopia |
| 2.16.840.1.113883.3.8420.2.1008 | Aphakia |
| 2.16.840.1.113883.3.8420.2.1010 | Infantile and Juvenile Cataract |
| 2.16.840.1.113883.3.8420.2.1012 | Congenital Corneal or Anterior Segment Conditions |
| 2.16.840.1.113883.3.8420.2.1014 | Eyelid or Orbital Conditions |
| 2.16.840.1.113883.3.8420.2.1016 | Coloboma of Optic Disc |
| 2.16.840.1.113883.3.8420.2.1018 | Hemorrhage of Optic Nerve Sheath |
| 2.16.840.1.113883.3.8420.2.1020 | Optic Nerve Hypoplasia |
| 2.16.840.1.113883.3.8420.2.1022 | Disorder of Visual Cortex Due to Underlying Condition |
| 2.16.840.1.113883.3.8420.2.1024 | Cortical Blindness |
| 2.16.840.1.113883.3.8420.2.1026 | Congenital Condition of Retina |
| 2.16.840.1.113883.3.8420.3.1000 | Strabismic Amblyopia |
| 2.16.840.1.113883.3.8420.3.1001 | Refractive Amblyopia |
| 2.16.840.1.113883.3.8420.3.1005 | Aphakia |
| 2.16.840.1.113883.3.8420.3.1006 | Infantile and Juvenile Cataract |
| 2.16.840.1.113883.3.8420.3.1007 | Congenital Corneal or Anterior Segment Conditions |
| 2.16.840.1.113883.3.8420.3.1008 | Eyelid or Orbital Conditions |
| 2.16.840.1.113883.3.8420.3.1009 | Coloboma of Optic Disc |
| 2.16.840.1.113883.3.8420.3.1010 | Hemorrhage of Optic Nerve Sheath |
| 2.16.840.1.113883.3.8420.3.1011 | Optic Nerve Hypoplasia |
| 2.16.840.1.113883.3.8420.3.1012 | Disorder of Visual Cortex Due to Underlying Condition |
| 2.16.840.1.113883.3.8420.3.1013 | Cortical Blindness |
| 2.16.840.1.113883.3.8420.3.1014 | Congenital Condition of Retina |
| 2.16.840.1.113883.3.88.12.3221.6.2 | Allergy and Intolerance Type |
| 2.16.840.1.113883.3.88.12.3221.6.8 | Severity |
| 2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type (SNOMEDCT) |
| 2.16.840.1.113883.3.88.12.3221.7.4 | Problem |
| 2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| 2.16.840.1.113883.3.88.12.80.28 | Procedure |
| 2.16.840.1.113883.3.88.12.80.60 | Social History Type (SCT) |
| 2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| 2.16.840.1.114222.24.7.14 | Clinically Important Bacteria and Fungi |
| 2.16.840.1.114222.24.7.281 | Bacterial Skin Commensals |
| 2.16.840.1.114222.4.11.3180 | NHSNInsertionSiteCode |
| 2.16.840.1.114222.4.11.3181 | NHSNRoleOfPerformerCode |
| 2.16.840.1.114222.4.11.3194 | NHSNSignificantPathogenCode |
| 2.16.840.1.114222.4.11.3195 | NHSNCriterionOfDiagnosisCode |
| 2.16.840.1.114222.4.11.3196 | NHSNInfectionConditionCode |
| 2.16.840.1.114222.4.11.3249 | NHSNSpecimenTypeCode |
| 2.16.840.1.114222.4.11.3283 | NHSNOrganismASTCode |
| 2.16.840.1.114222.4.11.3361 | NHSNRouteOfAdministrationAURPCode |
| 2.16.840.1.114222.4.11.6007 | NHSNVascularAccessTypeCode |
| 2.16.840.1.114222.4.11.6074 | NHSNStaphAureusTestResults |
| 2.16.840.1.114222.4.11.7214 | NHSNSameDayOutcomeMeasure |
| 2.16.840.1.114222.4.11.7215 | NHSNInfectionFirstReportedSource |
| 2.16.840.113883.3.67.1.101.3.2444 | Major Depression Including Remission |
| nkrs-serumtumourmarkers | NKRS - Serum Tumour Markers |
| nkrs-treatmentgoal | NKRS - Treatment Goal |
| nkrs-whocnsgradingsystem | NKRS - WHO(CNS) Grading System |
| KBV_VS_MIO_DIGA_Problem_Type | Problemtyp |
| JDV-J151-BodySiteBodyTemperature-ENS | JDV_J151_BodySiteBodyTemperature_ENS |
| designation-use | Designation Use |
| jdv-abord-veineux-central-cisis | JDV Abord Veineux Central CISIS |
| jdv-abord-veineux-peripherique-cisis | JDV Abord Veineux Peripherique CISIS |
| jdv-acces-artere-cisis | JDV Acces Artere CISIS |
| jdv-acte-obp-cisis | JDV Acte Obp CISIS |
| jdv-addition-grandeur-cisis | JDV Addition Grandeur CISIS |
| jdv-age-cisis | JDV Age CISIS |
| jdv-aide-au-deplacement-cisis | JDV Aide Au Deplacement CISIS |
| jdv-allergie-vaccin-cisis | JDV Allergie Vaccin CISIS |
| jdv-antecedent-personnel-cisis | JDV Antecedent Personnel CISIS |
| jdv-appreciation-diagnostic-centre-cisis | JDV Appreciation Diagnostic Centre CISIS |
| jdv-artere-anterieure-cisis | JDV Artere Anterieure CISIS |
| jdv-artere-cervelet-cisis | JDV Artere Cervelet CISIS |
| jdv-artere-posterieure-cisis | JDV Artere Posterieure CISIS |
| jdv-artere-tronc-cisis | JDV Artere Tronc CISIS |
| jdv-aspect-liquide-amniotique-cisis | JDV Aspect Liquide Amniotique CISIS |
| jdv-autre-risque-cisis | JDV Autre Risque CISIS |
| jdv-autre-symptome-avc-cisis | JDV Autre Symptome Avc CISIS |
| jdv-autre-symptome-ex-neuro-cisis | JDV Autre Symptome Ex Neuro CISIS |
| jdv-cas-sporadique-familial-cisis | JDV Cas Sporadique Familial CISIS |
| jdv-cdd-fa-cisis | JDV Cdd Fa CISIS |
| jdv-cervelet-localisation-cisis | JDV Cervelet Localisation CISIS |
| jdv-circonstance-deces-cisis | JDV Circonstance Deces CISIS |
| jdv-code-probleme-cisis | JDV Code Probleme CISIS |
| jdv-conduite-a-tenir-1-cisis | JDV Conduite A Tenir 1 CISIS |
| jdv-conduite-a-tenir-2-cisis | JDV Conduite A Tenir 2 CISIS |
| jdv-conduite-a-tenir-3-cisis | JDV Conduite A Tenir 3 CISIS |
| jdv-contexte-activite-cisis | JDV Contexte Activite CISIS |
| jdv-contre-indication-cisis | JDV Contrindication CISIS |
| jdv-date-consultation-cisis | JDV Date Consultation CISIS |
| jdv-deficience-physique-cisis | JDV Deficience Physique CISIS |
| jdv-depistage-neonatal-cisis | Jdv Depistage Neonatal CISIS |
| jdv-deplacement-cisis | JDV Deplacement CISIS |
| jdv-destination-obp-sne-cisis | JDV Destination Obp Sne CISIS |
| jdv-destination-transfert-cisis | JDV Destination Transfert CISIS |
| jdv-difficulte-cisis | JDV Difficulte CISIS |
| jdv-disposition-pretherapeutique-cisis | JDV Disposition Pretherapeutique CISIS |
| jdv-etat-naissance-cisis | JDV Etat Naissance CISIS |
| jdv-etat-perinee-cisis | JDV Etat Perinee CISIS |
| jdv-etat-psychique-cisis | JDV Etat Psychique CISIS |
| jdv-etiologie-avc-cisis | JDV Etiologie Avc CISIS |
| jdv-evaluation-depression-geriatrique-resultat-cisis | JDV Evaluation Depression Geriatrique Resultat CISIS |
| jdv-evaluation-douleur-cisis | JDV Evaluation Douleur CISIS |
| jdv-evolution-cisis | JDV Evolution CISIS |
| jdv-examen-realise-cisis | JDV Examen Realise CISIS |
| jdv-facteur-de-risque-professionnel-cisis | JDV Facteur De Risque Professionnel CISIS |
| jdv-facteur-de-risque-social-cisis | JDV Facteur De Risque Social CISIS |
| jdv-geste-reanimation-nouveau-ne-cisis | JDV Geste Reanimation Nouveau Ne CISIS |
| jdv-gravite-cisis | JDV Gravite CISIS |
| jdv-groupe-rhesus-cisis | JDV Groupe Rhesus CISIS |
| jdv-handicap-deficit-dlu-dom-cisis | JDV Handicap Deficit Dlu Dom CISIS |
| jdv-handicap-deficit-dlu-ehpad-cisis | JDV Handicap Deficit Dlu Ehpad CISIS |
| jdv-health-status-code-cisis | JDV Health Status Code CISIS |
| jdv-hemisphere-lobaire-cisis | JDV Hemisphere Lobaire CISIS |
| jdv-hemisphere-profond-cisis | JDV Hemisphere Profond CISIS |
| jdv-human-substance-administration-site-cisis | JDV Human Substance Administration Site CISIS |
| jdv-immunization-approach-site-code-cisis | JDV Immunization Approach Site Code CISIS |
| jdv-impact-mutation-cisis | JDV Impact Mutation CISIS |
| jdv-importance-clinique-cisis | JDV Importance Clinique CISIS |
| jdv-imputabilite-cisis | JDV Imputabilite CISIS |
| jdv-interpretation-ecg-cisis | JDV Interpretation Ecg CISIS |
| jdv-investigation-realisee-cisis | JDV Investigation Realisee CISIS |
| jdv-issue-grossesse-cisis | JDV Issue Grossesse CISIS |
| jdv-jour-semaine-cisis | JDV Jour Semaine CISIS |
| jdv-lateralite-cisis | JDV Lateralite CISIS |
| jdv-lateralite-manuelle-cisis | JDV Lateralite Manuelle CISIS |
| jdv-lateralite-technique-imagerie-cisis | JDV Lateralite Technique Imagerie CISIS |
| jdv-lieu-accouchement-cisis | JDV Lieu Accouchement CISIS |
| jdv-lieu-de-vie-cisis | JDV Lieu De Vie CISIS |
| jdv-localisation-anatomique-cisis | JDV Localisation Anatomique CISIS |
| jdv-localisation-anesthesie-cisis | JDV Localisation Anesthesie CISIS |
| jdv-localisation-hemorragie-cerebrale-cisis | JDV Localisation Hemorragie Cerebrale CISIS |
| jdv-localisation-infarctus-cerebral-cisis | JDV Localisation Infarctus Cerebral CISIS |
| jdv-localisation-prelevement-ccu-cisis | JDV Localisation Prelevement Ccu CISIS |
| jdv-localisation-thrombose-veineuse-cisis | JDV Localisation Thrombose Veineuse CISIS |
| jdv-malformation-antenatale-cisis | JDV Malformation Antenatale CISIS |
| jdv-mesure-associee-cisis | JDV Mesure Associee CISIS |
| jdv-methode-accouchement-cisis | JDV Methode Accouchement CISIS |
| jdv-methode-de-mesure-acuite-visuelle-cisis | JDV Methode De Mesure Acuite Visuelle CISIS |
| jdv-modalite-entree-cisis | JDV Modalite Entree CISIS |
| jdv-modalite-sortie-cisis | JDV Modalite Sortie CISIS |
| jdv-mode-accouchement-cisis | JDV Mode Accouchement CISIS |
| jdv-mode-de-vie-cisis | JDV Mode De Vie CISIS |
| jdv-mode-debut-travail-cisis | JDV Mode Debut Travail CISIS |
| jdv-mode-naissance-cisis | JDV Mode Naissance CISIS |
| jdv-mode-sortie-cisis | JDV Mode Sortie CISIS |
| jdv-mode-sortie-obp-scm-cisis | JDV Mode Sortie Obp Scm CISIS |
| jdv-mode-sortie-obp-sem-cisis | JDV Mode Sortie Obp Sem CISIS |
| jdv-mode-sortie-obp-sne-cisis | JDV Mode Sortie Obp Sne CISIS |
| jdv-mode-sortie-obp-snm-cisis | JDV Mode Sortie Obp Snm CISIS |
| jdv-modificateur-topographique-cisis | JDV Modificateur Topographique CISIS |
| jdv-motif-echographie-cisis | JDV Motif Echographie CISIS |
| jdv-motif-mise-a-jour-cisis | JDV Motif Mise A Jour CISIS |
| jdv-objectif-activite-cisis | JDV Objectif Activite CISIS |
| jdv-obp-test-audition-cisis | JDV Obp Test Audition CISIS |
| jdv-observation-enfant-cisis | JDV Observation Enfant CISIS |
| jdv-observation-etat-patient-cisis | JDV Observation Etat Patient CISIS |
| jdv-oeil-examine-cisis | JDV Oeil Examine CISIS |
| jdv-orientation-base-du-prisme-cisis | JDV Orientation Base Du Prisme CISIS |
| jdv-origine-effet-indesirable-cisis | JDV Origine Effet Indesirable CISIS |
| jdv-patho-1ere-semaine-cs8-cisis | JDV Patho 1ere Semaine Cs8 CISIS |
| jdv-presentation-foetale-cisis | JDV Presentation Foetale CISIS |
| jdv-prise-en-charge-reguliere-cisis | JDV Prise En Charge Reguliere CISIS |
| jdv-quantite-liquide-amniotique-cisis | JDV Quantite Liquide Amniotique CISIS |
| jdv-rcp-appareil-cisis | JDV RCP Appareil CISIS |
| jdv-rcp-organe-cisis | JDV RCP Organe CISIS |
| jdv-realisation-activite-cisis | JDV Realisation Activite CISIS |
| jdv-recherche-aghbs-cisis | JDV Recherche Aghbs CISIS |
| jdv-reference-range-applies-to-cisis | JDV Reference Range Applies To CISIS |
| jdv-region-anatomique-cisis | JDV Region Anatomique CISIS |
| jdv-reperage-trouble-neurodeveloppement-cisis | JDV Reperage Trouble Neurodeveloppement CISIS |
| jdv-ressource-utilisee-cisis | JDV Ressource Utilisee CISIS |
| jdv-resultat-depistage-acide-ascorbique-cisis | JDV Resultat Depistage Acide Ascorbique CISIS |
| jdv-resultat-depistage-bilirubinemie-cisis | JDV Resultat Depistage Bilirubinemie CISIS |
| jdv-resultat-depistage-bilirubinurie-cisis | JDV Resultat Depistage Bilirubinurie CISIS |
| jdv-resultat-depistage-cetonemie-cisis | JDV Resultat Depistage Cetonemie CISIS |
| jdv-resultat-depistage-cholesterol-cisis | JDV Resultat Depistage Cholesterol CISIS |
| jdv-resultat-depistage-cisis | JDV Resultat Depistage CISIS |
| jdv-resultat-depistage-corps-cetoniques-cisis | JDV Resultat Depistage Corps Cetoniques CISIS |
| jdv-resultat-depistage-crp-cisis | JDV Resultat Depistage Crp CISIS |
| jdv-resultat-depistage-glucose-cisis | JDV Resultat Depistage Glucose CISIS |
| jdv-resultat-depistage-glycemie-cisis | JDV Resultat Depistage Glycemie CISIS |
| jdv-resultat-depistage-hematurie-cisis | JDV Resultat Depistage Hematurie CISIS |
| jdv-resultat-depistage-leucocyturie-cisis | JDV Resultat Depistage Leucocyturie CISIS |
| jdv-resultat-depistage-nitriturie-cisis | JDV Resultat Depistage Nitriturie CISIS |
| jdv-resultat-depistage-proteinurie-cisis | JDV Resultat Depistage Proteinurie CISIS |
| jdv-resultat-depistage-rupture-membrane-ph-cisis | JDV Resultat Depistage Rupture Membrane Ph CISIS |
| jdv-resultat-depistage-urobilinogenurie-cisis | JDV Resultat Depistage Urobilinogenurie CISIS |
| jdv-resultat-recherche-hpv-ccu-cisis | JDV Resultat Recherche Hpv Ccu CISIS |
| jdv-score-asa-cisis | JDV Score Asa CISIS |
| jdv-score-cormack-cisis | JDV Score Cormack CISIS |
| jdv-score-mallampati-cisis | JDV Score Mallampati CISIS |
| jdv-sedentarite-cisis | JDV Sedentarite CISIS |
| jdv-severite-observation-cisis | JDV Severite Observation CISIS |
| jdv-site-intervention-cisis | JDV Site Intervention CISIS |
| jdv-static-sem-procedure-cisis | JDV Static Sem Procedure CISIS |
| jdv-statut-actuel-diagnostic-cisis | JDV Statut Actuel Diagnostic CISIS |
| jdv-statut-document-cisis | JDV Statut Document CISIS |
| jdv-statut-evt-cisis | JDV Statut Evt CISIS |
| jdv-statut-grossesse-cisis | JDV Statut Grossesse CISIS |
| jdv-statut-resultat-cisis | JDV Statut Resultat CISIS |
| jdv-statut-tabagique-cisis | JDV Statut Tabagique CISIS |
| jdv-symptome-avc-cisis | JDV Symptome Avc CISIS |
| jdv-taille-cisis | JDV Taille CISIS |
| jdv-technique-diagnostic-cisis | JDV Technique Diagnostic CISIS |
| jdv-topo-trouble-cisis | JDV Topo Trouble CISIS |
| jdv-traitement-preventif-cisis | JDV Traitement Preventif CISIS |
| jdv-transfert-mutation-cisis | JDV Transfert Mutation CISIS |
| jdv-type-acte-eunv-cisis | JDV Type Acte Eunv CISIS |
| jdv-type-acte-post-partum-cisis | JDV Type Acte Post Partum CISIS |
| jdv-type-analgesie-cisis | JDV Type Analgesie CISIS |
| jdv-type-anesthesie-apres-naissance-cisis | JDV Type Anesthesie Apres Naissance CISIS |
| jdv-type-anesthesie-avant-naissance-cisis | JDV Type Anesthesie Avant Naissance CISIS |
| jdv-type-anesthesie-cisis | JDV Type Anesthesie CISIS |
| jdv-type-de-distance-de-visualisation-cisis | JDV Type De Distance De Visualisation CISIS |
| jdv-type-de-suivi-cisis | JDV Type De Suivi CISIS |
| jdv-type-directive-anticipee-cisis | JDV Type Directive Anticipee CISIS |
| jdv-type-dispositif-oculaire-cisis | JDV Type Dispositif Oculaire CISIS |
| jdv-type-evenement-indesirable-previsible-cisis | JDV Type Evenement Indesirable Previsible CISIS |
| jdv-type-garde-cisis | JDV Type Garde CISIS |
| jdv-type-intervention-cisis | JDV Type Intervention CISIS |
| jdv-type-intervention-voie-basse-cisis | JDV Type Intervention Voie Basse CISIS |
| jdv-type-intubation-cisis | JDV Type Intubation CISIS |
| jdv-type-presentation-cisis | JDV Type Presentation CISIS |
| jdv-type-service-cisis | JDV Type Service CISIS |
| jdv-type-traitement-frcp-cisis | JDV Type Traitement Frcp CISIS |
| jdv-type-traitement-iv-cisis | JDV Type Traitement Iv CISIS |
| jdv-type-traitement-pps-cisis | JDV Type Traitement Pps CISIS |
| jdv-ufcv-composant-prothese-valvulaire-cisis | JDV UFCV Composant Prothese Valvulaire CISIS |
| jdv-ufcv-lateralite-cisis | JDV UFCV Lateralite CISIS |
| jdv-ufcv-localisation-defibrillateur-cisis | JDV UFCV Localisation Defibrillateur CISIS |
| jdv-ufcv-localisation-sonde-cisis | JDV UFCV Localisation Sonde CISIS |
| jdv-ufcv-stade-nyha-cisis | JDV UFCV Stade Nyha CISIS |
| jdv-ufcv-voie-abord-cisis | JDV UFCV Voie Abord CISIS |
| myhealthway-allergyintolerance-manifestation-codes | MyHealthWay AllergyIntolerance Manifestation Codes |
| myhealthway-snomedct-codes | MyHealthWay SNOMED CT Codes |
| family-member-relationship-code | FamilyMemberRelationshipCode_AB |
| amt-mp-codes | AMT Medicinal Product and Substances |
| smoking-status | Smoking Status |
| krcore-condition-codes | KR Core Condition Code |
| krcore-observation-labresult-codes | KR Core Lab Result Observation Codes |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem WHODDCCsnomed
This case-sensitive code system http://snomed.info/sct defines the following codes:
FHIR{
"resourceType": "CodeSystem",
"id": "WHODDCCsnomed",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://snomed.info/sct",
"version": "1.0.0",
"name": "WHODDCCsnomed",
"title": "SNOMED codes used in this IG",
"status": "draft",
"experimental": true,
"date": "2025-06-24T09:07:32+00:00",
"publisher": "WHO",
"contact": [
{
"name": "WHO",
"telecom": [
{
"system": "url",
"value": "http://who.int"
}
]
}
],
"description": "All SNOMED codes from `http://snomed.info/sct` used in this IG. Provided so the FHIR server can perform expansions.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001"
}
]
}
],
"caseSensitive": true,
"content": "complete",
"count": 113,
"concept": [
{
"code": "1031000172108",
"display": "COVID-19 mRNA vaccine (BNT162b2) of Pfizer-BioNTech"
},
{
"code": "10871000172106",
"display": "COVID-19 mRNA vaccine (mRNA-1273) of Moderna"
},
{
"code": "10891000172107",
"display": "COVID-19 viral vector vaccine (AZD1222 (ChAdOx1-S recombinant)) of AstraZeneca, Oxford"
},
{
"code": "10901000172106",
"display": "COVID-19 viral vector vaccine (JNJ-78436735( Ad26.COV2-S recombinant)) of Johnson and Johnson, Janssens"
},
{
"code": "125071000220108",
"display": "COVID-19 mRNA Vaccine Pfizer-BioNTech 10 micrograms/dose concentrate for dispersion for injection"
},
{
"code": "125081000220106",
"display": "COVID-19 mRNA Vaccine Ready to Use Pfizer-BioNTech 30 micrograms/ 0.3 milliliter dose dispersion for injection"
},
{
"code": "125091000220109",
"display": "COVID-19 mRNA Ready to Use Adapted BA.1 Vaccine Pfizer-BioNTech 15 / 15 micrograms/ 0.3 milliliter dose dispersion for injection"
},
{
"code": "125101000220104",
"display": "COVID-19 mRNA Ready to Use Adapted BA.4 and BA.5 Vaccine Pfizer-BioNTech 15 / 15 micrograms/ 0.3 milliliter dose dispersion for injection"
},
{
"code": "125111000220101",
"display": "COVID-19 mRNA Adapted BA.1 Vaccine Moderna (50 micrograms/50 micrograms) / milliliter dispersion for injection"
},
{
"code": "125121000220108",
"display": "COVID-19 mRNA Adapted BA.4 nd BA.5 Vaccine Moderna (50 micrograms/50 micrograms) / milliliter dispersion for injection"
},
{
"code": "1401000220108",
"display": "COVID-19 Vaccine AstraZeneca 5 x10,000,000,000 viral particles/per 0.5ml dose for injection multidose vials"
},
{
"code": "1411000220106",
"display": "COVID-19 mRNA Vaccine Pfizer-BioNTech 30 micrograms per 0.3ml dose concentrate for suspension for injection multidose vials"
},
{
"code": "1421000220104",
"display": "COVID-19 mRNA Vaccine Moderna 0.1mg per 0.5mL dose dispersion for injection multidose vials"
},
{
"code": "28571000087109",
"display": "COVID-19 SPIKEVAX 0.20 mg/mL mRNA Mod"
},
{
"code": "28581000087106",
"display": "COVID-19 COMIRNATY 30 mcg/0.3 ml mRNA PB"
},
{
"code": "28761000087108",
"display": "COVID-19 VAXZEVRIA AZC"
},
{
"code": "28951000087107",
"display": "COVID-19 JANSSEN COVID-19 VACCINE Jan"
},
{
"code": "28961000087105",
"display": "COVID-19 COVISHIELD VP"
},
{
"code": "29171000087106",
"display": "COVID-19 NUVAXOVID NOV"
},
{
"code": "30151000087105",
"display": "COVID-19 COVIFENZ VLP MED"
},
{
"code": "31301000087101",
"display": "COVID-19 SINOPHARM-BIBP"
},
{
"code": "31311000087104",
"display": "COVID-19 CoronaVac"
},
{
"code": "31341000087103",
"display": "COVID-19 Sputnik V"
},
{
"code": "31431000087100",
"display": "COVID-19 Convidecia"
},
{
"code": "33201000087108",
"display": "COVID-19 SINOPHARM-WIBP"
},
{
"code": "33211000087105",
"display": "COVID-19 COVAXIN"
},
{
"code": "33221000087102",
"display": "COVID-19 mRNA CureVac"
},
{
"code": "33361000087101",
"display": "COVID-19 COMIRNATY pediatric 10 mcg/0.2 ml mRNA PB"
},
{
"code": "33391000087109",
"display": "COVID-19 Abdala"
},
{
"code": "33401000087107",
"display": "COVID-19 COVIran Barekat"
},
{
"code": "33411000087109",
"display": "COVID-19 CoviVac"
},
{
"code": "33421000087101",
"display": "COVID-19 EpiVacCorona"
},
{
"code": "33431000087104",
"display": "COVID-19 KCONVAC"
},
{
"code": "33441000087105",
"display": "COVID-19 Medgen-Dynavax-NIAID"
},
{
"code": "33451000087108",
"display": "COVID-19 QazCovid-in"
},
{
"code": "33461000087106",
"display": "COVID-19 Sputnik Light"
},
{
"code": "33471000087102",
"display": "COVID-19 ZIFIVAX"
},
{
"code": "33581000087104",
"display": "COVID-19 pediatric mRNA unspecified"
},
{
"code": "33881000087102",
"display": "COVID-19 COMIRNATY tris-sucrose 30 mcg/0.3 ml mRNA PB"
},
{
"code": "34591000087100",
"display": "COVID-19 Soberana 02"
},
{
"code": "34601000087108",
"display": "COVID-19 SpikoGen"
},
{
"code": "34611000087105",
"display": "COVID-19 COMIRNATY pediatric 3 mcg/0.2 ml mRNA PB"
},
{
"code": "34921000087108",
"display": "COVID-19 COVOVAX"
},
{
"code": "35651000087105",
"display": "COVID-19 SPIKEVAX 0.10 mg/mL mRNA Mod"
},
{
"code": "37311000087109",
"display": "COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.1) 0.10 mg/mL mRNA Mod"
},
{
"code": "37651000087101",
"display": "COVID-19 SPIKEVAX Bivalent (Original / Omicron BA.4/BA.5) 0.10 mg/mL mRNA Mod"
},
{
"code": "384671000221101",
"display": "SINOPHARM - BIBP vacuna COVID-19 [SARS-COV-2 (células Vero) inactivado 1 dosis/0,5 ml] suspensión inyectable, vial de 0,5 ml (1 dosis), Sinopharm - Beijing Institute"
},
{
"code": "399651000221108",
"display": "vacuna COVID-19 virus entero inactivado 1 dosis/0,5 ml, suspensión inyectable, vial de 0,5 ml (1 dosis)"
},
{
"code": "399661000221105",
"display": "vacuna COVID-19 vector no replicante adenovirus de chimpancé 1 dosis/0,5 ml, solución inyectable, vial de 5 ml (10 dosis)"
},
{
"code": "399681000221103",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 5 1 dosis/0,5 ml, solución inyectable, vial de 3 ml (5 dosis)"
},
{
"code": "399691000221100",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, solución inyectable, vial de 3 ml (5 dosis)"
},
{
"code": "399701000221100",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, suspensión inyectable, vial de 3 ml (5 dosis)"
},
{
"code": "399771000221108",
"display": "COVISHIELD vacuna COVID-19 [ChAdOx1 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 5 ml (10 dosis), Serum Institute of India"
},
{
"code": "399781000221106",
"display": "VAXZEVRIA vacuna COVID-19 [ChAdOx1 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 5 ml (10 dosis), Astrazeneca"
},
{
"code": "399801000221105",
"display": "SPUTNIK V vacuna COVID-19 componente I [rAd 26 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 3 ml (5 dosis), Instituto Gamaleya"
},
{
"code": "399811000221108",
"display": "SPUTNIK V vacuna COVID-19 componente II [rAd 5 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 3 ml (5 dosis), Instituto Gamaleya"
},
{
"code": "399821000221103",
"display": "JANSSEN vacuna COVID-19 [rAd 26 SARS-CoV-2 S 1 dosis/0,5 ml] suspensión inyectable, vial de 3 ml (5 dosis), Janssen"
},
{
"code": "399861000221106",
"display": "vacuna COVID-19 ARNm 100 mcg/ml, suspensión inyectable, vial de 5,5 ml (10 dosis de 0,5 ml)"
},
{
"code": "399871000221102",
"display": "vacuna COVID-19 ARNm 100 mcg/ml, suspensión inyectable, vial de 7,5 ml (15 dosis de 0,5 ml)"
},
{
"code": "399881000221104",
"display": "vacuna COVID-19 ARNm 30 mcg/0,3 ml, suspensión inyectable, vial de 0,45 ml (6 dosis de 0,3 ml luego de dilución)"
},
{
"code": "399891000221101",
"display": "SPIKEVAX vacuna COVID-19 [SARS-CoV-2 S ARNm 100 mcg/0,5 ml] suspensión inyectable, vial de 5.5 ml (10 dosis), Moderna"
},
{
"code": "399901000221102",
"display": "SPIKEVAX vacuna COVID-19 [SARS-CoV-2 S ARNm 100 mcg/0,5 ml] suspensión inyectable, vial de 7,5 ml (15 dosis de 0,5 ml), Moderna"
},
{
"code": "399911000221104",
"display": "COMIRNATY vacuna COVID-19 [SARS-CoV-2 S ARNm 30 mcg/0,3 ml] suspensión inyectable, vial de 0,45 ml (6 dosis de 0,3 ml luego de dilución), Pfizer"
},
{
"code": "424531000221101",
"display": "vacuna COVID-19 virus entero inactivado 1 dosis/0,5 ml, suspensión inyectable"
},
{
"code": "424541000221108",
"display": "vacuna COVID-19 virus entero inactivado 1 dosis/0,5 ml, suspensión inyectable, vial de 1 ml (2 dosis)"
},
{
"code": "424551000221105",
"display": "SINOPHARM - BIBP vacuna COVID-19 [SARS-COV-2 (células Vero) inactivado 1 dosis/0,5 ml] suspensión inyectable, vial de 1 ml (2 dosis), Sinopharm - Beijing Institute"
},
{
"code": "424561000221107",
"display": "vacuna COVID-19 vector no replicante adenovirus de chimpancé 1 dosis/0,5 ml, solución inyectable"
},
{
"code": "424571000221103",
"display": "VAXZEVRIA vacuna COVID-19 vector viral no replicante"
},
{
"code": "424581000221100",
"display": "COVISHIELD vacuna COVID-19 vector viral no replicante"
},
{
"code": "424591000221102",
"display": "JANSSEN vacuna COVID-19 vector viral no replicante"
},
{
"code": "424601000221107",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, suspensión inyectable"
},
{
"code": "424611000221105",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, solución inyectable, vial de 0,5 ml (1 dosis)"
},
{
"code": "424621000221100",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, solución inyectable, vial de 1 ml (2 dosis)"
},
{
"code": "424631000221102",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 26 1 dosis/0,5 ml, solución inyectable"
},
{
"code": "424641000221109",
"display": "SPUTNIK V vacuna COVID-19 componente I [rAd 26 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 0,5 ml (1 dosis), Instituto Gamaleya"
},
{
"code": "424651000221106",
"display": "SPUTNIK V vacuna COVID-19 componente I [rAd 26 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 1 ml (2 dosis), Instituto Gamaleya"
},
{
"code": "424661000221108",
"display": "SPUTNIK V vacuna COVID-19 componente II [rAd 5 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 1 ml (2 dosis), Instituto Gamaleya"
},
{
"code": "424671000221104",
"display": "SPUTNIK V vacuna COVID-19 componente II [rAd 5 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 0,5 ml (1 dosis), Instituto Gamaleya"
},
{
"code": "424681000221101",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 5 1 dosis/0,5 ml, solución inyectable, vial de 1 ml (2 dosis)"
},
{
"code": "424691000221103",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 5 1 dosis/0,5 ml, solución inyectable, vial de 0,5 ml (1 dosis)"
},
{
"code": "424701000221103",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 5 1 dosis/0,5 ml, solución inyectable"
},
{
"code": "424711000221100",
"display": "SPUTNIK V vacuna COVID-19 vector viral no replicante"
},
{
"code": "424721000221105",
"display": "vacuna COVID-19 ARNm 100 mcg/0,5 ml, suspensión inyectable"
},
{
"code": "424731000221108",
"display": "SPIKEVAX vacuna COVID-19 ARNm"
},
{
"code": "424741000221101",
"display": "vacuna COVID-19 ARNm 30 mcg/0,3 ml, suspensión inyectable"
},
{
"code": "424751000221104",
"display": "COMIRNATY vacuna COVID-19 ARNm"
},
{
"code": "424781000221109",
"display": "CONVIDECIA vacuna COVID-19 [rAd 5 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 0,5 ml, (1 dosis), Cansino"
},
{
"code": "424791000221107",
"display": "CONVIDECIA vacuna COVID-19 [rAd 5 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 1,5 ml (3 dosis), Cansino"
},
{
"code": "424801000221108",
"display": "vacuna COVID-19 vector no replicante Adenovirus humano 5 1 dosis/0,5 ml, solución inyectable, vial de 1,5 ml (3 dosis)"
},
{
"code": "424821000221101",
"display": "SPUTNIK LIGTH vacuna COVID-19 vector viral no replicante"
},
{
"code": "424831000221103",
"display": "NOVAVAX vacuna COVID-19 proteÃna de espiga recombinante"
},
{
"code": "424971000221108",
"display": "ZYDUS CADILA vacuna COVID-19 ADN"
},
{
"code": "425001000221100",
"display": "SPUTNIK V componente I vacuna COVID-19 vector viral no replicante rAd 26"
},
{
"code": "425011000221102",
"display": "SPUTNIK V componente II vacuna COVID-19 vector viral no replicante rAd 5"
},
{
"code": "425031000221105",
"display": "VAXZEVRIA vacuna COVID-19 [ChAdOx1 SARS-CoV-2 S 1 dosis/0,5 ml] solución inyectable, vial de 4 ml (8 dosis), Astrazeneca"
},
{
"code": "425051000221101",
"display": "vacuna que contiene vector adenovirus de chimpancé no replicante que codifica proteÃna de espiga de SARS-CoV-2 1 dosis/0,5 ml, solución inyectable, vial de 4 ml (8 dosis)"
},
{
"code": "62051000220105",
"display": "Janssen COVID-19 Vaccine 0.5 millilitre suspension injection Janssen Inc"
},
{
"code": "407479009",
"display": "Influenza A virus (organism)"
},
{
"code": "407480007",
"display": "Influenza B virus (organism)"
},
{
"code": "840533007",
"display": "Severe acute respiratory syndrome coronavirus 2 (organism)"
},
{
"code": "10828004",
"display": "Positive (qualifier value)"
},
{
"code": "11214006",
"display": "Reactive (qualifier value)"
},
{
"code": "125154007",
"display": "Specimen unsatisfactory for evaluation (finding)"
},
{
"code": "131194007",
"display": "Non-reactive (qualifier value)"
},
{
"code": "260373001",
"display": "Detected (qualifier value)"
},
{
"code": "260385009",
"display": "Negative (qualifier value)"
},
{
"code": "260415000",
"display": "Not detected (qualifier value)"
},
{
"code": "415684004",
"display": "Suspected (qualifier value)"
},
{
"code": "419984006",
"display": "Inconclusive (qualifier value)"
},
{
"code": "42425007",
"display": "Equivocal (qualifier value)"
},
{
"code": "455371000124106",
"display": "Invalid result (qualifier value)"
},
{
"code": "720735008",
"display": "Presumptive positive (qualifier value)"
},
{
"code": "82334004",
"display": "Indeterminate (qualifier value)"
}
]
}